Citrus Sinensis ID: 036497
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 375 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S7T8 | 391 | Serpin-ZX OS=Arabidopsis | yes | no | 0.933 | 0.895 | 0.559 | 1e-106 | |
| Q75H81 | 396 | Serpin-ZXA OS=Oryza sativ | yes | no | 0.928 | 0.878 | 0.492 | 2e-88 | |
| Q40066 | 398 | Serpin-ZX OS=Hordeum vulg | N/A | no | 0.925 | 0.871 | 0.466 | 8e-86 | |
| Q43492 | 397 | Serpin-Z7 OS=Hordeum vulg | N/A | no | 0.928 | 0.876 | 0.448 | 2e-84 | |
| P06293 | 399 | Serpin-Z4 OS=Hordeum vulg | N/A | no | 0.930 | 0.874 | 0.445 | 5e-83 | |
| Q9SIR9 | 385 | Serpin-Z10 OS=Arabidopsis | no | no | 0.912 | 0.888 | 0.465 | 1e-82 | |
| Q10GX0 | 405 | Serpin-ZXB OS=Oryza sativ | yes | no | 0.928 | 0.859 | 0.456 | 2e-82 | |
| Q9ST58 | 398 | Serpin-Z1C OS=Triticum ae | N/A | no | 0.933 | 0.879 | 0.436 | 2e-79 | |
| Q9M1T7 | 393 | Serpin-Z4 OS=Arabidopsis | no | no | 0.912 | 0.870 | 0.447 | 2e-79 | |
| Q41593 | 398 | Serpin-Z1A OS=Triticum ae | N/A | no | 0.933 | 0.879 | 0.434 | 4e-79 |
| >sp|Q9S7T8|SPZX_ARATH Serpin-ZX OS=Arabidopsis thaliana GN=At1g47710 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 384 bits (986), Expect = e-106, Method: Compositional matrix adjust.
Identities = 213/381 (55%), Positives = 264/381 (69%), Gaps = 31/381 (8%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSFL 57
DV ESIS Q ++++L+KH+ S +S P SI+V+LS+IAAGS G T Q+LSFL
Sbjct: 2 DVRESISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFL 61
Query: 58 KSKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
K S +Q N F+SE+V+ V ADGSANGGP+LSVANG WID+SLSFK +FKQ +++ YKA+
Sbjct: 62 KFSSTDQLNSFSSEIVSAVLADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAA 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
S+Q DFQ+KAVEV E+N WAEKETNG I EVLP GS D +KL+FANALYFKG WNE F
Sbjct: 122 SNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE------------ 224
D S T+E +FHLL+G + PFMTSK KQ V+A+DGFKVL LPY Q +
Sbjct: 182 DESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYLP 241
Query: 225 -----LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
L L K S GFL +HIP ++V +F+IP+FK SFG + S VLK LGL F
Sbjct: 242 DANNGLSDLLDKIVSTPGFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSPF 301
Query: 280 SRKGGRLTEMVDS-HVG-----VGIFQKSFIEVKEEGTEAAAASAAVITLKS-LPRFDKI 332
S + G LTEMV+S +G IF K+ IEV EEGTEAAAASA VI L+ L D+I
Sbjct: 302 SGEEG-LTEMVESPEMGKNLCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDEI 360
Query: 333 DFVADHPFIFMIREDATGVVL 353
DFVADHPF+ ++ E+ TGVVL
Sbjct: 361 DFVADHPFLLVVTENITGVVL 381
|
Inhibits metacaspase-9 cysteine protease. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q75H81|SPZXA_ORYSJ Serpin-ZXA OS=Oryza sativa subsp. japonica GN=Os03g0610650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 189/384 (49%), Positives = 248/384 (64%), Gaps = 36/384 (9%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSS---------SPLSIHVLLSMIAAGSKGPTLQQL 53
D+ SI+ QT L L+ + +P + SPLS+HV LS++AAG+ G T QL
Sbjct: 4 DLRVSIAHQTSFALRLAAALSSPAHPAGGAGRNVAFSPLSLHVALSLVAAGAGGATRDQL 63
Query: 54 LSFLKSKSNEQ--QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDN 111
S L + + FA +LV +V AD S GGPR++ A+GV++D SLS K TF
Sbjct: 64 ASALGGPGSAEGLHAFAEQLVQLVLADASGAGGPRVAFADGVFVDASLSLKKTFGDVAVG 123
Query: 112 IYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGV 171
YKA +H VDFQ KA EV+ ++N W EK T+G IKE+LPPGSVD +++LV NALYFKG
Sbjct: 124 KYKAETHSVDFQTKAAEVASQVNSWVEKVTSGLIKEILPPGSVDHTTRLVLGNALYFKGA 183
Query: 172 WNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYK---------- 221
W E FD+SKTK+ +FHLL+G S++ PFM++ KQ + ++D KVL LPY+
Sbjct: 184 WTEKFDASKTKDGEFHLLDGKSVQAPFMSTSKKQYILSYDNLKVLKLPYQQGGDKRQFSM 243
Query: 222 -------QDELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALG 274
QD L +L +K S+ FL+ HIP + VG F++P+FKISFG E S +LK+LG
Sbjct: 244 YILLPEAQDGLWSLAEKLNSEPEFLEKHIPTRQVTVGQFKLPKFKISFGFEASDLLKSLG 303
Query: 275 LVLSFSRKGGRLTEMVDSHVG-----VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRF 329
L L FS + LTEMVDS G +F KSF+EV EEGTEAAAA+AAVITL+S P
Sbjct: 304 LHLPFSSE-ADLTEMVDSPEGKNLFVSSVFHKSFVEVNEEGTEAAAATAAVITLRSAPIA 362
Query: 330 DKIDFVADHPFIFMIREDATGVVL 353
+ DFVADHPF+F+I+ED TGVVL
Sbjct: 363 E--DFVADHPFLFLIQEDMTGVVL 384
|
Probable serine protease inhibitor. Oryza sativa subsp. japonica (taxid: 39947) |
| >sp|Q40066|SPZX_HORVU Serpin-ZX OS=Hordeum vulgare GN=PAZX PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (813), Expect = 8e-86, Method: Compositional matrix adjust.
Identities = 180/386 (46%), Positives = 239/386 (61%), Gaps = 39/386 (10%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSS--------SPLSIHVLLSMIAAGSKGPTLQQLL 54
D+ SI+ QT + L+ I +P+ + SPLS+HV LS++AAG+ T QL
Sbjct: 5 DIRLSIAHQTRFAVRLASAISSPSHAKGSSGNAAFSPLSLHVALSLVAAGAAA-TRDQLA 63
Query: 55 SFL----KSKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVD 110
+ L K + A ++V +V AD S GGPR S AN V++D SL K +FK V
Sbjct: 64 ATLGAAEKGDAEGLHALAEQVVQVVLADASGAGGPR-SFAN-VFVDSSLKLKPSFKDLVV 121
Query: 111 NIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKG 170
YK + VDFQ KA EV+ ++N W EK T G IKE+LP GSVD +++LV NALYFKG
Sbjct: 122 GKYKGETQSVDFQTKAPEVAGQVNSWVEKITTGLIKEILPAGSVDSTTRLVLGNALYFKG 181
Query: 171 VWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYK--------- 221
W E FD+SKTK+ FHLL+G S++ PFM+S KQ ++++D KVL LPY+
Sbjct: 182 SWTEKFDASKTKDEKFHLLDGSSVQTPFMSSTKKQYISSYDSLKVLKLPYQQGGDKRQFS 241
Query: 222 --------QDELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKAL 273
QD L L K ++ F++ H+P + + VG F++P+FKISFG E S +LK L
Sbjct: 242 MYILLPEAQDGLWNLANKLSTEPEFMEKHMPMQKVPVGQFKLPKFKISFGFEASDMLKGL 301
Query: 274 GLVLSFSRKGGRLTEMVDSHVG-----VGIFQKSFIEVKEEGTEAAAASAAVITLKSLP- 327
GL L FS + L+EMVDS +F KSF+EV EEGTEAAA +A V+TL+SLP
Sbjct: 302 GLQLPFSSE-ADLSEMVDSPAARSLYVSSVFHKSFVEVNEEGTEAAARTARVVTLRSLPV 360
Query: 328 RFDKIDFVADHPFIFMIREDATGVVL 353
K+DFVADHPF+F+IRED TGVVL
Sbjct: 361 EPVKVDFVADHPFLFLIREDLTGVVL 386
|
Inhibits chymotrypsin, cathepsin G and trypsin in vitro. Hordeum vulgare (taxid: 4513) |
| >sp|Q43492|BSZ7_HORVU Serpin-Z7 OS=Hordeum vulgare GN=PAZ7 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 171/381 (44%), Positives = 246/381 (64%), Gaps = 33/381 (8%)
Query: 3 DVLESISEQTDITLSLSKHIKA-PTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSF 56
D+ SI+ QT L L+ I + P S++ SP+S+HV LS++AAG++G T QL++
Sbjct: 8 DLRLSIAHQTRFGLRLASAISSDPESAATNVAFSPVSLHVALSLVAAGARGATRDQLVAV 67
Query: 57 LKSKSNEQ----QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNI 112
L + Q+ A ++V V AD S N GPR++ ANGV++D SLS K +F++
Sbjct: 68 LGGGGAGEAEALQSLAEQVVQFVLADASINSGPRIAFANGVFVDASLSLKPSFQELAVCN 127
Query: 113 YKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVW 172
YK+ VDF+ KA E + ++N W + T G I+E+LP GS+D++++LV NALYFKG+W
Sbjct: 128 YKSEVQSVDFKTKAPEAASQVNSWVKNVTAGLIEEILPAGSIDNTTRLVLGNALYFKGLW 187
Query: 173 NEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYK----------- 221
+ FD SKTK DFHLLNG +++ PFM+S NKQ +++ DG KVL LPY+
Sbjct: 188 TKKFDESKTKYDDFHLLNGSTVQTPFMSSTNKQYLSSSDGLKVLKLPYQHGGDNRQFSMY 247
Query: 222 ------QDELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGL 275
D L L +K ++ FL++ IP E +EVG F +P+FKISFG E +++LK LGL
Sbjct: 248 ILLPEAHDGLSRLAQKLSTEPDFLENRIPTEEVEVGQFMLPKFKISFGFEANKLLKTLGL 307
Query: 276 VLSFSRKGGRLTEMVDSHVGV---GIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKI 332
L FS + L+EMV+S +G+ +F K+F+EV EEGT+A AA+ VI +SLP ++
Sbjct: 308 QLPFSLE-ANLSEMVNSPMGLYISSVFHKTFVEVDEEGTKAGAATGDVIVDRSLPI--RM 364
Query: 333 DFVADHPFIFMIREDATGVVL 353
DFVA+HPF+F+IRED GVVL
Sbjct: 365 DFVANHPFLFLIREDIAGVVL 385
|
Inhibits chymotrypsin in vitro. Hordeum vulgare (taxid: 4513) |
| >sp|P06293|SPZ4_HORVU Serpin-Z4 OS=Hordeum vulgare GN=PAZ1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 308 bits (788), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 170/382 (44%), Positives = 240/382 (62%), Gaps = 33/382 (8%)
Query: 3 DVLESISEQTDITLSLSKHIKA-PTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSF 56
DV SI+ QT L L I + P ++ SPLS+HV LS+I AG+ T QL++
Sbjct: 8 DVRLSIAHQTRFALRLRSAISSNPERAAGNVAFSPLSLHVALSLITAGAAA-TRDQLVAI 66
Query: 57 L----KSKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNI 112
L + E A ++V V A+ S+ GGPR++ ANG+++D SLS K +F++
Sbjct: 67 LGDGGAGDAKELNALAEQVVQFVLANESSTGGPRIAFANGIFVDASLSLKPSFEELAVCQ 126
Query: 113 YKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVW 172
YKA + VDFQ+K +E ++N W E+ T G IK++LPPGSVD+++KL+ NALYFKG W
Sbjct: 127 YKAKTQSVDFQHKTLEAVGQVNSWVEQVTTGLIKQILPPGSVDNTTKLILGNALYFKGAW 186
Query: 173 NEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPY------------ 220
++ FD S TK FHLL+G SI+ FM+S KQ +++ D KVL LPY
Sbjct: 187 DQKFDESNTKCDSFHLLDGSSIQTQFMSSTKKQYISSSDNLKVLKLPYAKGHDKRQFSMY 246
Query: 221 -----KQDELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGL 275
QD L +L K+ ++ F+++HIP + +EVG F++P+FKIS+ E S +L+ALGL
Sbjct: 247 ILLPGAQDGLWSLAKRLSTEPEFIENHIPKQTVEVGRFQLPKFKISYQFEASSLLRALGL 306
Query: 276 VLSFSRKGGRLTEMVDSHVGVGI---FQKSFIEVKEEGTEAAAASAAVITLKSLP-RFDK 331
L FS + L+EMVDS G+ I F KSF+EV EEGTEA AA+ A+ S+P + D
Sbjct: 307 QLPFSEE-ADLSEMVDSSQGLEISHVFHKSFVEVNEEGTEAGAATVAMGVAMSMPLKVDL 365
Query: 332 IDFVADHPFIFMIREDATGVVL 353
+DFVA+HPF+F+IRED GVV+
Sbjct: 366 VDFVANHPFLFLIREDIAGVVV 387
|
A major component of the endosperm albumin, this protein acts as a storage protein during grain filling, contributing a substantial part of the grain's lysine. May have an inhibitory function during filling or germination. Inhibits cathepsin G in vitro. Hordeum vulgare (taxid: 4513) |
| >sp|Q9SIR9|SPZ10_ARATH Serpin-Z10 OS=Arabidopsis thaliana GN=At2g25240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 175/376 (46%), Positives = 229/376 (60%), Gaps = 34/376 (9%)
Query: 6 ESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSFLKSK 60
+SI D+ + L+KH+ A ++ S P+SI+VLLS+IAAGS T +Q+LSFL
Sbjct: 5 KSIENHNDVVVRLTKHVIATVANGSNLVFSPISINVLLSLIAAGSCSVTKEQILSFLMLP 64
Query: 61 SNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQV 120
S + N ++A + G+ RLS+ANGVWID+ S K +FK ++N YKA+ QV
Sbjct: 65 STDHLNL---VLAQIIDGGTEKSDLRLSIANGVWIDKFFSLKLSFKDLLENSYKATCSQV 121
Query: 121 DFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD--SSKLVFANALYFKGVWNEAFDS 178
DF +K EV E+N WAE TNG IK++L S+D SS LV ANA+YFKG W+ FD+
Sbjct: 122 DFASKPSEVIDEVNTWAEVHTNGLIKQILSRDSIDTIRSSTLVLANAVYFKGAWSSKFDA 181
Query: 179 SKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE-------------- 224
+ TK+ DFHLL+G S+KVPFMT+ Q + ++DGFKVL LPY +D+
Sbjct: 182 NMTKKNDFHLLDGTSVKVPFMTNYEDQYLRSYDGFKVLRLPYIEDQRQFSMYIYLPNDKE 241
Query: 225 -LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG 283
L L +K GS+ F +HIP I VG FRIP+FK SF S VLK +GL F+ G
Sbjct: 242 GLAPLLEKIGSEPSFFDNHIPLHCISVGAFRIPKFKFSFEFNASEVLKDMGLTSPFNNGG 301
Query: 284 GRLTEMVDSHVG------VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
G LTEMVDS I K+ IEV EEGTEAAA S V++ S R DFVAD
Sbjct: 302 G-LTEMVDSPSNGDDLYVSSILHKACIEVDEEGTEAAAVSVGVVSCTSFRR--NPDFVAD 358
Query: 338 HPFIFMIREDATGVVL 353
PF+F +RED +GV+L
Sbjct: 359 RPFLFTVREDKSGVIL 374
|
Probable serine protease inhibitor. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q10GX0|SPZXB_ORYSJ Serpin-ZXB OS=Oryza sativa subsp. japonica GN=Os03g0610800 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 179/392 (45%), Positives = 240/392 (61%), Gaps = 44/392 (11%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSS---------------SPLSIHVLLSMIAAGSKG 47
D+ SI+ QT L+ + +P + SPLS+HV LS++AAG+ G
Sbjct: 7 DLRVSIAHQTRFAFRLAAALSSPRAHPAAGGAAGAGGSNVAFSPLSLHVALSLVAAGAGG 66
Query: 48 PTLQQLLSFL----KSKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKN 103
T QL+S L + + FA ++V +V AD S GGPR++ A+GV+ID SLS
Sbjct: 67 ATRDQLVSLLGVPGRGTAEGLHAFAEQVVQLVLADSSPAGGPRVAFADGVFIDSSLSLMK 126
Query: 104 TFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFA 163
+FK YKA +H VDFQ KA EV+ ++N W ++ T+G IKE+LPPGSVD +++LV
Sbjct: 127 SFKDVAVGKYKAETHSVDFQTKAAEVASQVNSWVDRVTSGLIKEILPPGSVDHTTRLVLG 186
Query: 164 NALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYK-- 221
NALYFKG W E FD+SKTK+ +F LL+G S+ PFM++ KQ ++++D KVL LPY+
Sbjct: 187 NALYFKGAWTEKFDASKTKDGEFRLLDGKSVLAPFMSTSKKQYLSSYDSLKVLKLPYQKG 246
Query: 222 ---------------QDELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEV 266
QD L +L K S+ FL+ IP + VG F++P+FKISFG E
Sbjct: 247 RDLRQFSMYILLPEAQDGLWSLAAKLNSEPEFLEKRIPTRQVTVGKFKLPKFKISFGFEA 306
Query: 267 SRVLKALGLVLSFSRKGGRLTEMVDSH-----VGVGIFQKSFIEVKEEGTEAAAASAAVI 321
S +LK LGL L FS K LT MV S +F KSF++V EEGTEAAAASAAV+
Sbjct: 307 SDLLKILGLQLPFSSKAD-LTGMVGSPERHNLFVSSLFHKSFVQVDEEGTEAAAASAAVV 365
Query: 322 TLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
+ +S P +DFVADHPF+F+IRED TGVVL
Sbjct: 366 SFRSAPV--TVDFVADHPFLFLIREDMTGVVL 395
|
Probable serine protease inhibitor. Oryza sativa subsp. japonica (taxid: 39947) |
| >sp|Q9ST58|SPZ1C_WHEAT Serpin-Z1C OS=Triticum aestivum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 166/380 (43%), Positives = 237/380 (62%), Gaps = 30/380 (7%)
Query: 3 DVLESISEQTDITLSLSKHIKA-PTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSF 56
DV SI+ QT L L+ I + P S++S P+S+HV LS++AAG+ T QL++
Sbjct: 8 DVRLSIAHQTRFALRLASTISSNPKSAASNAVFSPVSLHVALSLLAAGAGSATRDQLVAT 67
Query: 57 LKSKSNEQ-QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKA 115
L + E A ++V V AD S+ GGP ++ ANGV++D SL K +F++ YKA
Sbjct: 68 LGTGEVEGLHALAEQVVQFVLADASSAGGPHVAFANGVFVDASLPLKPSFQELAVCKYKA 127
Query: 116 SSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEA 175
+ VDFQ KA EV+ ++N W EK T+G IK++LP GSVD+++KLV ANALYFKG W +
Sbjct: 128 DTQSVDFQTKAAEVATQVNSWVEKVTSGRIKDILPSGSVDNTTKLVLANALYFKGAWTDQ 187
Query: 176 FDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQD------------ 223
FDSS TK F+L +G S++ PFM+S + Q +++ DG KVL LPYKQ
Sbjct: 188 FDSSGTKNDYFYLPDGSSVQTPFMSSMDDQYLSSSDGLKVLKLPYKQGGDKRQFSMYILL 247
Query: 224 -ELPA----LEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLS 278
E P L +K ++ FL+ HIP + + + F++P+FKISF E S +LK LGL L
Sbjct: 248 PEAPGGLSNLAEKLSAEPDFLERHIPRQRVALRQFKLPKFKISFETEASDLLKCLGLQLP 307
Query: 279 FSRKGGRLTEMVDSHVGVG-----IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKID 333
FS + +EMVDS + G +F ++F+EV E+GTEAAA++A + L +D
Sbjct: 308 FSNEAD-FSEMVDSPMAHGLRVSSVFHQAFVEVNEQGTEAAASTAIKMALLQARPPSVMD 366
Query: 334 FVADHPFIFMIREDATGVVL 353
F+ADHPF+F++RED +GVVL
Sbjct: 367 FIADHPFLFLLREDISGVVL 386
|
Inhibits chymotrypsin and cathepsin G in vitro. Triticum aestivum (taxid: 4565) |
| >sp|Q9M1T7|SPZ4_ARATH Serpin-Z4 OS=Arabidopsis thaliana GN=At3g45220 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 172/384 (44%), Positives = 234/384 (60%), Gaps = 42/384 (10%)
Query: 6 ESISEQTDITLSLSKHIKAPTSSS------SPLSIHVLLSMIAAGSKGPTLQQLLSFLKS 59
+S+ QTD+ + L+KH+ PT ++ SP+SI+VLL +IAAGS T +Q+LSF+
Sbjct: 5 KSMENQTDVMVLLAKHV-IPTVANGSNLVFSPMSINVLLCLIAAGSNCVTKEQILSFIML 63
Query: 60 KSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSH 118
S++ N ++ V++ DG LS A GVWID+SLSFK +FK ++N Y A+ +
Sbjct: 64 PSSDYLNAVLAKTVSVALNDGMERSDLHLSTAYGVWIDKSLSFKPSFKDLLENSYNATCN 123
Query: 119 QVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD--SSKLVFANALYFKGVWNEAF 176
QVDF K EV E+N WAE TNG IKE+L S+ S L+ ANA+YFKG W++ F
Sbjct: 124 QVDFATKPAEVINEVNAWAEVHTNGLIKEILSDDSIKTIRESMLILANAVYFKGAWSKKF 183
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE------------ 224
D+ TK YDFHLL+G +KVPFMT+ KQ + +DGFKVL LPY +D+
Sbjct: 184 DAKLTKSYDFHLLDGTMVKVPFMTNYKKQYLEYYDGFKVLRLPYVEDQRQFAMYIYLPND 243
Query: 225 ---LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSR 281
LP L ++ S+ FL +HIP + I F+IP+FK SF + S VLK +GL L F+
Sbjct: 244 RDGLPTLLEEISSKPRFLDNHIPRQRILTEAFKIPKFKFSFEFKASDVLKEMGLTLPFTH 303
Query: 282 KGGRLTEMVDS-----HVGVG-------IFQKSFIEVKEEGTEAAAASAAVITLKSLPRF 329
G LTEMV+S ++ V +F K+ IEV EEGTEAAA S A +T L
Sbjct: 304 --GSLTEMVESPSIPENLCVAENLFVSNVFHKACIEVDEEGTEAAAVSVASMTKDMLLMG 361
Query: 330 DKIDFVADHPFIFMIREDATGVVL 353
DFVADHPF+F +RE+ +GV+L
Sbjct: 362 ---DFVADHPFLFTVREEKSGVIL 382
|
Probable serine protease inhibitor. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q41593|SPZ1A_WHEAT Serpin-Z1A OS=Triticum aestivum GN=WZCI PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 165/380 (43%), Positives = 236/380 (62%), Gaps = 30/380 (7%)
Query: 3 DVLESISEQTDITLSLSKHIKA-PTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSF 56
DV SI+ QT L L+ I + P S++S P+S++ LS++AAG+ T QL++
Sbjct: 8 DVRLSIAHQTRFALRLASTISSNPKSAASNAAFSPVSLYSALSLLAAGAGSATRDQLVAT 67
Query: 57 LKSKSNEQ-QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKA 115
L + E A ++V V AD S+ GG ANGV++D SL K +F++ YKA
Sbjct: 68 LGTGKVEGLHALAEQVVQFVLADASSTGGSACRFANGVFVDASLLLKPSFQEIAVCKYKA 127
Query: 116 SSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEA 175
+ VDFQ KA EV+ ++N W EK T+G IK++LPPGS+D+++KLV ANALYFKG W E
Sbjct: 128 ETQSVDFQTKAAEVTTQVNSWVEKVTSGRIKDILPPGSIDNTTKLVLANALYFKGAWTEQ 187
Query: 176 FDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQD------------ 223
FDS TK F+LL+G S++ PFM+S + Q + + DG KVL LPYKQ
Sbjct: 188 FDSYGTKNDYFYLLDGSSVQTPFMSSMDDQYLLSSDGLKVLKLPYKQGGDNRQFFMYILL 247
Query: 224 -ELP----ALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLS 278
E P +L +K ++ FL+ HIP + + + F++P+FKISFGIE S +LK LGL L
Sbjct: 248 PEAPGGLSSLAEKLSAEPDFLERHIPRQRVALRQFKLPKFKISFGIEASDLLKCLGLQLP 307
Query: 279 FSRKGGRLTEMVDSHVGVG-----IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKID 333
F + +EMVDS + G +F ++F+EV E+GTEAAA++A + L+ +D
Sbjct: 308 FGDEAD-FSEMVDSLMPQGLRVSSVFHQAFVEVNEQGTEAAASTAIKMVLQQARPPSVMD 366
Query: 334 FVADHPFIFMIREDATGVVL 353
F+ADHPF+F++RED +GVVL
Sbjct: 367 FIADHPFLFLVREDISGVVL 386
|
Inhibits chymotrypsin and cathepsin G in vitro. Triticum aestivum (taxid: 4565) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 375 | ||||||
| 26224736 | 389 | serpin-like protein, partial [Citrus x p | 0.933 | 0.899 | 0.701 | 1e-140 | |
| 255538432 | 391 | Protein Z, putative [Ricinus communis] g | 0.933 | 0.895 | 0.641 | 1e-128 | |
| 147810055 | 389 | hypothetical protein VITISV_021647 [Viti | 0.930 | 0.897 | 0.609 | 1e-120 | |
| 359492076 | 445 | PREDICTED: serpin-ZX [Vitis vinifera] | 0.922 | 0.777 | 0.611 | 1e-120 | |
| 356510338 | 389 | PREDICTED: serpin-ZX-like [Glycine max] | 0.930 | 0.897 | 0.617 | 1e-116 | |
| 449470035 | 389 | PREDICTED: serpin-ZX-like [Cucumis sativ | 0.930 | 0.897 | 0.598 | 1e-115 | |
| 58416137 | 389 | serpin [Cucumis sativus] | 0.930 | 0.897 | 0.598 | 1e-115 | |
| 224136672 | 391 | predicted protein [Populus trichocarpa] | 0.933 | 0.895 | 0.604 | 1e-113 | |
| 356519136 | 389 | PREDICTED: serpin-ZX-like [Glycine max] | 0.930 | 0.897 | 0.606 | 1e-110 | |
| 297846998 | 391 | hypothetical protein ARALYDRAFT_891566 [ | 0.933 | 0.895 | 0.559 | 1e-106 |
| >gi|26224736|gb|AAN76362.1| serpin-like protein, partial [Citrus x paradisi] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1296), Expect = e-140, Method: Compositional matrix adjust.
Identities = 265/378 (70%), Positives = 300/378 (79%), Gaps = 28/378 (7%)
Query: 4 VLESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSFLK 58
V ESIS QTD+ LSL+KH+ + S P SIHVLLS+I+AGSKGPTL QLLSFLK
Sbjct: 1 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK 60
Query: 59 SKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASS 117
SKS++Q N FASELVA+VFADGS +GGPRLSVANGVWID+SLS KNTFKQ VDN+YKA+S
Sbjct: 61 SKSDDQLNTFASELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAAS 120
Query: 118 HQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFD 177
+QVD Q KA EVSRE+N WAEKETNG +KEVLPPGSVD+S++L+FANALYFKG WNE FD
Sbjct: 121 NQVDSQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFD 180
Query: 178 SSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ--------------- 222
SSKTK+YDFHLLNGGSIKVPFMTSK Q V+AFDGFKVL LPYKQ
Sbjct: 181 SSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPD 240
Query: 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFS 280
D LP L +K GS+S FL H+P + +EVGDFRIPRFKISFGIEVS+VLK LGLVL FS
Sbjct: 241 AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFS 300
Query: 281 RKGGRLTEMVDSHVG-----VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFV 335
+GG L EMVDS VG IFQKSFIEV EEGTEAAAASAA + L+S+ DKIDFV
Sbjct: 301 GEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSILLLDKIDFV 360
Query: 336 ADHPFIFMIREDATGVVL 353
ADHPF+FMIRED TG+V+
Sbjct: 361 ADHPFVFMIREDMTGLVM 378
|
Source: Citrus x paradisi Species: Citrus x paradisi Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538432|ref|XP_002510281.1| Protein Z, putative [Ricinus communis] gi|223550982|gb|EEF52468.1| Protein Z, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 466 bits (1198), Expect = e-128, Method: Compositional matrix adjust.
Identities = 243/379 (64%), Positives = 287/379 (75%), Gaps = 29/379 (7%)
Query: 3 DVLESISEQTDITLSLSKHI-----KAPTSSSSPLSIHVLLSMIAAGSKGPTLQQLLSFL 57
D+ ESI Q D+ L+LSKH+ K+ S SPLSI V+L +IAAGSKG TL QLLSFL
Sbjct: 2 DLRESIKNQIDVALTLSKHVLLGEAKSSNSVFSPLSIQVVLGIIAAGSKGATLDQLLSFL 61
Query: 58 KSKSNEQ-QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
KSKSN+Q +F+SELVA+ FADGSA GGPRLS ANGVW+D++LS K++FKQ VDN+YKA+
Sbjct: 62 KSKSNDQLSSFSSELVAVAFADGSAAGGPRLSFANGVWVDKALSLKHSFKQVVDNVYKAA 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
S+ VDFQ KAVEV+ E+N WAEKET+G IKEVLP GSVD+S++LVFANALYFKG W E F
Sbjct: 122 SNNVDFQTKAVEVANEVNAWAEKETDGLIKEVLPSGSVDNSTRLVFANALYFKGAWTEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222
D+S TK++DF+LLNG S+ PFMTSK KQ + AF+GFKVL LPY Q
Sbjct: 182 DASITKDHDFYLLNGSSVHAPFMTSKKKQFIRAFEGFKVLGLPYYQGQDKRQFSMYFFLP 241
Query: 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
D LPAL +K GS+SGFL H+P + +EVGDFRIPRF+ISFG E S LK LGLVL F
Sbjct: 242 DAKDGLPALVEKVGSESGFLDHHLPRQQVEVGDFRIPRFRISFGFEASEALKGLGLVLPF 301
Query: 280 SRKGGRLTEMVDSHVG-----VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
S + G LTEMVDS VG IF KSFIEV EEGTEAAAASA VI L+SL DKIDF
Sbjct: 302 SGE-GDLTEMVDSSVGQKLYVSSIFHKSFIEVNEEGTEAAAASAGVIKLRSLAFSDKIDF 360
Query: 335 VADHPFIFMIREDATGVVL 353
VADHPF+F+IRE+ TG+VL
Sbjct: 361 VADHPFLFLIRENMTGLVL 379
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147810055|emb|CAN78278.1| hypothetical protein VITISV_021647 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1129), Expect = e-120, Method: Compositional matrix adjust.
Identities = 231/379 (60%), Positives = 271/379 (71%), Gaps = 30/379 (7%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSFL 57
D+ + I Q D+ L ++KH+ S S PLSIHV+LS++AAGSKG TL QLLSFL
Sbjct: 2 DLRQCIGNQNDVALGIAKHVALTESKDSNLVLSPLSIHVVLSLVAAGSKGATLDQLLSFL 61
Query: 58 KSKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
KSK++ N FASELV++VFADGS +GGP LS ANGVWID++L K +FKQ VD YKA+
Sbjct: 62 KSKASGDLNAFASELVSLVFADGSPSGGPCLSFANGVWIDKTLPLKPSFKQIVDTAYKAA 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
HQ DF+ KA EV+ E N WAEKETNG IKEVLPPGSVD S++L+FANALYFKG WNE F
Sbjct: 122 VHQADFRIKAAEVTSEANSWAEKETNGLIKEVLPPGSVDSSTRLIFANALYFKGAWNEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222
D+S TK+YDFHLLNG S++VPFMTSK KQL++ FD FKVL L YKQ
Sbjct: 182 DASATKDYDFHLLNGSSVQVPFMTSKKKQLISTFDDFKVLGLSYKQGGDKRSFSMYFFLP 241
Query: 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
D L AL K GS S FL H+P + VGDFRIPRFKISFG E S+VLK LGLVL F
Sbjct: 242 DAKDGLQALIDKVGSDSAFLDRHLPSMPVPVGDFRIPRFKISFGFEASKVLKGLGLVLPF 301
Query: 280 SRKGGRLTEMVDSHVG-----VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
+ G LTEMVDS +G IF KSFIEV EEGTEAAAAS V+ L+ + D IDF
Sbjct: 302 TEGG--LTEMVDSPMGQDLYVSSIFHKSFIEVNEEGTEAAAASVGVVKLRGMLSTDNIDF 359
Query: 335 VADHPFIFMIREDATGVVL 353
+ADHPF+F+IRED TGVVL
Sbjct: 360 IADHPFLFVIREDMTGVVL 378
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492076|ref|XP_002284126.2| PREDICTED: serpin-ZX [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1122), Expect = e-120, Method: Compositional matrix adjust.
Identities = 230/376 (61%), Positives = 269/376 (71%), Gaps = 30/376 (7%)
Query: 6 ESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSFLKSK 60
+ I Q D+ L ++KH+ S S PLSIHV+LS++AAGSKG TL QLLSFLKSK
Sbjct: 61 KCIGNQNDVALGIAKHVALTESKDSNLVLSPLSIHVVLSLVAAGSKGATLDQLLSFLKSK 120
Query: 61 SNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQ 119
++ N FASELV++VFADGS +GGP LS ANGVWID++L K +FKQ VD YKA+ HQ
Sbjct: 121 ASGDLNAFASELVSLVFADGSPSGGPCLSFANGVWIDKTLPLKPSFKQIVDTAYKAAVHQ 180
Query: 120 VDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSS 179
DF+ KA EV+ E N WAEKETNG IKEVLPPGSVD S++L+FANALYFKG WNE FD+S
Sbjct: 181 ADFRIKAAEVTSEANSWAEKETNGLIKEVLPPGSVDSSTRLIFANALYFKGAWNEKFDAS 240
Query: 180 KTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ----------------- 222
TK+YDFHLLNG S++VPFMTSK KQL++ FD FKVL L YKQ
Sbjct: 241 ATKDYDFHLLNGSSVQVPFMTSKKKQLISTFDDFKVLGLSYKQGGDKRSFSMYFFLPDAK 300
Query: 223 DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRK 282
D L AL K GS S FL H+P + VGDFRIPRFKISFG E S+VLK LGLVL F+
Sbjct: 301 DGLQALIDKVGSDSAFLDRHLPSMPVPVGDFRIPRFKISFGFEASKVLKGLGLVLPFTEG 360
Query: 283 GGRLTEMVDSHVG-----VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
G LTEMVDS +G IF KSFIEV EEGTEAAAAS V+ L+ + D IDF+AD
Sbjct: 361 G--LTEMVDSPMGQDLYVSSIFHKSFIEVNEEGTEAAAASVGVVKLRGMLSTDNIDFIAD 418
Query: 338 HPFIFMIREDATGVVL 353
HPF+F+IRED TGVVL
Sbjct: 419 HPFLFVIREDMTGVVL 434
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510338|ref|XP_003523896.1| PREDICTED: serpin-ZX-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1089), Expect = e-116, Method: Compositional matrix adjust.
Identities = 234/379 (61%), Positives = 278/379 (73%), Gaps = 30/379 (7%)
Query: 3 DVLESISEQTDITLS-----LSKHIKAPTSSSSPLSIHVLLSMIAAGSKGPTLQQLLSFL 57
D+ ESIS QTD+ LS LSK+ + SPLS+HV+LS+IA+GSKGPTL QLLSFL
Sbjct: 2 DLRESISNQTDVALSITKLLLSKNARDSNLVYSPLSLHVVLSIIASGSKGPTLDQLLSFL 61
Query: 58 KSKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
+SKS + N FAS+LVA+V +D + GGPRLS A+GVW++QSLS +FKQ V YKA+
Sbjct: 62 RSKSTDHLNSFASQLVAVVLSDAAPAGGPRLSFADGVWVEQSLSLHPSFKQLVSAQYKAT 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
VDFQ KAVEV+ E+N WAEKETNG +K++LPPGSVD+S++L+FANALYFKG WNE F
Sbjct: 122 LASVDFQTKAVEVTNEVNSWAEKETNGLVKDLLPPGSVDNSTRLIFANALYFKGAWNEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222
D+S TK+YDFHLLNG S+KVPFMTSK KQ + AFD FKVL LPYKQ
Sbjct: 182 DASITKDYDFHLLNGSSVKVPFMTSKKKQFIMAFDSFKVLGLPYKQGEDKRQFTMYFFLP 241
Query: 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
D L AL +K S+SGFL+ +P + +EVGDFRIPRFKISFG EVS VLK LG+VL F
Sbjct: 242 ETKDGLLALAEKLASESGFLERKLPNQKVEVGDFRIPRFKISFGFEVSNVLKELGVVLPF 301
Query: 280 SRKGGRLTEMVDSHVG-----VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
S G LTEMVDS VG IF KSFIEV EEGTEAAAA++A I L+S KIDF
Sbjct: 302 SVGG--LTEMVDSPVGQNLCVSNIFHKSFIEVNEEGTEAAAATSATIRLRSAMLPTKIDF 359
Query: 335 VADHPFIFMIREDATGVVL 353
VADHPF+F+IRED TG VL
Sbjct: 360 VADHPFLFLIREDLTGTVL 378
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470035|ref|XP_004152724.1| PREDICTED: serpin-ZX-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1081), Expect = e-115, Method: Compositional matrix adjust.
Identities = 227/379 (59%), Positives = 274/379 (72%), Gaps = 30/379 (7%)
Query: 3 DVLESISEQTDITLSLSKHI-----KAPTSSSSPLSIHVLLSMIAAGSKGPTLQQLLSFL 57
D++E+I ++ ++++KH+ KA SPLSIHV+LS+IA+GSKGP L QLLSFL
Sbjct: 2 DIMETIRSHGEVAIAITKHLLLNEAKASNVVLSPLSIHVVLSLIASGSKGPPLDQLLSFL 61
Query: 58 KSKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
KS S + N FAS++VA VFAD S +GGPRLS ANGVW+DQSL K++FKQ VD +YKA
Sbjct: 62 KSNSTDNLNSFASQIVATVFADASPSGGPRLSFANGVWVDQSLPLKSSFKQVVDTLYKAK 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
Q DF+ KA EV+ E+N WAEK+TNG I EVLPPGSVD SKL+ ANALYFKG W E F
Sbjct: 122 LSQADFKTKAAEVTSEVNSWAEKQTNGLITEVLPPGSVDSLSKLILANALYFKGEWEEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222
D+SKTK+ DF+LL+G S++VPFMTSKNKQ + AFDGFKVL L YKQ
Sbjct: 182 DASKTKKQDFYLLDGSSVEVPFMTSKNKQRIAAFDGFKVLGLSYKQGSDPRHFSMYIFLP 241
Query: 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
D LP+L ++ SQS F+ HIPYE ++VG+F+IP+FKISFGIEVS VLK LGLVL F
Sbjct: 242 DSRDGLPSLIERLDSQSNFIDRHIPYEKLKVGEFKIPKFKISFGIEVSNVLKGLGLVLPF 301
Query: 280 SRKGGRLTEMVDSHVGVG-----IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
S G LTEMV+S IF KSFIEV EEGTEAAAASAAVI L+ LP D IDF
Sbjct: 302 SEGG--LTEMVESQTAQNLHVSKIFHKSFIEVNEEGTEAAAASAAVIKLRGLPSMDIIDF 359
Query: 335 VADHPFIFMIREDATGVVL 353
VAD PF++ IRED TG +L
Sbjct: 360 VADRPFLYAIREDKTGSLL 378
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|58416137|emb|CAI43280.1| serpin [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1079), Expect = e-115, Method: Compositional matrix adjust.
Identities = 227/379 (59%), Positives = 274/379 (72%), Gaps = 30/379 (7%)
Query: 3 DVLESISEQTDITLSLSKHI-----KAPTSSSSPLSIHVLLSMIAAGSKGPTLQQLLSFL 57
D++E+I ++ ++++KH+ KA SPLSIHV+LS+IA+GSKGP L QLLSFL
Sbjct: 2 DIMETIRSHGEVAIAITKHLLLNEAKASNVVLSPLSIHVVLSLIASGSKGPPLDQLLSFL 61
Query: 58 KSKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
KS S + N FAS++VA VFAD S +GGPRLS ANGVW+DQSL K++FKQ VD +YKA
Sbjct: 62 KSNSTDNLNSFASQIVATVFADASPSGGPRLSFANGVWVDQSLPLKSSFKQVVDTLYKAK 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
Q DF+ KA EV+ E+N WAEK+TNG I EVLPPGSVD SKL+ ANALYFKG W E F
Sbjct: 122 LSQADFKTKAAEVTSEVNSWAEKQTNGLITEVLPPGSVDSLSKLILANALYFKGEWEEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222
D+SKTK+ DF+LL+G S++VPFMTSKNKQ + AFDGFKVL L YKQ
Sbjct: 182 DASKTKKQDFYLLDGSSVEVPFMTSKNKQHIAAFDGFKVLGLSYKQGSDPRHFSMYIFLP 241
Query: 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
D LP+L ++ SQS F+ HIPYE ++VG+F+IP+FKISFGIEVS VLK LGLVL F
Sbjct: 242 DSRDGLPSLIERLDSQSNFIDRHIPYEKLKVGEFKIPKFKISFGIEVSNVLKGLGLVLPF 301
Query: 280 SRKGGRLTEMVDSHVGVG-----IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
S G LTEMV+S IF KSFIEV EEGTEAAAASAAVI L+ LP D IDF
Sbjct: 302 SEGG--LTEMVESQTAQNLHVSKIFHKSFIEVNEEGTEAAAASAAVIKLRGLPSMDIIDF 359
Query: 335 VADHPFIFMIREDATGVVL 353
VAD PF++ IRED TG +L
Sbjct: 360 VADRPFLYAIREDKTGSLL 378
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136672|ref|XP_002326917.1| predicted protein [Populus trichocarpa] gi|222835232|gb|EEE73667.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1063), Expect = e-113, Method: Compositional matrix adjust.
Identities = 229/379 (60%), Positives = 274/379 (72%), Gaps = 29/379 (7%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSFL 57
D+ +SI QTD+ LSLSK I S++S PLSI VLLS+IA+GSKG TL+QLLSFL
Sbjct: 2 DLRDSIGNQTDVALSLSKQILLTESNNSNLVFSPLSIEVLLSLIASGSKGSTLEQLLSFL 61
Query: 58 KSKSNEQQNFAS-ELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
KSKS++ + S +L+A+V DGSA+GGP+L ANGVW+D SLS K +FKQ V + YKA+
Sbjct: 62 KSKSSDHLSSFSSQLLAVVLTDGSASGGPQLKFANGVWVDNSLSLKPSFKQVVGSTYKAA 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
++QVDFQ KAVEV+ E+N WAE ETNG IKEVLP GSVD +++L+ NALYFKG WNE F
Sbjct: 122 TNQVDFQTKAVEVTNEVNTWAENETNGLIKEVLPSGSVDRTTRLILTNALYFKGAWNEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222
D+S TK+ DF+LLNGGS++VPFMTSK KQ V FDGFKVL LPYKQ
Sbjct: 182 DASTTKDDDFYLLNGGSVRVPFMTSKKKQFVCDFDGFKVLALPYKQGEDKRKFSMYFYLP 241
Query: 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
D L AL +K S+SGFL H+P + ++V DFRIPRFKISFG E S LK LGLV F
Sbjct: 242 DAKDGLQALVEKMVSESGFLDRHLPPKQVKVDDFRIPRFKISFGFEASNALKGLGLVSPF 301
Query: 280 SRKGGRLTEMVDSHVGVG-----IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
S + LTEMVDS G G IF KSFIEV EEGTEAAAASA VI L+ + KIDF
Sbjct: 302 SNE-ADLTEMVDSSAGQGLCVSSIFHKSFIEVNEEGTEAAAASAGVIALRGIDIPTKIDF 360
Query: 335 VADHPFIFMIREDATGVVL 353
VADHPF+F+IRED TGVV+
Sbjct: 361 VADHPFLFLIREDMTGVVM 379
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519136|ref|XP_003528230.1| PREDICTED: serpin-ZX-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 403 bits (1035), Expect = e-110, Method: Compositional matrix adjust.
Identities = 230/379 (60%), Positives = 272/379 (71%), Gaps = 30/379 (7%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSFL 57
D+ ESIS QTD+ LS+SK + + + SPLS+HV+LS+IAAGSKGPTL QLLSFL
Sbjct: 2 DLRESISNQTDVALSISKLLLSKEARDKNLVYSPLSLHVVLSIIAAGSKGPTLDQLLSFL 61
Query: 58 KSKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
+SKS + N FAS+L A+V +D S GGPRLS A+GVW++QSLS +FKQ V YKA+
Sbjct: 62 RSKSTDHLNSFASQLFAVVLSDASPAGGPRLSFADGVWVEQSLSLLPSFKQLVSADYKAT 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
VDFQ KAVEV+ E+N WAEKETNG +K++LPPGSVD S++L+FANALYFKG WNE F
Sbjct: 122 LASVDFQTKAVEVANEVNSWAEKETNGLVKDLLPPGSVDSSTRLIFANALYFKGAWNEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222
DSS TK+YDFHLL+G SI+VPFMTS+ Q + AFDGFKVL LPYKQ
Sbjct: 182 DSSITKDYDFHLLDGRSIRVPFMTSRKNQFIRAFDGFKVLGLPYKQGEDKRQFTMYFFLP 241
Query: 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
D L AL +K S+SGFL+ +P +EVGDFRIPRFKISFG E S VLK LG+VL F
Sbjct: 242 ETKDGLLALAEKLASESGFLERKLPNNKLEVGDFRIPRFKISFGFEASNVLKELGVVLPF 301
Query: 280 SRKGGRLTEMVDSHVGVG-----IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
S G LTEMVDS VG IF KSFIEV EEGTEAAAA+AA I +IDF
Sbjct: 302 SVGG--LTEMVDSAVGQNLFVSDIFHKSFIEVNEEGTEAAAATAATIQFGCAMFPTEIDF 359
Query: 335 VADHPFIFMIREDATGVVL 353
VADHPF+F+IRED TG VL
Sbjct: 360 VADHPFLFLIREDLTGTVL 378
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297846998|ref|XP_002891380.1| hypothetical protein ARALYDRAFT_891566 [Arabidopsis lyrata subsp. lyrata] gi|297337222|gb|EFH67639.1| hypothetical protein ARALYDRAFT_891566 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1002), Expect = e-106, Method: Compositional matrix adjust.
Identities = 213/381 (55%), Positives = 267/381 (70%), Gaps = 31/381 (8%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTLQQLLSFL 57
DV ESIS Q ++++L+KH+ S +S P SI+V+LS+IAAGS G T Q+LSFL
Sbjct: 2 DVRESISMQNQVSMNLAKHVITTVSKNSNVVFSPASINVILSIIAAGSTGSTKDQILSFL 61
Query: 58 KSKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
K S +Q N F+S++V+ V ADGSANGGP+LSVANGVWID+SLSF +FK+ +++ YKA+
Sbjct: 62 KFSSTDQLNSFSSDIVSAVLADGSANGGPKLSVANGVWIDKSLSFNLSFKKLLEDSYKAA 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
S+Q DFQ+KAVEV+ E+N WAEKETNG I EVLP G+ D +KL+FANALYFKG WNE F
Sbjct: 122 SNQADFQSKAVEVTAEVNSWAEKETNGLITEVLPEGAADSMTKLIFANALYFKGTWNEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE------------ 224
D S TKE DFHLL+G + PFMTSK KQ V+A+DGFKVL LPY Q +
Sbjct: 182 DESLTKEDDFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYIYLP 241
Query: 225 -----LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
L L +K S GF+ HIP ++VG+F+IP+FK SFG + S VLK LGL F
Sbjct: 242 DANTGLSDLLEKIVSTPGFIDSHIPRRQVKVGEFKIPKFKFSFGFDASNVLKGLGLTSPF 301
Query: 280 SRKGGRLTEMVDS-----HVGV-GIFQKSFIEVKEEGTEAAAASAAVITLKSL-PRFDKI 332
S + G LTEMV+S H+ V IF K+ IEV EEGTEAAAASA VI L+ L D+I
Sbjct: 302 SGEDG-LTEMVESPEMGKHLCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLVMEEDEI 360
Query: 333 DFVADHPFIFMIREDATGVVL 353
DFVADHPF+ +I E+ TGV+L
Sbjct: 361 DFVADHPFLLVITENITGVIL 381
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 375 | ||||||
| TAIR|locus:2015443 | 391 | SERPIN1 "AT1G47710" [Arabidops | 0.626 | 0.601 | 0.559 | 4.1e-65 | |
| TAIR|locus:2059585 | 385 | CCP3 "AT2G25240" [Arabidopsis | 0.754 | 0.735 | 0.449 | 1.2e-58 | |
| TAIR|locus:2055185 | 407 | SRP2 "AT2G14540" [Arabidopsis | 0.914 | 0.842 | 0.383 | 1.1e-57 | |
| TAIR|locus:2096910 | 393 | AT3G45220 "AT3G45220" [Arabido | 0.757 | 0.722 | 0.434 | 5.9e-57 | |
| UNIPROTKB|Q94DW6 | 411 | LOC_Os01g56010 "Serpin-Z1" [Or | 0.581 | 0.530 | 0.350 | 6.9e-55 | |
| TAIR|locus:2024532 | 385 | SRP3 "AT1G64030" [Arabidopsis | 0.912 | 0.888 | 0.369 | 4.4e-52 | |
| TAIR|locus:2066316 | 389 | AT2G26390 "AT2G26390" [Arabido | 0.752 | 0.724 | 0.410 | 1.5e-49 | |
| TAIR|locus:2062400 | 374 | AT2G35580 "AT2G35580" [Arabido | 0.904 | 0.906 | 0.358 | 6.9e-47 | |
| UNIPROTKB|Q10GX0 | 405 | LOC_Os03g41438 "Serpin-ZXB" [O | 0.514 | 0.476 | 0.477 | 3e-46 | |
| UNIPROTKB|Q5NBM0 | 423 | LOC_Os01g16200 "Putative serpi | 0.501 | 0.444 | 0.345 | 2.5e-41 |
| TAIR|locus:2015443 SERPIN1 "AT1G47710" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 4.1e-65, P = 4.1e-65
Identities = 137/245 (55%), Positives = 173/245 (70%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTXXXXXXXX 57
DV ESIS Q ++++L+KH+ S +S P SI+V+LS+IAAGS G T
Sbjct: 2 DVRESISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFL 61
Query: 58 XXXXNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
+Q N F+SE+V+ V ADGSANGGP+LSVANG WID+SLSFK +FKQ +++ YKA+
Sbjct: 62 KFSSTDQLNSFSSEIVSAVLADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAA 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
S+Q DFQ+KAVEV E+N WAEKETNG I EVLP GS D +KL+FANALYFKG WNE F
Sbjct: 122 SNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEKF 181
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDELPALEKKTGSQS 236
D S T+E +FHLL+G + PFMTSK KQ V+A+DGFKVL LPY Q + +K+ S
Sbjct: 182 DESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQ----DKRQFSMY 237
Query: 237 GFLKD 241
+L D
Sbjct: 238 FYLPD 242
|
|
| TAIR|locus:2059585 CCP3 "AT2G25240" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 1.2e-58, P = 1.2e-58
Identities = 139/309 (44%), Positives = 184/309 (59%)
Query: 6 ESISEQTDITLSLSKHIKAPTSSSS-----PLSIHVLLSMIAAGSKGPTXXXXXXXXXXX 60
+SI D+ + L+KH+ A ++ S P+SI+VLLS+IAAGS T
Sbjct: 5 KSIENHNDVVVRLTKHVIATVANGSNLVFSPISINVLLSLIAAGSCSVTKEQILSFLMLP 64
Query: 61 XNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQV 120
+ N ++A + G+ RLS+ANGVWID+ S K +FK ++N YKA+ QV
Sbjct: 65 STDHLNL---VLAQIIDGGTEKSDLRLSIANGVWIDKFFSLKLSFKDLLENSYKATCSQV 121
Query: 121 DFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD--SSKLVFANALYFKGVWNEAFDS 178
DF +K EV E+N WAE TNG IK++L S+D SS LV ANA+YFKG W+ FD+
Sbjct: 122 DFASKPSEVIDEVNTWAEVHTNGLIKQILSRDSIDTIRSSTLVLANAVYFKGAWSSKFDA 181
Query: 179 SKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE--------LP---- 226
+ TK+ DFHLL+G S+KVPFMT+ Q + ++DGFKVL LPY +D+ LP
Sbjct: 182 NMTKKNDFHLLDGTSVKVPFMTNYEDQYLRSYDGFKVLRLPYIEDQRQFSMYIYLPNDKE 241
Query: 227 ---ALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG 283
L +K GS+ F +HIP I VG FRIP+FK SF S VLK +GL F+ G
Sbjct: 242 GLAPLLEKIGSEPSFFDNHIPLHCISVGAFRIPKFKFSFEFNASEVLKDMGLTSPFNNGG 301
Query: 284 GRLTEMVDS 292
G LTEMVDS
Sbjct: 302 G-LTEMVDS 309
|
|
| TAIR|locus:2055185 SRP2 "AT2G14540" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 593 (213.8 bits), Expect = 1.1e-57, P = 1.1e-57
Identities = 141/368 (38%), Positives = 205/368 (55%)
Query: 3 DVLESISEQTDITLSL-SKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTXXXXXXXX 57
D+ E++ Q +++L L K I A +S SP SI+ +L++ AA + T
Sbjct: 30 DMQEAMKNQNEVSLLLVGKVISAVAKNSNCVFSPASINAVLTVTAANTDNKTLRSFILSF 89
Query: 58 XXXXNEQQNFA--SELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKA 115
+ ++ A EL ++VF DGS GGP+++ NGVW++QSLS ++ N +KA
Sbjct: 90 LKSSSTEETNAIFHELASVVFKDGSETGGPKIAAVNGVWMEQSLSCNPDWEDLFLNFFKA 149
Query: 116 SSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEA 175
S +VDF++KA EV ++N WA + TN IKE+LP GSV + ++ NALYFKG W +A
Sbjct: 150 SFAKVDFRHKAEEVRLDVNTWASRHTNDLIKEILPRGSVTSLTNWIYGNALYFKGAWEKA 209
Query: 176 FDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ--DELP---ALEK 230
FD S T++ FHLLNG S+ VPFM S KQ + A+DGFKVL LPY+Q D+ ++
Sbjct: 210 FDKSMTRDKPFHLLNGKSVSVPFMRSYEKQFIEAYDGFKVLRLPYRQGRDDTNREFSMYL 269
Query: 231 KTGSQSGFLKDHIPYEMIEVG--DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTE 288
+ G L + + G D IP +++ G R+ K + F + +
Sbjct: 270 YLPDKKGELDNLLERITSNPGFLDSHIPEYRVDVGD--FRIPK---FKIEFGFEASSVFN 324
Query: 289 MVDSHVGVGIFQKSFIEVKEEGTEXXXXXXXVITLKSL---PRFDKIDFVADHPFIFMIR 345
D + V + QK+ IE+ EEGTE V+ S P+ KIDFVADHPF+F+IR
Sbjct: 325 --DFELNVSLHQKALIEIDEEGTEAAAATTVVVVTGSCLWEPK-KKIDFVADHPFLFLIR 381
Query: 346 EDATGVVL 353
ED TG +L
Sbjct: 382 EDKTGTLL 389
|
|
| TAIR|locus:2096910 AT3G45220 "AT3G45220" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 5.9e-57, P = 5.9e-57
Identities = 135/311 (43%), Positives = 184/311 (59%)
Query: 6 ESISEQTDITLSLSKHIKAPTSSS------SPLSIHVLLSMIAAGSKGPTXXXXXXXXXX 59
+S+ QTD+ + L+KH+ PT ++ SP+SI+VLL +IAAGS T
Sbjct: 5 KSMENQTDVMVLLAKHV-IPTVANGSNLVFSPMSINVLLCLIAAGSNCVTKEQILSFIML 63
Query: 60 XXNEQQNFA-SELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSH 118
++ N ++ V++ DG LS A GVWID+SLSFK +FK ++N Y A+ +
Sbjct: 64 PSSDYLNAVLAKTVSVALNDGMERSDLHLSTAYGVWIDKSLSFKPSFKDLLENSYNATCN 123
Query: 119 QVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD--SSKLVFANALYFKGVWNEAF 176
QVDF K EV E+N WAE TNG IKE+L S+ S L+ ANA+YFKG W++ F
Sbjct: 124 QVDFATKPAEVINEVNAWAEVHTNGLIKEILSDDSIKTIRESMLILANAVYFKGAWSKKF 183
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE------------ 224
D+ TK YDFHLL+G +KVPFMT+ KQ + +DGFKVL LPY +D+
Sbjct: 184 DAKLTKSYDFHLLDGTMVKVPFMTNYKKQYLEYYDGFKVLRLPYVEDQRQFAMYIYLPND 243
Query: 225 ---LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSR 281
LP L ++ S+ FL +HIP + I F+IP+FK SF + S VLK +GL L F+
Sbjct: 244 RDGLPTLLEEISSKPRFLDNHIPRQRILTEAFKIPKFKFSFEFKASDVLKEMGLTLPFTH 303
Query: 282 KGGRLTEMVDS 292
G LTEMV+S
Sbjct: 304 --GSLTEMVES 312
|
|
| UNIPROTKB|Q94DW6 LOC_Os01g56010 "Serpin-Z1" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 358 (131.1 bits), Expect = 6.9e-55, Sum P(2) = 6.9e-55
Identities = 81/231 (35%), Positives = 121/231 (52%)
Query: 3 DVLESISEQTDITLSLSKHI-KAPTSSS-------SPLSIHVLLSMIAAGSKGPTXXXXX 54
++ E++ ++T + + L H+ +AP SPLS+H L+++ AG++G T
Sbjct: 2 ELAEAVRDETAMAMRLLGHLARAPRGGGGDKNLAVSPLSLHAALALLGAGARGETLDQII 61
Query: 55 XXXXXXXNEQQN-FASELVAIVFAD----GSANGGPRLSVANGVWIDQSLSFKNTFKQTV 109
AS + AD G GGP++ ANGVW+D +L K + + V
Sbjct: 62 AFLGPAGGPAHAALASHVALCSLADDSGPGDDRGGPKVRFANGVWVDAALRLKAAYARVV 121
Query: 110 DNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFK 169
+ Y+A + V F++K E REIN W E T G IK+ LP +VD ++ V NALYFK
Sbjct: 122 ADKYRAEARPVSFRDKLEEARREINEWFESATAGRIKDFLPKDAVDRATPAVLGNALYFK 181
Query: 170 GVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPY 220
G W FD+ T + F+L +GG + PFM+S Q + G+KVL LPY
Sbjct: 182 GDWESKFDARSTSDDVFYLPDGGHVSAPFMSSGKWQYIACRAGYKVLRLPY 232
|
|
| TAIR|locus:2024532 SRP3 "AT1G64030" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 4.4e-52, P = 4.4e-52
Identities = 137/371 (36%), Positives = 201/371 (54%)
Query: 3 DVLESISEQTDITLSLSKHI--KAPTSSS---SPLSIHVLLSMIAAGSKGP--TXXXXXX 55
DV E++ QT + + LS H+ AP S+ SP SI+ ++M AAG G +
Sbjct: 2 DVREAMKNQTHVAMILSGHVLSSAPKDSNVIFSPASINSAITMHAAGPGGDLVSGQILSF 61
Query: 56 XXXXXXNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKA 115
+E + EL ++V+AD SA GGP+++ ANG+WID+SL FK +N +KA
Sbjct: 62 LRSSSIDELKTVFRELASVVYADRSATGGPKITAANGLWIDKSLPTDPKFKDLFENFFKA 121
Query: 116 SSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEA 175
VDF+++A EV +E+N W E TN IK++LP GSV + ++ANAL FKG W
Sbjct: 122 VYVPVDFRSEAEEVRKEVNSWVEHHTNNLIKDLLPDGSVTSLTNKIYANALSFKGAWKRP 181
Query: 176 FDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDELPALEKKT--- 232
F+ T++ DF+L+NG S+ VPFM+S Q V A+DGFKVL LPY++ K +
Sbjct: 182 FEKYYTRDNDFYLVNGTSVSVPFMSSYENQYVRAYDGFKVLRLPYQRGSDDTNRKFSMYF 241
Query: 233 --GSQSGFLKDHIPYEMIEVG--DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTE 288
+ L D + G D IP ++ +E R+ K + F G +T
Sbjct: 242 YLPDKKDGLDDLLEKMASTPGFLDSHIPTYRDE--LEKFRIPK---FKIEF---GFSVTS 293
Query: 289 MVDSHVGV---GIFQKSFIEVKEEGTEXXXXXXXVITLKSLPRFD---KIDFVADHPFIF 342
++D +G+ ++ K+ +E+ EEG E SL + KIDFVADHPF+F
Sbjct: 294 VLD-RLGLRSMSMYHKACVEIDEEGAEAAAATADGDCGCSLDFVEPPKKIDFVADHPFLF 352
Query: 343 MIREDATGVVL 353
+IRE+ TG VL
Sbjct: 353 LIREEKTGTVL 363
|
|
| TAIR|locus:2066316 AT2G26390 "AT2G26390" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 1.5e-49, P = 1.5e-49
Identities = 129/314 (41%), Positives = 170/314 (54%)
Query: 6 ESISEQTDITLSLSKHI---KAPTSSS---SPLSIHVLLSMIAAGSKGPTXXXXXXXXXX 59
+SI Q ++ L+K + S+ SP+SI+VLLS+IAAGS T
Sbjct: 5 KSIENQNNVVARLAKKVIETDVANGSNVVFSPMSINVLLSLIAAGSNPVTKEEILSFLMS 64
Query: 60 XXNEQQNFASELVAIVFADGSANGGPR-LSVANGVWIDQSLSFKNTFKQTVDNIYKASSH 118
+ N V ADG LS A+GVWID+S K +FK+ ++N YKAS
Sbjct: 65 PSTDHLN----AVLAKIADGGTERSDLCLSTAHGVWIDKSSYLKPSFKELLENSYKASCS 120
Query: 119 QVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD-----SSKLVFANALYFKGVWN 173
QVDF K VEV E+N WA+ TNG IK++L D +S L+ ANA+YFK W+
Sbjct: 121 QVDFATKPVEVIDEVNIWADVHTNGLIKQILSRDCTDTIKEIRNSTLILANAVYFKAAWS 180
Query: 174 EAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE--------L 225
FD+ TK+ DFHLL+G ++KVPFM S Q + +DGF+VL LPY +D+ L
Sbjct: 181 RKFDAKLTKDNDFHLLDGNTVKVPFMMSYKDQYLRGYDGFQVLRLPYVEDKRHFSMYIYL 240
Query: 226 P-------ALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLS 278
P AL +K ++ GFL HIP V RIP+ SF + S VLK +GL
Sbjct: 241 PNDKDGLAALLEKISTEPGFLDSHIPLHRTPVDALRIPKLNFSFEFKASEVLKDMGLTSP 300
Query: 279 FSRKGGRLTEMVDS 292
F+ KG LTEMVDS
Sbjct: 301 FTSKGN-LTEMVDS 313
|
|
| TAIR|locus:2062400 AT2G35580 "AT2G35580" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 491 (177.9 bits), Expect = 6.9e-47, P = 6.9e-47
Identities = 132/368 (35%), Positives = 197/368 (53%)
Query: 1 MDDVLESISEQTDITLSLSKHIKAPTSSSSPLSIHVLLSMIAAGSKGPTXXXXXXXXXXX 60
M D+ ES+ Q DI L L+ +PL I+V+LS+IAA S G T
Sbjct: 14 MMDLKESVGNQNDIVLRLT----------APL-INVILSIIAASSPGDTDTADKIVSLLQ 62
Query: 61 XNEQQNF---ASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASS 117
+ +SE+V V AD +A+GGP +S ANG+WI+++L+ + +FK + N YKA+
Sbjct: 63 ASSTDKLHAVSSEIVTTVLADSTASGGPTISAANGLWIEKTLNVEPSFKDLLLNSYKAAF 122
Query: 118 HQVDFQNKAVEVSREINFWAEKETNGFIKEVLP--PGSVDDSSKLVFANALYFKGVWNEA 175
++VDF+ KA EV+RE+N W EK+TNG I +LP P S + +FANAL+F G W+
Sbjct: 123 NRVDFRTKADEVNREVNSWVEKQTNGLITNLLPSNPKSAPLTDH-IFANALFFNGRWDSQ 181
Query: 176 FDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDELPALEKKTGSQ 235
FD S TK+ DFHLL+G ++VPFMT + + ++GFKV+ L Y++ + ++ S
Sbjct: 182 FDPSLTKDSDFHLLDGTKVRVPFMTGASCRYTHVYEGFKVINLQYRRGRE---DSRSFSM 238
Query: 236 SGFL---KDHIPYEMIE----VGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTE 288
+L KD +P M+E F + V + LK F+ + +
Sbjct: 239 QIYLPDEKDGLP-SMLERLASTRGFLKDNEVLPSHSAVIKELKIPRFKFDFAFEASEALK 297
Query: 289 MVDSHVGVG-IFQKSFIEVKEEGTEXXXXXXXVITLKSLPRFDKIDFVADHPFIFMIRED 347
V + I KS IEV E G++ P +K DFVADHPF+F+++E
Sbjct: 298 GFGLVVPLSMIMHKSCIEVDEVGSKAAAAAAFRGIGCRRPPPEKHDFVADHPFLFIVKEY 357
Query: 348 ATGVVLSL 355
+G+VL L
Sbjct: 358 RSGLVLFL 365
|
|
| UNIPROTKB|Q10GX0 LOC_Os03g41438 "Serpin-ZXB" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 3.0e-46, P = 3.0e-46
Identities = 94/197 (47%), Positives = 130/197 (65%)
Query: 30 SPLSIHVLLSMIAAGSKGPTXXXXXXXXXX----XXNEQQNFASELVAIVFADGSANGGP 85
SPLS+HV LS++AAG+ G T FA ++V +V AD S GGP
Sbjct: 49 SPLSLHVALSLVAAGAGGATRDQLVSLLGVPGRGTAEGLHAFAEQVVQLVLADSSPAGGP 108
Query: 86 RLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFI 145
R++ A+GV+ID SLS +FK YKA +H VDFQ KA EV+ ++N W ++ T+G I
Sbjct: 109 RVAFADGVFIDSSLSLMKSFKDVAVGKYKAETHSVDFQTKAAEVASQVNSWVDRVTSGLI 168
Query: 146 KEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQ 205
KE+LPPGSVD +++LV NALYFKG W E FD+SKTK+ +F LL+G S+ PFM++ KQ
Sbjct: 169 KEILPPGSVDHTTRLVLGNALYFKGAWTEKFDASKTKDGEFRLLDGKSVLAPFMSTSKKQ 228
Query: 206 LVTAFDGFKVLVLPYKQ 222
++++D KVL LPY++
Sbjct: 229 YLSSYDSLKVLKLPYQK 245
|
|
| UNIPROTKB|Q5NBM0 LOC_Os01g16200 "Putative serpin-Z12" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 291 (107.5 bits), Expect = 2.5e-41, Sum P(2) = 2.5e-41
Identities = 67/194 (34%), Positives = 99/194 (51%)
Query: 30 SPLSIHVLLSMIAAGSKGPTXXXXXXXXXXXXNEQQNFASELVAIVFADGSANGGPRLSV 89
SPLS H L+++A G++G T + + S +V P S
Sbjct: 64 SPLSFHAALALVADGARGETQRELLGFLGSPSLAELH-RSPTTRLV---ARLRHLPNTSF 119
Query: 90 ANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVL 149
A GVW+D+ + F + Y A + DF + + +N + T G I++VL
Sbjct: 120 ACGVWVDRGRALTPEFADAAASRYAAVAEPADFATQPEQARERVNAFVSDATEGLIRDVL 179
Query: 150 PPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN--KQLV 207
PP SVD S+ +V ANA++FKG W+ F S T FHLL+GG+++ PFMT++ ++ V
Sbjct: 180 PPNSVDSSTVVVLANAVHFKGTWSLPFHPSATFHAPFHLLDGGAVRAPFMTTEIPFERHV 239
Query: 208 TAFDGFKVLVLPYK 221
AF GF L LPYK
Sbjct: 240 AAFPGFTALKLPYK 253
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S7T8 | SPZX_ARATH | No assigned EC number | 0.5590 | 0.9333 | 0.8951 | yes | no |
| P50453 | SPB9_HUMAN | No assigned EC number | 0.3154 | 0.856 | 0.8537 | yes | no |
| Q75H81 | SPZXA_ORYSJ | No assigned EC number | 0.4921 | 0.928 | 0.8787 | yes | no |
| Q10GX0 | SPZXB_ORYSJ | No assigned EC number | 0.4566 | 0.928 | 0.8592 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00014745001 | SubName- Full=Putative uncharacterized protein (Chromosome chr18 scaffold_1, whole genome shotgun sequence); (389 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 375 | |||
| cd02043 | 381 | cd02043, plant_SERPIN, SERine Proteinase INhibitor | 1e-143 | |
| pfam00079 | 369 | pfam00079, Serpin, Serpin (serine protease inhibit | 6e-90 | |
| cd00172 | 364 | cd00172, SERPIN, SERine Proteinase INhibitors (ser | 4e-82 | |
| smart00093 | 359 | smart00093, SERPIN, SERine Proteinase INhibitors | 1e-69 | |
| cd02049 | 364 | cd02049, bacterial_SERPIN, SERine Proteinase INhib | 1e-56 | |
| cd02059 | 389 | cd02059, ovalbumin_like, The ovalbumin_like group | 1e-55 | |
| cd02058 | 380 | cd02058, PAI-2, Plasminogen Activator Inhibitor-2 | 3e-55 | |
| COG4826 | 410 | COG4826, COG4826, Serine protease inhibitor [Postt | 6e-55 | |
| cd02045 | 381 | cd02045, antithrombin-III_like, Antithrombin is a | 4e-48 | |
| cd02048 | 388 | cd02048, neuroserpin, Neuroserpin is a inhibitory | 2e-45 | |
| cd02044 | 370 | cd02044, ov-serpin, ovalbumin family of serpins (o | 5e-44 | |
| cd02051 | 377 | cd02051, PAI-1_nexin-1, Plasminogen activator inhi | 7e-39 | |
| cd02056 | 361 | cd02056, alpha-1-antitrypsin_like, alpha-1-antitry | 6e-36 | |
| cd02047 | 436 | cd02047, HCII, Heparin cofactor II (HCII) inhibits | 3e-30 | |
| cd02055 | 365 | cd02055, PZI, Protein Z-dependent protease inhibit | 1e-27 | |
| cd02057 | 372 | cd02057, maspin_like, Maspin (mammary serine prote | 2e-24 | |
| cd02053 | 351 | cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) i | 5e-21 | |
| cd02052 | 374 | cd02052, PEDF, Pigment epithelium-derived factor ( | 5e-18 | |
| cd02050 | 352 | cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protea | 6e-18 | |
| PHA02948 | 373 | PHA02948, PHA02948, serine protease inhibitor-like | 1e-12 | |
| cd02046 | 366 | cd02046, hsp47, Heat shock protein 47 (Hsp47), als | 3e-12 | |
| cd02054 | 372 | cd02054, angiotensinogen, Angiotensinogen is part | 8e-09 | |
| PHA02660 | 364 | PHA02660, PHA02660, serpin-like protein; Provision | 7e-05 |
| >gnl|CDD|238998 cd02043, plant_SERPIN, SERine Proteinase INhibitors (serpins), plant specific subgroup | Back alignment and domain information |
|---|
Score = 410 bits (1055), Expect = e-143
Identities = 197/372 (52%), Positives = 243/372 (65%), Gaps = 30/372 (8%)
Query: 11 QTDITLSLSKHI-KAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS-NEQ 64
Q + + LS H+ A S SPLSI+V LS++AAG++G TL QLLSFL S S +E
Sbjct: 3 QCLVAMRLSGHVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTDEL 62
Query: 65 QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQN 124
A+ +V +V AD SA+GGPRLS ANGVW+D+SLS K +FK N YKA + VDF+
Sbjct: 63 HAVAASIVDLVLADASASGGPRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRT 122
Query: 125 KAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEY 184
KA EV RE+N W EK TNG IK++LPPGSVD S+KLV ANALYFKG W+ FD+S TK+
Sbjct: 123 KAEEVRREVNSWVEKATNGLIKDILPPGSVDSSTKLVLANALYFKGAWSSKFDASDTKDR 182
Query: 185 DFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------------DEL 225
DFHLL+G S++VPFM+S+ Q V AFDGFKVL LPYK+ D L
Sbjct: 183 DFHLLDGTSVRVPFMSSEKDQYVAAFDGFKVLRLPYKRGGHDDARQFSMYIYLPDKKDGL 242
Query: 226 PALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGR 285
L +K S+ GFL HIP EVG F IP+FK SFG E S VLK LGL L F GG
Sbjct: 243 ADLLEKLVSEPGFLDRHIPASEQEVGAFMIPKFKFSFGFEASEVLKKLGLTLPFD-PGGA 301
Query: 286 LTEMV----DSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFI 341
L M ++ ++ K+ +EV EEGTEAAAA+A V++ S P +DFVADHPF+
Sbjct: 302 LLSMSSPEGENLYVSSVYHKACVEVDEEGTEAAAATAVVMSGTSSPPPRPVDFVADHPFL 361
Query: 342 FMIREDATGVVL 353
F+IRED TGVVL
Sbjct: 362 FLIREDKTGVVL 373
|
It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 381 |
| >gnl|CDD|215699 pfam00079, Serpin, Serpin (serine protease inhibitor) | Back alignment and domain information |
|---|
Score = 274 bits (704), Expect = 6e-90
Identities = 130/368 (35%), Positives = 190/368 (51%), Gaps = 34/368 (9%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK---SKSNE 63
D L K + + SPLSI L+M+ G++G T +QLLS L E
Sbjct: 3 NNDFAFDLYKQLSKESPDKNIFFSPLSISTALAMLYLGARGETAEQLLSVLGFPELDDEE 62
Query: 64 QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQ 123
L++ + + G L +AN +++D+ L K F Q + Y A VDF
Sbjct: 63 IHEGFQSLLSSLNKP---DKGYTLKIANRLFVDKGLKLKPDFLQLLKKYYGAEVESVDFS 119
Query: 124 NKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKE 183
+ A E ++IN W EK+TNG IK++LP GS+D ++LV NA+YFKG W FD TKE
Sbjct: 120 DPA-EARKQINSWVEKKTNGKIKDLLPEGSLDPDTRLVLVNAIYFKGKWKTPFDPELTKE 178
Query: 184 YDFHLLNGGSIKVPFMTSKN--KQLVTAFDGFKVLVLPYK------------QDELPALE 229
FH+ NG ++KVP M+ + + G KVL LPYK L LE
Sbjct: 179 EPFHVDNGTTVKVPMMSQEGTFRYAEDEELGCKVLELPYKGNLSMLIILPDEGGGLEELE 238
Query: 230 KKTGSQ--SGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG--GR 285
K ++ +L P ++ E + +P+FKI ++ VLK LG+ +FS K
Sbjct: 239 KSLTAELLEEWLSSLKPRKVRE--ELYLPKFKIESSYDLKEVLKKLGITDAFSSKADFSG 296
Query: 286 LTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIR 345
++ +V + K+FIEV EEGTEAAAA+ VI ++ P +FVAD PF+F+IR
Sbjct: 297 ISSSEPLYVS-KVVHKAFIEVNEEGTEAAAATGVVIVPRAPP--PPPEFVADRPFLFLIR 353
Query: 346 EDATGVVL 353
+++TG +L
Sbjct: 354 DNSTGSIL 361
|
Structure is a multi-domain fold containing a bundle of helices and a beta sandwich. Length = 369 |
| >gnl|CDD|238101 cd00172, SERPIN, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 4e-82
Identities = 114/363 (31%), Positives = 177/363 (48%), Gaps = 25/363 (6%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN 66
D L L K + SPLSI L+++ G+ G T +QL L S + ++
Sbjct: 2 NNDFALDLYKQLAKSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSLDDED 61
Query: 67 FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKA 126
+++ + + G L +AN +++ + L+ K F Y A VDF N
Sbjct: 62 VHQAFKSLLSSLKDSEKGVELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVESVDFANPE 121
Query: 127 VEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDF 186
+ +IN W E++TNG IK++L P ++D ++LV NA+YFKG W FD T++ F
Sbjct: 122 -AAAAQINNWVEEKTNGKIKDLLSPDALDPDTRLVLVNAIYFKGKWKTPFDPELTRKRPF 180
Query: 187 HLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK-------------QDELPALEKK 231
++ G S++VP M K + +VL LPYK L LE+K
Sbjct: 181 YVSEGESVQVPMMYQTGKFRYAEDEELDAQVLELPYKGSDLSMLIILPKEVTGLAELEEK 240
Query: 232 TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD 291
++ L D + + +P+FKI +++ VL+ALG+ FS + D
Sbjct: 241 LSAEK--LDDLLSNLKEREVEVTLPKFKIESSLDLKEVLQALGITDLFSPSADLSSISSD 298
Query: 292 SHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATG 350
+ V + K+FIEV EEGTEAAAA+A I + ++F AD PF+F+IR+D TG
Sbjct: 299 EPLYVSKVIHKAFIEVNEEGTEAAAATAVSIVPRRPS--PPVEFKADRPFLFLIRDDTTG 356
Query: 351 VVL 353
+L
Sbjct: 357 TIL 359
|
Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 364 |
| >gnl|CDD|214513 smart00093, SERPIN, SERine Proteinase INhibitors | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 1e-69
Identities = 117/346 (33%), Positives = 177/346 (51%), Gaps = 35/346 (10%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLK------SKSNEQQNFASELVAIVFADGSANG 83
SP+SI L+M++ G+KG T Q+L L S+++ Q F L + D
Sbjct: 19 SPVSISSALAMLSLGAKGSTATQILEVLGFNLTETSEADIHQGFQHLLHLLNRPDSQLE- 77
Query: 84 GPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNG 143
L AN +++D+SL K++F + + +Y A VDF +KA E ++IN W EK+T G
Sbjct: 78 ---LKTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAEEAKKQINDWVEKKTQG 134
Query: 144 FIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN 203
IK++L +D ++LV NA+YFKG W FD T+E DFH+ ++KVP M+
Sbjct: 135 KIKDLLSD--LDSDTRLVLVNAIYFKGKWKTPFDPELTREEDFHVDETTTVKVPMMSQTG 192
Query: 204 KQLVTAFD---GFKVLVLPYK-----------QDELPALEKKTGSQSGFLKDHIPYEMIE 249
+ D +VL LPYK + L LEK + K
Sbjct: 193 RTFNYGHDEELNCQVLELPYKGNASMLIILPDEGGLEKLEKAL-TPETLKKWMKSLTKRS 251
Query: 250 VGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG--GRLTEMVDSHVGVGIFQKSFIEVK 307
V + +P+FKI ++ VL+ LG+ FS K ++E D V + K+ +EV
Sbjct: 252 V-ELYLPKFKIEGTYDLKDVLEKLGITDLFSNKADLSGISEDKDLKVS-KVLHKAVLEVN 309
Query: 308 EEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
EEGTEAAAA+ + +SLP +F A+ PF+F+IR++ TG +L
Sbjct: 310 EEGTEAAAATGVIAVPRSLP----PEFKANRPFLFLIRDNKTGSIL 351
|
Length = 359 |
| >gnl|CDD|239004 cd02049, bacterial_SERPIN, SERine Proteinase INhibitors (serpins), prokaryotic subgroup | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 1e-56
Identities = 112/340 (32%), Positives = 173/340 (50%), Gaps = 24/340 (7%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN---EQQNFASELVAIVFADGSANGGPR 86
SPLSI + LSM G+ G T +++L L N E N A + +
Sbjct: 28 SPLSIALALSMTYNGADGTTRKEMLKALG-LDNIDLEDLNSALATLMDQLNT--HDKTVE 84
Query: 87 LSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQN-KAVEVSREINFWAEKETNGFI 145
L +AN +WI+ + K F QT+ + Y+A ++DFQ+ A E EIN W +++T G I
Sbjct: 85 LIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELDFQSPAAAE---EINRWVKEKTKGKI 141
Query: 146 KEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQ 205
+++ +D + NA+YFKG W E FD T E F+L +G + +VPFM+
Sbjct: 142 DKIVDK--IDPDDVMFLINAVYFKGDWQEPFDKQSTYEAPFYLPDGSTKEVPFMSRTGNF 199
Query: 206 LVTAFDGFKVLVLPYKQDELPA---LEKKTGSQSGFLKDHIPYEMIE--------VGDFR 254
GF+ + LPY L L K+ S F+K + + G
Sbjct: 200 RYLETPGFQAVRLPYGDGRLSMYVFLPKENVSLREFVKTLTAEKWRKWIEQFRMREGSLS 259
Query: 255 IPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSHVGV-GIFQKSFIEVKEEGTEA 313
+PRF++ + IE+ LKALG+ +F+ +++ + ++ + + K+FIEV EEGTEA
Sbjct: 260 LPRFQLEYEIELRDALKALGMEEAFTPDAADFSKLGEGNLYISKVIHKTFIEVNEEGTEA 319
Query: 314 AAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
AAA++ IT S P + VAD PF+F IR++ TG +L
Sbjct: 320 AAATSVEITETSAPAGEPFTMVADRPFLFAIRDNRTGSIL 359
|
Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors. Length = 364 |
| >gnl|CDD|239014 cd02059, ovalbumin_like, The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 110/357 (30%), Positives = 165/357 (46%), Gaps = 36/357 (10%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFL---------------KSKSNEQQNFASELVAI 74
SPLSI L M+ G++ T Q+ L ++ N+ S+ +
Sbjct: 28 SPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSSKPAASAQCNQSGGVHSQFKDL 87
Query: 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREIN 134
+ N LS+AN ++ +++ F + V+ +Y+A VDFQN A ++IN
Sbjct: 88 LSQINKPNDDYELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAAEASRKKIN 147
Query: 135 FWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSI 194
W E +TNG IK + G++D S+ LV NA+YFKG W + F+ T + F L +
Sbjct: 148 SWVESQTNGKIKNLFGKGTIDSSTVLVLVNAIYFKGKWEKKFEKENTVDAPFKLNENENK 207
Query: 195 KVPFMTSKNKQLVTAFD--GFKVLVLPYKQ-------------DELPALEKKTGSQSGFL 239
V M K + + + K+L LPY L LE K + +
Sbjct: 208 PVQMMYQIGKFKLASIEEPKMKILELPYAGGGLSMIVLLPDEISGLEQLESKLTYEK-LM 266
Query: 240 KDHIPYEMIEVG-DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGV 296
+ M E + +PRFK+ + VLKA+G+ FS L+ + S
Sbjct: 267 EWTSSENMRERKVEVYLPRFKLEEKYNLKSVLKAMGMTDIFSESKADLSGISSSKSLYLS 326
Query: 297 GIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
KS++EV EEGTEAAAA+ A I KSLP + +F ADHPF+F IR + T +L
Sbjct: 327 KAIHKSYVEVNEEGTEAAAATGAGIVEKSLPVSE--EFRADHPFLFFIRHNKTNTIL 381
|
Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. Length = 389 |
| >gnl|CDD|239013 cd02058, PAI-2, Plasminogen Activator Inhibitor-2 (PAI-2) | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 119/382 (31%), Positives = 177/382 (46%), Gaps = 43/382 (11%)
Query: 12 TDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LSFLKSKSNEQ 64
T L+L K + + + SP SI L+M+ G+KG T Q+ L F + N +
Sbjct: 6 TSFALNLFKKLAESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNSE 65
Query: 65 Q---NFASELVAIVFADGSANGGPR-LSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQV 120
F S L I + G L AN ++ +++ F F Q Y+A V
Sbjct: 66 DIHSGFQSLLSEI-----NKPGTNYLLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAV 120
Query: 121 DFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSK 180
DF A + +EIN W E++T G I+ +LPPGSVD ++LV NA+YFKG W E F
Sbjct: 121 DFVEAAEQARKEINSWVERQTEGKIQNLLPPGSVDSLTRLVLVNAIYFKGNWEEKFLKEN 180
Query: 181 TKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDG--FKVLVLPYKQDELPAL--------EK 230
T+E F L + V M K K +T + +VL LPY EL +
Sbjct: 181 TRERPFRLNKNTTKPVQMMFLKKKFPITYIEELKAQVLELPYVGKELSMFILLPDEIEDV 240
Query: 231 KTGSQSGFLKDHIPYE-----------MIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
TG + L+ + YE + +P+FK+ ++ L ++G+ +F
Sbjct: 241 TTGLEK--LEKELTYEKLNEWTSPEMMEEYEVEVYLPKFKLEESYDLKSTLSSMGMEDAF 298
Query: 280 SRKGGRLTEMVDSH--VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
+ M ++ +F K+F+EV EEGTEAAAA+AA++ L+ L F AD
Sbjct: 299 DPGKADFSGMSSANDLFLSKVFHKAFVEVNEEGTEAAAATAAIMMLRCLMP--SPRFNAD 356
Query: 338 HPFIFMIREDATGVVLSLVMFS 359
HPF+F IR + T +L F
Sbjct: 357 HPFLFFIRHNKTNTILFFGRFC 378
|
PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. Length = 380 |
| >gnl|CDD|227163 COG4826, COG4826, Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 6e-55
Identities = 98/341 (28%), Positives = 155/341 (45%), Gaps = 25/341 (7%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQL---LSFLKSKSNEQQNFASELVAIVFADGSANGGPR 86
SP S+ ++M G++G T +Q+ F +K+ + S I S N
Sbjct: 66 SPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPINKTVLKVREKSLNDKIN----SPNDSYE 121
Query: 87 LSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIK 146
L AN +W+ + K + V N Y A +DF NK IN W E++TNG IK
Sbjct: 122 LETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPDASRDTINKWVEEKTNGKIK 181
Query: 147 EVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQL 206
+++P + ++LV NA+YF G W FD T + F+ G V M+
Sbjct: 182 DLVPEDYIGPDTRLVLTNAIYFNGKWWPEFDKQMTGKRTFYPAKGEDKSVDMMSICGDFN 241
Query: 207 VTAFDGFKVLVLPYKQDEL------------PALEKK-TGSQSGFLKDHIPYEMIEVGDF 253
K++ LPYK D+L E T + LK ++ + +
Sbjct: 242 YGETSKAKIVELPYKGDDLSMYIVLPKDNNITEFENNFTLEKYTELKSNME--DQDEVEV 299
Query: 254 RIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSHVGVG-IFQKSFIEVKEEGTE 312
IP+FK E+ L +G+V +F + + D + + +F ++FI+V EEGTE
Sbjct: 300 EIPKFKFETKTELKDALIEMGVVDAFENTAN-FSGISDRRLEISDVFHQAFIDVDEEGTE 358
Query: 313 AAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
AAAA+A V + ++FV DHPF+F+I + +G +L
Sbjct: 359 AAAATAVVFKAVCA-KGGWVEFVVDHPFLFVIEDRRSGCIL 398
|
Length = 410 |
| >gnl|CDD|239000 cd02045, antithrombin-III_like, Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-48
Identities = 115/349 (32%), Positives = 174/349 (49%), Gaps = 30/349 (8%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFAD------GSANG 83
SPLSI +M G+ TL+QL+ + + ++ S+ V FA AN
Sbjct: 33 SPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEK--TSDQVHFFFAKLNCRLYRKANK 90
Query: 84 GPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSRE-INFWAEKETN 142
L AN ++ D+SL+F T++ + +Y A +DF+ K E+SR IN W +T
Sbjct: 91 SSELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEKP-ELSRITINEWIANKTE 149
Query: 143 GFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSK 202
I +V+P G++D ++ LV NA+YFKG+W FD T++ FH G VP M +
Sbjct: 150 NRITDVIPEGAIDTNTVLVLVNAIYFKGLWKSKFDKENTRKDLFHKAPGEKCPVPMMYQE 209
Query: 203 NKQLVTAF--DGFKVLVLPYKQDE------LPALEKKTGS-----QSGFLKDHIPYEMIE 249
+K D +VL LPYK D+ LP L+ + M E
Sbjct: 210 SKFRYAKIPEDKVQVLELPYKGDDITMVLILPKEGTTLSEVEQNLTLDKLQGWL-DAMKE 268
Query: 250 VG-DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD---SHVGVG-IFQKSFI 304
+IPRF++ V L+ +GL FS + +L +V + + V F K+F+
Sbjct: 269 TTLAVQIPRFRVEDSFSVKEQLQKMGLEDLFSPENAKLPGIVAGGRTDLYVSDAFHKAFL 328
Query: 305 EVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
EV EEG+EA+AA+A VIT +SL ++I FVA+ PF+ IRE A ++
Sbjct: 329 EVNEEGSEASAATAVVITGRSLN-INRIIFVANRPFLLFIREVAINAII 376
|
It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily. Length = 381 |
| >gnl|CDD|239003 cd02048, neuroserpin, Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA) | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 104/373 (27%), Positives = 167/373 (44%), Gaps = 41/373 (10%)
Query: 12 TDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNF 67
++++ L ++A SPLS + L M+ G+KG L+++ L +
Sbjct: 5 AELSVDLYNALRASKEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGLKNGEE 64
Query: 68 ASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAV 127
S L + + ++AN +++ K F Q+ + A+ VDF
Sbjct: 65 FSFLKDLSSMITAKEKEYVFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFSQ-VK 123
Query: 128 EVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFH 187
V+ IN W E TN IK++ ++LV NALYFKG W F T+ + F
Sbjct: 124 AVAEHINKWVENHTNNKIKDMFSSRDFTPLTRLVLVNALYFKGNWKSQFRPENTRTFSFT 183
Query: 188 LLNGGSIKVPFMTSKNKQLVTAF-DG-------FKVLVLPYKQDE------LPALEKKTG 233
+ +++P M + + F DG ++VL LPY+ DE L E
Sbjct: 184 KDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLELPYEGDEISLMIILSRQEVPLA 243
Query: 234 SQSGFLK--------DHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGR 285
+ +K + + + +EV +PRFK+ I++ VLK LG+ FS G
Sbjct: 244 TLEPLVKAPLIEEWANSVKKQKVEV---YLPRFKVEQKIDLKDVLKNLGITEIFSG-GAD 299
Query: 286 LTEMVDS-HVGVG-IFQKSFIEVKEEGTEAAAASAAVITLK---SLPRFDKIDFVADHPF 340
L+ + DS + V +F K F+EV EEG+EAAA+S + + P+ + DHPF
Sbjct: 300 LSGISDSKELYVSKVFHKVFLEVNEEGSEAAASSGMIAISRMAVLYPQ-----VIVDHPF 354
Query: 341 IFMIREDATGVVL 353
F+IR TG +L
Sbjct: 355 FFLIRNRRTGSIL 367
|
It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. Length = 388 |
| >gnl|CDD|238999 cd02044, ov-serpin, ovalbumin family of serpins (ov-serpins) | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 5e-44
Identities = 99/352 (28%), Positives = 165/352 (46%), Gaps = 33/352 (9%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFADGSANGGPRLSV 89
SP++I L+M+ G+KG T Q+ L + ++ S ++ N L +
Sbjct: 28 SPIAIMSSLAMVYLGAKGSTANQIGKVLHF--DNVKDVHSSFQTLLSDINKLNSFYSLKL 85
Query: 90 ANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVL 149
N ++ ++ +F F + Y VDF++KA E +IN W + +T G I+ +L
Sbjct: 86 VNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEETRGQINSWIKDQTKGKIENLL 145
Query: 150 PPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA 209
P SVD + +V NA YFKG W + F +TKE F + + V M + +
Sbjct: 146 PENSVDSQTAMVVVNAAYFKGKWMKKFSEEETKESPFRVNKTETKPVQMMYMEATFNMGN 205
Query: 210 FD--GFKVLVLPYKQ----------DELPALEKKTGSQSGFLK-------DHIPYEMIEV 250
+ K+L LP+ DE+ LE K S+ + K + ++V
Sbjct: 206 IESLKMKILELPFANKDLSMFILLPDEVTGLE-KLESEINYEKLNKWTSPSTMAEAKVKV 264
Query: 251 GDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSHVGVGI---FQKSFIEVK 307
+PRFK+ ++ VL++LG+ +FS + M G+ + K+ +E+
Sbjct: 265 ---YLPRFKMEKMYDLKSVLESLGMKDAFSEGRANFSGM-SETKGLALSNVIHKASLEIN 320
Query: 308 EEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFS 359
E+GTEAA + AV+ +S+ K +F ADHPF+F+IR + T +L FS
Sbjct: 321 EDGTEAAEVTGAVMLQRSV----KEEFNADHPFLFIIRHNKTNCILFFGKFS 368
|
Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 370 |
| >gnl|CDD|239006 cd02051, PAI-1_nexin-1, Plasminogen activator inhibitor-1_like | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 96/347 (27%), Positives = 162/347 (46%), Gaps = 34/347 (9%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFADGSANGGPRLSV 89
SP I +L M+ G+ G T +QL + ++ K N +L + + + + ++
Sbjct: 34 SPHGIASVLGMLQLGADGKTKKQLQTVMRYKINGVAKALKKLNKAIVSKKNKD---IVTT 90
Query: 90 ANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVL 149
AN V+ + F +++ VDF + + IN W + ET G I +L
Sbjct: 91 ANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSDPE-TAAFSINDWVKNETKGMIDNLL 149
Query: 150 PPGSVDDS-SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVT 208
P DD+ ++LV NALYFKG+W F TK+ FH +G + +VP + +
Sbjct: 150 SPDLADDALTRLVLVNALYFKGLWKSRFQPESTKKRTFHAGDGKTYQVPMLAQLSVFRSG 209
Query: 209 AF---DG--FKVLVLPYKQDELPAL-----EKKTGSQSGFLKDHIPYEMIEVG------- 251
+ +G + ++ LPY + + L EK T + + HI + I+
Sbjct: 210 SASTPNGLWYNIIELPYHGESISMLIALPTEKSTPLSA--IIPHISTKTIQSWMGTMVPK 267
Query: 252 --DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS---HVGVGIFQKSFIEV 306
+P+F + ++ LKALG+ F + T++ S HV QK+ IEV
Sbjct: 268 RMQLVLPKFTVEAETDLKEPLKALGITDMFDQSKANFTKISRSESLHVS-HALQKAKIEV 326
Query: 307 KEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
E+GT+A+AA+ A++ +S P + F+ D PF+F IR + TG +L
Sbjct: 327 NEDGTKASAATTAILIARSSPPW----FIVDRPFLFFIRHNPTGTIL 369
|
Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 377 |
| >gnl|CDD|239011 cd02056, alpha-1-antitrypsin_like, alpha-1-antitrypsin_like | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 6e-36
Identities = 100/369 (27%), Positives = 177/369 (47%), Gaps = 38/369 (10%)
Query: 12 TDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLS---F-LKSKSNE 63
D L + + + + S SP+SI L+M++ G++ TL Q+L F L S E
Sbjct: 3 ADFAFRLYRQLASESPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISEE 62
Query: 64 Q--QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVD 121
+ Q F L + + G +L++ N +++D+ L + F + V ++Y++ + D
Sbjct: 63 EIHQGFQHLLHLL----NQPDSGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTD 118
Query: 122 FQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKT 181
FQ+ A E ++IN + EK+T+G I +++ +D + +V N +YFKG W + FD T
Sbjct: 119 FQDSA-EAKKQINDYVEKKTHGKIVDLVK--DLDSDTVMVLVNYIYFKGKWEKPFDPELT 175
Query: 182 KEYDFHLLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYKQDE-----LPALEKKTG 233
+E DF + ++KVP M + + D V+ +PYK + LP K
Sbjct: 176 QEEDFFVDEKTTVKVPMM-HQTGRYDYLHDSELSCTVVQMPYKGNATAFFVLPDEGKMKQ 234
Query: 234 SQSGFLKDHIP--YEMIE--VGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG--GRLT 287
++ +D + +++ D +P+F IS + +L +G+ FS K +T
Sbjct: 235 VEAALSRDTLKKWSKLLSKRSVDLYLPKFSISGTYNLKDILPKMGITDVFSDKADLSGIT 294
Query: 288 EMVDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIRE 346
E ++ V K+ ++V E+GTEAAAA+ IT S + PF+ +I +
Sbjct: 295 E--QPNLKVSKAVHKAVLDVDEKGTEAAAATGVEITPMSALP---PILKFNRPFLLLIFD 349
Query: 347 DATGVVLSL 355
T +L L
Sbjct: 350 RTTESILFL 358
|
This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 361 |
| >gnl|CDD|239002 cd02047, HCII, Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 97/347 (27%), Positives = 155/347 (44%), Gaps = 35/347 (10%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS--NEQQNFASELVAIVFADGS-----AN 82
+P+ I + MI+ G KG T +Q+LS L K N + V +F + N
Sbjct: 93 APVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSKYEITTVHNLFRKLTHRLFRRN 152
Query: 83 GGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETN 142
G L N ++I + FK V Y A + DF + A + N +K T
Sbjct: 153 FGYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFSDPAFIT--KTNNRIQKLTK 210
Query: 143 GFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSK 202
G IKE L +VD ++ ++ N +YFKG W F T +F L +KVP M +K
Sbjct: 211 GLIKEALE--NVDPATLMMILNCIYFKGTWENKFPVEMTHNRNFRLNEKEVVKVPMMQTK 268
Query: 203 NKQLVTA------------FDG--FKVLVLPYKQDELPALEKKTGSQSGFLKDHIPYEMI 248
L A + G ++V+P+K + LEK+ Q + + M
Sbjct: 269 GNFLAAADPELDCDILQLPYVGNISMLIVVPHKLSGMKTLEKQITPQ---VVERWQKSMT 325
Query: 249 -EVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSHVGVGIFQ-KSFIEV 306
+ +P+FK+ + LK +G+ F+ + G + + D + + +F+ + I V
Sbjct: 326 NRTREVVLPKFKLEKNYNLIESLKLMGITDLFT-EKGNMAGVSDEKIAIDLFKHQGTITV 384
Query: 307 KEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
EEGTEA AAV T+ +P ++ F+ D PF+F+I E T +L
Sbjct: 385 NEEGTEA----AAVTTVGFMPLSTQVRFIVDRPFLFLIYEHRTNCLL 427
|
HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily. Length = 436 |
| >gnl|CDD|239010 cd02055, PZI, Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10) | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 97/343 (28%), Positives = 155/343 (45%), Gaps = 25/343 (7%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLS--FLKSKSNEQQNFASELVAIVFADGSANGGPRL 87
SP + + ++ + ++G T +Q+ L + + L + + S N
Sbjct: 28 SPFGMSLAMAGLLLAAEGETERQIAKALHLHALKDRDPGLLPALFKGLKDNISRNEELGF 87
Query: 88 SVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKE 147
+ +I + K F + +DFQN A + IN +KET G I E
Sbjct: 88 TQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQN-ASQAKFLINHNIKKETKGKIPE 146
Query: 148 VLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLV 207
+ +D SKL+ + ++FKG W FD T+ FH+ SIKVP M +K
Sbjct: 147 LFD--EIDPESKLILLDYIFFKGKWLTPFDPEFTEIDTFHIDKYKSIKVPMMFGADKFAS 204
Query: 208 TAFDGFK--VLVLPYKQDE--LPALEKKTGSQSGFLKDHIPYEMIEVG---------DFR 254
T + F+ V+ LPYK L + +K L+DH+ +++E D
Sbjct: 205 TFDENFRCHVIKLPYKGKATMLIVIMEKGEDHLA-LEDHLTMDLVESWLANMKSRNMDIF 263
Query: 255 IPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS-HVGVG-IFQKSFIEVKEEGTE 312
P+FK+ E+ +L+ALG+ F+ + D H+ V + QK+ IEV E+GTE
Sbjct: 264 FPKFKLDQKYEMHELLRALGIKNIFAPFADLSELLADGKHLQVSQVLQKAVIEVDEKGTE 323
Query: 313 AAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSL 355
AAAA + I S+P K+ D PF FMI E+ G++L +
Sbjct: 324 AAAAIGSEIIAFSMPPVIKV----DRPFHFMIFEETFGMLLFI 362
|
ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Length = 365 |
| >gnl|CDD|239012 cd02057, maspin_like, Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 89/343 (25%), Positives = 152/343 (44%), Gaps = 33/343 (9%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFADGSA-NGGPRLS 88
SP+ + L++ G+KG T ++ L ++ + F + V +D S + L
Sbjct: 28 SPICLSTSLALAQVGAKGDTANEIGKVLHFENVKDVPFGFQTVT---SDVSKLSSFYSLK 84
Query: 89 VANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEV 148
+ +++D+SL+ F + Y VDF++K E +IN ++ T+G + +
Sbjct: 85 LIKRLYVDKSLNLSTDFINSTKRPYPKELETVDFKDKLEETRGQINNSIKELTDGHFENI 144
Query: 149 LPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVT 208
L SV+D +K++ NA YF G W + F S+TKE F + + V M + +
Sbjct: 145 LNENSVNDQTKILVVNAAYFVGNWMKKFPESETKECPFRVNKTETKPVQMMNLEATFSMG 204
Query: 209 AFDGFKVLV--LPYK--------------QDELPALEK--KTGSQSGFLKDHIPYEMIEV 250
D + LP++ +DE LEK K + + P M
Sbjct: 205 YIDELNTKILELPFQNKHLSMLILLPKDIEDESTGLEKLEKQLTSESLSQWTNPSMMANA 264
Query: 251 G-DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSHVGVGIFQ---KSFIEV 306
+P+FK+ I++ +L++LGL F+ + M ++ GV + K +EV
Sbjct: 265 KVKVSLPKFKVEKMIDLKAMLESLGLKHIFNEDASDFSGMSETK-GVALSNVIHKVCLEV 323
Query: 307 KEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDAT 349
E+G E+ A I K +F ADHPFIF+IR + T
Sbjct: 324 NEDGGESIEVPGARILQ------HKDEFNADHPFIFIIRHNKT 360
|
Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372 |
| >gnl|CDD|239008 cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 90/342 (26%), Positives = 148/342 (43%), Gaps = 41/342 (11%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFADGSANGGPRLSV 89
SPLSI + LS +A G++ T Q+LL L ++S + + G+ L +
Sbjct: 28 SPLSIALALSHLALGAQNETEQRLLKTLHAESLPCLHHLLSRLRQDLGPGA------LRL 81
Query: 90 ANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVL 149
A +++ + K +F + + +Y A V + IN W ++ T G I L
Sbjct: 82 ATRMYLQKGFEIKESFLEESEKLYGAKP--VSLTGTKEDDLANINKWVKEATEGQIPNFL 139
Query: 150 PPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQL--- 206
+ + L+ NA++FKG W FD S T+ FHL + ++ V M + L
Sbjct: 140 --SDLPHDTVLLLLNAIHFKGFWRNKFDPSLTQRDAFHLDDDFTVSVEMMQASTYPLRWF 197
Query: 207 --------VTAFD-----GFKVLV-LPYKQDELPALEKKTGSQSGFLKDHIPYEMIEVGD 252
V F F VL+ P+ + L L +P E
Sbjct: 198 HLEQPEIQVAKFPFKGNMSFVVLMPTPFTWNVSQVLANLNWDD---LYRRLPKERPT--K 252
Query: 253 FRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSHVGVGIFQ-KSFIEVKEEGT 311
++P+ K+ + +E++ L LGL F L+ + D + V Q +S +E+ E+G
Sbjct: 253 VKLPKLKLDYQLELNEALSQLGLQELFQ--APDLSGISDEPLFVSSVQHQSTLELSEKGV 310
Query: 312 EAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
EA+AA+ +V T +SL F + PF+F I ED G+ L
Sbjct: 311 EASAAT-SVATSRSLSS-----FSVNRPFLFFIFEDTMGLPL 346
|
Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily. Length = 351 |
| >gnl|CDD|239007 cd02052, PEDF, Pigment epithelium-derived factor (PEDF)_like | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 86/363 (23%), Positives = 154/363 (42%), Gaps = 61/363 (16%)
Query: 23 KAPTSSS--SPLSIHVLLSMIAAGSKGPTLQQL---LSFLKSKSNEQQNFASELVAIVFA 77
+ PT++ SPLSI LS ++ G+ T Q+ L + E + +L+A + A
Sbjct: 33 RDPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYYDLLNDPELHDTYKDLLASLTA 92
Query: 78 DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKA-----SSHQVDFQNKAVEVSRE 132
L A+ + +++ L + F V+ Y + + +D Q E
Sbjct: 93 PAKG-----LKSASRILLERKLRLRLEFVNQVEKSYGERPRILAGNALDLQ--------E 139
Query: 133 INFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGG 192
IN W +++T G + + + + ++ + YFKG W FD T DFHL
Sbjct: 140 INDWVQQQTGGKVDRFVK--EIPRNVSILLLGSAYFKGQWITKFDKRNTVLTDFHLDEQR 197
Query: 193 SIKVPFMTSKNKQLVTAFD---GFKVLVLPYKQ-------------DELPALEKKTGSQS 236
++ VP M+ N + D K+ LP L +E+ S+
Sbjct: 198 TVVVPMMSDPNAPVRYGLDSDLNCKIAQLPLTGGVSIMFFLPDKVTQNLTLIEESLTSE- 256
Query: 237 GFLKDHIPYEMIEV-GDFRIPRFKISFGIEVSRVLKALGL-----VLSFSRKGGRLTEMV 290
F+ D I E+ V +P+ K+S+ E+ L+ L L F++ + ++
Sbjct: 257 -FVHD-IDRELKTVKAVLTLPKLKLSYETELLPSLQELKLQSLFASPDFTKITSKPIKL- 313
Query: 291 DSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATG 350
SHV K+ +E+ E+G E A + T + P +++ D PF+F++R++ TG
Sbjct: 314 -SHV----HHKAVLELNEDGAE-TAPTPGSATALTFP----LEYHVDRPFLFVLRDEDTG 363
Query: 351 VVL 353
+L
Sbjct: 364 ALL 366
|
PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily. Length = 374 |
| >gnl|CDD|239005 cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 88/344 (25%), Positives = 145/344 (42%), Gaps = 42/344 (12%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFADGSANGGPRLSV 89
SP+SI +LLS + G++G T ++L S L ++ + + A L
Sbjct: 26 SPVSIALLLSHLLLGARGKTQRRLESIL--------SYPHDFACVHSALKKLKNKLGLLS 77
Query: 90 ANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVL 149
A+ ++ L + +F YKA + N + IN W K TN I +L
Sbjct: 78 ASQIFHHPDLHLRESFTNESWQFYKARP--RELSNNSELNLEMINSWVAKATNNKIPRLL 135
Query: 150 PPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA 209
S+ ++LV NA+YF+ W + FD+ T F NG +KVP M SK + +
Sbjct: 136 --DSLPSETRLVLLNAVYFQAQWKKKFDTKHTVLLPFK-RNGDPVKVPVMYSKKYPVASF 192
Query: 210 FD----------------GFKVLVLPYKQDELPALEKKTGSQSGFLKDHIPYEMI--EVG 251
D VLV +++L A+E+ + FL +
Sbjct: 193 TDPRLKAQVGRLELSGGLSLVVLVPRGPKEDLEAVERAL-TPPAFLAMLEKMAANTPQRT 251
Query: 252 DFRIPRFKISFGIEVSRVLKALGLV-LSFSRKGGRLTEMVDSHVGVGIFQ-KSFIEVKEE 309
+ +PR K+ +++ ++ LGL L L + D + V Q ++ + + E+
Sbjct: 252 EVTLPRIKLDLAVDMVALMHKLGLFGLFLDANLCGLYQ--DPELAVDAAQHRAVLTLTEK 309
Query: 310 GTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
G EAAAA+A S R + F A PF+F++ +D V L
Sbjct: 310 GVEAAAATAT-----SFAR-TALSFEALQPFLFVLWDDQAKVPL 347
|
It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily. Length = 352 |
| >gnl|CDD|165258 PHA02948, PHA02948, serine protease inhibitor-like protein; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 69/277 (24%), Positives = 130/277 (46%), Gaps = 35/277 (12%)
Query: 94 WIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGS 153
++D ++ K ++ Q ++ ++++F+ AV +IN E+ + + V+
Sbjct: 107 FVDNTVCIKPSYYQ---QYHRFGLYRLNFRRDAVN---KINSIVERRSG--MSNVVDSTM 158
Query: 154 VDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNK---QLVTAF 210
+D+++ N +YFKG W FD +KT F G+ VP M K +T
Sbjct: 159 LDNNTLWAIINTIYFKGTWQYPFDITKTHNASF-TNKYGTKTVPMMNVVTKLQGNTITID 217
Query: 211 D-GFKVLVLPYKQDELPALEKKTGSQSGFLKDHIPYEMIE---------VGDFRIPRFKI 260
D + ++ LPYK + ++ G D I ++ V + ++PRF
Sbjct: 218 DEEYDMVRLPYKDANI-SMYLAIGDNMTHFTDSITAAKLDYWSSQLGNKVYNLKLPRFS- 275
Query: 261 SFGIEVSRVLKALGLVLS---FSRKGGRLTEMVDSHVGV-GIFQKSFIEVKEEGTEAAAA 316
IE R +K++ +++ F+ M + + +FQ + I+V E+GT A A+
Sbjct: 276 ---IENKRDIKSIAEMMAPSMFNPDNASFKHMTRDPLYIYKMFQNAKIDVDEQGTVAEAS 332
Query: 317 SAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
+ V T +S P ++++F + PF+F+IR D TG +L
Sbjct: 333 TIMVATARSSP--EELEF--NTPFVFIIRHDITGFIL 365
|
Length = 373 |
| >gnl|CDD|239001 cd02046, hsp47, Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 77/345 (22%), Positives = 142/345 (41%), Gaps = 34/345 (9%)
Query: 30 SPLSIHVLLSMIAAGSKGPTLQQLLSFLKS---KSNEQQNFASELVAIVFADGSANGGPR 86
SP+ + L +++ G K T Q + L + K SEL+ V + N +
Sbjct: 30 SPVVVASSLGLVSMGGKASTASQAKAVLSADKLKDEHVHTGLSELLNEVSNSTARNVTWK 89
Query: 87 LSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIK 146
+ N ++ S+SF + F + Y +++F++K + IN WA + T+G +
Sbjct: 90 IG--NRLYGPSSVSFADDFVKNSKKHYNYEHSKINFRDKRSAL-NSINEWAAQTTDGKLP 146
Query: 147 EVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFM------- 199
EV D + +V NA++FK W+E F F + ++ VP M
Sbjct: 147 EVTKDVEKTDGALIV--NAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVSVPMMHRTGLYG 204
Query: 200 ----TSKNKQLVTAFDGFK----VLVLPYKQDELPALEKKTGSQSGFLKDHIPYEMIEVG 251
Q+V K + ++PY + L LEK + LK I
Sbjct: 205 YYDDEENKLQIVEMPLAHKLSSMIFIMPYHVEPLERLEKLLTREQ--LKTWISKMKKRAV 262
Query: 252 DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMV---DSHVGVGIFQKSFIEVKE 308
+P+ + ++ + L LGL + + L+++ D ++ +F + +E
Sbjct: 263 AISLPKVSLEVSHDLQKHLGDLGLTEAIDKSKADLSKISGKKDLYLS-NVFHAAALEWDT 321
Query: 309 EGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
EG +++ P+ F ADHPFIF+++++ T +L
Sbjct: 322 EGNPFDPDIYGREEMRN-PKL----FYADHPFIFLVKDNKTNSIL 361
|
It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H. Length = 366 |
| >gnl|CDD|239009 cd02054, angiotensinogen, Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 60/259 (23%), Positives = 109/259 (42%), Gaps = 45/259 (17%)
Query: 120 VDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSS 179
VDF +IN + + ++G +K L + S L+FA +++F+G W A
Sbjct: 130 VDFTE-PDVAEEKINNFVQATSDGKVKSSLK--GLSPDSDLLFATSVHFQGNWKTASQLE 186
Query: 180 KTKEYDFHLLNGGSIKVPFM--TSKNKQLVTAFDGFKV------------LVLPYKQDEL 225
+ +E+ N S+ VP + T K L D F + LV P++ +L
Sbjct: 187 EPQEFWVD--NNTSVSVPMLSHTGTFKYLSDIQDNFSITQLPLSKRACLLLVQPHEGSDL 244
Query: 226 PALEKKTGSQ--SGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVL------KALGLVL 277
+E K Q S +LK ++ IE+ +P+F + ++ +L LG
Sbjct: 245 DKVEGKLPQQNSSNWLK-NLSPRTIEL---TLPKFSLQGSYDLQDLLAQMELPALLGSEA 300
Query: 278 SFSRKGGRLTEMVDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVA 336
+ S+ + + VG + K F E+ E+GTE ++ + P ++
Sbjct: 301 NLSK-------LSNDRFTVGKVLNKVFFELSEDGTEVQESTQQ----LNKPEVLEVTL-- 347
Query: 337 DHPFIFMIREDATGVVLSL 355
+ PF+F + E + +L L
Sbjct: 348 NRPFLFAVYEANSNAILFL 366
|
It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372 |
| >gnl|CDD|165039 PHA02660, PHA02660, serpin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 43/283 (15%)
Query: 93 VWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETN--GFIKEVLP 150
V++D L + F +++++ D N A + R IN W ++TN F+ +P
Sbjct: 79 VYVDSHLPIHSAFVASMNDM-GIDVILADLANHAEPIRRSINEWVYEKTNIINFL-HYMP 136
Query: 151 PGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF 210
D+S L+ NA+ F G+W F KT F++ V MT+K +
Sbjct: 137 -----DTSILII-NAVQFNGLWKYPFLRKKTTMDIFNIDKVSFKYVNMMTTKGIFNAGRY 190
Query: 211 DGFKVLVLPY----------------KQDELPALEKKTGSQSGFLKDHIPYEMIEVGDFR 254
++ +PY D+L LE + LK + +
Sbjct: 191 HQSNIIEIPYDNCSRSHMWIVFPDAISNDQLNQLENMMHGDT--LKAFKHASRKKYLEIS 248
Query: 255 IPRFKISFGIEVSRVLKALGLVLSFSRKG-GRLTEMVDSHVGV-----GIFQKSFIEVKE 308
IP+F+I +L + G+ F+ R+ D + ++QK +E+ E
Sbjct: 249 IPKFRIEHSFNAEHLLPSAGIKTLFTNPNLSRMITQGDKEDDLYPLPPSLYQKIILEIDE 308
Query: 309 EGTEAAAASAAVI-------TLKSLPRFDKIDFVADHPFIFMI 344
EGT + + T + L R + I + PFIF+I
Sbjct: 309 EGTNTKNIAKKMRRNPQDEDTQQHLFRIESI--YVNRPFIFII 349
|
Length = 364 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 375 | |||
| COG4826 | 410 | Serine protease inhibitor [Posttranslational modif | 100.0 | |
| KOG2392 | 380 | consensus Serpin [Defense mechanisms] | 100.0 | |
| cd02044 | 370 | ov-serpin ovalbumin family of serpins (ov-serpins) | 100.0 | |
| cd02054 | 372 | angiotensinogen Angiotensinogen is part of the ren | 100.0 | |
| cd02043 | 381 | plant_SERPIN SERine Proteinase INhibitors (serpins | 100.0 | |
| cd02048 | 388 | neuroserpin Neuroserpin is a inhibitory member of | 100.0 | |
| cd02059 | 389 | ovalbumin_like The ovalbumin_like group of serpins | 100.0 | |
| cd02045 | 381 | antithrombin-III_like Antithrombin is a serine pro | 100.0 | |
| cd02057 | 372 | maspin_like Maspin (mammary serine proteinase inhi | 100.0 | |
| cd02058 | 380 | PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2). P | 100.0 | |
| cd02051 | 377 | PAI-1_nexin-1 Plasminogen activator inhibitor-1_li | 100.0 | |
| cd02047 | 436 | HCII Heparin cofactor II (HCII) inhibits thrombin, | 100.0 | |
| cd02049 | 364 | bacterial_SERPIN SERine Proteinase INhibitors (ser | 100.0 | |
| cd02056 | 361 | alpha-1-antitrypsin_like alpha-1-antitrypsin_like. | 100.0 | |
| smart00093 | 359 | SERPIN SERine Proteinase INhibitors. | 100.0 | |
| cd00172 | 364 | SERPIN SERine Proteinase INhibitors (serpins) exhi | 100.0 | |
| cd02046 | 366 | hsp47 Heat shock protein 47 (Hsp47), also called c | 100.0 | |
| cd02052 | 374 | PEDF Pigment epithelium-derived factor (PEDF)_like | 100.0 | |
| PF00079 | 371 | Serpin: Serpin (serine protease inhibitor); InterP | 100.0 | |
| cd02055 | 365 | PZI Protein Z-dependent protease inhibitor (ZPI) i | 100.0 | |
| PHA02948 | 373 | serine protease inhibitor-like protein; Provisiona | 100.0 | |
| cd02053 | 351 | alpha2AP Alpha2-antiplasmin (alpha2AP) is the prim | 100.0 | |
| cd02050 | 352 | C1_inh C1 inhibitor (C1-Inh) is a protease inhibit | 100.0 | |
| PHA02660 | 364 | serpin-like protein; Provisional | 100.0 |
| >COG4826 Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-79 Score=539.85 Aligned_cols=351 Identities=26% Similarity=0.411 Sum_probs=316.7
Q ss_pred HHhhhhhhhHHHHHHHHhcCCC----C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-hhHH-HHHHHHHHHHh
Q 036497 5 LESISEQTDITLSLSKHIKAPT----S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-EQQN-FASELVAIVFA 77 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~~----~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~-~~~~l~~~l~~ 77 (375)
+..++++|.|+++||.++.+.+ + .|||+||+.+|||-|.||.|.|++||..+++++.+ ..++ ..+.+...+.
T Consensus 36 y~ia~ANNaF~FdlyS~~~~~~~~~~Ni~fSPySV~~AmAmcY~GaeGsTkeqmsnvfyfp~n~~vl~~~~~~~nd~i~- 114 (410)
T COG4826 36 YDIAAANNAFAFDLYSELAKQEGEAENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPINKTVLKVREKSLNDKIN- 114 (410)
T ss_pred cchhhcccchhHHHHHHHHhhcccccceeeccHHHHHHHHHHhcccCcchHHHHHhheeccccchHhhhhHHhhccccc-
Confidence 3467899999999999998544 2 99999999999999999999999999999999965 4455 6666655443
Q ss_pred CCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCcc
Q 036497 78 DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDS 157 (375)
Q Consensus 78 ~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~ 157 (375)
++.++..+..||++|++++++++++|+..++.+|.+++..+||.++|+.++.+||+|++++|+|+|+++++.+.+.+|
T Consensus 115 --sp~~~y~le~AnalWvqedyplke~yv~n~r~yy~aevtnlDF~~~p~~s~dtINkWvEekT~gkIkdlVp~~~i~~d 192 (410)
T COG4826 115 --SPNDSYELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPDASRDTINKWVEEKTNGKIKDLVPEDYIGPD 192 (410)
T ss_pred --CCccchhhhhhhhHHHhcCCCCCHHHHHHHHhhhhcceeecccccCchHHHHHHHHHHHHhhcchHhhcCCccccCCc
Confidence 466778899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecCCeEEEEecccC------------CCh
Q 036497 158 SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ------------DEL 225 (375)
Q Consensus 158 t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLPy~~------------~~l 225 (375)
++++|+||+||+|+|...|++..|.++.|+...|..+.|+||++.+.+.|++..++++|||||++ ..+
T Consensus 193 ~rlvltnAiYFnGkW~~efDk~~t~krtFy~a~~~d~sv~mMs~~g~fny~et~kakiveLPy~gd~lSmYIvLPk~nNi 272 (410)
T COG4826 193 TRLVLTNAIYFNGKWWPEFDKQMTGKRTFYPAKGEDKSVDMMSICGDFNYGETSKAKIVELPYKGDDLSMYIVLPKDNNI 272 (410)
T ss_pred eeEEEEeeEEEcCeeccccchhhccceeeecCChhhhcchhHHhcCCCCcccCcCceEEEcccCCCceEEEEEeeCCCCh
Confidence 99999999999999999999999999999999999999999999999999999999999999998 457
Q ss_pred HHHHHHccCcHHHHhccCCcccee-eeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-CccceeeeeE
Q 036497 226 PALEKKTGSQSGFLKDHIPYEMIE-VGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQKSF 303 (375)
Q Consensus 226 ~~l~~~L~~~~~~l~~~~~~~~~~-~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~qk~~ 303 (375)
.++++.++. +.+..++..++.. .+++.||||+.+++..|+++|..||+.++|++ .||||||++.+ .|++++|+++
T Consensus 273 ~~Fe~nft~--e~y~elk~~m~~~~~v~v~iPkFkfetk~el~~aLieMGvvdAF~n-~AnFSgI~~~~L~Is~V~Hqa~ 349 (410)
T COG4826 273 TEFENNFTL--EKYTELKSNMEDQDEVEVEIPKFKFETKTELKDALIEMGVVDAFEN-TANFSGISDRRLEISDVFHQAF 349 (410)
T ss_pred HHHHhhccH--HHHHHHHhcCCccceEEEEecceeeeehhhhhHHHHHhhHHHHhhc-ccCcccccCCcccHHHHhhhhh
Confidence 888888873 3344444443332 57899999999999999999999999999996 89999999999 9999999999
Q ss_pred EEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 304 IEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 304 iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
|+|+|+||+|||+|+++....|+..+ -.+|++||||+|+|.|+.||.|||||+|.+|+
T Consensus 350 idv~EeGteAaAAT~v~~~a~~~~~~-~~e~~vD~PFlf~i~D~~s~~IlFiG~Vv~P~ 407 (410)
T COG4826 350 IDVDEEGTEAAAATAVVFKAVCAKGG-WVEFVVDHPFLFVIEDRRSGCILFIGKVVNPE 407 (410)
T ss_pred eeccccchhhhhhceeeeeeeeeccc-ceEEEecCceEEEEecCCcceEEEEeeecCCC
Confidence 99999999999999888777777543 34999999999999999999999999999996
|
|
| >KOG2392 consensus Serpin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-74 Score=548.27 Aligned_cols=351 Identities=38% Similarity=0.581 Sum_probs=313.0
Q ss_pred hHHhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChh---hHH-HHHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNE---QQN-FASELVAIV 75 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~---~~~-~~~~l~~~l 75 (375)
+........+|+++||+.+.... + +|||+||.++|+|+++||+|+|++||+++|+++..+ .++ .++.+....
T Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~~~~~Ni~fSP~SI~~aL~m~~lGa~g~T~~qi~~~L~~~~~~~~~~~~~~~~~~~~~~ 83 (380)
T KOG2392|consen 4 MASLSQSEADFALDLYRQLAKSAPDENVVFSPLSISSALAMVSLGAKGETADQILKALHFNSTDEENEVHESFQSLLLLL 83 (380)
T ss_pred hhhhhhhhhHHHHHHHHHHHhhCCCCCEEEChHHHHHHHHHHHhcCCccHHHHHHHHhCCCCCcchHHHHHHHHHHHHHh
Confidence 44556778999999999999532 3 999999999999999999999999999999999653 345 666665422
Q ss_pred HhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCC
Q 036497 76 FADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVD 155 (375)
Q Consensus 76 ~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~ 155 (375)
.....+..++++|++|+++++.+.++|.+.++++|+++++.+||.++++.+++.||.|++++|+|+|++++++++++
T Consensus 84 ---~~~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~~dF~~~~e~~~~~IN~wv~~~T~gkI~~ll~~~~~~ 160 (380)
T KOG2392|consen 84 ---NSTESGYELKLANRLFVSKSLKLLQKFLELVKKLYKAEAESLDFSNDTEEAAKEINEWVEEHTNGKIKDLLSPDSID 160 (380)
T ss_pred ---ccccCCceEEEeeeheecCCccccHHHHHHHHHHHhCcceeecCccChHHHHHHHHHHHHHHcCCchhhhcCCCCCC
Confidence 23456789999999999999999999999999999999999999965789999999999999999999999999999
Q ss_pred ccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC-----------
Q 036497 156 DSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ----------- 222 (375)
Q Consensus 156 ~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~----------- 222 (375)
+.|.++|+||+||+|.|+.+|++..|+..+|++.+++.++||||++.+.+.|.. +..+++++|||++
T Consensus 161 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~VpmM~~~~~f~~~~~~~l~~~vl~LpY~~~~~sm~i~LP~ 240 (380)
T KOG2392|consen 161 SLTVLVLVNAIYFKGKWEKKFDKELTKESDFFLSEGTSVKVPMMHQEGSFRYAEDEDLFAVVLELPYKGSNLSMLILLPD 240 (380)
T ss_pred cchhheeeehheeehhhcCCCChhhccccccEECCCeEEEeechhccCccceEEeCCcceEEEECccCCCCeEEEEEeCC
Confidence 999999999999999999999999999999999999999999999999776544 4589999999997
Q ss_pred --CChHHHHHHccCcHHHHhccC-CccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccc
Q 036497 223 --DELPALEKKTGSQSGFLKDHI-PYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVG 297 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~-~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~ 297 (375)
+||.+++++|+. ..+..|. +......++|.||||+++.++||+++|++|||+++|++..|||++|+.++ +|++
T Consensus 241 ~~~gL~~le~~L~~--~~~~~~~~~~~~~~~v~v~lPKfkie~~~dL~~~L~~lGi~~~F~~~~adls~ls~~~~l~vs~ 318 (380)
T KOG2392|consen 241 ERDGLKELEKKLTS--ETLVEWLFSRMSEKVVEVSLPKFKIEFDYDLKEVLKQLGITDIFSESKADLSGLSESSNLYISK 318 (380)
T ss_pred CCCCHHHHHHHhCh--hhHHHhhhhhhhceeEEEECCCEEEEEEechHHHHHHcCChhccCCCccccccCccCCCeeeee
Confidence 589999999974 3444555 56667778999999999999999999999999999999669999999985 9999
Q ss_pred eeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 298 IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 298 ~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++||+.|||||+||+|||+|.+....++.+. +.+|.|||||+|+|+|+.|+.|||+|+|.+|
T Consensus 319 v~Hka~ieV~E~GteAaaat~~~~~~~~~~~--~~~f~adhPFlF~I~~~~t~~iLF~G~v~~P 380 (380)
T KOG2392|consen 319 VIHKAFIEVDEEGTEAAAATAVEIVLRSLPP--PEEFVADHPFLFVIRDNKTGSILFLGRVVDP 380 (380)
T ss_pred eeEEEEEEECCCCchhhhhhhhHHhhccCCC--CCeEECCCCEEEEEEECCCCcEEEEEEccCC
Confidence 9999999999999999999997666665533 5699999999999999999999999999998
|
|
| >cd02044 ov-serpin ovalbumin family of serpins (ov-serpins) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-73 Score=550.52 Aligned_cols=344 Identities=28% Similarity=0.412 Sum_probs=304.2
Q ss_pred hhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCCCCC
Q 036497 9 SEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGSANG 83 (375)
Q Consensus 9 ~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~~~~ 83 (375)
.++++||++||+++.... + ++||+||+.+|+||+.||+|+|++||.++||++..++++ .++.+...+.. ...
T Consensus 3 ~~~~~F~~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~---~~~ 79 (370)
T cd02044 3 LANSAFAVDVFKELSKKSALQNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHFDNVKDVHSSFQTLLSDINK---LNS 79 (370)
T ss_pred chhhHHHHHHHHHHhhcCCCCcEEECHHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCHHHHHHHHHHHHHHHhc---CCC
Confidence 467899999999997643 3 999999999999999999999999999999998766676 88888776652 234
Q ss_pred CCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEE
Q 036497 84 GPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFA 163 (375)
Q Consensus 84 ~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlv 163 (375)
+..+.++|++|++++++++++|.+.++++|+++++.+||.+++..+++.||+||+++|+|+|++++++++++++|+++|+
T Consensus 80 ~~~l~~a~~~~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~lv~~~~l~~~t~lvlv 159 (370)
T cd02044 80 FYSLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEETRGQINSWIKDQTKGKIENLLPENSVDSQTAMVVV 159 (370)
T ss_pred CceEeeeeehhhcCCCcccHHHHHHHHHhhccceEeccccCCHHHHHHHHHHHHHHhcCCchhhcCCCCCCCcchhheee
Confidence 56899999999999999999999999999999999999998777899999999999999999999998899999999999
Q ss_pred EeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC-------------CChHHH
Q 036497 164 NALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ-------------DELPAL 228 (375)
Q Consensus 164 na~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~-------------~~l~~l 228 (375)
||+||+|.|+.||++..|..++|+..+|+++.||||++.+.++|.+ ..++++|+|||++ .+|.++
T Consensus 160 nai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~~l~~l 239 (370)
T cd02044 160 NAAYFKGKWMKKFSEEETKESPFRVNKTETKPVQMMYMEATFNMGNIESLKMKILELPFANKDLSMFILLPDEVTGLEKL 239 (370)
T ss_pred eeeeEcccccCCCChhhCccCcCCcCCCcEEEeeCccccCceeeEEcCCCCeEEEEcccCCCceEEEEEcCCCCCcHHHH
Confidence 9999999999999999999999999999999999999988777654 3489999999987 568899
Q ss_pred HHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--CccceeeeeEE
Q 036497 229 EKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQKSFI 304 (375)
Q Consensus 229 ~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk~~i 304 (375)
++.|+. ..+..+.. ..+...++|.||||++++++||+++|++||++++|++..|||++|++.+ +|++++|++.|
T Consensus 240 ~~~l~~--~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~mGl~~~F~~~~Adfs~ms~~~~l~vs~v~qka~i 317 (370)
T cd02044 240 ESEINY--EKLNKWTSPSTMAEAKVKVYLPRFKMEKMYDLKSVLESLGMKDAFSEGRANFSGMSETKGLALSNVIHKASL 317 (370)
T ss_pred HHHhCH--HHHHHhhccccceeeEEEEEeeEEEEeeEEccHHHHHHcCchhhCCCCCCChhhcCCCCCeeEeeeeEeeEE
Confidence 999863 34544442 3344556899999999999999999999999999998679999999754 99999999999
Q ss_pred EEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 305 EVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 305 ev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
+|||+|++|+|+|......++. +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 318 evdE~Gt~aaa~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 370 (370)
T cd02044 318 EINEDGTEAAEVTGAVMLQRSV----KEEFNADHPFLFIIRHNKTNCILFFGKFSSP 370 (370)
T ss_pred EECCCccccccccceeeeccCC----CCeEEeeCCEEEEEEECCCCeEEEEEEecCC
Confidence 9999999999999754333332 3589999999999999999999999999988
|
Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >cd02054 angiotensinogen Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-73 Score=545.29 Aligned_cols=338 Identities=18% Similarity=0.267 Sum_probs=290.9
Q ss_pred hhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChh------------hHH-HHH
Q 036497 7 SISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNE------------QQN-FAS 69 (375)
Q Consensus 7 ~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~------------~~~-~~~ 69 (375)
+.+++++||++||+++...+ + ++||+||+.+|+|++.||+|+|++||.++||++... ++. .++
T Consensus 2 ~~~~~~~f~~~l~~~l~~~~~~~N~v~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (372)
T cd02054 2 LAMLVNVLGLRMYGMLSELWVHTNTLLSPTSVFGTLASLYLGASKKTADSLQALLGLPWKSKNSDCTSRVDGHKVLSTLQ 81 (372)
T ss_pred hHHHHHHHHHHHHHHHHhhCCCCCEEEChHHHHHHHHHHHcCCCccHHHHHHHHhCCCcccccccccccccHHHHHHHHH
Confidence 35678899999999997532 3 999999999999999999999999999999997421 222 455
Q ss_pred HHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCe-eeEeeCCCChHHHHHHHHHHHHHHhccccccc
Q 036497 70 ELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS-SHQVDFQNKAVEVSREINFWAEKETNGFIKEV 148 (375)
Q Consensus 70 ~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~-~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~ 148 (375)
.+...+. .......+..+|++|++++++++++|++.++++|+++ ++.+||.+ ++.+++.||+||+++|+|+|+++
T Consensus 82 ~~~~~~~---~~~~~~~l~~a~~i~~~~~~~l~~~f~~~~~~~y~a~~~~~vdF~~-~~~a~~~IN~WV~~~T~g~I~~l 157 (372)
T cd02054 82 AIQSLVD---AQGRQLLLSTVVWTFTAPGIHLSQPFVQGLADFSDASFPRSVDFTE-PDVAEEKINNFVQATSDGKVKSS 157 (372)
T ss_pred HHHHHHc---CCCCccEEEEEEEEEecCCCCccHHHHHHHHHHhCcccceeecCCC-hHHHHHHHHHHHHHHhcCchhhh
Confidence 5554442 2234567999999999999999999999999999997 99999986 67889999999999999999999
Q ss_pred CCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC----
Q 036497 149 LPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ---- 222 (375)
Q Consensus 149 l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~---- 222 (375)
++ +++++|+++|+||+||+|.|+.||++..|. +|+..+|..++||||++.+.+.|.+.+ ++++++|||++
T Consensus 158 l~--~~~~~t~lvLvNaiyFkg~W~~~F~~~~T~--~f~~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~~~sm 233 (372)
T cd02054 158 LK--GLSPDSDLLFATSVHFQGNWKTASQLEEPQ--EFWVDNNTSVSVPMLSHTGTFKYLSDIQDNFSITQLPLSKRACL 233 (372)
T ss_pred cc--CCCCCCeEEEEEEEEEEHhhcCCCCcccce--eEEeCCCCEEEEeeeeccCcEEEEEecCCCcEEEEEeeCCCeEE
Confidence 95 688999999999999999999999999986 688888999999999999888877654 88999999986
Q ss_pred --------CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-
Q 036497 223 --------DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH- 293 (375)
Q Consensus 223 --------~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~- 293 (375)
.+|.++++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|+. .|||++|++.+
T Consensus 234 ~iiLP~~~~~l~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGi~~~F~~-~Adfs~i~~~~l 310 (372)
T cd02054 234 LLVQPHEGSDLDKVEGKLPQ--QNSSNWLKNLSPRTIELTLPKFSLQGSYDLQDLLAQMELPALLGS-EANLSKLSNDRF 310 (372)
T ss_pred EEEeCCCCCCHHHHHHhhCH--HHHHHHHHhCCceEEEEECCeEEEEEEeccHHHHHHcCCcccccC-ccccccccCCCc
Confidence 569999999963 344444444444556899999999999999999999999999986 89999999666
Q ss_pred CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 294 VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 294 ~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
+|++++||+.|||||+||+|+|+|... . . +.+.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 311 ~vs~v~hka~ieVdE~GteAaaat~~~---~-~--~~~~~f~~drPF~f~I~d~~t~~iLF~G~v~~P 372 (372)
T cd02054 311 TVGKVLNKVFFELSEDGTEVQESTQQL---N-K--PEVLEVTLNRPFLFAVYEANSNAILFLGRVTNP 372 (372)
T ss_pred eeeeeeeeEEEEEccCceecccccccc---c-C--CCCceEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999999999999999999742 1 1 124589999999999999999999999999988
|
It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02043 plant_SERPIN SERine Proteinase INhibitors (serpins), plant specific subgroup | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-73 Score=549.73 Aligned_cols=350 Identities=56% Similarity=0.875 Sum_probs=304.4
Q ss_pred hhhHHHHHHHHhcCCC----C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCCCCCC
Q 036497 11 QTDITLSLSKHIKAPT----S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGSANGG 84 (375)
Q Consensus 11 ~~~f~~~l~~~~~~~~----~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~~~~~ 84 (375)
+++||++||+++...+ + |+||+||+.+|+||++||+|+|++||.++||++..++++ .++.+.+.+..+.....+
T Consensus 3 ~~~~~~~l~~~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (381)
T cd02043 3 QCLVAMRLSGHVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTDELHAVAASIVDLVLADASASGG 82 (381)
T ss_pred hHHHHHHHHHHHhccCCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCChHHHHHHHHHHHHHHhhhcccCCC
Confidence 6789999999998763 2 999999999999999999999999999999998666666 777777665432122345
Q ss_pred CeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEEE
Q 036497 85 PRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFAN 164 (375)
Q Consensus 85 ~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlvn 164 (375)
..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++|+++++|
T Consensus 83 ~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l~lvn 162 (381)
T cd02043 83 PRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRTKAEEVRREVNSWVEKATNGLIKDILPPGSVDSSTKLVLAN 162 (381)
T ss_pred cEEehhhhHHHhCCCCcCHHHHHHHHhhhhccceeecCCCCHHHHHHHHHHHHHHHhcChHHhhCCCCCcCCCceEEEEe
Confidence 68999999999999999999999999999999999999977788999999999999999999999888999999999999
Q ss_pred eEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecCCeEEEEecccC-------------------CCh
Q 036497 165 ALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------------DEL 225 (375)
Q Consensus 165 a~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLPy~~-------------------~~l 225 (375)
|+||+|.|++||++..|.+++||..+|+++.||||++.+.++|.+.+++++|+|||++ .+|
T Consensus 163 ai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~~veLPy~~~~~~~~~~~sm~iiLP~~~~~L 242 (381)
T cd02043 163 ALYFKGAWSSKFDASDTKDRDFHLLDGTSVRVPFMSSEKDQYVAAFDGFKVLRLPYKRGGHDDARQFSMYIYLPDKKDGL 242 (381)
T ss_pred eeEEeeeeccCCccccCccccceeCCCCeEEeeeeeccCcccccccCCCEEEEcCCCCCCCCCCCcEEEEEEccCCCCCH
Confidence 9999999999999999999999999999999999998876667666789999999963 458
Q ss_pred HHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcC---CC-Cccceeee
Q 036497 226 PALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD---SH-VGVGIFQK 301 (375)
Q Consensus 226 ~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~---~~-~vs~~~qk 301 (375)
.+++++|......+..+....+...++|.||||++++++||+++|++||++++|++ .+++.+++. .+ +|++++|+
T Consensus 243 ~~l~~~l~~~~~~~~~~~~~~~~~~v~l~lPKF~i~~~~dl~~~L~~mGl~~~F~~-~~~~~~~~~~~~~~l~vs~v~hk 321 (381)
T cd02043 243 ADLLEKLVSEPGFLDRHIPASEQEVGAFMIPKFKFSFGFEASEVLKKLGLTLPFDP-GGALLSMSSPEGENLYVSSVYHK 321 (381)
T ss_pred HHHHHhhccChhhhhhhcccceeeEEEEEcccEEEEeecchHHHHHHCCCccccCC-ccccccCccCCCCCeeEEeeeeE
Confidence 88999986544455556666566667899999999999999999999999999998 666666542 34 99999999
Q ss_pred eEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 302 SFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 302 ~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
+.|+|||+||+|+|+|......++.+.+++.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 322 a~ieVdE~Gt~aaa~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 381 (381)
T cd02043 322 ACVEVDEEGTEAAAATAVVMSGTSSPPPRPVDFVADHPFLFLIREDKTGVVLFLGQVMNP 381 (381)
T ss_pred EEEEECCCcceehhccceeeccccCCCCCCceEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999999999985444344333445689999999999999999999999999998
|
It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02048 neuroserpin Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-74 Score=553.95 Aligned_cols=348 Identities=28% Similarity=0.474 Sum_probs=305.0
Q ss_pred hhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChh--hHH-HHHHHHHHHHhCCCC
Q 036497 9 SEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNE--QQN-FASELVAIVFADGSA 81 (375)
Q Consensus 9 ~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~--~~~-~~~~l~~~l~~~~~~ 81 (375)
++.++||++||+++...+ + |+||+||+.+|+||+.||+|+|++||.++||++... +.. .++.+...+.. .
T Consensus 2 ~~~~~Fa~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~---~ 78 (388)
T cd02048 2 EAIAELSVDLYNALRASKEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGLKNGEEFSFLKDLSSMITA---K 78 (388)
T ss_pred chhhHHHHHHHHHhhccCCCCcEEEChHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCCChHHHHHHHHHHHHHhcc---C
Confidence 467899999999997653 2 999999999999999999999999999999998642 333 56666655532 2
Q ss_pred CCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeE
Q 036497 82 NGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLV 161 (375)
Q Consensus 82 ~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lv 161 (375)
.....+.++|++|++++++++++|++.++++|+++++.+||.+ ++.+++.||+|++++|+|+|++++++.+++++|+++
T Consensus 79 ~~~~~l~~an~i~v~~~~~l~~~f~~~~~~~f~~~~~~vdF~~-~~~~~~~IN~wv~~~T~g~I~~l~~~~~l~~~t~lv 157 (388)
T cd02048 79 EKEYVFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFSQ-VKAVAEHINKWVENHTNNKIKDMFSSRDFTPLTRLV 157 (388)
T ss_pred CCccchHHhhhhHhhcCCCccHHHHHHHHHHhcCeeEEECCCC-hHHHHHHHHHHHHHhccCchhhcCCCccCCHHHHHH
Confidence 3456799999999999999999999999999999999999987 578999999999999999999999888899999999
Q ss_pred EEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--------CeEEEEecccC-----------
Q 036497 162 FANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--------GFKVLVLPYKQ----------- 222 (375)
Q Consensus 162 lvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--------~~~vveLPy~~----------- 222 (375)
|+||+||+|.|++||++..|...+|+..+|+.++||||++.+.++|++.+ ++++|+|||++
T Consensus 158 lvNai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~ 237 (388)
T cd02048 158 LVNALYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLELPYEGDEISLMIILSR 237 (388)
T ss_pred hhheEEEeeeccCCCCHHHCeeccEEECCCceEEeehhcccCcEEEEeccccccccccCcEEEEEecCCCceEEEEEccC
Confidence 99999999999999999999999999999999999999999988887754 48999999986
Q ss_pred --CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccce
Q 036497 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGI 298 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~ 298 (375)
.+|.++++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|++ .|||++|++++ +|+++
T Consensus 238 ~~~~l~~l~~~l~~--~~l~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~lGi~~~F~~-~adfs~i~~~~~l~vs~v 314 (388)
T cd02048 238 QEVPLATLEPLVKA--PLIEEWANSVKKQKVEVYLPRFKVEQKIDLKDVLKNLGITEIFSG-GADLSGISDSKELYVSKV 314 (388)
T ss_pred CCCCHHHHHHHhCh--HHHHHHHHhCceeEEEEEccEEEEEEEechHHHHHHcCCchhhcC-ccCcccccCCCCeEEEEE
Confidence 578999999963 345555555555667999999999999999999999999999996 89999999765 99999
Q ss_pred eeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcchhh
Q 036497 299 FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSIIN 365 (375)
Q Consensus 299 ~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~~~ 365 (375)
+|++.|+|||+|++|+|+|......++.. .+.+|+|||||+|+|+|+.||.|||+|+|.+|+..+
T Consensus 315 ~hka~ieV~E~Gt~a~a~t~~~~~~~~~~--~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P~~~~ 379 (388)
T cd02048 315 FHKVFLEVNEEGSEAAASSGMIAISRMAV--LYPQVIVDHPFFFLIRNRRTGSILFMGRVMHPETMT 379 (388)
T ss_pred EeeeEEEECCCcceehhhcccccccccCC--CCceEEecCCEEEEEEECCCCeEEEEEEecCCCccc
Confidence 99999999999999999997543334332 234899999999999999999999999999998765
|
It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. |
| >cd02059 ovalbumin_like The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-72 Score=546.24 Aligned_cols=346 Identities=33% Similarity=0.464 Sum_probs=303.0
Q ss_pred hhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-----------------hhHH-
Q 036497 9 SEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-----------------EQQN- 66 (375)
Q Consensus 9 ~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-----------------~~~~- 66 (375)
.++++||++||+++.... + |+||+||+.+|+||+.||+|+|++||.++|+++.. .+++
T Consensus 3 ~~~~~Fa~~l~~~~~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (389)
T cd02059 3 AANTEFCFDLFKELKKNHKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSSKPAASAQCNQSGGVHS 82 (389)
T ss_pred chhhHHHHHHHHHHhhcCCCCCEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCccccccccccccccccccHHHHHH
Confidence 578999999999998642 3 99999999999999999999999999999999742 2355
Q ss_pred HHHHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhccccc
Q 036497 67 FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIK 146 (375)
Q Consensus 67 ~~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~ 146 (375)
.++.+...+.+ +..+..++++|+||++++++++++|++.++++|+++++.+||.+.++.+++.||+|++++|+|+|+
T Consensus 83 ~~~~l~~~~~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I~ 159 (389)
T cd02059 83 QFKDLLSQINK---PNDDYELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAAEASRKKINSWVESQTNGKIK 159 (389)
T ss_pred HHHHHHHHHcC---CCCCcEEEEeeehhhhCCCCccHHHHHHHHHHhcCeeEEEcCCCCHHHHHHHHHHHHHHhccchhh
Confidence 77777766642 345678999999999999999999999999999999999999986667889999999999999999
Q ss_pred ccCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC--
Q 036497 147 EVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ-- 222 (375)
Q Consensus 147 ~~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~-- 222 (375)
+++++++++++|+++++||+||+|.|+.+|++..|..++|+..+|+.++|+||++.+.+.|+. ..+++||+|||++
T Consensus 160 ~~~~~~~i~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~~~vl~LPy~~~~ 239 (389)
T cd02059 160 NLFGKGTIDSSTVLVLVNAIYFKGKWEKKFEKENTVDAPFKLNENENKPVQMMYQIGKFKLASIEEPKMKILELPYAGGG 239 (389)
T ss_pred hcCCCCCCCcccceeeEeeeEEeeeccCCCCcccCccCccEeCCCceEEeehhcccCcEEEEEeCCCCcEEEEeecCCCc
Confidence 999988999999999999999999999999999999999999999999999999988776544 4589999999987
Q ss_pred -----------CChHHHHHHccCcHHHHhccC--CccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCC
Q 036497 223 -----------DELPALEKKTGSQSGFLKDHI--PYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEM 289 (375)
Q Consensus 223 -----------~~l~~l~~~L~~~~~~l~~~~--~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~i 289 (375)
.+|.+++++|+. ..+..+. ...+...++|.||||++++++||+++|++||++++|++..|||++|
T Consensus 240 ~sm~iiLP~~~~~L~~l~~~l~~--~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~mGi~~~F~~~~adfs~~ 317 (389)
T cd02059 240 LSMIVLLPDEISGLEQLESKLTY--EKLMEWTSSENMRERKVEVYLPRFKLEEKYNLKSVLKAMGMTDIFSESKADLSGI 317 (389)
T ss_pred eEEEEEccCCCCCHHHHHHHhCH--HHHHHhhhhhcceeeEEEEECCCEEeeeeecHHHHHHHcCCccccCCcccccccc
Confidence 479999999963 2343333 2344556789999999999999999999999999999866999999
Q ss_pred cCCC--CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 290 VDSH--VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 290 s~~~--~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++++ +|++++|++.|||||+|++|+|+|......++. +++.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 318 ~~~~~l~v~~v~hka~ieV~E~G~~a~a~t~~~~~~~~~--~~~~~f~~nrPF~f~I~~~~t~~iLF~G~v~~P 389 (389)
T cd02059 318 SSSKSLYLSKAIHKSYVEVNEEGTEAAAATGAGIVEKSL--PVSEEFRADHPFLFFIRHNKTNTILFFGRFSSP 389 (389)
T ss_pred CCCCCceEeeeeeeEEEEECCCceeecccccceeeecCC--CCCceEEecCCEEEEEEECCCCeEEEEEEecCC
Confidence 9764 999999999999999999999999854443443 335689999999999999999999999999998
|
Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. |
| >cd02045 antithrombin-III_like Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-73 Score=546.34 Aligned_cols=348 Identities=32% Similarity=0.503 Sum_probs=302.3
Q ss_pred HhhhhhhhHHHHHHHHhcCC----CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC-----hhhHH-HHHHHHHH
Q 036497 6 ESISEQTDITLSLSKHIKAP----TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS-----NEQQN-FASELVAI 74 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~----~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~-----~~~~~-~~~~l~~~ 74 (375)
.+..++++||++||+++... .+ ++||+||+.+|+||+.||+|+|++||.++|+++. .++++ .++.+...
T Consensus 4 ~~~~~~~~Fa~~l~~~l~~~~~~~~Niv~SP~si~~aL~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~~~ 83 (381)
T cd02045 4 ELSKANSRFALAFYKHLADSKSNDENIFLSPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEKTSDQVHFFFAKLNCR 83 (381)
T ss_pred hhhhhhhHHHHHHHHHHhcccCCCCCEEECcHHHHHHHHHHhhhcCCcHHHHHHHHhCCCccccccHHHHHHHHHHHHHH
Confidence 45668899999999999753 23 9999999999999999999999999999999963 13455 67777666
Q ss_pred HHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCC
Q 036497 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSV 154 (375)
Q Consensus 75 l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~ 154 (375)
+... ...+..+.++|++|++++++++++|.+.++++|+++++.+||.++++.+++.||+|++++|+|+|+++++++++
T Consensus 84 ~~~~--~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I~~ll~~~~l 161 (381)
T cd02045 84 LYRK--ANKSSELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEKPELSRITINEWIANKTENRITDVIPEGAI 161 (381)
T ss_pred Hhcc--cCCcchhhhhhhhhhcCCCchhHHHHHHHHHhhcCeeEEecCCCCHHHHHHHHHHHHHHHHhhHHHhhCCCCCC
Confidence 5421 23456799999999999999999999999999999999999987677788999999999999999999988899
Q ss_pred CccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC----------
Q 036497 155 DDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ---------- 222 (375)
Q Consensus 155 ~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~---------- 222 (375)
+++|+++|+||+||+|.|+.||++..|..++||..+|++++||||++.+.+.|+.. .++++|+|||++
T Consensus 162 ~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~~l~LPy~~~~~sm~iilP 241 (381)
T cd02045 162 DTNTVLVLVNAIYFKGLWKSKFDKENTRKDLFHKAPGEKCPVPMMYQESKFRYAKIPEDKVQVLELPYKGDDITMVLILP 241 (381)
T ss_pred CCccceeeEeeeEEeccccCCCCcccCcccccCcCCCcEEEEeccCccceeeeEecCCCCcEEEEeecCCCceEEEEEeC
Confidence 99999999999999999999999999999999999999999999999988888764 489999999986
Q ss_pred ---CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC---C-Cc
Q 036497 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS---H-VG 295 (375)
Q Consensus 223 ---~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~---~-~v 295 (375)
.+|.+++++|+. ..+..++...+...++|.||||++++++||+++|++||++++|++..|||++|+.+ + +|
T Consensus 242 ~~~~~l~~l~~~l~~--~~l~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~lGi~~~F~~~~Adfs~i~~~~~~~l~v 319 (381)
T cd02045 242 KEGTTLSEVEQNLTL--DKLQGWLDAMKETTLAVQIPRFRVEDSFSVKEQLQKMGLEDLFSPENAKLPGIVAGGRTDLYV 319 (381)
T ss_pred CCCCCHHHHHHhcCH--HHHHHHHHhCcCcEEEEECCCEEEeeEecHHHHHHHcCCcccCCCCCCCccccccCCCCCcee
Confidence 569999999963 34544544444445689999999999999999999999999999867999999853 4 99
Q ss_pred cceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEe
Q 036497 296 VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMF 358 (375)
Q Consensus 296 s~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 358 (375)
++++||+.|+|||+|++|+|+|......++.+ .++++|++||||+|+|+|+.|+.|||+|||
T Consensus 320 s~v~hka~ieV~E~GteAaaat~~~~~~~s~~-~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v 381 (381)
T cd02045 320 SDAFHKAFLEVNEEGSEASAATAVVITGRSLN-INRIIFVANRPFLLFIREVAINAIIFMGRV 381 (381)
T ss_pred eccceeeEEEECCCCeehhhhhhhhhhhccCC-CCCCEEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 99999999999999999999997544445442 234689999999999999999999999996
|
It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily. |
| >cd02057 maspin_like Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-73 Score=545.44 Aligned_cols=342 Identities=26% Similarity=0.370 Sum_probs=298.2
Q ss_pred hhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCCCCC
Q 036497 9 SEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGSANG 83 (375)
Q Consensus 9 ~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~~~~ 83 (375)
.++++||++||+++...+ + ++||+||+.+|+||+.||+|+|++||.++||++...+++ .++.+...+.+ ...
T Consensus 3 ~~~~~F~~~l~~~~~~~~~~~Nvv~SP~si~~aL~ml~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~---~~~ 79 (372)
T cd02057 3 LANTAFAVDLFKKLCEKEPTGNVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFENVKDVPFGFQTVTSDVSK---LSS 79 (372)
T ss_pred chhhHHHHHHHHHHhccCCCCcEEECHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCChhHHHHHHHHHHHHHhc---CCc
Confidence 478999999999997643 3 999999999999999999999999999999998655555 67777665532 123
Q ss_pred CCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEE
Q 036497 84 GPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFA 163 (375)
Q Consensus 84 ~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlv 163 (375)
...+.++|++|++++++++++|.+.++++|+++++.+||.+++..+++.||+||+++|+|+|++++++++++++|+++++
T Consensus 80 ~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~l~~~~~i~~~t~l~lv 159 (372)
T cd02057 80 FYSLKLIKRLYVDKSLNLSTDFINSTKRPYPKELETVDFKDKLEETRGQINNSIKELTDGHFENILNENSVNDQTKILVV 159 (372)
T ss_pred cchhHhhhhhhhhCCCCccHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhccChhhhcCCCCCCCCCCceeee
Confidence 45689999999999999999999999999999999999998777899999999999999999999988899999999999
Q ss_pred EeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC-----------------CC
Q 036497 164 NALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ-----------------DE 224 (375)
Q Consensus 164 na~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~-----------------~~ 224 (375)
||+||+|.|+.||++..|..++|+..+|+.+.||||++.+.+.|+. ..++++|+|||++ .+
T Consensus 160 Na~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~~~~~~ 239 (372)
T cd02057 160 NAAYFVGNWMKKFPESETKECPFRVNKTETKPVQMMNLEATFSMGYIDELNTKILELPFQNKHLSMLILLPKDIEDESTG 239 (372)
T ss_pred ehheeccccCCCCCccccccCCCEECCCceEeeEhhheeceEEeEEeCCcCceEEEeecCCCCEEEEEEecCcccccccc
Confidence 9999999999999999999999999999999999999887766544 4589999999986 16
Q ss_pred hHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccceee
Q 036497 225 LPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQ 300 (375)
Q Consensus 225 l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~q 300 (375)
|.++++.|+. ..+..+.. ..+...++|.||||++++++||+++|++||++++|++..|||++|++++ +|++++|
T Consensus 240 L~~l~~~l~~--~~l~~~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGi~~~F~~~~adfs~i~~~~~l~vs~v~h 317 (372)
T cd02057 240 LEKLEKQLTS--ESLSQWTNPSMMANAKVKVSLPKFKVEKMIDLKAMLESLGLKHIFNEDASDFSGMSETKGVALSNVIH 317 (372)
T ss_pred HHHHHHhcCh--hHHHHhhchhcceeEEEEEECCcEEEEEEechHHHHHHcCChhhcCCcccccccccCCCceEEEeeee
Confidence 8899999963 33444432 2334556899999999999999999999999999998679999999765 9999999
Q ss_pred eeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 301 KSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 301 k~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++.|||||+|++|+|+|.... . +.+..|+|||||+|+|+|+.|+.|||+|+|.+|
T Consensus 318 k~~ieVdE~Gt~a~a~t~~~~----~--~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~p 372 (372)
T cd02057 318 KVCLEVNEDGGESIEVPGARI----L--QHKDEFNADHPFIFIIRHNKTRNIIFFGRFCSP 372 (372)
T ss_pred eeEEEECCCCeecchhcceec----c--CCCCeEEeeCCEEEEEEECCCCeEEEEEEecCC
Confidence 999999999999999987421 1 123579999999999999999999999999988
|
Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02058 PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-72 Score=543.15 Aligned_cols=347 Identities=32% Similarity=0.471 Sum_probs=302.4
Q ss_pred hhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHHHhC
Q 036497 8 ISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIVFAD 78 (375)
Q Consensus 8 ~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l~~~ 78 (375)
..++++||++||+++.... + ++||+||+.+|+||+.||+|+|++||.++||++.. .+++ .++.+.+.+.+
T Consensus 2 ~~~~~~F~~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~~~~- 80 (380)
T cd02058 2 SAANTSFALNLFKKLAESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNSEDIHSGFQSLLSEINK- 80 (380)
T ss_pred chhhhHHHHHHHHHHhhcCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCcCccccchHHHHHHHHHHHHHHhC-
Confidence 3578999999999997643 3 99999999999999999999999999999999764 4566 78888876642
Q ss_pred CCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccC
Q 036497 79 GSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSS 158 (375)
Q Consensus 79 ~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t 158 (375)
+.....+.++|+||++++++++++|++.++++|++++..+||.+++..+++.||+||+++|+|+|++++++++++++|
T Consensus 81 --~~~~~~l~~~n~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t 158 (380)
T cd02058 81 --PGTNYLLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVDFVEAAEQARKEINSWVERQTEGKIQNLLPPGSVDSLT 158 (380)
T ss_pred --CCCccEeehhhhhhhcCCCcHhHHHHHHHHhhhcCceEEecCCCCHHHHHHHHHHHHHHhcccchhhcCCcCCCChhH
Confidence 334568999999999999999999999999999999999999887778999999999999999999999888999999
Q ss_pred eeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC--------------
Q 036497 159 KLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ-------------- 222 (375)
Q Consensus 159 ~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~-------------- 222 (375)
+++++||+||+|.|+.||++..|..++|+..+|+.++||||++.+.+.|.+ ..++++|+|||++
T Consensus 159 ~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~ 238 (380)
T cd02058 159 RLVLVNAIYFKGNWEEKFLKENTRERPFRLNKNTTKPVQMMFLKKKFPITYIEELKAQVLELPYVGKELSMFILLPDEIE 238 (380)
T ss_pred HhHhhheeEEccccCCCCCcccCCcccccCCCCceEEeechhhcCceeeEEcCCCCcEEEEccCCCCceEEEEEeccccc
Confidence 999999999999999999999999999999999999999999988766654 4588999999986
Q ss_pred ---CChHHHHHHccCcHHHHhccC--CccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cc
Q 036497 223 ---DELPALEKKTGSQSGFLKDHI--PYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VG 295 (375)
Q Consensus 223 ---~~l~~l~~~L~~~~~~l~~~~--~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~v 295 (375)
.+|.+++++|+. ..+..+. ...+...++|.||||++++++||+++|++||++++|++..|||++|+.++ +|
T Consensus 239 ~~~~~L~~l~~~l~~--~~l~~~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGl~~~F~~~~adfs~i~~~~~l~v 316 (380)
T cd02058 239 DVTTGLEKLEKELTY--EKLNEWTSPEMMEEYEVEVYLPKFKLEESYDLKSTLSSMGMEDAFDPGKADFSGMSSANDLFL 316 (380)
T ss_pred cccchHHHHHHHhCH--HHHHHhhhhhcceeeEEEEEeeEEEEeeeeccHHHHHHcCccccCCcccccccCCCCCCCCcc
Confidence 247888888853 3344443 23344556899999999999999999999999999998679999998754 99
Q ss_pred cceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 296 VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 296 s~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++++|++.|||||+|++|+|+|......++. +++++|+|||||+|+|+|+.|+.|||+|+|.+|
T Consensus 317 s~v~hk~~ieV~E~G~~a~a~t~~~~~~~~~--~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P 380 (380)
T cd02058 317 SKVFHKAFVEVNEEGTEAAAATAAIMMLRCL--MPSPRFNADHPFLFFIRHNKTNTILFFGRFCSP 380 (380)
T ss_pred cccceeeEEEECCCCcccccccchheeeccC--CCCCeEEEECCEEEEEEECCCCeEEEEEEecCC
Confidence 9999999999999999999999754433332 224689999999999999999999999999988
|
PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. |
| >cd02051 PAI-1_nexin-1 Plasminogen activator inhibitor-1_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-72 Score=540.70 Aligned_cols=344 Identities=25% Similarity=0.423 Sum_probs=300.7
Q ss_pred hhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCCC
Q 036497 7 SISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGSA 81 (375)
Q Consensus 7 ~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~~ 81 (375)
...+.++||++||+++.... + ++||+||+.+|+||+.||+|+|+.||.++||++. +++. .++.+.+.+.. .
T Consensus 7 ~~~~~~~F~~~l~~~~~~~~~~~N~v~SP~si~~~L~~l~~GA~g~T~~el~~~L~~~~-~~~~~~~~~l~~~l~~---~ 82 (377)
T cd02051 7 LEELGSDFGIQVFNQVAQARPQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYKI-NGVAKALKKLNKAIVS---K 82 (377)
T ss_pred HHHHHhHHHHHHHHHHHhcCCCCcEEECcHHHHHHHHHHHhhcCCcHHHHHHHHhCCCh-hHHHHHHHHHHHHHhc---c
Confidence 45688999999999997643 2 9999999999999999999999999999999975 3454 67777666532 2
Q ss_pred CCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCC-CCCccCee
Q 036497 82 NGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPG-SVDDSSKL 160 (375)
Q Consensus 82 ~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~-~~~~~t~l 160 (375)
.++..+.++|++|++++++++++|.+.++++|+++++.+||.+ ++.+++.||+|++++|+|+|++++++. .++++|++
T Consensus 83 ~~~~~l~~an~i~~~~~~~l~~~f~~~~~~~f~a~~~~vdF~~-~~~a~~~IN~Wv~~~T~g~I~~~l~~~~~i~~~t~l 161 (377)
T cd02051 83 KNKDIVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSD-PETAAFSINDWVKNETKGMIDNLLSPDLADDALTRL 161 (377)
T ss_pred CCccchHHHHHHHhcCCCchhHHHHHHHHHHhcCeeEEECCCC-HHHHHHHHHHHHHHhcCCCccccCCCCCCCCccceE
Confidence 3345789999999999999999999999999999999999986 678999999999999999999999876 78889999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec-----CCeEEEEecccC-------------
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF-----DGFKVLVLPYKQ------------- 222 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~-----~~~~vveLPy~~------------- 222 (375)
+|+||+||+|.|+.||++..|.+++||..+|+.+.||||++.+.++|++. .++++|+|||++
T Consensus 162 ~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~ 241 (377)
T cd02051 162 VLVNALYFKGLWKSRFQPESTKKRTFHAGDGKTYQVPMLAQLSVFRSGSASTPNGLWYNIIELPYHGESISMLIALPTEK 241 (377)
T ss_pred EEEeeeEeeeeecCCCChhhCcccccCcCCCcEEeehhhcccCceeeEeeccccccccEEEEEecCCCeEEEEEEecccc
Confidence 99999999999999999999999999999999999999999887777653 248999999976
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Ccccee
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIF 299 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~ 299 (375)
.+|.+++++|+. ..+..+.+..+...++|.||||++++++||+++|++||++++|++..|||++|++.+ +|++++
T Consensus 242 ~~~L~~l~~~l~~--~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGl~~~F~~~~Adfs~i~~~~~l~v~~v~ 319 (377)
T cd02051 242 STPLSAIIPHIST--KTIQSWMGTMVPKRMQLVLPKFTVEAETDLKEPLKALGITDMFDQSKANFTKISRSESLHVSHAL 319 (377)
T ss_pred CCCHHHHHHhcCH--HHHHHHHHhCCceEEEEEccCEEEEEecChHHHHHHCCCcccccCCCCCcccccCCCCEEEEeEE
Confidence 258999999863 445555555555667999999999999999999999999999997689999998764 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 300 QKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
|++.|+|||+|++|+|+|......++. +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 320 hka~iev~E~Gt~aaa~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~~LF~G~v~~P 377 (377)
T cd02051 320 QKAKIEVNEDGTKASAATTAILIARSS----PPWFIVDRPFLFFIRHNPTGTILFMGQINKP 377 (377)
T ss_pred EEEEEEECCCccchhhhcceeeeccCC----CCeEEeeCCEEEEEEeCCCCcEEEEEEecCC
Confidence 999999999999999999754444443 3479999999999999999999999999998
|
Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02047 HCII Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-71 Score=542.38 Aligned_cols=346 Identities=27% Similarity=0.394 Sum_probs=301.4
Q ss_pred hhHHhhhhhhhHHHHHHHHhcCC----CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh---------hhHH-H
Q 036497 3 DVLESISEQTDITLSLSKHIKAP----TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN---------EQQN-F 67 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~~~----~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~---------~~~~-~ 67 (375)
.+..+..++++||++||+++... .+ ++||+||+.+|+||++||+|+|++||.++||+++. .+++ .
T Consensus 61 ~~~~~~~~~~~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~Lg~~~~~~~~~~~~~~~~~~~ 140 (436)
T cd02047 61 RIQRLNILNANFGFNLYRVLKDQVNTSDNILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSKYEITTVHNL 140 (436)
T ss_pred hhhHHHHHHhHHHHHHHHHHhhccCCCCcEEEChHHHHHHHHHHHhhcccHHHHHHHHHhcccccccccccccHHHHHHH
Confidence 35567778999999999999752 23 99999999999999999999999999999999631 2355 7
Q ss_pred HHHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccc
Q 036497 68 ASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKE 147 (375)
Q Consensus 68 ~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~ 147 (375)
++.+.+.+.. ...+..+.++|++|+++++.++++|++.++++|+++++.+||.+ + .++..||+||+++|+|+|++
T Consensus 141 ~~~l~~~l~~---~~~~~~L~~an~l~v~~~~~l~~~F~~~~~~~y~a~v~~vdF~~-~-~~~~~IN~wV~~~T~g~I~~ 215 (436)
T cd02047 141 FRKLTHRLFR---RNFGYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFSD-P-AFITKTNNRIQKLTKGLIKE 215 (436)
T ss_pred HHHHHHHhhc---CCCCcEEeeeeehhhhCCCCccHHHHHHHHHHhcCceEEeCCCC-H-HHHHHHHHHHHHhcCCcccc
Confidence 7777766642 23456899999999999999999999999999999999999987 4 45678999999999999999
Q ss_pred cCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC---
Q 036497 148 VLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ--- 222 (375)
Q Consensus 148 ~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~--- 222 (375)
++. +++++|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|++.+ ++++++|||++
T Consensus 216 ~l~--~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~MM~~~~~~~y~~~~~l~~~vleLPy~~~~S 293 (436)
T cd02047 216 ALE--NVDPATLMMILNCIYFKGTWENKFPVEMTHNRNFRLNEKEVVKVPMMQTKGNFLAAADPELDCDILQLPYVGNIS 293 (436)
T ss_pred ccc--cCCcccceeeeeeeEEechhhCcCCcccccCcCCEeCCCCEEEEehhcccceEEEEEcCCcCcEEEEecCCCCee
Confidence 995 68899999999999999999999999999999999999999999999988877776654 68999999986
Q ss_pred ---------CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC
Q 036497 223 ---------DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH 293 (375)
Q Consensus 223 ---------~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~ 293 (375)
.+|.+++++|+. ..+..+......+.++|.||||++++++||+++|++||++++|+. .|||++|++++
T Consensus 294 M~iiLP~~~~gL~~l~~~L~~--~~l~~~~~~~~~~~v~v~LPKFkie~~~dL~~~L~~lGi~~lF~~-~adfs~is~~~ 370 (436)
T cd02047 294 MLIVVPHKLSGMKTLEKQITP--QVVERWQKSMTNRTREVVLPKFKLEKNYNLIESLKLMGITDLFTE-KGNMAGVSDEK 370 (436)
T ss_pred EEEEeCcccCCHHHHHHHhCH--HHHHHHHHhCceeEEEEEeccEEEEeeecHHHHHHhcChhhhcCC-cccccccCCCC
Confidence 579999999963 445555555555567899999999999999999999999999997 89999999888
Q ss_pred -CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 294 -VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 294 -~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
+|++++|++.|+|||+|++|+|+|.+....++ .+..|++||||+|+|+|+.|+.|||+|+|.+|+
T Consensus 371 l~vs~v~hka~IeVdE~GteAaa~T~~~~~~~~----~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~ 436 (436)
T cd02047 371 IAIDLFKHQGTITVNEEGTEAAAVTTVGFMPLS----TQVRFIVDRPFLFLIYEHRTNCLLFMGRVANPS 436 (436)
T ss_pred eEEEeeeeeeEEEEcCCcccchhccccccccCC----CCcEEEeeCCEEEEEEECCCCcEEEEEEecCCC
Confidence 99999999999999999999999974333222 235799999999999999999999999999995
|
HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily. |
| >cd02049 bacterial_SERPIN SERine Proteinase INhibitors (serpins), prokaryotic subgroup | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-72 Score=536.80 Aligned_cols=342 Identities=32% Similarity=0.516 Sum_probs=302.4
Q ss_pred hhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh--hhHH-HHHHHHHHHHhCCC
Q 036497 8 ISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN--EQQN-FASELVAIVFADGS 80 (375)
Q Consensus 8 ~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--~~~~-~~~~l~~~l~~~~~ 80 (375)
..++++||++||+++.... + ++||+||+.+|+||+.||+|+|++||.++||++.. .+++ .++.+...+..
T Consensus 2 ~~~~~~F~~~l~~~~~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l~~--- 78 (364)
T cd02049 2 NDANTRFGFKLFSELNKEDVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALGLDNIDLEDLNSALATLMDQLNT--- 78 (364)
T ss_pred cchhhHHHHHHHHHHhhcCCCCCEEECHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHhc---
Confidence 3578999999999997652 3 99999999999999999999999999999999863 3566 78888776642
Q ss_pred CCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCee
Q 036497 81 ANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKL 160 (375)
Q Consensus 81 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~l 160 (375)
...+..+.++|++|++++++++++|++.++++|+++++.+||.+ + .+++.||+|++++|+|+|++++.+ ++++|++
T Consensus 79 ~~~~~~l~~an~i~~~~~~~~~~~f~~~~~~~~~~~v~~~dF~~-~-~a~~~IN~wv~~~T~g~I~~~~~~--i~~~t~l 154 (364)
T cd02049 79 HDKTVELIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELDFQS-P-AAAEEINRWVKEKTKGKIDKIVDK--IDPDDVM 154 (364)
T ss_pred CCCCcEEEeehhhHhhCCCCccHHHHHHHHHhhcccceeeCCCC-H-HHHHHHHHHHHHhhcChHHHhcCC--CCCCceE
Confidence 23457899999999999999999999999999999999999987 4 589999999999999999999963 9999999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecCCeEEEEecccC-------------CChHH
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------DELPA 227 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLPy~~-------------~~l~~ 227 (375)
+++||+||+|.|+.||++..|.+++|++.+|+.+.||||++.+.+.|.+.+++++++|||++ .+|.+
T Consensus 155 vlvna~~fk~~W~~~F~~~~T~~~~F~~~~~~~~~v~mM~~~~~~~y~~~~~~~~l~Lpy~~~~~sm~iiLP~~~~~l~~ 234 (364)
T cd02049 155 FLINAVYFKGDWQEPFDKQSTYEAPFYLPDGSTKEVPFMSRTGNFRYLETPGFQAVRLPYGDGRLSMYVFLPKENVSLRE 234 (364)
T ss_pred EEEeeEEEeeeecCCCChhhcccCcCCCCCCCEEECcccCCcCcEeeEEcCCCeEEEeecCCCcEEEEEEecCCCCCHHH
Confidence 99999999999999999999999999999999999999999999999988899999999986 56999
Q ss_pred HHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-CccceeeeeEEEE
Q 036497 228 LEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQKSFIEV 306 (375)
Q Consensus 228 l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~qk~~iev 306 (375)
++++|+. ..+..+....+...++|.||||++++++||+++|++||++++|++..|||+++++++ +|++++|++.|+|
T Consensus 235 l~~~l~~--~~~~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~mGi~~~F~~~~a~~s~~~~~~l~vs~v~hka~iev 312 (364)
T cd02049 235 FVKTLTA--EKWRKWIEQFRMREGSLSLPRFQLEYEIELRDALKALGMEEAFTPDAADFSKLGEGNLYISKVIHKTFIEV 312 (364)
T ss_pred HHHHhCH--HHHHHHHHhCceeEEEEEeeeEEccceechHHHHHHCcccccCCCCcCCCCCCCCCCeEEEeeeeeEEEEE
Confidence 9999973 344555555555667999999999999999999999999999998789999998877 9999999999999
Q ss_pred cCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEe
Q 036497 307 KEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMF 358 (375)
Q Consensus 307 ~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 358 (375)
||+|++|+|+|......++.+.+++++|++||||+|+|+|+.|+.|||+|||
T Consensus 313 ~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v 364 (364)
T cd02049 313 NEEGTEAAAATSVEITETSAPAGEPFTMVADRPFLFAIRDNRTGSILFMGAV 364 (364)
T ss_pred ccCceeecccceeeeeeccCCCCCCceEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 9999999999985433333321345789999999999999999999999996
|
Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors. |
| >cd02056 alpha-1-antitrypsin_like alpha-1-antitrypsin_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-72 Score=535.55 Aligned_cols=337 Identities=26% Similarity=0.419 Sum_probs=296.9
Q ss_pred hhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHHHhCCC
Q 036497 10 EQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIVFADGS 80 (375)
Q Consensus 10 ~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l~~~~~ 80 (375)
|+++||++||+++.... + ++||+||+.+|+||+.||+|+|++||.++||++.. ++++ .++.+...+..
T Consensus 1 ~~~~F~~~l~~~~~~~~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~~--- 77 (361)
T cd02056 1 ANADFAFRLYRQLASESPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISEEEIHQGFQHLLHLLNQ--- 77 (361)
T ss_pred CccHHHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHCccchhHHHHHHHHhcCCccCCCHHHHHHHHHHHHHHHcC---
Confidence 46899999999997542 3 99999999999999999999999999999999753 3556 78888776642
Q ss_pred CCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCee
Q 036497 81 ANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKL 160 (375)
Q Consensus 81 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~l 160 (375)
...+..+.++|+||++++++++++|++.++++|+++++.+||.+ +..+++.||+|++++|+|+|+++++ +++++|++
T Consensus 78 ~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~~dF~~-~~~~~~~IN~wv~~~T~g~I~~~~~--~i~~~t~l 154 (361)
T cd02056 78 PDSGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTDFQD-SAEAKKQINDYVEKKTHGKIVDLVK--DLDSDTVM 154 (361)
T ss_pred CCCcceEEeeeehhhhCCCChhHHHHHHHHHHhcCceEeeCCCC-hHHHHHHHHHHHHHHhhhhHHhhcC--CCCCCceE
Confidence 23456899999999999999999999999999999999999986 5789999999999999999999996 68999999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC-----------CChHH
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ-----------DELPA 227 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~-----------~~l~~ 227 (375)
+++||+||+|.|+.+|++..|..++|+..+|+.+.||||++.+.+.|++.+ ++++|+|||++ .+|.+
T Consensus 155 vlvna~~Fk~~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~~veLPy~~~~sm~iiLP~~~~l~~ 234 (361)
T cd02056 155 VLVNYIYFKGKWEKPFDPELTQEEDFFVDEKTTVKVPMMHQTGRYDYLHDSELSCTVVQMPYKGNATAFFVLPDEGKMKQ 234 (361)
T ss_pred EEEEEEeeeehccCCCCcccCcccCCEeCCCcEEEeecccccCcEeeEEcCCCCcEEEEEecCCCcEEEEEecCcchHHH
Confidence 999999999999999999999999999999999999999999988887766 89999999987 35888
Q ss_pred HHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--CccceeeeeEEE
Q 036497 228 LEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQKSFIE 305 (375)
Q Consensus 228 l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk~~ie 305 (375)
+++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|++ .|||++|++++ +|++++|++.|+
T Consensus 235 l~~~l~~--~~l~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~~Gi~~~F~~-~adfs~i~~~~~l~vs~v~qk~~ie 311 (361)
T cd02056 235 VEAALSR--DTLKKWSKLLSKRSVDLYLPKFSISGTYNLKDILPKMGITDVFSD-KADLSGITEQPNLKVSKAVHKAVLD 311 (361)
T ss_pred HHHhhCH--HHHHHHHHhCceeEEEEEeeeEEEeeeechHHHHHhcChhhhcCC-cCCccccCCCCCEEEEeeeeeeEEE
Confidence 8888863 345555555555667999999999999999999999999999986 89999999754 999999999999
Q ss_pred EcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEe
Q 036497 306 VKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMF 358 (375)
Q Consensus 306 v~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 358 (375)
|||+||+|+|+|......++. .+.+|+|||||+|+|+|+.|+.|||+|+|
T Consensus 312 v~E~Gt~aaa~t~~~~~~~~~---~~~~f~~drPF~f~I~~~~t~~iLF~G~v 361 (361)
T cd02056 312 VDEKGTEAAAATGVEITPMSA---LPPILKFNRPFLLLIFDRTTESILFLGKV 361 (361)
T ss_pred EcCCCcccccccchhhhcccC---CCCEEEEeCCEEEEEEECCCCcEEEEEeC
Confidence 999999999999854443332 24589999999999999999999999997
|
This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >smart00093 SERPIN SERine Proteinase INhibitors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-71 Score=533.74 Aligned_cols=334 Identities=33% Similarity=0.520 Sum_probs=292.4
Q ss_pred HHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHHHhCCCCCCCCe
Q 036497 16 LSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIVFADGSANGGPR 86 (375)
Q Consensus 16 ~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l~~~~~~~~~~~ 86 (375)
++||+++...+ + ++||+||+.+|+||+.||+|+|++||.++||++.. ++++ .++.+.+.+.. ...+..
T Consensus 1 ~~l~~~l~~~~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~~---~~~~~~ 77 (359)
T smart00093 1 FDLYKELAKESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGFNLTELSEADIHQGFQHLLQLLNR---PDSQLE 77 (359)
T ss_pred ChHHHHHhccCCCCeEEEChHHHHHHHHHHHcccCchHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHHhC---CCCcce
Confidence 36899987643 2 99999999999999999999999999999999854 2555 78888776642 234568
Q ss_pred EEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEEEeE
Q 036497 87 LSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANAL 166 (375)
Q Consensus 87 l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlvna~ 166 (375)
+.++|++|++++++++++|++.++++|+++++.+||.+.++.+++.||+||+++|+|+|+++++ +++++|+++|+||+
T Consensus 78 l~~an~i~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~lvlvnai 155 (359)
T smart00093 78 LKTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAEEAKKQINDWVEKKTQGKIKDLLS--DLDSDTRLVLVNAI 155 (359)
T ss_pred EEeeeeehccCCCchhHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhhhchHHHhcc--cCCCCceEEEEeeE
Confidence 9999999999999999999999999999999999999865679999999999999999999996 48899999999999
Q ss_pred EeeccccccccCCCCeeeeeecCCCcEEeecceecccc-ceeeec--CCeEEEEecccC-----------CChHHHHHHc
Q 036497 167 YFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNK-QLVTAF--DGFKVLVLPYKQ-----------DELPALEKKT 232 (375)
Q Consensus 167 ~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~-~~~~~~--~~~~vveLPy~~-----------~~l~~l~~~L 232 (375)
||+|.|+.||++..|..++|+..+|+.+.||||++.+. +.|++. .++++|+|||++ .+|.+++++|
T Consensus 156 yFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~y~~~~~~~~~vv~Lpy~~~~sm~iilP~~~~l~~l~~~l 235 (359)
T smart00093 156 YFKGKWKTPFDPELTREEDFHVDETTTVKVPMMSQTGRTFNYGHDEELNCQVLELPYKGNASMLIILPDEGGLEKLEKAL 235 (359)
T ss_pred EEeeECCCCCCcccceecccEeCCCeEEEEeceeccCceeEEEEcCCCCcEEEEEecCCCeeEEEEccCccHHHHHHHhh
Confidence 99999999999999999999999999999999999987 877754 479999999987 4588888888
Q ss_pred cCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC-C-CccceeeeeEEEEcCCc
Q 036497 233 GSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS-H-VGVGIFQKSFIEVKEEG 310 (375)
Q Consensus 233 ~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-~-~vs~~~qk~~iev~E~G 310 (375)
+. ..+..+....+...++|.||||++++++||+++|++||++++|+. .|||++|+++ + +|++++|++.|+|||+|
T Consensus 236 ~~--~~l~~~~~~~~~~~v~l~lPkf~i~~~~~l~~~L~~lGl~~~F~~-~adfs~i~~~~~l~vs~v~hka~ieVdE~G 312 (359)
T smart00093 236 TP--ETLKKWMKSLTKRSVELYLPKFKIEGTYDLKDVLEKLGITDLFSN-KADLSGISEDKDLKVSKVLHKAVLEVNEEG 312 (359)
T ss_pred CH--HHHHHHHHhccceEEEEEccEEEEEEEecHHHHHHHcCcchhccC-ccCcccccCCCCeEEEeeeeEEEEEEcCCC
Confidence 63 344444444455567899999999999999999999999999995 8999999975 4 99999999999999999
Q ss_pred ccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 311 TEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 311 ~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++|+|+|......++. +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 313 t~aaa~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 359 (359)
T smart00093 313 TEAAAATGVIAVPRSL----PPEFKANRPFLFLIRDNKTGSILFMGKVVNP 359 (359)
T ss_pred ccccccccccccccCC----CceEEecCCEEEEEEECCCCeEEEEEecCCC
Confidence 9999999854333332 2689999999999999999999999999988
|
|
| >cd00172 SERPIN SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-71 Score=534.65 Aligned_cols=340 Identities=34% Similarity=0.538 Sum_probs=302.2
Q ss_pred hhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC--hhhHH-HHHHHHHHHHhCCCCC
Q 036497 10 EQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS--NEQQN-FASELVAIVFADGSAN 82 (375)
Q Consensus 10 ~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~--~~~~~-~~~~l~~~l~~~~~~~ 82 (375)
++++||++||+++...+ + ++||+||+.+|+||+.||+|+|++||.++||++. ..+++ .++.+.+.+.. ..
T Consensus 1 ~~~~Fa~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~l~~---~~ 77 (364)
T cd00172 1 ANNDFALDLYKQLAKSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSLDDEDVHQAFKSLLSSLKD---SE 77 (364)
T ss_pred CcchHHHHHHHHHhhcCCCCCEEEcHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHhC---CC
Confidence 36889999999998752 3 9999999999999999999999999999999984 45666 88888877753 23
Q ss_pred CCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEE
Q 036497 83 GGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVF 162 (375)
Q Consensus 83 ~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvl 162 (375)
+...+.++|++|+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++++++++++|+++|
T Consensus 78 ~~~~l~~an~~~~~~~~~~~~~f~~~~~~~~~~~~~~~dF~~-~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l~l 156 (364)
T cd00172 78 KGVELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVESVDFAN-PEAAAAQINNWVEEKTNGKIKDLLSPDALDPDTRLVL 156 (364)
T ss_pred CCceeeeehhhhhhCCCchhHHHHHHHHHHhcCeeEEEcCCC-hHHHHHHHHHHHHhhhcccchhhCCCCCCCcccceee
Confidence 456899999999999999999999999999999999999998 4789999999999999999999999888999999999
Q ss_pred EEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC-------------CChHH
Q 036497 163 ANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ-------------DELPA 227 (375)
Q Consensus 163 vna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~-------------~~l~~ 227 (375)
+||+||+|.|++||++..|..++|+..+|+.+.||||++.+.++|++.+ ++++|+|||++ .+|.+
T Consensus 157 vnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vv~lpy~~~~~sm~iilP~~~~~l~~ 236 (364)
T cd00172 157 VNAIYFKGKWKTPFDPELTRKRPFYVSEGESVQVPMMYQTGKFRYAEDEELDAQVLELPYKGSDLSMLIILPKEVTGLAE 236 (364)
T ss_pred eeheeeeeccCCCCChhhceecccEeCCCcEEEEeCccccCcEEEEEcCccCcEEEEeecCCCceEEEEEecCCCCcHHH
Confidence 9999999999999999999999999999999999999999988888877 99999999987 47999
Q ss_pred HHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--CccceeeeeEEE
Q 036497 228 LEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQKSFIE 305 (375)
Q Consensus 228 l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk~~ie 305 (375)
++++|+. ..++.+....+...++|.||||++++++||+++|++||++++|++ .|+|++++.++ +|++++|++.|+
T Consensus 237 l~~~l~~--~~l~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~~Gl~~~F~~-~a~~~~~~~~~~l~v~~v~hk~~ie 313 (364)
T cd00172 237 LEEKLSA--EKLDDLLSNLKEREVEVTLPKFKIESSLDLKEVLQALGITDLFSP-SADLSSISSDEPLYVSKVIHKAFIE 313 (364)
T ss_pred HHHhcCH--HHHHHHHHhCCeEEEEEEeeEEEEeeeeCcHHHHHHcCCccccCC-ccccccCCCCCCeEEEeeeeeeEEE
Confidence 9999963 445555555555667999999999999999999999999999998 89999987655 999999999999
Q ss_pred EcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEe
Q 036497 306 VKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMF 358 (375)
Q Consensus 306 v~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 358 (375)
|||+|++|+|+|......+ ..+.+..|++||||+|+|+|+.|+.|||+|+|
T Consensus 314 vdE~Gt~aaa~t~~~~~~~--~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v 364 (364)
T cd00172 314 VNEEGTEAAAATAVSIVPR--RPSPPVEFKADRPFLFLIRDDTTGTILFLGRV 364 (364)
T ss_pred ECCCceehhcccceeeccc--cCCCCCEEEEECCEEEEEEECCCCeEEEEEEC
Confidence 9999999999998533222 12335689999999999999999999999996
|
Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >cd02046 hsp47 Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-71 Score=532.22 Aligned_cols=340 Identities=21% Similarity=0.333 Sum_probs=294.5
Q ss_pred hhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh--hhHH-HHHHHHHHHHhCC
Q 036497 7 SISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN--EQQN-FASELVAIVFADG 79 (375)
Q Consensus 7 ~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--~~~~-~~~~l~~~l~~~~ 79 (375)
+..++++||++||+++...+ + ++||+||+.+|+||+.||+|+|++||.++|+++.. .+++ .++++...+..
T Consensus 3 ~~~~~~~f~~~l~~~~~~~~~~~N~v~SP~si~~aLa~l~~Ga~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l~~-- 80 (366)
T cd02046 3 LADRSAGLAFNLYHAMAKDKGVENILLSPVVVASSLGLVSMGGKASTASQAKAVLSADKLKDEHVHTGLSELLNEVSN-- 80 (366)
T ss_pred hhhhhhHHHHHHHHHhhccCCCCeEEEChHHHHHHHHHHHhhcCccHHHHHHHHhCCCCCCcHHHHHHHHHHHHHhhc--
Confidence 34578899999999998643 2 99999999999999999999999999999998643 3566 77777766532
Q ss_pred CCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCe
Q 036497 80 SANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSK 159 (375)
Q Consensus 80 ~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~ 159 (375)
....+..+.++|++|+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +++++|+
T Consensus 81 ~~~~~~~l~~an~~~~~~~~~l~~~F~~~~~~~y~~~~~~vdF~~-~~~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~ 157 (366)
T cd02046 81 STARNVTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFRD-KRSALNSINEWAAQTTDGKLPEVTK--DVEKTDG 157 (366)
T ss_pred CCCCCcEEEEeeehhhcCCCChhHHHHHHHHHHhcCeeEEecCCC-hHHHHHHHHHHHHHhcCCchhHhhc--cCCcchH
Confidence 122456899999999999999999999999999999999999987 5789999999999999999999984 6889999
Q ss_pred eEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC-------------CC
Q 036497 160 LVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ-------------DE 224 (375)
Q Consensus 160 lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~-------------~~ 224 (375)
++|+||+||+|.|+.||++..|..++||+.+|+.++||||++.+.+.|+.. .++++|+|||++ .+
T Consensus 158 l~lvnaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~y~~~~~~~~~vl~LPy~~~~~sm~iiLP~~~~~ 237 (366)
T cd02046 158 ALIVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVSVPMMHRTGLYGYYDDEENKLQIVEMPLAHKLSSMIFIMPYHVEP 237 (366)
T ss_pred hhhhheEEEcchhcCCCCHHhceeccEEeCCCeEEEhhHhhccCceeeEEeCCCCeEEEEEEcCCCcEEEEEEecCCCCC
Confidence 999999999999999999999999999999999999999999887777654 589999999986 57
Q ss_pred hHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC-C-Cccceeeee
Q 036497 225 LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS-H-VGVGIFQKS 302 (375)
Q Consensus 225 l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-~-~vs~~~qk~ 302 (375)
|.++++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|++..|||++|+++ + +|++++||+
T Consensus 238 L~~l~~~L~~--~~l~~~~~~~~~~~v~l~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~l~vs~v~hka 315 (366)
T cd02046 238 LERLEKLLTR--EQLKTWISKMKKRAVAISLPKVSLEVSHDLQKHLGDLGLTEAIDKSKADLSKISGKKDLYLSNVFHAA 315 (366)
T ss_pred HHHHHHHhCH--HHHHHHHHhcceeEEEEEcceEEeeEEEcHHHHHHHcCCccccCCCCCCcccCCCCCceeeeeeEEEE
Confidence 9999999963 34444555555566799999999999999999999999999999768999999976 4 999999999
Q ss_pred EEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEe
Q 036497 303 FIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMF 358 (375)
Q Consensus 303 ~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 358 (375)
.|||||+|++|++++.. .+. .+.+..|+|||||+|+|+|+.||.|||+|||
T Consensus 316 ~ieV~E~G~~aaa~~~~----~~~-~~~~~~f~~nrPF~f~I~~~~t~~iLF~G~v 366 (366)
T cd02046 316 ALEWDTEGNPFDPDIYG----REE-MRNPKLFYADHPFIFLVKDNKTNSILFIGRL 366 (366)
T ss_pred EEEECCCcchhhhhhhh----ccc-CCCCCEEEecCCEEEEEEECCCCcEEEEEeC
Confidence 99999999999876431 111 1224579999999999999999999999996
|
It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H. |
| >cd02052 PEDF Pigment epithelium-derived factor (PEDF)_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-71 Score=534.78 Aligned_cols=341 Identities=22% Similarity=0.313 Sum_probs=297.8
Q ss_pred chhHHhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh--hhHH-HHHHHHHH
Q 036497 2 DDVLESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN--EQQN-FASELVAI 74 (375)
Q Consensus 2 ~~~~~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--~~~~-~~~~l~~~ 74 (375)
|+...+..+.++||++||+++.... + ++||+||+.+|+||+.||+|+|++||+++||++.. .+++ .++.+.+.
T Consensus 10 ~~~~~l~~~~~~Fa~~l~~~l~~~~~~~Nvv~SP~si~~~L~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~ 89 (374)
T cd02052 10 TPRNKLAAAVSNFGYDLYRQQASRDPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYYDLLNDPELHDTYKDLLAS 89 (374)
T ss_pred CcHHHHHHHHHHHHHHHHHHHhccCCCCcEEEChHHHHHHHHHHHhccChHHHHHHHHHhCCCCCChHHHHHHHHHHHHH
Confidence 4667788899999999999997643 3 99999999999999999999999999999998642 4566 88888877
Q ss_pred HHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCC
Q 036497 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSV 154 (375)
Q Consensus 75 l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~ 154 (375)
+.. ....+.++|++|++++++++++|++.++++|+++++.+||.. .+++.||+|++++|+|+|+++++ ++
T Consensus 90 l~~-----~~~~l~~an~i~v~~~~~l~~~f~~~~~~~~~~~~~~~~~~~---~~~~~IN~wv~~~T~g~I~~~l~--~i 159 (374)
T cd02052 90 LTA-----PAKGLKSASRILLERKLRLRLEFVNQVEKSYGERPRILAGNA---LDLQEINDWVQQQTGGKVDRFVK--EI 159 (374)
T ss_pred hcC-----CCccchhhhHHHHhCCCchhHHHHHHHHHHhhCccccccCCH---HHHHHHHHHHHHhhcCcHHHhCC--CC
Confidence 642 223589999999999999999999999999999999999843 68899999999999999999996 48
Q ss_pred CccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccc-cceeeec--CCeEEEEecccC---------
Q 036497 155 DDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN-KQLVTAF--DGFKVLVLPYKQ--------- 222 (375)
Q Consensus 155 ~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~-~~~~~~~--~~~~vveLPy~~--------- 222 (375)
+++|+++|+||+||+|.|+.+|++..|..++||..+|++++||||++.+ .++|++. .++++|+|||++
T Consensus 160 ~~~t~l~lvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~vveLPy~~~~sm~iiLP 239 (374)
T cd02052 160 PRNVSILLLGSAYFKGQWITKFDKRNTVLTDFHLDEQRTVVVPMMSDPNAPVRYGLDSDLNCKIAQLPLTGGVSIMFFLP 239 (374)
T ss_pred CCccceEEEeeEEEechhcCCCCcccCccccEEcCCCcEEEEEeeccCCcceeeEEcCCCCcEEEEEecCCCeEEEEEec
Confidence 8999999999999999999999999999999999999999999999854 6666654 478999999987
Q ss_pred ---C-ChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-Cccc
Q 036497 223 ---D-ELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVG 297 (375)
Q Consensus 223 ---~-~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~ 297 (375)
. +|..+++.|+. ..++.+....+...++|.||||++++++||+++|++||++++|+. |||++|++++ +|++
T Consensus 240 ~~~~~~L~~l~~~l~~--~~~~~~~~~~~~~~v~v~lPKF~i~~~~~l~~~L~~lGl~~~F~~--adfs~i~~~~l~v~~ 315 (374)
T cd02052 240 DKVTQNLTLIEESLTS--EFVHDIDRELKTVKAVLTLPKLKLSYETELLPSLQELKLQSLFAS--PDFTKITSKPIKLSH 315 (374)
T ss_pred CCCCCCHHHHHhhcCH--HHHHHHHHhCeEEEEEEECccEEEEEEechHHHHHhcCCcccccc--cchhhccccceEeEe
Confidence 2 58889988863 445555555555667999999999999999999999999999985 9999999877 9999
Q ss_pred eeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 298 IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 298 ~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++|++.|||||+|++|+|+|..... ++ .+.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 316 v~hk~~ieVdE~Gt~aaa~t~~~~~-~~----~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 374 (374)
T cd02052 316 VHHKAVLELNEDGAETAPTPGSATA-LT----FPLEYHVDRPFLFVLRDEDTGALLFIGKVLDP 374 (374)
T ss_pred eEEEEEEEECCCccccccccccccc-cC----CCeEEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 9999999999999999999974321 22 14689999999999999999999999999998
|
PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily. |
| >PF00079 Serpin: Serpin (serine protease inhibitor); InterPro: IPR023796 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-70 Score=529.02 Aligned_cols=346 Identities=33% Similarity=0.537 Sum_probs=307.4
Q ss_pred hhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC--hhhHH-HHHHHHHHHHhCCCC
Q 036497 9 SEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS--NEQQN-FASELVAIVFADGSA 81 (375)
Q Consensus 9 ~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~--~~~~~-~~~~l~~~l~~~~~~ 81 (375)
+++++||++||+++...+ + |+||+||+.+|+||+.||+|+|++||.++||++. .++++ .++.+...+.. .+
T Consensus 1 ~a~~~f~~~L~~~~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l~~--~~ 78 (371)
T PF00079_consen 1 AANNQFALKLFKALSKSNPDENFVFSPLSIYSALAMLYLGASGETRKELRKVLGLPGSDDEEIHEYFKKLLQSLNS--SP 78 (371)
T ss_dssp HHHHHHHHHHHHHHHHHSTTSSEEE-HHHHHHHHHHHHHTSCHHHHHHHHHHTTCTTSTHHHHHHHHHHHHHHHHS--CS
T ss_pred ChHHHHHHHHHHHHHhhCCCCcEEEChHHHHHHHHHHHhhccCCHHHHHHHHhhhcccccccchhhhhhhhhhhhc--cc
Confidence 478999999999998755 2 9999999999999999999999999999999973 35666 88888887763 24
Q ss_pred CCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeE
Q 036497 82 NGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLV 161 (375)
Q Consensus 82 ~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lv 161 (375)
.++..+.++|++|++++++++++|++.++++|+++++.+||.+. ..+++.||+|++++|+|+|++++++++++++|.++
T Consensus 79 ~~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~-~~~~~~IN~wv~~~T~g~I~~~v~~~~i~~~t~~v 157 (371)
T PF00079_consen 79 SDNPQLKLANKLFVDKNLPLKPEFKKTLKKYFNAEVESVDFSDP-PQAAKEINKWVSEKTNGKIKNLVSPNDIDPDTRLV 157 (371)
T ss_dssp TSSSEEEEEEEEEEETTSEBEHHHHHHHHHHHSEEEEEEETTSH-HHHHHHHHHHHHHHTTTSSSTSSSTTSSSTTEEEE
T ss_pred cccccceeeeeeecccccccccccchhhhhcccccccccccccc-chhhhhhcchhhhhccceeeccccccchhhHHHHh
Confidence 56789999999999999999999999999999999999999984 56999999999999999999999988999999999
Q ss_pred EEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC------------CChHH
Q 036497 162 FANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ------------DELPA 227 (375)
Q Consensus 162 lvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~------------~~l~~ 227 (375)
|+||+||+|.|+.||++..|..++|+..+|+.+.|+||++.+.+.|++.+ ++++|+|||++ .+|.+
T Consensus 158 lina~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~l~~~~v~Lp~~~~~sm~iilP~~~~~l~~ 237 (371)
T PF00079_consen 158 LINAIYFKGKWKYPFDPENTEKRPFYVSDGKSVSVPMMHQSGRFRYAEDEDLDAQVVELPYKGNFSMLIILPDEGDGLDE 237 (371)
T ss_dssp EEEEEEEEEEBSSTEEGGGEEEEEEECSSSEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSTSEEEEEEEESSTTTHHH
T ss_pred hcccccccccccccccccccccccccccccccceEEEEecccccccccccccceeEEEeccccceeeEEEEeccccchhh
Confidence 99999999999999999999999999999999999999999988887766 99999999987 57999
Q ss_pred HHHHccCcHHHHhccCCccceeeee--eeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--CccceeeeeE
Q 036497 228 LEKKTGSQSGFLKDHIPYEMIEVGD--FRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQKSF 303 (375)
Q Consensus 228 l~~~L~~~~~~l~~~~~~~~~~~~~--l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk~~ 303 (375)
++++|+. ..+..++...+...++ |.||||++++++||+++|++||++++|++..|||++|+++. +|++++|++.
T Consensus 238 l~~~l~~--~~l~~~~~~~~~~~~~~~l~lPkf~i~~~~dl~~~L~~lGi~~~F~~~~adfs~i~~~~~~~v~~v~qk~~ 315 (371)
T PF00079_consen 238 LEKKLTS--ERLQEIISNLKMRKVDEELSLPKFKIESSIDLKELLKKLGIKDLFDPDSADFSGISDDEPLYVSDVIQKAV 315 (371)
T ss_dssp HHHHHSH--HHHHHHHHHCEEEEEEEEEEEEEEEEEEEEEHHHHHHHTTTTGGGSTTTSSCTTTBSSSTEEEEEEEEEEE
T ss_pred hhhhccc--ccccccccccccccccceeeecccccccccccceeeehhhcccccccccccccccccceeeeeeeccceee
Confidence 9999973 3455555555555556 99999999999999999999999999996589999999544 9999999999
Q ss_pred EEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 304 IEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 304 iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
|+|||+|++|+|+|.. ... ....+++.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 316 i~v~E~G~~a~a~t~~-~~~-~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 371 (371)
T PF00079_consen 316 IEVDEEGTEAAAATAV-MAS-ISSPPPPIEFIADRPFLFFIRDRSTGSILFMGKVVDP 371 (371)
T ss_dssp EEEESSEEEEEEEEEE-EEE-ESSSSSSEEEECSSEEEEEEEETTTTEEEEEEEESST
T ss_pred eccccccccccccccc-ccc-ccccccCcEEEEcCCEEEEEEECCCCcEEEEEEecCC
Confidence 9999999999999942 222 2223457899999999999999999999999999998
|
In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. Serpins (SERine Proteinase INhibitors) [, , ] belong to MEROPS inhibitor family I4, clan ID. Serpins are proteins that are primarily known as irreversible serine protease inhibitors active against S1 (IPR001254 from INTERPRO), S8 (IPR000209 from INTERPRO) and C14 (IPR002398 from INTERPRO) peptidases. There are both extra- and intra-cellular serpins, which are found in all groups of organisms with the notable exception of fungi [, ]. In contrast to "rigid" proteinase inhibitors, such as those of the Kunitz or Kazal families, the serpins are metastable proteins (active-state proteins) which interact with their substrate and irreversibly trap the acyl intermediate as a result of a major conformational change []; they are best described as suicide substrate inhibitors. The common structure of these proteins is a multi-domain fold containing a bundle of 8 or 9 alpha helices and a beta sandwich formed by 3 beta sheets. The reactive centre loop (RCL) is found in the C-terminal part of these proteins. Serpins and their homologues are a group of high molecular weight (40 to 50 kDa) structurally related proteins involved in a number of fundamental biological processes such as blood coagulation, complement activation, fibrinolysis, angiogenesis, inflammation, tumour suppression and hormone transport. All known serpins have been classified into 16 clades and 10 orphan sequences; the vertebrate serpins can be conveniently classified into six sub-groups []. In human plasma they represent approximately 2% of the total protein, of which 70% is alpha-1-antitrypsin. On the basis of strong sequence similarities, a number of proteins with no known inhibitory activity also belong to this family, these include: angiotensinogen, corticosteroid-binding globulin and thyroxin-binding globulin []. This entry represents the structural domain of serpins. It consists of a cluster of helices and a beta-sandwich.; PDB: 3PZF_A 3B9F_I 1MTP_A 1SNG_A 1ANT_I 2ZNH_B 1BR8_I 1SR5_A 1E03_L 1AZX_L .... |
| >cd02055 PZI Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-70 Score=524.05 Aligned_cols=336 Identities=28% Similarity=0.383 Sum_probs=287.3
Q ss_pred hhhhhhhHHHHHHHHhcCC--CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-----hhHH-HHHHHHHHHHh
Q 036497 7 SISEQTDITLSLSKHIKAP--TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-----EQQN-FASELVAIVFA 77 (375)
Q Consensus 7 ~~~~~~~f~~~l~~~~~~~--~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-----~~~~-~~~~l~~~l~~ 77 (375)
+..++++||++||+++... .+ ++||+||+.+|+|+++||+|+|+.||.++||++.. .+++ .++.+.+.+.
T Consensus 2 ~~~~~~~Fa~~l~~~~~~~~~~Nvv~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~~l~~~~~- 80 (365)
T cd02055 2 FAEETANFGFNLLRKIAMKHDGNIIFSPFGMSLAMAGLLLAAEGETERQIAKALHLHALKDRDPGLLPALFKGLKDNIS- 80 (365)
T ss_pred cchhhhHHHHHHHHHHhcCCCCcEEEChHHHHHHHHHHHhhcCchHHHHHHHHcCCCCCccccHHHHHHHHHHHHHHhc-
Confidence 4577899999999998753 23 99999999999999999999999999999999752 2344 6666665442
Q ss_pred CCCCCCCCeEEEEEee--eecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCC
Q 036497 78 DGSANGGPRLSVANGV--WIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVD 155 (375)
Q Consensus 78 ~~~~~~~~~l~~an~l--~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~ 155 (375)
.+..+.+++++ |+++++.++++|++.++++|++++..+||.+ ++.+++.||+|++++|+|+|+++++ +++
T Consensus 81 -----~~~~~~l~~~~~~~v~~~~~l~~~F~~~~~~~y~~~~~~vdF~~-~~~a~~~IN~wv~~~T~g~I~~~~~--~i~ 152 (365)
T cd02055 81 -----RNEELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQN-ASQAKFLINHNIKKETKGKIPELFD--EID 152 (365)
T ss_pred -----CCcceehHHHHHHHHHCCCCccHHHHHHHHHHhcCeeEEECCCC-hHHHHHHHHHHHHHhhcchHHHHhh--cCC
Confidence 12335555555 9999999999999999999999999999987 5678999999999999999999995 688
Q ss_pred ccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC-----------
Q 036497 156 DSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ----------- 222 (375)
Q Consensus 156 ~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~----------- 222 (375)
++|+++|+||+||+|.|+.||++..|..++||+.+|+.+.||||++.+.+.|.. ..++++++|||++
T Consensus 153 ~~t~l~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~sm~iiLP~~ 232 (365)
T cd02055 153 PESKLILLDYIFFKGKWLTPFDPEFTEIDTFHIDKYKSIKVPMMFGADKFASTFDENFRCHVIKLPYKGKATMLIVIMEK 232 (365)
T ss_pred ccchhhhhHHHHHHHHHhCCCChhhCccceEEcCCCcEEEehhhcccCceeeEEeCCCCeEEEEeeeCCCcEEEEEEcCC
Confidence 999999999999999999999999999999999999999999999988776554 4479999999987
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCc-CC-C-Cccce
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMV-DS-H-VGVGI 298 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is-~~-~-~vs~~ 298 (375)
.+|..+++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|++ .|||++|+ ++ + +|+++
T Consensus 233 ~~~l~~l~~~l~~--~~l~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGi~~~F~~-~adls~i~~~~~~l~vs~v 309 (365)
T cd02055 233 GEDHLALEDHLTM--DLVESWLANMKSRNMDIFFPKFKLDQKYEMHELLRALGIKNIFAP-FADLSELLADGKHLQVSQV 309 (365)
T ss_pred CCCHHHHHHHhhH--HHHHHHHHhccceEEEEEEEEEEEEEEeehHHHHHHcCcchhhcC-cCCcccccCCCCcEEEEee
Confidence 568889999863 345555444455557899999999999999999999999999997 89999986 33 4 99999
Q ss_pred eeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEe
Q 036497 299 FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMF 358 (375)
Q Consensus 299 ~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 358 (375)
+|++.|||||+|++|+|+|......++. +..|++||||+|+|+|+.+|.|||+|||
T Consensus 310 ~hka~ievdE~Gt~aaa~t~~~~~~~~~----~~~f~~nrPF~f~I~~~~~~~~LF~G~v 365 (365)
T cd02055 310 LQKAVIEVDEKGTEAAAAIGSEIIAFSM----PPVIKVDRPFHFMIFEETFGMLLFIGRV 365 (365)
T ss_pred eEEEEEEEccCCchhhhhhcceecccCC----CCeEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 9999999999999999999743333332 2479999999999999999999999996
|
ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. |
| >PHA02948 serine protease inhibitor-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-69 Score=518.04 Aligned_cols=333 Identities=21% Similarity=0.320 Sum_probs=279.0
Q ss_pred hhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCCCCCC
Q 036497 10 EQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGSANGG 84 (375)
Q Consensus 10 ~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~~~~~ 84 (375)
++++||++||+++...+ + +|||+||+.+|+|++.||+|+|++||.++||++. ++++ .++.+.+.+... ...+
T Consensus 20 ~~~~f~~~l~~~l~~~~~~~Nv~~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~-~~~~~~~~~l~~~~~~~--~~~~ 96 (373)
T PHA02948 20 GFTNAGILAYKNIQDGNEDDNIVFSPFGYSFSMFMSLLPASGNTRVELLKTMDLRK-RDLGPAFTELISGLAKL--KTSK 96 (373)
T ss_pred cchHHHHHHHHHHHhcCCCCCEEEchHHHHHHHHHHHhccCCcHHHHHHHHhCCCc-hhHHHHHHHHHHHHhcc--cccC
Confidence 67899999999996642 3 9999999999999999999999999999999974 3455 677777666421 1122
Q ss_pred Ce-EEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEE
Q 036497 85 PR-LSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFA 163 (375)
Q Consensus 85 ~~-l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlv 163 (375)
.. +.++|++|+++++.++++|.+ .+|+++++.+||.+ .+++.||+||+++| +|++++++++++++|+++|+
T Consensus 97 ~~~~~~an~~~v~~~~~~~~~f~~---~~~~~~v~~vdF~~---~a~~~IN~WV~~~T--~I~~~~~~~~i~~~t~lvLv 168 (373)
T PHA02948 97 YTYTDLTYQSFVDNTVCIKPSYYQ---QYHRFGLYRLNFRR---DAVNKINSIVERRS--GMSNVVDSTMLDNNTLWAII 168 (373)
T ss_pred cchHHHHHHHHHhcCCCccHHHHH---HHhhCceEecCccH---HHHHHHHHHHHhcC--CCcccCCCCCCCCCceEEEE
Confidence 23 368999999999999999997 45667999999973 58999999999998 59999988889999999999
Q ss_pred EeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccc----eeeecCCeEEEEecccC----------CChHHHH
Q 036497 164 NALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQ----LVTAFDGFKVLVLPYKQ----------DELPALE 229 (375)
Q Consensus 164 na~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~----~~~~~~~~~vveLPy~~----------~~l~~l~ 229 (375)
||+||+|.|+.||++..|++++||..+| .+.||||++.+.+ .+.+..++++++|||++ +++..++
T Consensus 169 NaiyFkg~W~~~F~~~~T~~~~F~~~~~-~~~V~mM~~~~~~~~~~~~~~~~~~~vl~LPY~~~~~sM~iiLP~~l~~l~ 247 (373)
T PHA02948 169 NTIYFKGTWQYPFDITKTHNASFTNKYG-TKTVPMMNVVTKLQGNTITIDDEEYDMVRLPYKDANISMYLAIGDNMTHFT 247 (373)
T ss_pred EEEEEeeeecCCCCcccCeeceeEeCCC-CEEchhheeccccccceeeccCcCceEEEEecCCCcEEEEEEcCCcHHHHH
Confidence 9999999999999999999999998877 4799999987644 23355689999999986 4578888
Q ss_pred HHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-CccceeeeeEEEEcC
Q 036497 230 KKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQKSFIEVKE 308 (375)
Q Consensus 230 ~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~qk~~iev~E 308 (375)
+.|+. ..+..+.+..+...++|.||||++++++||+++|+ +|++++|++..|||++|++++ +|++++||+.|||||
T Consensus 248 ~~l~~--~~l~~~~~~~~~~~v~v~lPKFki~~~~~L~~~L~-~~i~~~F~~~~Adfs~is~~~l~vs~v~hka~IeVdE 324 (373)
T PHA02948 248 DSITA--AKLDYWSSQLGNKVYNLKLPRFSIENKRDIKSIAE-MMAPSMFNPDNASFKHMTRDPLYIYKMFQNAKIDVDE 324 (373)
T ss_pred HHhCH--HHHHHHHHhCcceEEEEEeeCEeeeeeccHHHHHH-hhhHhhCCCCcCchhhhccCceEEEeeEEEEEEEECC
Confidence 88863 33444444444455689999999999999999995 669999997679999999877 999999999999999
Q ss_pred CcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 309 EGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 309 ~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
+||+|+|+|......++. +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 325 ~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 373 (373)
T PHA02948 325 QGTVAEASTIMVATARSS----PEELEFNTPFVFIIRHDITGFILFMGKVESP 373 (373)
T ss_pred CceEEeecceeeeeccCC----CCeEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999743332222 2469999999999999999999999999998
|
|
| >cd02053 alpha2AP Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-69 Score=514.13 Aligned_cols=328 Identities=25% Similarity=0.394 Sum_probs=278.3
Q ss_pred hhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 036497 9 SEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFADGSANGG 84 (375)
Q Consensus 9 ~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~l~~~l~~~~~~~~~ 84 (375)
.++++||++||+++...+ + ++||+||+.+|+||++||+|+|++||.++||++.... +..+.+.+.+ ...+
T Consensus 3 ~~~~~F~~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~---~~~~~~~l~~---~~~~ 76 (351)
T cd02053 3 RAMMGFSTDLLSEVAQESTKPNLILSPLSIALALSHLALGAQNETEQRLLKTLHAESLPC---LHHLLSRLRQ---DLGP 76 (351)
T ss_pred cchhhHHHHHHHHHHhhCCCCcEEECcHHHHHHHHHHHhhcChHHHHHHHHhcCCCChHH---HHHHHHHHhc---cCCc
Confidence 467899999999997643 2 9999999999999999999999999999999975433 3344444432 1235
Q ss_pred CeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEEE
Q 036497 85 PRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFAN 164 (375)
Q Consensus 85 ~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlvn 164 (375)
..+.++|++|++++++++++|.+.++++|++++ +||.+.+..+++.||+||+++|+|+|+++++ +++++|.++|+|
T Consensus 77 ~~l~~an~i~v~~~~~~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~IN~wv~~~T~g~I~~~~~--~~~~~t~~vlvN 152 (351)
T cd02053 77 GALRLATRMYLQKGFEIKESFLEESEKLYGAKP--VSLTGTKEDDLANINKWVKEATEGQIPNFLS--DLPHDTVLLLLN 152 (351)
T ss_pred cEeehhhHHHHhCCCchhHHHHHHHHHHcCCEE--eecCCCCHHHHHHHHHHHHHhccCchhHhcC--CCCcchHhheee
Confidence 679999999999999999999999999999875 5665445788999999999999999999985 688999999999
Q ss_pred eEEeeccccccccCCCCeeeeeecCCCcEEeecceeccc-cceeee--cCCeEEEEecccC------------C-ChHHH
Q 036497 165 ALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN-KQLVTA--FDGFKVLVLPYKQ------------D-ELPAL 228 (375)
Q Consensus 165 a~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~-~~~~~~--~~~~~vveLPy~~------------~-~l~~l 228 (375)
|+||+|.|+++|++..|.+++||..+|++++||||++.. .+.|.. ..++++++|||++ . +|.++
T Consensus 153 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~vleLPy~~~~Sm~iiLP~~~~~~l~~~ 232 (351)
T cd02053 153 AIHFKGFWRNKFDPSLTQRDAFHLDDDFTVSVEMMQASTYPLRWFHLEQPEIQVAKFPFKGNMSFVVLMPTPFTWNVSQV 232 (351)
T ss_pred EEEEeeeecCCCChhcCeecceEECCCceEEeehhcccccceeeEecCCCCeEEEEEecCCCeEEEEEecccccccHHHH
Confidence 999999999999999999999999999999999998753 455543 4589999999997 2 38888
Q ss_pred HHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-CccceeeeeEEEEc
Q 036497 229 EKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQKSFIEVK 307 (375)
Q Consensus 229 ~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~qk~~iev~ 307 (375)
+++|+. ..+..+.. +...++|.||||++++++||+++|++||++++|+. |||++|++++ +|++++||+.||||
T Consensus 233 ~~~l~~--~~l~~~~~--~~~~v~v~lPKFki~~~~~L~~~L~~lGi~~~F~~--adfs~i~~~~~~vs~v~hka~ieVd 306 (351)
T cd02053 233 LANLNW--DDLYRRLP--KERPTKVKLPKLKLDYQLELNEALSQLGLQELFQA--PDLSGISDEPLFVSSVQHQSTLELS 306 (351)
T ss_pred HHhCCH--HHHHHhhc--cceEEEEEccCEEEEeeechHHHHHhCCchhcccc--ccccccCCCCceeeeeeEEEEEEEC
Confidence 888863 23333332 22335899999999999999999999999999985 9999999888 99999999999999
Q ss_pred CCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEe
Q 036497 308 EEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMF 358 (375)
Q Consensus 308 E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 358 (375)
|+||+|+|+|.+. ..++ ...|+|||||+|+|+|+.||.|||+|+|
T Consensus 307 E~Gt~aaa~t~~~-~~~~-----~~~f~~drPF~f~I~~~~t~~~LF~G~v 351 (351)
T cd02053 307 EKGVEASAATSVA-TSRS-----LSSFSVNRPFLFFIFEDTMGLPLFMGSV 351 (351)
T ss_pred CCcceehhcceee-cccc-----cCeEEcCCCEEEEEEECCCCCEEEEEeC
Confidence 9999999999743 2222 2379999999999999999999999996
|
Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily. |
| >cd02050 C1_inh C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-67 Score=504.77 Aligned_cols=324 Identities=24% Similarity=0.357 Sum_probs=274.1
Q ss_pred hhhhHHHHHHHHhcCCC----C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-hhHH-HHHHHHHHHHhCCCCC
Q 036497 10 EQTDITLSLSKHIKAPT----S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-EQQN-FASELVAIVFADGSAN 82 (375)
Q Consensus 10 ~~~~f~~~l~~~~~~~~----~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~-~~~~l~~~l~~~~~~~ 82 (375)
++++||++||+++.... + ++||+||+.+|+||+.||+|+|++||.++|+++.. .+++ .++.+.+
T Consensus 1 ~~~~F~~~l~~~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~l~~--------- 71 (352)
T cd02050 1 ALGEFSLKLYQHLSESAKPDTNLLFSPVSIALLLSHLLLGARGKTQRRLESILSYPHDFACVHSALKKLKN--------- 71 (352)
T ss_pred CcchHHHHHHHHHhhccCCCCCEEEChHHHHHHHHHHhcccCccHHHHHHHhcCCCCchhHHHHHHHHhhh---------
Confidence 46899999999997543 3 99999999999999999999999999999999754 2343 4444432
Q ss_pred CCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEE
Q 036497 83 GGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVF 162 (375)
Q Consensus 83 ~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvl 162 (375)
...+.++|+||++++++++++|++.++++|++++..+||.. +.+++.||+||+++|+|+|+++++ +++++|++++
T Consensus 72 -~~~l~~an~i~~~~~~~l~~~f~~~~~~~y~~~~~~~~~~~--~~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~l~l 146 (352)
T cd02050 72 -KLGLLSASQIFHHPDLHLRESFTNESWQFYKARPRELSNNS--ELNLEMINSWVAKATNNKIPRLLD--SLPSETRLVL 146 (352)
T ss_pred -cchhHHHHHHHHhCCCCccHHHHHHHHHHhCCcceeecCCh--HHHHHHHHHHHHHHhcchHHHHhc--ccCCCceEEE
Confidence 12488899999999999999999999999999999999853 678999999999999999999994 6999999999
Q ss_pred EEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccc-cceeee--cCCeEEEEecccC-------------CChH
Q 036497 163 ANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN-KQLVTA--FDGFKVLVLPYKQ-------------DELP 226 (375)
Q Consensus 163 vna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~-~~~~~~--~~~~~vveLPy~~-------------~~l~ 226 (375)
+||+||+|.|++||++..|..++|+..+ ..+.||||++.. .+.|.. ..++++++|||++ .+|.
T Consensus 147 vnaiyFkg~W~~~F~~~~T~~~~F~~~~-~~~~V~mM~~~~~~~~~~~~~~l~~~v~~lp~~~~~sm~iiLP~~~~~~l~ 225 (352)
T cd02050 147 LNAVYFQAQWKKKFDTKHTVLLPFKRNG-DPVKVPVMYSKKYPVASFTDPRLKAQVGRLELSGGLSLVVLVPRGPKEDLE 225 (352)
T ss_pred EeeEEEeeecCCCCCcccCccCceeECC-ceEEeeEeecCccceeeEEcCCcCeEEEEecCCCceEEEEEeeCCCCCCHH
Confidence 9999999999999999999999999865 489999998764 333333 3478999999985 3688
Q ss_pred HHHHHccCcHHHHhccCC---ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccceeee
Q 036497 227 ALEKKTGSQSGFLKDHIP---YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQK 301 (375)
Q Consensus 227 ~l~~~L~~~~~~l~~~~~---~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk 301 (375)
+++++|+. ..+..+.. ......++|.||||++++++||+++|++||++++|+. |||++|+.++ +|++++||
T Consensus 226 ~l~~~l~~--~~~~~~~~~l~~~~~~~v~l~lPKF~i~~~~dl~~~L~~lGi~~~F~~--adfs~i~~~~~l~v~~v~hk 301 (352)
T cd02050 226 AVERALTP--PAFLAMLEKMAANTPQRTEVTLPRIKLDLAVDMVALMHKLGLFGLFLD--ANLCGLYQDPELAVDAAQHR 301 (352)
T ss_pred HHHHhcCH--HHHHHHHHhhhhcCceEEEEEcceEEEeeccchHHHHHHcCChhhccc--cchhhccCCCCeEEEeeEEe
Confidence 99999863 33333322 2223456899999999999999999999999999974 9999999765 99999999
Q ss_pred eEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEe
Q 036497 302 SFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMF 358 (375)
Q Consensus 302 ~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 358 (375)
+.|+|||+||+|+|+|.+. ..++ ..+|++||||+|+|+|+.||.|||+|+|
T Consensus 302 ~~ieVdE~Gt~Aaa~t~~~-~~~~-----~~~f~~drPF~f~I~~~~t~~~LF~G~v 352 (352)
T cd02050 302 AVLTLTEKGVEAAAATATS-FART-----ALSFEALQPFLFVLWDDQAKVPLFMGRV 352 (352)
T ss_pred eEEEECCCchhhhhhcccc-cccc-----cceEEcCCCEEEEEEECCCCceEEEEeC
Confidence 9999999999999999742 2222 2479999999999999999999999996
|
It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily. |
| >PHA02660 serpin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-68 Score=505.96 Aligned_cols=320 Identities=23% Similarity=0.350 Sum_probs=271.0
Q ss_pred hhhhhhHHHHHHHHhcCCCC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHHHHHHHHHHHHhCCCCCCCCe
Q 036497 8 ISEQTDITLSLSKHIKAPTS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFADGSANGGPR 86 (375)
Q Consensus 8 ~~~~~~f~~~l~~~~~~~~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~l~~~l~~~~~~~~~~~ 86 (375)
.....+||++||+++.. ++ ++||+||+.+|+||+.||+|+|+.||.++||+.... +. ...
T Consensus 12 ~~~~~~f~~~l~~~~~~-~Nvv~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~-~~-----------------~~~ 72 (364)
T PHA02660 12 IKMSLDLGFCILKSLHR-FNIVFSPESLKAFLHVLYLGSERETKNELSKYIGHAYSP-IR-----------------KNH 72 (364)
T ss_pred HHHHHHHHHHHHHhcCC-CCEEEChHHHHHHHHHHHhhcCchHHHHHHHHhCccccc-cc-----------------hhh
Confidence 45678899999999975 45 999999999999999999999999999999985321 00 012
Q ss_pred EEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEEEeE
Q 036497 87 LSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANAL 166 (375)
Q Consensus 87 l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlvna~ 166 (375)
+..+|++|+++++.++++|++.++. |+++++.+||.++++.+++.||+||+++|+ |++++ +++++|+++|+||+
T Consensus 73 l~~an~l~v~~~~~l~~~F~~~~~~-~~~~v~~vdF~~~~~~a~~~IN~WV~~~T~--I~~~~---~~~~~t~l~LvNai 146 (364)
T PHA02660 73 IHNITKVYVDSHLPIHSAFVASMND-MGIDVILADLANHAEPIRRSINEWVYEKTN--IINFL---HYMPDTSILIINAV 146 (364)
T ss_pred HHHHHHHHHhcCCchhHHHHHHHHH-cCCceEEeccccCHHHHHHHHHHHHHhccC--Ccccc---ccCCCchhhhhhhh
Confidence 3458999999999999999999987 899999999987667799999999999998 88887 37889999999999
Q ss_pred EeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecCCeEEEEecccC----------------CChHHHHH
Q 036497 167 YFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ----------------DELPALEK 230 (375)
Q Consensus 167 ~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLPy~~----------------~~l~~l~~ 230 (375)
||+|.|++||++..|..++||..+|+.+.||||++.+.+.|++.+++++++|||++ ++|.++++
T Consensus 147 yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~vleLPY~~~~~~sM~iiLP~~~~~~~L~~l~~ 226 (364)
T PHA02660 147 QFNGLWKYPFLRKKTTMDIFNIDKVSFKYVNMMTTKGIFNAGRYHQSNIIEIPYDNCSRSHMWIVFPDAISNDQLNQLEN 226 (364)
T ss_pred hcccHhhcCCCcccCcccccccCCCceEeceeccccCeeeeeecCCCeEEECccCCCCceEEEEEeeCCcccchHHHHHH
Confidence 99999999999999999999999999999999999988888877789999999985 14888888
Q ss_pred HccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC-----C-C--ccceeeee
Q 036497 231 KTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS-----H-V--GVGIFQKS 302 (375)
Q Consensus 231 ~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-----~-~--vs~~~qk~ 302 (375)
.|+. ..+..+........++|.||||++++++||+++|++||++++|+. |||++|+++ + + +++++||+
T Consensus 227 ~l~~--~~l~~~~~~~~~~~v~l~LPKFki~~~~~L~~~L~~lGi~~~F~~--Adfs~i~~~~~~~~~l~~~vs~v~hka 302 (364)
T PHA02660 227 MMHG--DTLKAFKHASRKKYLEISIPKFRIEHSFNAEHLLPSAGIKTLFTN--PNLSRMITQGDKEDDLYPLPPSLYQKI 302 (364)
T ss_pred hhhH--HHHHHHHhhCceeEEEEEccceEeeeeechHHHHHHcCchhhccc--cCccccccCCCcccccccccccceEee
Confidence 8863 334444333344556899999999999999999999999999984 999999753 3 5 79999999
Q ss_pred EEEEcCCcccchhhhhhhhhhccCCCC--------CCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 303 FIEVKEEGTEAAAASAAVITLKSLPRF--------DKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 303 ~iev~E~G~~aaa~t~~~~~~~~~~~~--------~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
.|||||+||+|+|+|... . ..+.+ .+.+|++||||+|+|++ ++.|||+|+|.+|
T Consensus 303 ~ieVdE~GteAaaat~~~-~--~~~~~~~~~~~~~~~~~f~~drPFlf~I~~--~~~iLF~G~v~~P 364 (364)
T PHA02660 303 ILEIDEEGTNTKNIAKKM-R--RNPQDEDTQQHLFRIESIYVNRPFIFIIEY--ENEILFIGRISIP 364 (364)
T ss_pred EEEECCCCcHHHHhhhhh-h--hcccccccccccCCCceEEcCCCEEEEEec--CCeEEEEEEecCC
Confidence 999999999999988521 1 11110 12479999999999986 5899999999998
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 375 | ||||
| 3le2_A | 393 | Structure Of Arabidopsis Atserpin1. Native Stressed | 9e-99 | ||
| 1att_A | 429 | Crystal Structure Of Cleaved Bovine Antithrombin Ii | 6e-29 | ||
| 3kcg_I | 432 | Crystal Structure Of The Antithrombin-Factor Ixa- P | 1e-28 | ||
| 1tb6_I | 432 | 2.5a Crystal Structure Of The Antithrombin-Thrombin | 1e-28 | ||
| 1ath_A | 432 | The Intact And Cleaved Human Antithrombin Iii Compl | 1e-28 | ||
| 2b4x_L | 427 | Crystal Structure Of Antithrombin-Iii Length = 427 | 1e-28 | ||
| 2gd4_I | 443 | Crystal Structure Of The Antithrombin-S195a Factor | 2e-28 | ||
| 1dzg_I | 432 | N135q-S380c-Antithrombin-Iii Length = 432 | 8e-28 | ||
| 1by7_A | 382 | Human Plasminogen Activator Inhibitor-2. Loop (66-9 | 9e-28 | ||
| 1dzh_I | 432 | P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length | 1e-27 | ||
| 2hij_I | 432 | Crystal Structure Of P14 Alanine Variant Of Antithr | 1e-27 | ||
| 2arq_A | 382 | Human Plasminogen Activator Inhibitor-2.[loop (66-9 | 3e-27 | ||
| 4eb1_I | 440 | Hyperstable In-Frame Insertion Variant Of Antithrom | 6e-27 | ||
| 3f5n_A | 407 | Structure Of Native Human Neuroserpin Length = 407 | 9e-27 | ||
| 3fgq_A | 397 | Crystal Structure Of Native Human Neuroserpin Lengt | 1e-26 | ||
| 2b4x_I | 427 | Crystal Structure Of Antithrombin-Iii Length = 427 | 1e-26 | ||
| 1oyh_I | 432 | Crystal Structure Of P13 Alanine Variant Of Antithr | 4e-26 | ||
| 3cvm_A | 392 | High Resolution Structure Of A Stable Plasminogen A | 2e-25 | ||
| 3ut3_A | 375 | A Novel Pai-i Inhibitor And Its Structural Mechanis | 2e-25 | ||
| 1b3k_A | 379 | Plasminogen Activator Inhibitor-1 Length = 379 | 2e-25 | ||
| 2dut_A | 423 | Crystal Structure Of A M-Loop Deletion Variant Of M | 4e-25 | ||
| 1db2_A | 377 | Crystal Structure Of Native Plasminogen Activator I | 5e-25 | ||
| 1c5g_A | 402 | Plasminogen Activator Inhibitor-1 Length = 402 | 5e-25 | ||
| 1dvn_A | 379 | Latent Form Of Plasminogen Activator Inhibitor-1 (P | 5e-25 | ||
| 3eox_A | 379 | High Quality Structure Of Cleaved Pai-1-Stab Length | 5e-25 | ||
| 4aqh_A | 383 | Plasminogen Activator Inhibitor Type-1 In Complex W | 6e-25 | ||
| 1a7c_A | 379 | Human Plasminogen Activator Inhibitor Type-1 In Com | 6e-25 | ||
| 1dvm_A | 379 | Active Form Of Human Pai-1 Length = 379 | 1e-24 | ||
| 3r4l_A | 379 | Human Very Long Half Life Plasminogen Activator Inh | 1e-24 | ||
| 3vvj_A | 392 | Structure Of Ovalbumin From Emu (Dromaius Novaeholl | 2e-24 | ||
| 2h4r_A | 415 | Crystal Structure Of Wildtype Ment In The Native Co | 6e-24 | ||
| 3q02_A | 379 | Crystal Structure Of Plasminogen Activator Inhibito | 1e-23 | ||
| 3lw2_A | 379 | Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Len | 1e-22 | ||
| 1k9o_I | 378 | Crystal Structure Of Michaelis Serpin-Trypsin Compl | 1e-22 | ||
| 4ga7_A | 389 | Crystal Structure Of Human Serpinb1 Mutant Length = | 3e-22 | ||
| 1sek_A | 378 | The Structure Of Active Serpin K From Manduca Sexta | 5e-22 | ||
| 3f02_A | 359 | Cleaved Human Neuroserpin Length = 359 | 2e-21 | ||
| 2zv6_A | 401 | Crystal Structure Of Human Squamous Cell Carcinoma | 1e-20 | ||
| 2h4q_A | 382 | Crystal Structure Of A M-Loop Deletion Variant Of M | 2e-20 | ||
| 1jti_A | 385 | Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin | 4e-20 | ||
| 4dy0_A | 379 | Crystal Structure Of Native Protease Nexin-1 With H | 4e-20 | ||
| 1hle_A | 345 | Crystal Structure Of Cleaved Equine Leucocyte Elast | 5e-20 | ||
| 1ova_C | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 5e-20 | ||
| 1ova_B | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 5e-20 | ||
| 1ova_A | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 6e-20 | ||
| 2h4p_A | 394 | Crystal Structure Of Wildtype Ment In The Cleaved C | 1e-19 | ||
| 1uhg_A | 385 | Crystal Structure Of S-ovalbumin At 1.9 Angstrom Re | 1e-19 | ||
| 9pai_A | 346 | Cleaved Substrate Variant Of Plasminogen Activator | 3e-19 | ||
| 3ozq_A | 376 | Crystal Structure Of Serpin48, Which Is A Highly Sp | 4e-19 | ||
| 2vdx_A | 373 | Crystal Structure Of The Reactive Loop Cleaved Cort | 2e-18 | ||
| 3nda_A | 377 | Crystal Structure Of Serpin From Tick Ixodes Ricinu | 2e-18 | ||
| 3h5c_A | 423 | X-Ray Structure Of Protein Z-Protein Z Inhibitor Co | 5e-18 | ||
| 3f1s_A | 385 | Crystal Structure Of Protein Z Complexed With Prote | 8e-18 | ||
| 1jjo_C | 261 | Crystal Structure Of Mouse Neuroserpin (Cleaved For | 8e-18 | ||
| 1xu8_A | 380 | The 2.8 A Structure Of A Tumour Suppressing Serpin | 5e-17 | ||
| 1wz9_A | 375 | The 2.1 A Structure Of A Tumour Suppressing Serpin | 1e-16 | ||
| 2ol2_A | 395 | High Resolution Structure Of Native Pci In Space Gr | 2e-16 | ||
| 4if8_A | 414 | Structure Of Vaspin Length = 414 | 3e-16 | ||
| 2hi9_A | 363 | Crystal Structure Of Human Native Protein C Inhibit | 7e-16 | ||
| 1xqg_A | 389 | 3.10 A Crystal Structure Of Maspin, Space Group P 4 | 8e-16 | ||
| 1jmo_A | 480 | Crystal Structure Of The Heparin Cofactor Ii-S195a | 9e-16 | ||
| 4ajt_A | 427 | The Cystal Structure Of Mouse Protein-Z Dependent P | 1e-15 | ||
| 1jmj_A | 480 | Crystal Structure Of Native Heparin Cofactor Ii Len | 1e-15 | ||
| 3dlw_A | 411 | Antichymotrypsin Length = 411 | 2e-15 | ||
| 2ach_A | 360 | Crystal Structure Of Cleaved Human Alpha1-antichymo | 9e-15 | ||
| 3caa_A | 341 | Cleaved Antichymotrypsin A347r Length = 341 | 9e-15 | ||
| 1as4_A | 341 | Cleaved Antichymotrypsin A349r Length = 341 | 9e-15 | ||
| 2pee_A | 387 | Crystal Structure Of A Thermophilic Serpin, Tengpin | 1e-14 | ||
| 2vh4_A | 381 | Structure Of A Loop C-sheet Serpin Polymer Length = | 1e-14 | ||
| 2pef_A | 373 | Crystal Structure Of A Thermophilic Serpin, Tengpin | 1e-14 | ||
| 1qmn_A | 401 | Alpha1-Antichymotrypsin Serpin In The Delta Conform | 2e-14 | ||
| 4bb2_A | 340 | Crystal Structure Of Cleaved Corticosteroid-binding | 2e-14 | ||
| 1lq8_A | 346 | Crystal Structure Of Cleaved Protein C Inhibitor Le | 2e-14 | ||
| 3pzf_A | 397 | 1.75a Resolution Structure Of Serpin-2 From Anophel | 3e-14 | ||
| 4caa_A | 341 | Cleaved Antichymotrypsin T345r Length = 341 | 4e-14 | ||
| 1oo8_A | 394 | Crystal Structure Of A1pi-Pittsburgh In The Native | 4e-14 | ||
| 3dy0_A | 336 | Crystal Structure Of Cleaved Pci Bound To Heparin L | 8e-14 | ||
| 1atu_A | 374 | Uncleaved Alpha-1-Antitrypsin Length = 374 | 1e-13 | ||
| 1kct_A | 394 | Alpha1-Antitrypsin Length = 394 | 4e-13 | ||
| 1iz2_A | 394 | Interactions Causing The Kinetic Trap In Serpin Pro | 4e-13 | ||
| 3t1p_A | 371 | Crystal Structure Of An Alpha-1-Antitrypsin Trimer | 7e-13 | ||
| 1yxa_A | 398 | Serpina3n, A Murine Orthologue Of Human Antichymotr | 8e-13 | ||
| 1hp7_A | 394 | A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-An | 8e-13 | ||
| 3ne4_A | 424 | 1.8 Angstrom Structure Of Intact Native Wild-Type A | 1e-12 | ||
| 1qlp_A | 394 | 2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsi | 2e-12 | ||
| 1mtp_A | 323 | The X-Ray Crystal Structure Of A Serpin From A Ther | 2e-12 | ||
| 4afx_A | 387 | Crystal Structure Of The Reactive Loop Cleaved Zpi | 2e-12 | ||
| 3drm_A | 404 | 2.2 Angstrom Crystal Structure Of Thr114phe Alpha1- | 2e-12 | ||
| 2qug_A | 394 | Crystal Structure Of Alpha-1-Antitrypsin, Crystal F | 3e-12 | ||
| 1psi_A | 394 | Intact Recombined Alpha1-Antitrypsin Mutant Phe 51 | 3e-12 | ||
| 1sng_A | 370 | Structure Of A Thermophilic Serpin In The Native St | 9e-12 | ||
| 2d26_A | 358 | Active Site Distortion Is Sufficient For Proteinase | 1e-11 | ||
| 2v95_A | 371 | Struture Of Corticosteroid-Binding Globulin In Comp | 2e-11 | ||
| 3sto_A | 406 | Serpin From The Trematode Schistosoma Haematobium L | 2e-11 | ||
| 1ezx_A | 335 | Crystal Structure Of A Serpin:protease Complex Leng | 3e-11 | ||
| 1d5s_A | 334 | Crystal Structure Of Cleaved Antitrypsin Polymer Le | 3e-11 | ||
| 3dru_A | 404 | Crystal Structure Of Gly117phe Alpha1-Antitrypsin L | 3e-11 | ||
| 7api_A | 347 | The S Variant Of Human Alpha1-Antitrypsin, Structur | 3e-11 | ||
| 1qmb_A | 326 | Cleaved Alpha-1-Antitrypsin Polymer Length = 326 | 4e-11 | ||
| 3ndf_A | 343 | Cleaved Antitrypsin With P8-P6 Asp Length = 343 | 4e-11 | ||
| 3ndd_A | 343 | Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Len | 4e-11 | ||
| 2r9y_A | 430 | Structure Of Antiplasmin Length = 430 | 2e-10 | ||
| 4au2_A | 392 | Crystal Structure Of A Hsp47-Collagen Complex Lengt | 3e-09 | ||
| 1f0c_A | 305 | Structure Of The Viral Serpin Crma Length = 305 | 3e-09 | ||
| 1c8o_A | 300 | 2.9 A Structure Of Cleaved Viral Serpin Crma Length | 8e-09 | ||
| 1m93_B | 245 | 1.65 A Structure Of Cleaved Viral Serpin Crma Lengt | 1e-08 | ||
| 1imv_A | 398 | 2.85 A Crystal Structure Of Pedf Length = 398 | 7e-08 | ||
| 2oay_A | 390 | Crystal Structure Of Latent Human C1-Inhibitor Leng | 8e-08 | ||
| 2ceo_A | 379 | Thyroxine-Binding Globulin Complex With Thyroxine L | 2e-07 | ||
| 2xn6_A | 350 | Crystal Structure Of Thyroxine-Binding Globulin Com | 3e-07 | ||
| 2xn5_A | 350 | Crystal Structure Of Thyroxine-Binding Globulin Com | 5e-07 | ||
| 2riv_A | 343 | Crystal Structure Of The Reactive Loop Cleaved Huma | 5e-07 | ||
| 2riw_A | 338 | The Reactive Loop Cleaved Human Thyroxine Binding G | 5e-07 | ||
| 4au3_A | 392 | Crystal Structure Of A Hsp47-Collagen Complex Lengt | 1e-06 | ||
| 4au3_B | 392 | Crystal Structure Of A Hsp47-Collagen Complex Lengt | 1e-06 |
| >pdb|3LE2|A Chain A, Structure Of Arabidopsis Atserpin1. Native Stressed Conforma Length = 393 | Back alignment and structure |
|
| >pdb|1ATT|A Chain A, Crystal Structure Of Cleaved Bovine Antithrombin Iii At 3.2 Angstroms Resolution Length = 429 | Back alignment and structure |
|
| >pdb|3KCG|I Chain I, Crystal Structure Of The Antithrombin-Factor Ixa- Pentasaccharide Complex Length = 432 | Back alignment and structure |
|
| >pdb|1TB6|I Chain I, 2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin Ternary Complex Length = 432 | Back alignment and structure |
|
| >pdb|1ATH|A Chain A, The Intact And Cleaved Human Antithrombin Iii Complex As A Model For Serpin-Proteinase Interactions Length = 432 | Back alignment and structure |
|
| >pdb|2B4X|L Chain L, Crystal Structure Of Antithrombin-Iii Length = 427 | Back alignment and structure |
|
| >pdb|2GD4|I Chain I, Crystal Structure Of The Antithrombin-S195a Factor Xa-Pentasaccharide Complex Length = 443 | Back alignment and structure |
|
| >pdb|1DZG|I Chain I, N135q-S380c-Antithrombin-Iii Length = 432 | Back alignment and structure |
|
| >pdb|1BY7|A Chain A, Human Plasminogen Activator Inhibitor-2. Loop (66-98) Deletion Mutant Length = 382 | Back alignment and structure |
|
| >pdb|1DZH|I Chain I, P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length = 432 | Back alignment and structure |
|
| >pdb|2HIJ|I Chain I, Crystal Structure Of P14 Alanine Variant Of Antithrombin Length = 432 | Back alignment and structure |
|
| >pdb|2ARQ|A Chain A, Human Plasminogen Activator Inhibitor-2.[loop (66-98) Deletion Mutant] Complexed With Peptide N-Acetyl-Teaaagdggvmtgr-Oh Length = 382 | Back alignment and structure |
|
| >pdb|4EB1|I Chain I, Hyperstable In-Frame Insertion Variant Of Antithrombin Length = 440 | Back alignment and structure |
|
| >pdb|3F5N|A Chain A, Structure Of Native Human Neuroserpin Length = 407 | Back alignment and structure |
|
| >pdb|3FGQ|A Chain A, Crystal Structure Of Native Human Neuroserpin Length = 397 | Back alignment and structure |
|
| >pdb|2B4X|I Chain I, Crystal Structure Of Antithrombin-Iii Length = 427 | Back alignment and structure |
|
| >pdb|1OYH|I Chain I, Crystal Structure Of P13 Alanine Variant Of Antithrombin Length = 432 | Back alignment and structure |
|
| >pdb|3CVM|A Chain A, High Resolution Structure Of A Stable Plasminogen Activator Inhibitor Type-1 In Its Protease Cleaved Form Length = 392 | Back alignment and structure |
|
| >pdb|3UT3|A Chain A, A Novel Pai-i Inhibitor And Its Structural Mechanism Length = 375 | Back alignment and structure |
|
| >pdb|1B3K|A Chain A, Plasminogen Activator Inhibitor-1 Length = 379 | Back alignment and structure |
|
| >pdb|2DUT|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Native Conformation Length = 423 | Back alignment and structure |
|
| >pdb|1DB2|A Chain A, Crystal Structure Of Native Plasminogen Activator Inhibitor- 1 Length = 377 | Back alignment and structure |
|
| >pdb|1C5G|A Chain A, Plasminogen Activator Inhibitor-1 Length = 402 | Back alignment and structure |
|
| >pdb|1DVN|A Chain A, Latent Form Of Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379 | Back alignment and structure |
|
| >pdb|3EOX|A Chain A, High Quality Structure Of Cleaved Pai-1-Stab Length = 379 | Back alignment and structure |
|
| >pdb|4AQH|A Chain A, Plasminogen Activator Inhibitor Type-1 In Complex With The Inhibitor Az3976 Length = 383 | Back alignment and structure |
|
| >pdb|1A7C|A Chain A, Human Plasminogen Activator Inhibitor Type-1 In Complex With A Pentapeptide Length = 379 | Back alignment and structure |
|
| >pdb|1DVM|A Chain A, Active Form Of Human Pai-1 Length = 379 | Back alignment and structure |
|
| >pdb|3R4L|A Chain A, Human Very Long Half Life Plasminogen Activator Inhibitor Type-1 Length = 379 | Back alignment and structure |
|
| >pdb|3VVJ|A Chain A, Structure Of Ovalbumin From Emu (Dromaius Novaehollandiae) Length = 392 | Back alignment and structure |
|
| >pdb|2H4R|A Chain A, Crystal Structure Of Wildtype Ment In The Native Conformation Length = 415 | Back alignment and structure |
|
| >pdb|3Q02|A Chain A, Crystal Structure Of Plasminogen Activator Inhibitor-1 In A Metastable Active Conformation. Length = 379 | Back alignment and structure |
|
| >pdb|3LW2|A Chain A, Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379 | Back alignment and structure |
|
| >pdb|1K9O|I Chain I, Crystal Structure Of Michaelis Serpin-Trypsin Complex Length = 378 | Back alignment and structure |
|
| >pdb|4GA7|A Chain A, Crystal Structure Of Human Serpinb1 Mutant Length = 389 | Back alignment and structure |
|
| >pdb|1SEK|A Chain A, The Structure Of Active Serpin K From Manduca Sexta And A Model For Serpin-Protease Complex Formation Length = 378 | Back alignment and structure |
|
| >pdb|3F02|A Chain A, Cleaved Human Neuroserpin Length = 359 | Back alignment and structure |
|
| >pdb|2ZV6|A Chain A, Crystal Structure Of Human Squamous Cell Carcinoma Antigen 1 Length = 401 | Back alignment and structure |
|
| >pdb|2H4Q|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Cleaved Conformation Length = 382 | Back alignment and structure |
|
| >pdb|1JTI|A Chain A, Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin Mutant R339t Length = 385 | Back alignment and structure |
|
| >pdb|4DY0|A Chain A, Crystal Structure Of Native Protease Nexin-1 With Heparin Length = 379 | Back alignment and structure |
|
| >pdb|1HLE|A Chain A, Crystal Structure Of Cleaved Equine Leucocyte Elastase Inhibitor Determined At 1.95 Angstroms Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1OVA|C Chain C, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|1OVA|B Chain B, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|1OVA|A Chain A, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|2H4P|A Chain A, Crystal Structure Of Wildtype Ment In The Cleaved Conformation Length = 394 | Back alignment and structure |
|
| >pdb|1UHG|A Chain A, Crystal Structure Of S-ovalbumin At 1.9 Angstrom Resolution Length = 385 | Back alignment and structure |
|
| >pdb|9PAI|A Chain A, Cleaved Substrate Variant Of Plasminogen Activator Inhibitor-1 Length = 346 | Back alignment and structure |
|
| >pdb|3OZQ|A Chain A, Crystal Structure Of Serpin48, Which Is A Highly Specific Serpin In The Insect Tenebrio Molitor Length = 376 | Back alignment and structure |
|
| >pdb|2VDX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Corticosteroid Binding Globulin Length = 373 | Back alignment and structure |
|
| >pdb|3NDA|A Chain A, Crystal Structure Of Serpin From Tick Ixodes Ricinus Length = 377 | Back alignment and structure |
|
| >pdb|3H5C|A Chain A, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex Length = 423 | Back alignment and structure |
|
| >pdb|3F1S|A Chain A, Crystal Structure Of Protein Z Complexed With Protein Z-Dependent Inhibitor Length = 385 | Back alignment and structure |
|
| >pdb|1JJO|C Chain C, Crystal Structure Of Mouse Neuroserpin (Cleaved Form) Length = 261 | Back alignment and structure |
|
| >pdb|1XU8|A Chain A, The 2.8 A Structure Of A Tumour Suppressing Serpin Length = 380 | Back alignment and structure |
|
| >pdb|1WZ9|A Chain A, The 2.1 A Structure Of A Tumour Suppressing Serpin Length = 375 | Back alignment and structure |
|
| >pdb|2OL2|A Chain A, High Resolution Structure Of Native Pci In Space Group P21 Length = 395 | Back alignment and structure |
|
| >pdb|4IF8|A Chain A, Structure Of Vaspin Length = 414 | Back alignment and structure |
|
| >pdb|2HI9|A Chain A, Crystal Structure Of Human Native Protein C Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1XQG|A Chain A, 3.10 A Crystal Structure Of Maspin, Space Group P 4 21 2 Length = 389 | Back alignment and structure |
|
| >pdb|1JMO|A Chain A, Crystal Structure Of The Heparin Cofactor Ii-S195a Thrombin Complex Length = 480 | Back alignment and structure |
|
| >pdb|4AJT|A Chain A, The Cystal Structure Of Mouse Protein-Z Dependent Protease Inhibitor(Mzpi) Length = 427 | Back alignment and structure |
|
| >pdb|1JMJ|A Chain A, Crystal Structure Of Native Heparin Cofactor Ii Length = 480 | Back alignment and structure |
|
| >pdb|3DLW|A Chain A, Antichymotrypsin Length = 411 | Back alignment and structure |
|
| >pdb|2ACH|A Chain A, Crystal Structure Of Cleaved Human Alpha1-antichymotrypsin At 2.7 Angstroms Resolution And Its Comparison With Other Serpins Length = 360 | Back alignment and structure |
|
| >pdb|3CAA|A Chain A, Cleaved Antichymotrypsin A347r Length = 341 | Back alignment and structure |
|
| >pdb|1AS4|A Chain A, Cleaved Antichymotrypsin A349r Length = 341 | Back alignment and structure |
|
| >pdb|2PEE|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Native State Length = 387 | Back alignment and structure |
|
| >pdb|2VH4|A Chain A, Structure Of A Loop C-sheet Serpin Polymer Length = 381 | Back alignment and structure |
|
| >pdb|2PEF|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Latent State Length = 373 | Back alignment and structure |
|
| >pdb|1QMN|A Chain A, Alpha1-Antichymotrypsin Serpin In The Delta Conformation (Partial Loop Insertion) Length = 401 | Back alignment and structure |
|
| >pdb|4BB2|A Chain A, Crystal Structure Of Cleaved Corticosteroid-binding Globulin In Complex With Progesterone Length = 340 | Back alignment and structure |
|
| >pdb|1LQ8|A Chain A, Crystal Structure Of Cleaved Protein C Inhibitor Length = 346 | Back alignment and structure |
|
| >pdb|3PZF|A Chain A, 1.75a Resolution Structure Of Serpin-2 From Anopheles Gambiae Length = 397 | Back alignment and structure |
|
| >pdb|4CAA|A Chain A, Cleaved Antichymotrypsin T345r Length = 341 | Back alignment and structure |
|
| >pdb|1OO8|A Chain A, Crystal Structure Of A1pi-Pittsburgh In The Native Conformation Length = 394 | Back alignment and structure |
|
| >pdb|3DY0|A Chain A, Crystal Structure Of Cleaved Pci Bound To Heparin Length = 336 | Back alignment and structure |
|
| >pdb|1ATU|A Chain A, Uncleaved Alpha-1-Antitrypsin Length = 374 | Back alignment and structure |
|
| >pdb|1KCT|A Chain A, Alpha1-Antitrypsin Length = 394 | Back alignment and structure |
|
| >pdb|1IZ2|A Chain A, Interactions Causing The Kinetic Trap In Serpin Protein Folding Length = 394 | Back alignment and structure |
|
| >pdb|3T1P|A Chain A, Crystal Structure Of An Alpha-1-Antitrypsin Trimer Length = 371 | Back alignment and structure |
|
| >pdb|1YXA|A Chain A, Serpina3n, A Murine Orthologue Of Human Antichymotrypsin Length = 398 | Back alignment and structure |
|
| >pdb|1HP7|A Chain A, A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-Antitrypsin Shows Variability Of The Reactive Center And Other Loops Length = 394 | Back alignment and structure |
|
| >pdb|3NE4|A Chain A, 1.8 Angstrom Structure Of Intact Native Wild-Type Alpha-1-Antitrypsin Length = 424 | Back alignment and structure |
|
| >pdb|1QLP|A Chain A, 2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsin: A Canonical Template For Active Serpins Length = 394 | Back alignment and structure |
|
| >pdb|1MTP|A Chain A, The X-Ray Crystal Structure Of A Serpin From A Thermophilic Prokaryote Length = 323 | Back alignment and structure |
|
| >pdb|4AFX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Zpi In I2 Space Group Length = 387 | Back alignment and structure |
|
| >pdb|3DRM|A Chain A, 2.2 Angstrom Crystal Structure Of Thr114phe Alpha1- Antitrypsin Length = 404 | Back alignment and structure |
|
| >pdb|2QUG|A Chain A, Crystal Structure Of Alpha-1-Antitrypsin, Crystal Form A Length = 394 | Back alignment and structure |
|
| >pdb|1PSI|A Chain A, Intact Recombined Alpha1-Antitrypsin Mutant Phe 51 To Leu Length = 394 | Back alignment and structure |
|
| >pdb|1SNG|A Chain A, Structure Of A Thermophilic Serpin In The Native State Length = 370 | Back alignment and structure |
|
| >pdb|2D26|A Chain A, Active Site Distortion Is Sufficient For Proteinase Inhibit Second Crystal Structure Of Covalent Serpin-Proteinase Complex Length = 358 | Back alignment and structure |
|
| >pdb|2V95|A Chain A, Struture Of Corticosteroid-Binding Globulin In Complex With Cortisol Length = 371 | Back alignment and structure |
|
| >pdb|3STO|A Chain A, Serpin From The Trematode Schistosoma Haematobium Length = 406 | Back alignment and structure |
|
| >pdb|1EZX|A Chain A, Crystal Structure Of A Serpin:protease Complex Length = 335 | Back alignment and structure |
|
| >pdb|1D5S|A Chain A, Crystal Structure Of Cleaved Antitrypsin Polymer Length = 334 | Back alignment and structure |
|
| >pdb|3DRU|A Chain A, Crystal Structure Of Gly117phe Alpha1-Antitrypsin Length = 404 | Back alignment and structure |
|
| >pdb|7API|A Chain A, The S Variant Of Human Alpha1-Antitrypsin, Structure And Implications For Function And Metabolism Length = 347 | Back alignment and structure |
|
| >pdb|1QMB|A Chain A, Cleaved Alpha-1-Antitrypsin Polymer Length = 326 | Back alignment and structure |
|
| >pdb|3NDF|A Chain A, Cleaved Antitrypsin With P8-P6 Asp Length = 343 | Back alignment and structure |
|
| >pdb|3NDD|A Chain A, Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Length = 343 | Back alignment and structure |
|
| >pdb|2R9Y|A Chain A, Structure Of Antiplasmin Length = 430 | Back alignment and structure |
|
| >pdb|4AU2|A Chain A, Crystal Structure Of A Hsp47-Collagen Complex Length = 392 | Back alignment and structure |
|
| >pdb|1F0C|A Chain A, Structure Of The Viral Serpin Crma Length = 305 | Back alignment and structure |
|
| >pdb|1C8O|A Chain A, 2.9 A Structure Of Cleaved Viral Serpin Crma Length = 300 | Back alignment and structure |
|
| >pdb|1M93|B Chain B, 1.65 A Structure Of Cleaved Viral Serpin Crma Length = 245 | Back alignment and structure |
|
| >pdb|1IMV|A Chain A, 2.85 A Crystal Structure Of Pedf Length = 398 | Back alignment and structure |
|
| >pdb|2OAY|A Chain A, Crystal Structure Of Latent Human C1-Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2CEO|A Chain A, Thyroxine-Binding Globulin Complex With Thyroxine Length = 379 | Back alignment and structure |
|
| >pdb|2XN6|A Chain A, Crystal Structure Of Thyroxine-Binding Globulin Complexed With Thyroxine-Fluoresein Length = 350 | Back alignment and structure |
|
| >pdb|2XN5|A Chain A, Crystal Structure Of Thyroxine-Binding Globulin Complexed With Furosemide Length = 350 | Back alignment and structure |
|
| >pdb|2RIV|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Human Thyroxine Binding Globulin Length = 343 | Back alignment and structure |
|
| >pdb|2RIW|A Chain A, The Reactive Loop Cleaved Human Thyroxine Binding Globulin Complexed With Thyroxine Length = 338 | Back alignment and structure |
|
| >pdb|4AU3|A Chain A, Crystal Structure Of A Hsp47-Collagen Complex Length = 392 | Back alignment and structure |
|
| >pdb|4AU3|B Chain B, Crystal Structure Of A Hsp47-Collagen Complex Length = 392 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} Length = 393 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-125
Identities = 212/381 (55%), Positives = 262/381 (68%), Gaps = 31/381 (8%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSFL 57
DV ESIS Q ++++L+KH+ S + SP SI+V+LS+IAAGS G T Q+LSFL
Sbjct: 4 DVRESISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFL 63
Query: 58 KSKSNEQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
K S +Q N F+SE+V+ V ADGSANGGP+LSVANG WID+SLSFK +FKQ +++ YKA+
Sbjct: 64 KFSSTDQLNSFSSEIVSAVLADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAA 123
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
S+Q DFQ+KAVEV E+N WAEKETNG I EVLP GS D +KL+FANALYFKG WNE F
Sbjct: 124 SNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEKF 183
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222
D S T+E +FHLL+G + PFMTSK KQ V+A+DGFKVL LPY Q
Sbjct: 184 DESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYLP 243
Query: 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
+ L L K S GFL +HIP ++V +F+IP+FK SFG + S VLK LGL F
Sbjct: 244 DANNGLSDLLDKIVSTPGFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSPF 303
Query: 280 SRKGGRLTEMVDSHVGVG------IFQKSFIEVKEEGTEAAAASAAVITLKSL-PRFDKI 332
S + G LTEMV+S IF K+ IEV EEGTEAAAASA VI L+ L D+I
Sbjct: 304 SGEEG-LTEMVESPEMGKNLCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDEI 362
Query: 333 DFVADHPFIFMIREDATGVVL 353
DFVADHPF+ ++ E+ TGVVL
Sbjct: 363 DFVADHPFLLVVTENITGVVL 383
|
| >1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 Length = 370 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-102
Identities = 74/364 (20%), Positives = 139/364 (38%), Gaps = 39/364 (10%)
Query: 9 SEQTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNE- 63
+ + L L + + SP S+ L ++AAG++ T +L + L +
Sbjct: 12 DDHLEFALHLHRRLAEAVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLGTDPAPL 71
Query: 64 QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQ 123
+ P L+ +W+ + +++F+ T+ + + DF+
Sbjct: 72 LAALDRAV----------TDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFR 121
Query: 124 NKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKE 183
V +N T G I+E+LP G+V + + NAL+ K W F++ T+
Sbjct: 122 TNPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTRA 181
Query: 184 YDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYK------------QDELPALEKK 231
F G +VPFM G++++ L +
Sbjct: 182 GTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHAHDELAVDVLLPPGTNAAAVPTAP 240
Query: 232 TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD 291
+ L +E+ +PRF+++ ++ VL G+ F+ L+ +
Sbjct: 241 LLTA---LHRRSASTSVEL---ALPRFELTQPHQLVEVLAEAGVRTLFTAS-ADLSGIST 293
Query: 292 SHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSL-PRFDKIDFVADHPFIFMIREDAT 349
+ V + ++ + V E G E AAA+AA++ L P I F D PF ++R
Sbjct: 294 VPLYVDTVIHQARLRVDERGAEGAAATAAMMLLAGAMPPRRTIRFSVDRPFHIVVRR--R 351
Query: 350 GVVL 353
G +L
Sbjct: 352 GAIL 355
|
| >1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I Length = 378 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 93/371 (25%), Positives = 161/371 (43%), Gaps = 32/371 (8%)
Query: 3 DVLESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFL 57
D+ + + E T + + S S+ L +A S G + +LL L
Sbjct: 6 DLQKILRESNDQFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRAL 65
Query: 58 K-SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS 116
N ++ ++L V A G L +A+ +++ + L + F +++ +
Sbjct: 66 ALPNDNVTKDVFADLNRGV----RAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSE 121
Query: 117 SHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAF 176
VDF +VE + IN W E +TN IK ++ P ++D++++ V NA+YFKG W + F
Sbjct: 122 VQNVDFVK-SVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKF 180
Query: 177 DSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE---------- 224
+ +T + DFH+ +IKVP M K K++ + Y+ D+
Sbjct: 181 NKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPNQ 240
Query: 225 ---LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSR 281
+ ALE+K L + +P+FKI ++ VL + + F+
Sbjct: 241 VDGITALEQKL-KDPKALSRAEERLYNTEVEIYLPKFKIETTTDLKEVLSNMNIKKLFTP 299
Query: 282 KGGRLTEMVDSHVGVGI---FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADH 338
RL ++ + + + QK+FIEV EEG EAAAA+A IT S +
Sbjct: 300 GAARLENLLKTKESLYVDAAIQKAFIEVNEEGAEAAAANAFKITTYSFHF--VPKVEINK 357
Query: 339 PFIFMIREDAT 349
PF F ++ +
Sbjct: 358 PFFFSLKYNRN 368
|
| >3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... Length = 432 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-100
Identities = 101/381 (26%), Positives = 180/381 (47%), Gaps = 39/381 (10%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK 58
+ +S+ + + +H+ + + SPLSI +M G+ TLQQL+ K
Sbjct: 48 VWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFK 107
Query: 59 -------SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDN 111
+ FA + AN +L AN ++ D+SL+F T++ +
Sbjct: 108 FDTISEKTSDQIHFFFAKLNCRL---YRKANKASKLVSANRLFGDKSLTFNETYQDISEL 164
Query: 112 IYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGV 171
+Y A +DF+ A + IN W +T G I +V+P ++++ + LV N +YFKG+
Sbjct: 165 VYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGL 224
Query: 172 WNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNK-QLVTAFDGFKVLVLPYKQDELPAL-- 228
W F T++ F+ +G S M + K + +G +VL LP+K D++ +
Sbjct: 225 WKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLI 284
Query: 229 --EKKTGSQSGFLKDHIPYEMIE---------VGDFRIPRFKISFGIEVSRVLKALGLVL 277
+ + ++ + E+++ + +PRF+I G + L+ +GLV
Sbjct: 285 LPKPEKSLAK--VEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVD 342
Query: 278 SFSRKGGRLTEMVDS-----HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKI 332
FS + +L +V +V F K+F+EV EEG+EAAA++A VI +SL +++
Sbjct: 343 LFSPEKSKLPGIVAEGRDDLYVS-DAFHKAFLEVNEEGSEAAASTAVVIAGRSLN-PNRV 400
Query: 333 DFVADHPFIFMIREDATGVVL 353
F A+ PF+ IRE ++
Sbjct: 401 TFKANRPFLVFIREVPLNTII 421
|
| >3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} Length = 376 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 3e-98
Identities = 99/378 (26%), Positives = 170/378 (44%), Gaps = 41/378 (10%)
Query: 2 DDVLESISE-QTDITLSLSKHIKAPTSSS---SPLSIHVLLSMIAAGSKGPTLQQL---L 54
D L+ T S+ K + ++ SP S LL++ +G +G T +++ L
Sbjct: 5 DATLQEFPNAVNSFTPSVYKEVLKTEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVL 64
Query: 55 SFLKSKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYK 114
F+ + + L + N L AN +++ + S + F++ +Y
Sbjct: 65 HFVGDREKAEGAVKEVLSKL------TNEEYTLHTANKIYVKTNFSVREEFQKIAVEVYG 118
Query: 115 ASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNE 174
A S VDF K + ++ +N W E++T I+ ++ P +++ +++V NALYF W
Sbjct: 119 AQSENVDFSEKN-DAAKLMNAWVEEQTQHKIQNLVDPEILNNLTRVVLINALYFNAKWLV 177
Query: 175 AFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYKQDE------- 224
F T++ DFH ++V M + K+L LP+K
Sbjct: 178 PFPPFHTRKSDFHKSAKEVVQVDTMYLDEQYFNYYECHHLDAKLLELPFKGGASLTIVLS 237
Query: 225 -----LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
L +LE K FL ++ +++ V +P+FKI ++ +VLK LG+ +F
Sbjct: 238 NQIEGLVSLESKIKRS--FLPHNLTKQLVNV---ALPKFKIESTVDFKKVLKKLGVKKAF 292
Query: 280 SRKGGRLTEMVDSHVGVGI---FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDK-IDFV 335
+ L+ + + I QKSFI+V EEG EAAAA+ + L + D F+
Sbjct: 293 GDE-ADLSGIAGEKGDLVISNIVQKSFIDVSEEGVEAAAATYIPVILPEMALPDSPKQFI 351
Query: 336 ADHPFIFMIREDATGVVL 353
DHPFIF I+ G++L
Sbjct: 352 VDHPFIFYIKV--KGMIL 367
|
| >2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A Length = 382 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 7e-96
Identities = 100/380 (26%), Positives = 172/380 (45%), Gaps = 37/380 (9%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK- 58
+E + T L+L KH+ + + SP SI ++M+ GS+G T Q+ S L+
Sbjct: 1 MEDLCVANTLFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQF 60
Query: 59 -SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASS 117
S ++ A ++ G L N ++ ++S SF+ + + Y +
Sbjct: 61 NEVGAAADKIHSSFRSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEP 120
Query: 118 HQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFD 177
VDF A E ++IN W + +T G I +LP GSVD +++V NA+YFKG W F+
Sbjct: 121 QAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFE 180
Query: 178 SSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK-------------- 221
+ F + + V M + K + + ++L LPY
Sbjct: 181 KKLNGLFPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAGDVSMFLLLPDEIA 240
Query: 222 --QDELPALEKKTGS---QSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLV 276
L LE + KD + + +EV IP+FK+ E+ +L+++G+
Sbjct: 241 DVSTGLELLESEITYDKLNKWTSKDKMAEDEVEV---YIPQFKLEEHYELRSILRSMGME 297
Query: 277 LSFSRKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKID 333
+F++ + M + + +F ++ ++V EEGTEAAA + V+T ++
Sbjct: 298 DAFNKGRANFSGMSERNDLFLS-EVFHQAMVDVNEEGTEAAAGTGGVMTGRTGH--GGPQ 354
Query: 334 FVADHPFIFMIREDATGVVL 353
FVADHPF+F+I T +L
Sbjct: 355 FVADHPFLFLIMHKITNCIL 374
|
| >3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} Length = 397 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 2e-95
Identities = 85/386 (22%), Positives = 157/386 (40%), Gaps = 44/386 (11%)
Query: 2 DDVLESISE-QTDITLSLSKHIKAPTSSS---SPLSIHVLLSMIAAGSK-------GPTL 50
D + Q + L K I +S+ SP S+ +LL++I S T
Sbjct: 12 DVHGPFQGQRQNEFDLMFVKEIFKNHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTK 71
Query: 51 QQLLSFLKSKSNEQ--QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQT 108
++L S +++ + + + L + N L++A ++D + N ++Q
Sbjct: 72 RELSSVIQNDNIDHTRSYYKQLLESA----QQDNKDYDLNIATNFFVDDFIEVINKYQQI 127
Query: 109 VDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYF 168
+ Y A +V + N + + IN W + TNG ++E++ P S++ + + N +YF
Sbjct: 128 ANTHYHAMLEKVSYSN-PTQTAATINNWVSEHTNGRLREIVTPDSLEGA-VITLVNVIYF 185
Query: 169 KGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE-- 224
KG+W F F+ G +M + G ++L LPY+ ++
Sbjct: 186 KGLWTYPFPEVANNVKPFYGTRGKPTNAQYMEQNGQFYYDNSADLGAQILRLPYRGNKLA 245
Query: 225 -----------LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKAL 273
+ + + S S L + Y + +P+FK F +++ L+ +
Sbjct: 246 MYFILPNPDNTVNQVLDRINSAS--LHQALWYMEENEVNVTLPKFKFDFSEQLNEPLQQV 303
Query: 274 GLVLSFSRKGGRLTEMVDSHVGVG------IFQKSFIEVKEEGTEAAAASAAVITLKSLP 327
G+ FS+ L + IFQK+ I + E G+EA AA+ + K
Sbjct: 304 GIREIFSQN-ASLPLLARGRGARDEVRVSRIFQKAGITINELGSEAYAATEIQLVNKFGG 362
Query: 328 RFDKIDFVADHPFIFMIREDATGVVL 353
F A+ PFIF I ++ G +L
Sbjct: 363 D-GVQIFNANRPFIFFIEDETLGTML 387
|
| >2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A Length = 415 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 9e-95
Identities = 96/405 (23%), Positives = 168/405 (41%), Gaps = 55/405 (13%)
Query: 2 DDVLESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSF 56
+ +E +S + T+ L + SP SI L++ +KG T +++
Sbjct: 3 EISMEQVSASIGNFTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEV 62
Query: 57 LK--------------------------SKSNEQQNFASELVAIVFADGSANGGPRLSVA 90
L + + +N S ++ A L A
Sbjct: 63 LHFTEAVRAESSSVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSA 122
Query: 91 NGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLP 150
N ++++++ + T+ Q YKA +V+F+ + +EIN W EK+T IK +L
Sbjct: 123 NRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLS 182
Query: 151 PGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF 210
V +++L+ NA+YFK W F + KT F L S V M ++ V
Sbjct: 183 SDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIM 242
Query: 211 D--GFKVLVLPYKQDE------LPALEKKTGSQSGFLKDHIPYEMIE-----------VG 251
+ FK++ LPY + E LP K + L+ + YE + +
Sbjct: 243 EKMNFKMIELPYVKRELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLV 302
Query: 252 DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS---HVGVGIFQKSFIEVKE 308
D +P+F + I++ L+ +G+ +F+ M D + + +SF+ V E
Sbjct: 303 DLHLPKFSLEDRIDLRDTLRNMGMTTAFTTN-ADFRGMTDKKDLAIS-KVIHQSFVAVDE 360
Query: 309 EGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVL 353
+GTEAAAA+A +I+ + + F DHPF F IR + + +L
Sbjct: 361 KGTEAAAATAVIISFTTSVINHVLKFKVDHPFHFFIRHNKSKTIL 405
|
| >2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A Length = 373 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 1e-94
Identities = 86/376 (22%), Positives = 157/376 (41%), Gaps = 38/376 (10%)
Query: 2 DDVLESISE-QTDITLSLSKHIKAPTSSS--SPLSIHVLLSMIAAGSKGPTLQQLLSFLK 58
++ E D ++ L K+ +S SPLS + L+M A G+ TL Q+ L
Sbjct: 3 KNIDEKFIYNTADFSIELFKNSIDDKENSLISPLSAMLALAMTANGADNETLAQMEKALG 62
Query: 59 ---SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWI-DQSLSFKNTFKQTVDNIYK 114
S + + + + + +L++AN +W + F Q + + YK
Sbjct: 63 KDISIEDLNKYLYTYMKKL-----PNEEKSKLTIANSIWFKENDFMPSKDFLQIIADYYK 117
Query: 115 ASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNE 174
A + F + V +IN W + +TNG I ++L +D + NA+ F W
Sbjct: 118 ADIFKAAFDSSTVS---DINNWVKSKTNGMIDKIL--NKIDPEDVMYLINAVAFDAEWET 172
Query: 175 AFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE---------- 224
++ + E F + G KV FM S+ + + V PY ++
Sbjct: 173 VYEKASVHEDIFTDVYGNRQKVEFMNSEENLYIEE-ENAVGFVKPYAKNHYSFVAILPDE 231
Query: 225 ---LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSR 281
+ K Q D I I + +P+FK + I+++ L++LG+ +F
Sbjct: 232 NISVNEYIKTLTGQK--FIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDAFLP 289
Query: 282 KGGRLTEMVDSHVG---VG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
+++ S +G + + K+FI V E GT+A A ++ IT +P + +
Sbjct: 290 DKADFSKLGKSDIGNLYISEVLHKTFISVDELGTKAGAVTSVDITAAGIP-VNFKTVKLN 348
Query: 338 HPFIFMIREDATGVVL 353
PFIF I +++T + +
Sbjct: 349 RPFIFAIIDNSTNLPI 364
|
| >1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B Length = 379 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 3e-94
Identities = 89/378 (23%), Positives = 161/378 (42%), Gaps = 44/378 (11%)
Query: 7 SISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS 61
++ +D + + + + + SP + +L+M+ + G T QQ+ + + K
Sbjct: 7 YVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKI 66
Query: 62 NEQ---QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSH 118
+++ + +S + +++ + L F +++++
Sbjct: 67 DDKGMAPALRHLYKEL----MGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVK 122
Query: 119 QVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDS 178
QVDF IN W + T G I +L G+VD ++LV NALYF G W F
Sbjct: 123 QVDFSE-VERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPD 181
Query: 179 SKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD-----GFKVLVLPYKQDE------LPA 227
S T FH +G ++ VP M NK T F + +L LPY D P
Sbjct: 182 SSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPY 241
Query: 228 LEKKTGSQSGFLKDHIPYEMIE---------VGDFRIPRFKISFGIEVSRVLKALGLVLS 278
EK+ + L + + ++I +P+F + +++ + L+ LG+
Sbjct: 242 -EKEVPLSA--LTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDM 298
Query: 279 FSRKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFV 335
F + T + D HV QK IEV E GT A++++A +++ + P + +
Sbjct: 299 FRQFQADFTSLSDQEPLHVA-QALQKVKIEVNESGTVASSSTAVIVSARMAP----EEII 353
Query: 336 ADHPFIFMIREDATGVVL 353
D PF+F++R + TG VL
Sbjct: 354 MDRPFLFVVRHNPTGTVL 371
|
| >4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C Length = 379 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 1e-93
Identities = 87/376 (23%), Positives = 155/376 (41%), Gaps = 40/376 (10%)
Query: 7 SISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS 61
S+ E ++ + + I SP I +L M+ G+ G T +QL ++
Sbjct: 7 SLEELGSNTGIQVFNQIVKSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGV 66
Query: 62 NEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVD 121
N ++ + S ++VAN V++ + + F ++++ V+
Sbjct: 67 NGVGKILKKINKAIV---SKKNKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVN 123
Query: 122 FQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSS-KLVFANALYFKGVWNEAFDSSK 180
F++ A IN W + ET I +L P +D +LV NA+YFKG+W F
Sbjct: 124 FEDPA-SACDSINAWVKNETRDMIDNLLSPDLIDGVLTRLVLVNAVYFKGLWKSRFQPEN 182
Query: 181 TKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD-----GFKVLVLPYKQDE----------- 224
TK+ F +G S +VP + + + + + LPY +
Sbjct: 183 TKKRTFVAADGKSYQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGESISMLIALPTES 242
Query: 225 ---LPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFS 280
L A+ + + + ++V +P+F ++ LK LG+ F
Sbjct: 243 STPLSAIIPHISTKTIDSWMSIMVPKRVQV---ILPKFTAVAQTDLKEPLKVLGITDMFD 299
Query: 281 RKGGRLTEMVDSHVGVGI---FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
++ + + QK+ IEV E+GT+A+AA+ A++ +S P F+ D
Sbjct: 300 SSKANFAKITTGSENLHVSHILQKAKIEVSEDGTKASAATTAILIARSSP----PWFIVD 355
Query: 338 HPFIFMIREDATGVVL 353
PF+F IR + TG VL
Sbjct: 356 RPFLFFIRHNPTGAVL 371
|
| >1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A Length = 375 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-92
Identities = 83/378 (21%), Positives = 155/378 (41%), Gaps = 40/378 (10%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKS 59
++++ + + L K + SP+ + LS+ G+KG T ++ L
Sbjct: 1 MDALQLANSAFAVDLFKQLCEKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHF 60
Query: 60 KSNEQ--QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASS 117
++ + F + + + L + +++D+SL+ F + Y
Sbjct: 61 ENVKDVPFGFQTVTSDV----NKLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKEL 116
Query: 118 HQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFD 177
VDF++K E +IN + T+G + +L SV+D +K++ NA YF G W + F
Sbjct: 117 ETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFP 176
Query: 178 SSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE------LPALE 229
S+TKE F L + V M + + D K++ LP++ LP
Sbjct: 177 ESETKECPFRLNKTDTKPVQMMNMEATFCMGNIDSINCKIIELPFQNKHLSMFILLPKDV 236
Query: 230 KKTGSQSGFLKDHIPYEMI------------EVGDFRIPRFKISFGIEVSRVLKALGLVL 277
+ + ++ + E + +V IP+FK+ I+ L+ LGL
Sbjct: 237 EDESTGLEKIEKQLNSESLSQWTNPSTMANAKV-KLSIPKFKVEKMIDPKACLENLGLKH 295
Query: 278 SFSRKGGRLTEMVDSH-VGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFV 335
FS + M ++ V + + K +E+ E+G ++ A I
Sbjct: 296 IFSEDTSDFSGMSETKGVALSNVIHKVCLEITEDGGDSIEVPGARILQHKDE------LN 349
Query: 336 ADHPFIFMIREDATGVVL 353
ADHPFI++IR + T ++
Sbjct: 350 ADHPFIYIIRHNKTRNII 367
|
| >3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} Length = 407 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 7e-92
Identities = 95/372 (25%), Positives = 162/372 (43%), Gaps = 37/372 (9%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN 66
D+++++ ++A SPLSI + + M+ G++G T +++ + S +
Sbjct: 23 IADLSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGE 82
Query: 67 FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKA 126
S L + + +AN +++ F Q + + A+ + VDF
Sbjct: 83 EFSFLKEFSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQ-N 141
Query: 127 VEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDF 186
V V+ IN W E TN +K+++ P D ++ L NA+YFKG W F T+ + F
Sbjct: 142 VAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSF 201
Query: 187 HLLNGGSIKVPFMTSKNKQLVTAFD--------GFKVLVLPYKQDE-------------L 225
+ +++P M + + F ++VL +PY+ DE L
Sbjct: 202 TKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSRQEVPL 261
Query: 226 PALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGG 284
LE + + + +EV +PRF + I++ VLKALG+ F +
Sbjct: 262 ATLEPLVKAQLVEEWANSVKKQKVEV---YLPRFTVEQEIDLKDVLKALGITEIFIKD-A 317
Query: 285 RLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFI 341
LT + D+ + KSF+EV EEG+EAAA S + + + DHPF
Sbjct: 318 NLTGLSDNKEIFLS-KAIHKSFLEVNEEGSEAAAVSGMIAISRMAVL--YPQVIVDHPFF 374
Query: 342 FMIREDATGVVL 353
F+IR TG +L
Sbjct: 375 FLIRNRRTGTIL 386
|
| >1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A Length = 385 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-90
Identities = 88/385 (22%), Positives = 149/385 (38%), Gaps = 47/385 (12%)
Query: 7 SISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS 61
SI + + K +K ++ P++I L+M+ G+K T Q+ ++
Sbjct: 2 SIGAASMEFCFDVFKELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDK 61
Query: 62 NEQQNFASELVAIVFAD------------GSANGGPRLSVANGVWIDQSLSFKNTFKQTV 109
+ E + N S+A+ ++ ++ + Q V
Sbjct: 62 LPGFGDSIEAQCGTSVNVHSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCV 121
Query: 110 DNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFK 169
+Y+ ++FQ A + IN W E +TNG I+ VL P SVD + +V NA+ FK
Sbjct: 122 KELYRGGLEPINFQTAADQARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFK 181
Query: 170 GVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE--- 224
G+W +AF T+ F + S V M V + K+L LP+
Sbjct: 182 GLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMSM 241
Query: 225 ----------LPALEKKTGS---QSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLK 271
L LE + + I+V +PR K+ ++ VL
Sbjct: 242 LVLLPDEVSGLEQLESIINFEKLTEWTSSNVMEERKIKV---YLPRMKMEEKYNLTSVLM 298
Query: 272 ALGLVLSFSRKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPR 328
A+G+ FS L+ + + + + E+ E G E ++ A + S+
Sbjct: 299 AMGITDVFSSS-ANLSGISSAESLKIS-QAVHAAHAEINEAGREVVGSAEAGVDAASVS- 355
Query: 329 FDKIDFVADHPFIFMIREDATGVVL 353
+F ADHPF+F I+ AT VL
Sbjct: 356 ---EEFRADHPFLFCIKHIATNAVL 377
|
| >3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} Length = 406 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 4e-90
Identities = 73/389 (18%), Positives = 153/389 (39%), Gaps = 41/389 (10%)
Query: 2 DDVLESISEQTDITLSLSKHIKAPTSSS----SPLSIHVLLSMI--AAGSKGPTLQQLLS 55
DD +IS T + + A PL I L ++ + G++G T Q+
Sbjct: 10 DDPYANISSHKAFTHAYLSTVTADFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGK 69
Query: 56 FLK--------SKSNEQQNFASELVAI------VFADGSANGGPRLSVANGVWIDQSLSF 101
++ + S QQ S + + + ++ G++++++
Sbjct: 70 TMRLKSTSSSWNSSEAQQEMKSLYQELNNSLTSEKTFLNEKEENVVRISTGIFVEKTYEV 129
Query: 102 KNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLV 161
+ F +++ N + QVDF N + +IN W ++++NG +++ + D + ++
Sbjct: 130 ERRFNESIANDSEGELKQVDFSN-RTSATVDINDWVDQQSNGLLEKFFTD-DIPDDTAMI 187
Query: 162 FANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLP 219
N YF+ W F+ T++ DF++ I V MT + F+ GF+++ P
Sbjct: 188 LVNVFYFRDFWQSPFEPHYTRKEDFYISPDRQITVDMMTQEGVMKYGKFEDEGFEIVSKP 247
Query: 220 YKQDE-------------LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEV 266
L + + + V R+P+F + +++
Sbjct: 248 LNNTRFTFVIVLPLEKWSLNGATELLNGNKVLSEYVKNLKETTV-SLRLPKFTLKNTLDL 306
Query: 267 SRVLKALGLVLSFSRKGGRLTEMVDSH-VGVG-IFQKSFIEVKEEGTEAAAASAAVITLK 324
LK++G+V F L+ + + + V Q + +++ E G EA ++ +
Sbjct: 307 VPTLKSIGVVDLFDPVKSDLSGITPNPNLYVNEFIQTNVLKLNESGIEATTVTSPIFVPF 366
Query: 325 SLPRFDKIDFVADHPFIFMIREDATGVVL 353
S ++DF HPFI I + + +
Sbjct: 367 SAI-IPEVDFHVTHPFICFIYDQQLTMPI 394
|
| >3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} Length = 377 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 2e-89
Identities = 91/379 (24%), Positives = 161/379 (42%), Gaps = 36/379 (9%)
Query: 1 MDDVLESISEQTDITLSLSKHIKAPTSSS---SPLSIHVLLSMIAAGSKGPTLQQLLSFL 57
M + + L L + + + + SP S+ + M AG++G T Q+L L
Sbjct: 1 MQEEAKLTKANNRFGLRLLRALPSGPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGL 60
Query: 58 K------SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDN 111
+ + + + S L VAN I ++L+ N+++ + +
Sbjct: 61 GFSDVDLTDAGVLDAYTHHTERL----KSTPSNSTLDVANAAAIQRTLALLNSYESALQS 116
Query: 112 IYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGV 171
+ A H+VDF + +N W +++T+ I+++ +D + LV NA+YFKG
Sbjct: 117 SFGAELHKVDFAGEPQAAVDFVNNWVKRKTHDKIEKLFNE-PLDPDTLLVLLNAIYFKGE 175
Query: 172 WNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE----- 224
WN AF T++ F ++V M + + FD +V+ LPY+ +
Sbjct: 176 WNTAFVKEHTEKRQFFNGGVTPVEVDTMRLEARIKYRFFDDLQVEVVELPYRGLDYTMAI 235
Query: 225 --------LPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGL 275
+ L++ T + + I V +P+FK+ + L++LG+
Sbjct: 236 LLPKENTGVEGLKQNLTIDRFQNYLSDLRERKITV---LLPKFKLETKYSLKAPLQSLGI 292
Query: 276 VLSFSRKGGRLTEMVDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
F L+ + D + V + K+ +EV EEGT AAA + VI SL + + F
Sbjct: 293 KQIFESG-ADLSGINDGSLRVSAVEHKAVVEVNEEGTVAAATTGVVIVPYSLG-PEPVVF 350
Query: 335 VADHPFIFMIREDATGVVL 353
DHPF+F IR T +
Sbjct: 351 RVDHPFLFFIRNTRTDDIF 369
|
| >1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 Length = 323 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 1e-88
Identities = 70/332 (21%), Positives = 134/332 (40%), Gaps = 34/332 (10%)
Query: 9 SEQTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQ 64
+ + L L + + SP S+ L ++AAG++ T +L + L +
Sbjct: 8 DDHLEFALHLHRRLAEAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLGT----- 62
Query: 65 QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQN 124
+ A L A+ D + P L+ +W+ + +++F+ T+ + + DF+
Sbjct: 63 -DPAPLLAAL---DRAVTDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRT 118
Query: 125 KAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEY 184
V +N T G I+E+LP G+V + + NAL+ K W F++ T+E
Sbjct: 119 NPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTREG 178
Query: 185 DFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ------------DELPALEKKT 232
F G +VPFM G++++ L +
Sbjct: 179 TFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHAHDELAVDVLLPPGTNAAAVPTAPL 237
Query: 233 GSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS 292
+ L +E+ +PRF+++ ++ VL G+ F+ L+ +
Sbjct: 238 LTA---LHRRSASTSVEL---ALPRFELTQPHQLVEVLAEAGVRTLFTAS-ADLSGISTV 290
Query: 293 HVGVG-IFQKSFIEVKEEGTEAAAASAAVITL 323
+ V + ++ + V E G E AAA+AA++ L
Sbjct: 291 PLYVDTVIHQARLRVDERGAEGAAATAAMMLL 322
|
| >2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} Length = 401 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 1e-88
Identities = 100/379 (26%), Positives = 164/379 (43%), Gaps = 40/379 (10%)
Query: 11 QTDITLSLSKHIKAPTSSS---SPLSIHVLLSMIAAGSKGPTLQQLLSFLK--------- 58
T L + + ++ SP+SI L M+ G+K T QQ+ L
Sbjct: 19 NTKFMFDLFQQFRKSKENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTT 78
Query: 59 -----SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIY 113
+ N + ++ + L +AN ++ +++ F + + Y
Sbjct: 79 GKAATYHVDRSGNVHHQFQKLLTEFNKSTDAYELKIANKLFGEKTYLFLQEYLDAIKKFY 138
Query: 114 KASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWN 173
+ S VDF N E ++IN W E +TN IK ++P G++ ++ LV NA+YFKG W
Sbjct: 139 QTSVESVDFANAPEESRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFKGQWE 198
Query: 174 EAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE------- 224
+ F+ TKE F + M + + KVL +PYK +
Sbjct: 199 KKFNKEDTKEEKFWPNKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYKGKDLSMIVLL 258
Query: 225 ------LPALEKKTGSQSGFLKDHIPYEMIEV-GDFRIPRFKISFGIEVSRVLKALGLVL 277
L LE+K ++ ++ M E D +PRFK+ ++ L+ +G+V
Sbjct: 259 PNEIDGLQKLEEKLTAEK-LMEWTSLQNMRETRVDLHLPRFKVEESYDLKDTLRTMGMVD 317
Query: 278 SFSRKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
F+ L+ M S + G+ K+F+EV EEG EAAAA+A V S +F
Sbjct: 318 IFNGD-ADLSGMTGSRGLVLS-GVLHKAFVEVTEEGAEAAAATAVVGFGSSPTS-TNEEF 374
Query: 335 VADHPFIFMIREDATGVVL 353
+HPF+F IR++ T +L
Sbjct: 375 HCNHPFLFFIRQNKTNSIL 393
|
| >3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* Length = 385 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-87
Identities = 92/373 (24%), Positives = 156/373 (41%), Gaps = 35/373 (9%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS---SPLSIHVLLSMIAAGSKGPTLQQLLSFLK-- 58
+ +++ ++ SL + I + SP + + ++ + G+ GPT Q+ L
Sbjct: 13 RQQLAKETSNFGFSLLRKISMRHDGNMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQ 72
Query: 59 SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSH 118
+ + L + S N L+ + +I + K TF +
Sbjct: 73 ALKPTKPGLLPSLFKGLRETLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECV 132
Query: 119 QVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDS 178
++F+N A + R +N + KET G I ++ ++ +KL+ + + FKG W FD
Sbjct: 133 PMNFRN-ASQAKRLMNHYINKETRGKIPKLFD--EINPETKLILVDYILFKGKWLTPFDP 189
Query: 179 SKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE------------ 224
T+ FHL +IKVP M K T VL LPY+ +
Sbjct: 190 VFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQGNATMLVVLMEKMGD 249
Query: 225 LPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG 283
ALE T ++ +EV P+FK+ E+ +L+ +G+ FS
Sbjct: 250 HLALEDYLTTDLVETWLRNMKTRNMEV---FFPKFKLDQKYEMHELLRQMGIRRIFSPF- 305
Query: 284 GRLTEMVDSHVGVGI---FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPF 340
L+E+ + + + Q++ IEV E GTEA A + IT S+P D PF
Sbjct: 306 ADLSELSATGRNLQVSRVLQRTVIEVDERGTEAVAGILSEITAYSMP----PVIKVDRPF 361
Query: 341 IFMIREDATGVVL 353
FMI E+ +G++L
Sbjct: 362 HFMIYEETSGMLL 374
|
| >1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* Length = 480 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 9e-86
Identities = 87/378 (23%), Positives = 148/378 (39%), Gaps = 41/378 (10%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK 58
++ ++ +L + +K ++ +P+ I + MI+ G KG T +Q+ S L
Sbjct: 104 IQRLNILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILH 163
Query: 59 SKSNEQQNFASELVAI--VFAD-----GSANGGPRLSVANGVWIDQSLSFKNTFKQTVDN 111
K + E+ I +F N G L N ++I + FK V
Sbjct: 164 FKDFVNASSKYEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVRE 223
Query: 112 IYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGV 171
Y A + DF + A + N K T G IK+ L ++D +++++ N +YFKG
Sbjct: 224 YYFAEAQIADFSDPAFI--SKTNNHIMKLTKGLIKDALE--NIDPATQMMILNCIYFKGS 279
Query: 172 WNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK-------- 221
W F T ++F L +KV M +K L +L L Y
Sbjct: 280 WVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGGISMLIV 339
Query: 222 ----QDELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLV 276
+ LE + T + + EV +P+FK+ + LK +G+
Sbjct: 340 VPHKMSGMKTLEAQLTPRVVERWQKSMTNRTREV---LLPKFKLEKNYNLVESLKLMGIR 396
Query: 277 LSFSRKGGRLTEMVDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFV 335
+ F + G + + D + + + I V EEGT+A + S + F
Sbjct: 397 MLFDKNGN-MAGISDQRIAIDLFKHQGTITVNEEGTQATTVTTVGFMPLSTQ----VRFT 451
Query: 336 ADHPFIFMIREDATGVVL 353
D PF+F+I E T +L
Sbjct: 452 VDRPFLFLIYEHRTSCLL 469
|
| >2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} Length = 430 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 1e-84
Identities = 82/365 (22%), Positives = 149/365 (40%), Gaps = 44/365 (12%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQ-Q 65
T L + ++SS SPLS+ + LS +A G++ TL L L +
Sbjct: 25 MMAFTTDLFSLVAQTSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNTGSCLP 84
Query: 66 NFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNK 125
+ S G + +A +++ + K+ F + + ++ A ++ + +
Sbjct: 85 HLLSHFY-------QNLGPGTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTGKQE 137
Query: 126 AVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYD 185
E IN W ++ T G I++ L + DS+ L+ NA++F G W FD S T++
Sbjct: 138 --EDLANINQWVKEATEGKIEDFLS--ELPDSTVLLLLNAIHFHGFWRTKFDPSLTQKDF 193
Query: 186 FHLLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYKQDE-------------LPALE 229
FHL ++ V M + + L +V P+K + + +
Sbjct: 194 FHLDERFTVSVDMMHAVSYPLRWFLLEQPEIQVAHFPFKNNMSFVVVMPTYFEWNVSEVL 253
Query: 230 KKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEM 289
+ + +V +P+ + +++ L LGL F G L +
Sbjct: 254 ANLTWDT-LYHPSLQERPTKV---WLPKLHLQQQLDLVATLSQLGLQELFQ--GPDLRGI 307
Query: 290 VDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDA 348
+ ++ V + +S +E+ E G EAAAA++ + SL F + PF+F I ED
Sbjct: 308 SEQNLVVSSVQHQSTMELSEAGVEAAAATSVAMNRMSLS-----SFTVNRPFLFFIMEDT 362
Query: 349 TGVVL 353
GV L
Sbjct: 363 IGVPL 367
|
| >1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A Length = 401 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 2e-84
Identities = 88/379 (23%), Positives = 165/379 (43%), Gaps = 36/379 (9%)
Query: 2 DDVLESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL--- 53
V ++ D SL K + SP SI L+ ++ G+ TL ++
Sbjct: 21 THVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKG 80
Query: 54 LSFLKSKSNE---QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVD 110
L F ++++E Q+F L + ++ +LS+ N +++ + LS + F +
Sbjct: 81 LKFNLTETSEAEIHQSFQHLLRTL----NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAK 136
Query: 111 NIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKG 170
+Y + + DFQ+ + + IN + + T G I +++ +D + +V N ++FK
Sbjct: 137 RLYGSEAFATDFQD-SAAAKKLINDYVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKA 193
Query: 171 VWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYK------ 221
W FD T + F+L + VP M+ + + D V+ L Y
Sbjct: 194 KWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASAL 253
Query: 222 -----QDELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLV 276
QD++ +E ++ + E E+G+ +P+F IS ++ +L LG+
Sbjct: 254 FILPDQDKMEEVEAMLLPET-LKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIE 312
Query: 277 LSFSRKG--GRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDF 334
+F+ K +T + V + K+ ++V EEGTEA+AA+A ITL S +
Sbjct: 313 EAFTSKADLSGITGARNLAVS-QVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIV 371
Query: 335 VADHPFIFMIREDATGVVL 353
+ PF+ +I T +
Sbjct: 372 RFNRPFLMIIVPTDTQNIF 390
|
| >2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* Length = 373 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 4e-84
Identities = 84/375 (22%), Positives = 162/375 (43%), Gaps = 42/375 (11%)
Query: 6 ESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LSFL 57
++ D SL KH+ A + SP+SI + L+M++ G+ G T QL L F
Sbjct: 5 RGLASANVDFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFN 64
Query: 58 KSKSNE---QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYK 114
++ +E Q F ++ +++ N +++D SL +F + + Y+
Sbjct: 65 LTERSETEIHQGFQHLHQLF----AKSDTSLEMTMGNALFLDGSLELLESFSADIKHYYE 120
Query: 115 ASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNE 174
+ ++FQ+ SR+IN + + +T G I ++ +D + LV N ++FKG W +
Sbjct: 121 SEVLAMNFQD-WATASRQINSYVKNKTQGKIVDLFS--GLDSPAILVLVNYIFFKGTWTQ 177
Query: 175 AFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK----------- 221
FD + T+E +F++ +KVP M + +++ + Y
Sbjct: 178 PFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVGNGTVFFILPD 237
Query: 222 QDELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFS 280
+ ++ + + + +++ IP+ IS ++ VL+ +G+ F+
Sbjct: 238 KGKMNTVIAALSRDTINRWSAGLTSSQVDL---YIPKVTISGVYDLGDVLEEMGIADLFT 294
Query: 281 RKG--GRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADH 338
+ R+T+ + K+ +++ EEGTEAA A +S P I +
Sbjct: 295 TQANFSRITQDAQLKSS-KVVHKAVLQLNEEGTEAAGAMFLEAIPRSKP----IILRFNQ 349
Query: 339 PFIFMIREDATGVVL 353
PFI MI + T L
Sbjct: 350 PFIIMIFDHFTWSSL 364
|
| >2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} Length = 371 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 1e-83
Identities = 69/371 (18%), Positives = 155/371 (41%), Gaps = 38/371 (10%)
Query: 6 ESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSK 60
++ D +L + + A SP+SI + L+M++ GS Q L F ++
Sbjct: 7 RGLAPTNVDFAFNLYQRLVALNPDKNTLISPVSISMALAMVSLGSAQTQSLQSLGFNLTE 66
Query: 61 SNE---QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASS 117
++E Q+F + ++ G +++ N +++ Q L K++F V Y++ +
Sbjct: 67 TSEAEIHQSFQYLNYLL----KQSDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEA 122
Query: 118 HQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFD 177
+DF++ + S++IN + +T G I+ V +D + + N ++ +G+W F
Sbjct: 123 LAIDFED-WTKASQQINQHVKDKTQGKIEHVFS--DLDSPASFILVNYIFLRGIWELPFS 179
Query: 178 SSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGF--KVLVLPYK-----------QDE 224
T+E DF++ ++KVP M F +++ + Y Q +
Sbjct: 180 PENTREEDFYVNETSTVKVPMMVQSGSIGYFRDSVFPCQLIQMDYVGNGTAFFILPDQGQ 239
Query: 225 LPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG 283
+ + + + + + IP+F +S ++ VL+ L + + +
Sbjct: 240 MDTVIAALSRDTIDRWGKLMTPRQVNL---YIPKFSMSDTYDLKDVLEDLNIKDLLTNQS 296
Query: 284 GRLTEMVDSH-VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIF 342
+ + + + K+ +++ E + + A + L+S P +D + PFI
Sbjct: 297 D-FSGNTKDVPLTLTMVHKAMLQLDEGNVLPNSTNGAPLHLRSEP----LDIKFNKPFIL 351
Query: 343 MIREDATGVVL 353
++ + T L
Sbjct: 352 LLFDKFTWSSL 362
|
| >1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} Length = 398 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 4e-83
Identities = 90/378 (23%), Positives = 158/378 (41%), Gaps = 38/378 (10%)
Query: 3 DVLESISEQTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LS 55
D L S TD SL K + + SPLSI L++++ G+KG TL+++ L
Sbjct: 23 DSLTLASINTDFAFSLYKELVLKNPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLK 82
Query: 56 FLKSKSNE---QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNI 112
F ++++E Q F L + ++S + ++I++ F++ +
Sbjct: 83 FNLTETSEADIHQGFGHLLQRL----NQPKDQVQISTGSALFIEKRQQILTEFQEKAKTL 138
Query: 113 YKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVW 172
Y+A + DFQ + + IN + K+T G IKE++ +D + +V N +YFK W
Sbjct: 139 YQAEAFTADFQQ-PRQAKKLINDYVRKQTQGMIKELVS--DLDKRTLMVLVNYIYFKAKW 195
Query: 173 NEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYK-------- 221
FD T + +F+ + VP M+ ++ D V+ L Y
Sbjct: 196 KVPFDPLDTFKSEFYCGKRRPVIVPMMSMEDLTTPYFRDEELSCTVVELKYTGNASALFI 255
Query: 222 ---QDELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLS 278
Q + +E K + + + +P+F IS + VL LG+
Sbjct: 256 LPDQGRMQQVEASL-QPETLRKWKNSLKPRMIDELHLPKFSISTDYSLEDVLSKLGIREV 314
Query: 279 FSRKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFV 335
FS + L+ + + V + K+ ++V E GTEAAAA+ S +
Sbjct: 315 FSTQAD-LSAITGTKDLRVS-QVVHKAVLDVAETGTEAAAATGVKFVPMSAK-LYPLTVY 371
Query: 336 ADHPFIFMIREDATGVVL 353
+ PF+ MI + T +
Sbjct: 372 FNRPFLIMIFDTETEIAP 389
|
| >2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} Length = 390 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 2e-82
Identities = 81/371 (21%), Positives = 134/371 (36%), Gaps = 54/371 (14%)
Query: 11 QTDITLSLSKHIKAPTSSS-----SPLSIHVLLSMIAAGSKGPTLQQL---LSFLKSKSN 62
D +L L A SP SI LL+ + G+ T L LS+ K +
Sbjct: 36 LVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTC 95
Query: 63 EQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDF 122
Q ++ + ++ L+ ++TF +Y +S +
Sbjct: 96 VHQALKGFT------------TKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSN 143
Query: 123 QNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTK 182
+ IN W K TN I +L S+ ++LV NA+Y W FD KT+
Sbjct: 144 NSD--ANLELINTWVAKNTNNKISRLL--DSLPSDTRLVLLNAIYLSAKWKTTFDPKKTR 199
Query: 183 EYDFHLLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYK-------------QDELP 226
FH IKVP M SK + D KV L + L
Sbjct: 200 MEPFH-FKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSHNLSLVILVPQNLKHRLE 258
Query: 227 ALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGR 285
+E+ + S + + + + +PR K++ ++ +++ L FS
Sbjct: 259 DMEQALSPSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFF-DFSYD-LN 316
Query: 286 LTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIF 342
L + + V + ++ +E+ E G EAAAASA + L F PF+F
Sbjct: 317 LCGLTEDPDLQVS-AMQHQTVLELTETGVEAAAASAISVARTLLV------FEVQQPFLF 369
Query: 343 MIREDATGVVL 353
M+ + +
Sbjct: 370 MLWDQQHKFPV 380
|
| >4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B Length = 392 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 3e-82
Identities = 70/377 (18%), Positives = 138/377 (36%), Gaps = 43/377 (11%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK- 58
+++E + SL + + + SP+ + L +++ G K T Q + L
Sbjct: 6 AATLAERSAGLAFSLYQAMAKDQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSA 65
Query: 59 ---SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKA 115
L ++ S + + ++ S+SF F ++ Y
Sbjct: 66 EQLRDEEVHAGLGELLRSL---SNSTARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNC 122
Query: 116 SSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEA 175
+++F++K + IN WA + T+G + EV V+ + + NA++FK W+E
Sbjct: 123 EHSKINFRDKR-SALQSINEWAAQTTDGKLPEVTK--DVERTDGALLVNAMFFKPHWDEK 179
Query: 176 FDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE--------- 224
F F + ++ V M + +++ +P
Sbjct: 180 FHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKLQIVEMPLAHKLSSLIILMPH 239
Query: 225 ----LPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
L LEK T Q + + + + +P+ + ++ + L LGL +
Sbjct: 240 HVEPLERLEKLLTKEQLKIWMGKMQKKAVAI---SLPKGVVEVTHDLQKHLAGLGLTEAI 296
Query: 280 SRKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVA 336
+ L+ M ++ +F + E EG L+S F A
Sbjct: 297 DKNKADLSRMSGKKDLYLA-SVFHATAFEWDTEGNPFDQDIYGREELRSPKL-----FYA 350
Query: 337 DHPFIFMIREDATGVVL 353
DHPFIF++R+ +G +L
Sbjct: 351 DHPFIFLVRDTQSGSLL 367
|
| >3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* Length = 395 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 8e-82
Identities = 81/365 (22%), Positives = 168/365 (46%), Gaps = 38/365 (10%)
Query: 9 SEQTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LSFLKSKS 61
S + D T L + + + S SP+SI + L+M++ G+ T Q+ L KS
Sbjct: 32 SSRRDFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKS 91
Query: 62 NEQ---QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSH 118
+E+ + F L + G +LS+ N ++ D + ++TF + +Y A +
Sbjct: 92 SEKELHRGFQQLLQEL----NQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTF 147
Query: 119 QVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDS 178
+F++ A ++IN + K+T G I ++L ++D ++ ++ N ++FK W +F+
Sbjct: 148 PTNFRDSA-GAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNH 204
Query: 179 SKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK-----------QDEL 225
T+E DF++ + ++VP M+ +++ +V+ +PY+ + ++
Sbjct: 205 KGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNATALFILPSEGKM 264
Query: 226 PALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG- 283
+E + +E+ +P+F I ++ +VL +LG+ F+
Sbjct: 265 QQVENGLSEKTLRKWLKMFKKRQLEL---YLPKFSIEGSYQLEKVLPSLGISNVFTSHAD 321
Query: 284 -GRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIF 342
++ + V + K+ +EV E GT AAAA+ + T +S + V + PF+
Sbjct: 322 LSGISNHSNIQVS-EMVHKAVVEVDESGTRAAAATGTIFTFRSAR-LNSQRLVFNRPFLM 379
Query: 343 MIRED 347
I ++
Sbjct: 380 FIVDN 384
|
| >2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} Length = 379 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 2e-81
Identities = 76/377 (20%), Positives = 145/377 (38%), Gaps = 39/377 (10%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LSF 56
L +S D +L + T SP+SI L M++ G+ T ++ L F
Sbjct: 3 LYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGF 62
Query: 57 LKSKSNE---QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIY 113
+ + Q F + ++ L + N ++I + L F V +Y
Sbjct: 63 NLTDTPMVEIQHGFQHLICSL----NFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLY 118
Query: 114 KASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWN 173
+ DF N +EIN E +T G + ++ + ++ +V N ++FK W
Sbjct: 119 ETEVFSTDFSN-ISAAKQEINSHVEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWA 175
Query: 174 EAFDSSKTKE-YDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK--------- 221
FD SKT++ F + +++VP M + VL + Y
Sbjct: 176 NPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVL 235
Query: 222 --QDELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLS 278
+ ++ ++E + + +++ +P+F IS ++ L +G+ +
Sbjct: 236 PKEGQMESVEAAMSSKTLKKWNRLLQKGWVDL---FVPKFSISATYDLGATLLKMGIQHA 292
Query: 279 FSRKG--GRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVA 336
+S LTE + K+ + + E+GTEAAA ++ + F
Sbjct: 293 YSENADFSGLTEDNGLKLS-NAAHKAVLHIGEKGTEAAAVPEVELSDQPENTFLHPIIQI 351
Query: 337 DHPFIFMIREDATGVVL 353
D F+ +I E +T +L
Sbjct: 352 DRSFMLLILERSTRSIL 368
|
| >3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B Length = 424 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 8e-81
Identities = 83/376 (22%), Positives = 158/376 (42%), Gaps = 42/376 (11%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LSF 56
I+ + SL + + ++S+ SP+SI +M++ G+K T ++ L+F
Sbjct: 53 FNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNF 112
Query: 57 LKSKSNE---QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIY 113
++ E + F L + + +L+ NG+++ + L + F + V +Y
Sbjct: 113 NLTEIPEAQIHEGFQELLRTL----NQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLY 168
Query: 114 KASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWN 173
+ + V+F + E ++IN + EK T G I +++ +D + N ++FKG W
Sbjct: 169 HSEAFTVNFGD-TEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWE 225
Query: 174 EAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK---------- 221
F+ T+E DFH+ ++KVP M + VL++ Y
Sbjct: 226 RPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLP 285
Query: 222 -QDELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
+ +L LE + T ++ + +P+ I+ ++ VL LG+ F
Sbjct: 286 DEGKLQHLENELTHDIITKFLENEDRRSASL---HLPKLSITGTYDLKSVLGQLGITKVF 342
Query: 280 SRKG--GRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
S +TE + K+ + + E+GTEAA A S+P + +
Sbjct: 343 SNGADLSGVTEEAPLKLS-KAVHKAVLTIDEKGTEAAGAMFLEAIPMSIP----PEVKFN 397
Query: 338 HPFIFMIREDATGVVL 353
PF+F++ E T L
Sbjct: 398 KPFVFLMIEQNTKSPL 413
|
| >1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 Length = 398 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 3e-80
Identities = 68/376 (18%), Positives = 141/376 (37%), Gaps = 46/376 (12%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK- 58
+ ++ ++ L + + + ++ SPLS+ LS ++ G+ T + L
Sbjct: 31 VNKLAAAVSNFGYDLYRVRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYY 90
Query: 59 ---SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKA 115
S + + L + L A+ + ++ L K++F ++ Y
Sbjct: 91 DLISSPDIHGTYKELLDTV------TAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGT 144
Query: 116 SSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEA 175
+ + +EIN W + + G + + D ++ +FKG W
Sbjct: 145 RPRVLTGNPR--LDLQEINNWVQAQMKGKLARSTK--EIPDEISILLLGVAHFKGQWVTK 200
Query: 176 FDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYK----------- 221
FDS KT DF+L +++VP M+ L D K+ LP
Sbjct: 201 FDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGSMSIIFFLPL 260
Query: 222 --QDELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLS 278
L +E+ T + + + +P+ K+S+ EV++ L+ + L
Sbjct: 261 KVTQNLTLIEESLTSEFIHDIDRELKTVQAVL---TVPKLKLSYEGEVTKSLQEMKLQSL 317
Query: 279 FSRKGGRLTEMVDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
F +++ + + + ++ E E+G + + P +D+ +
Sbjct: 318 FDS--PDFSKITGKPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLTFP----LDYHLN 371
Query: 338 HPFIFMIREDATGVVL 353
PFIF++R+ TG +L
Sbjct: 372 QPFIFVLRDTDTGALL 387
|
| >2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B Length = 453 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 1e-78
Identities = 58/381 (15%), Positives = 122/381 (32%), Gaps = 55/381 (14%)
Query: 11 QTDITLSLSKHIKAPTSSS------SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQ 64
+ + SP ++ L+ + G+ T +L + L ++
Sbjct: 78 ANFLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDK 137
Query: 65 ---------------QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTV 109
Q LVA + LS GV+ L K F Q +
Sbjct: 138 NCTSRLDAHKVLSALQAVQGLLVAQ--GRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGL 195
Query: 110 DNIYKASSHQ-VDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYF 168
+ +DF + +I+ + + T L SVD S L F ++F
Sbjct: 196 ALYTPVVLPRSLDFTE-LDVAAEKIDRFMQAVTGWKTGCSLMGASVD--STLAFNTYVHF 252
Query: 169 KGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQD--- 223
+G S + +F + N S+ VP ++ + F V +P+ +
Sbjct: 253 QGKM--KGFSLLAEPQEFWVDNSTSVSVPMLSGMGTFQHWSDIQDNFSVTQVPFTESACL 310
Query: 224 ---------ELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKAL 273
+L +E S + I + +P+ + ++ +L
Sbjct: 311 LLIQPHYASDLDKVEGLTFQQNSLNWMKKLSPRTIHL---TMPQLVLQGSYDLQDLLAQA 367
Query: 274 GLVLSFSRKGGRLTEMVDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKI 332
L + L ++ + + VG + F E++ + E ++ + + L
Sbjct: 368 ELPAILHTE-LNLQKLSNDRIRVGEVLNSIFFELEADEREPTESTQQLNKPEVL------ 420
Query: 333 DFVADHPFIFMIREDATGVVL 353
+ + PF+F + + + +
Sbjct: 421 EVTLNRPFLFAVYDQSATALH 441
|
| >1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 345 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 5e-78
Identities = 100/349 (28%), Positives = 156/349 (44%), Gaps = 36/349 (10%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKS 59
+E +S T + L + + + SPLSI L+MI G++G T Q+ L
Sbjct: 2 MEQLSTANTHFAVDLFRALNESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYF 61
Query: 60 KSNEQ--QNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASS 117
+ E F S I L +AN ++ +++ +F F + +Y A
Sbjct: 62 DTVEDIHSRFQSLNADI----NKPGAPYILKLANRLYGEKTYNFLADFLASTQKMYGAEL 117
Query: 118 HQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFD 177
VDFQ + +EIN W + +T G I E+L G VD+ +KLV NA+YFKG W + F
Sbjct: 118 ASVDFQQAPEDARKEINEWVKGQTEGKIPELLVKGMVDNMTKLVLVNAIYFKGNWQQKFM 177
Query: 178 SSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE------LPALE 229
T++ F L + V M K K + +VL LPY+ E LP
Sbjct: 178 KEATRDAPFRLNKKDTKTVKMMYQKKKFPYNYIEDLKCRVLELPYQGKELSMIILLPDDI 237
Query: 230 KKTGSQSGFLKDHIPYEMI------------EVGDFRIPRFKISFGIEVSRVLKALGLVL 277
+ + ++ + + + EV + +PRFK+ +++ L LG+
Sbjct: 238 EDESTGLEKIEKQLTLDKLREWTKPENLYLAEV-NVHLPRFKLEESYDLTSHLARLGVQD 296
Query: 278 SFSRKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITL 323
F+R L+ M + V I KSF+++ EEGTEAAAA+A I L
Sbjct: 297 LFNRGKADLSGMSGARDLFVS-KIIHKSFVDLNEEGTEAAAATAGTILL 344
|
| >2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A Length = 453 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-77
Identities = 64/377 (16%), Positives = 125/377 (33%), Gaps = 48/377 (12%)
Query: 12 TDITLSLSKHIKAPTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN 66
+ + K + S + SP ++ L GS PT QL + L E
Sbjct: 78 NFVGFRMYKMLNEAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVKEGDC 137
Query: 67 FASELVAIVFA-------------DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIY 113
+ V A S+ S+ G++ K++F Q++
Sbjct: 138 TSRLDGHKVLAALRAVQGLLVTQGGSSSQTPLLQSIVVGLFTAPGFRLKHSFVQSLALFT 197
Query: 114 KASSHQ-VDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVW 172
A + +D V + +IN + + T + L V S L+F ++F+G
Sbjct: 198 PALFPRSLDLSTDPVLATEKINRFIKAVTGWKMNLPL--EGVSTDSTLLFNTYVHFQGTM 255
Query: 173 NEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQD------- 223
++F + N S+ VP ++ + F V +P +
Sbjct: 256 RGFSQ--LPGVHEFWVDNSISVSVPMISGTGNFQHWSDAQNNFSVTCVPLGERATLLLIQ 313
Query: 224 -----ELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVL 277
+L +E + ++ P I + +P+ +I + +L L
Sbjct: 314 PHCISDLDRVEALIFQNDLLTWIENPPPRAIRL---TLPQLEIRGSYNLQDLLAEDKLPT 370
Query: 278 SFSRKGGRLTEMVDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVA 336
+ L + D++ VG + +E+ + G E ++ +D
Sbjct: 371 LLGAEA-NLNNIGDTNPRVGEVLNSILLEL-KAGEEEQPTTSVQQPGSPEA----LDVTL 424
Query: 337 DHPFIFMIREDATGVVL 353
PF+F I E +G +
Sbjct: 425 SSPFLFAIYEQDSGTLH 441
|
| >3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A Length = 359 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 1e-74
Identities = 85/343 (24%), Positives = 149/343 (43%), Gaps = 35/343 (10%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN 66
D+++++ ++A SPLSI + + M+ G++G T +++ + S +
Sbjct: 23 IADLSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGE 82
Query: 67 FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKA 126
S L + + +AN +++ F Q + + A+ + VDF
Sbjct: 83 EFSFLKEFSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQ-N 141
Query: 127 VEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDF 186
V V+ IN W E TN +K+++ P D ++ L NA+YFKG W F T+ + F
Sbjct: 142 VAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSF 201
Query: 187 HLLNGGSIKVPFMTSKNKQLVTAFD--------GFKVLVLPYKQDE-------------L 225
+ +++P M + + F ++VL +PY+ DE L
Sbjct: 202 TKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSRQEVPL 261
Query: 226 PALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGG 284
LE + + + +EV +PRF + I++ VLKALG+ F +
Sbjct: 262 ATLEPLVKAQLVEEWANSVKKQKVEV---YLPRFTVEQEIDLKDVLKALGITEIFIKD-A 317
Query: 285 RLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLK 324
LT + D+ + KSF+EV EEG+EAAA S + +
Sbjct: 318 NLTGLSDNKEIFLS-KAIHKSFLEVNEEGSEAAAVSGMIAISR 359
|
| >2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A Length = 394 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-73
Identities = 87/370 (23%), Positives = 152/370 (41%), Gaps = 53/370 (14%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LSF 56
+E +S + T+ L + SP SI L++ +KG T +++ L F
Sbjct: 26 MEQVSASIGNFTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHF 85
Query: 57 LKSKSNEQQNFASELVAIVFADGSA-----------------------NGGPRLSVANGV 93
++ E + A L AN +
Sbjct: 86 TEAVRAESSSVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRI 145
Query: 94 WIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGS 153
+++++ + T+ Q YKA +V+F+ + +EIN W EK+T IK +L
Sbjct: 146 YVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDD 205
Query: 154 VDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD-- 211
V +++L+ NA+YFK W F + KT F L S V M ++ V +
Sbjct: 206 VKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIMEKM 265
Query: 212 GFKVLVLPYKQDE------LPALEKKTGSQSGFLKDHIPYEMIE-----------VGDFR 254
FK++ LPY + E LP K + L+ + YE + + D
Sbjct: 266 NFKMIELPYVKRELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLH 325
Query: 255 IPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVG-IFQKSFIEVKEEGTE 312
+P+F + I++ L+ +G+ +F+ M D + + + +SF+ V E+GTE
Sbjct: 326 LPKFSLEDRIDLRDTLRNMGMTTAFTTN-ADFRGMTDKKDLAISKVIHQSFVAVDEKGTE 384
Query: 313 AAAASAAVIT 322
AAAA+A +I+
Sbjct: 385 AAAATAVIIS 394
|
| >1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A Length = 341 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 2e-71
Identities = 83/339 (24%), Positives = 151/339 (44%), Gaps = 35/339 (10%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK------SK 60
D SL K + SPLSI L+ ++ G+ TL ++L LK S+
Sbjct: 11 NVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSE 70
Query: 61 SNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQV 120
+ Q+F L + ++ +LS+ N +++ + LS + F + +Y + +
Sbjct: 71 AEIHQSFQHLLRTL----NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFAT 126
Query: 121 DFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSK 180
DFQ+ + + IN + + T G I +++ +D + +V N ++FK W FD
Sbjct: 127 DFQD-SAAAKKLINDYVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQD 183
Query: 181 TKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYK-----------QDELP 226
T + F+L + VP M+ + + D V+ L Y QD++
Sbjct: 184 THQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKME 243
Query: 227 ALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG--G 284
+E ++ + E E+G+ +P+F IS ++ +L LG+ +F+ K
Sbjct: 244 EVEAMLLPET-LKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLS 302
Query: 285 RLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITL 323
+T + V + K+ ++V EEGTEA+ A+A ITL
Sbjct: 303 GITGARNLAVS-QVVHKAVLDVFEEGTEASRATAVKITL 340
|
| >1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A Length = 305 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-70
Identities = 76/330 (23%), Positives = 139/330 (42%), Gaps = 51/330 (15%)
Query: 16 LSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASEL 71
+ + + I + SP SI +L+++ G+ G T +QL +++ ++++ ++
Sbjct: 1 MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADKNKD----- 55
Query: 72 VAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSR 131
N V+ S FK++F + + + ++ VDF +
Sbjct: 56 ------------DISFKSMNKVYGRYSAVFKDSFLRKIGDNFQT----VDFTDC--RTVD 97
Query: 132 EINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNG 191
IN + T G I +L + + L+ +A+YFK W F+ T +Y F++
Sbjct: 98 AINKCVDIFTEGKINPLLDE-PLSPDTCLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPT 156
Query: 192 GSIKVPFMTSKNKQLVTAFD-----GFKVLVLPYK------------QDELPALEKK-TG 233
+ V M+ + A F ++ LPY D L ++E+ T
Sbjct: 157 EMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYVGDTSMVVILPDNIDGLESIEQNLTD 216
Query: 234 SQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH 293
+ D + I+V IP+FK++ + L LGL F G + M +S
Sbjct: 217 TNFKKWCDSMDAMFIDV---HIPKFKVTGSYNLVDALVKLGLTEVFGST-GDYSNMCNSD 272
Query: 294 VGVG-IFQKSFIEVKEEGTEAAAASAAVIT 322
V V + K++I+V EE TEAAAA+ A++
Sbjct: 273 VSVDAMIHKTYIDVNEEYTEAAAATCALVA 302
|
| >3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* Length = 336 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-69
Identities = 75/339 (22%), Positives = 155/339 (45%), Gaps = 37/339 (10%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LSFLKSKSNE 63
+ D T L + + + S SP+SI + L+M++ G+ T Q+ L KS+E
Sbjct: 9 RRDFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSE 68
Query: 64 ---QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQV 120
+ F L + G +LS+ N ++ D + ++TF + +Y A +
Sbjct: 69 KELHRGFQQLLQEL----NQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPT 124
Query: 121 DFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSK 180
+F++ A ++IN + K+T G I ++L ++D ++ ++ N ++FK W +F+
Sbjct: 125 NFRDSA-GAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKG 181
Query: 181 TKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK-----------QDELPA 227
T+E DF++ + ++VP M+ +++ +V+ +PY+ + ++
Sbjct: 182 TQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNATALFILPSEGKMQQ 241
Query: 228 LEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG--G 284
+E + +E+ +P+F I ++ +VL +LG+ F+
Sbjct: 242 VENGLSEKTLRKWLKMFKKRQLEL---YLPKFSIEGSYQLEKVLPSLGISNVFTSHADLS 298
Query: 285 RLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITL 323
++ + V + K+ +EV E GT AAAA+ + T
Sbjct: 299 GISNHSNIQVS-EMVHKAVVEVDESGTRAAAATGTIFTF 336
|
| >3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A Length = 343 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-69
Identities = 74/347 (21%), Positives = 144/347 (41%), Gaps = 38/347 (10%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQL---LSF 56
I+ + SL + + ++S+ SP+SI +M++ G+K T ++ L+F
Sbjct: 8 FNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNF 67
Query: 57 LKSKSNE---QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIY 113
++ E + F L + + +L+ NG+++ + L + F + V +Y
Sbjct: 68 NLTEIPEAQIHEGFQELLRTL----NQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLY 123
Query: 114 KASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWN 173
+ + V+F + E ++IN + EK T G I +++ +D + N ++FKG W
Sbjct: 124 HSEAFTVNFGD-TEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWE 180
Query: 174 EAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK---------- 221
F+ T+E DFH+ ++KVP M + VL++ Y
Sbjct: 181 RPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHAKKLSSWVLLMKYLGNATAIFFLP 240
Query: 222 -QDELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSF 279
+ +L LE + T ++ + +P+ I+ ++ VL LG+ F
Sbjct: 241 DEGKLQHLENELTHDIITKFLENEDRRSASL---HLPKLSITGTYDLKSVLGQLGITKVF 297
Query: 280 SRKG--GRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLK 324
S +TE + K+ + + E+GTEAA +
Sbjct: 298 SNGADLSGVTEEAPLKLS-KAVHKAVLTIDEKGTEAAPDDDDEAIPR 343
|
| >2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* Length = 350 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-69
Identities = 70/354 (19%), Positives = 136/354 (38%), Gaps = 39/354 (11%)
Query: 2 DDVLESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSF 56
+ L +S D +L + T SP+SI L M++ G+ T +++
Sbjct: 5 NATLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVET 64
Query: 57 LKSKSNE------QQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVD 110
L + Q F + ++ L + N ++I + L F V
Sbjct: 65 LGFNLTDTPMVEIQHGFQHLICSL----NFPKKELELQIGNALFIGKHLKPLAKFLNDVK 120
Query: 111 NIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKG 170
+Y+ DF N +EIN E +T G + ++ + ++ +V N ++FK
Sbjct: 121 TLYETEVFSTDFSN-ISAAKQEINSHVEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKA 177
Query: 171 VWNEAFDSSKTKE-YDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK------ 221
W FD SKT++ F + +++VP M ++ VL + Y
Sbjct: 178 QWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMDQYYHLVDMELNCTVLQMDYSKNALAL 237
Query: 222 -----QDELPALEKK-TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGL 275
+ ++ ++E + + +++ +P+F IS ++ L +G+
Sbjct: 238 FVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDL---FVPKFSISATYDLGATLLKMGI 294
Query: 276 VLSFSRKG--GRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLP 327
++S LTE + K+ + + E+GTEAA A +S+P
Sbjct: 295 QHAYSENADFSGLTEDNGLKLS-NAAHKAVLHIGEKGTEAAGAMFLEAIPRSIP 347
|
| >1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 245 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 3e-62
Identities = 65/253 (25%), Positives = 106/253 (41%), Gaps = 30/253 (11%)
Query: 87 LSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIK 146
N V+ S FK++F + + VDF + IN + T G I
Sbjct: 4 FKSMNKVYGRYSAVFKDSFLR----KIGDNFQTVDFTDS--RTVDAINKSVDIFTEGKIN 57
Query: 147 EVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQL 206
+L + + L+ +A+YFK W F+ T +Y F++ + V M+ +
Sbjct: 58 PLLDE-PLSPDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAF 116
Query: 207 VTAFD-----GFKVLVLPYK------------QDELPALEKK-TGSQSGFLKDHIPYEMI 248
A F ++ LPY D L ++E+ T + D + I
Sbjct: 117 NHASVKESFGNFSIIELPYVGDTSMVVILPDNIDGLESIEQNLTDTNFKKWSDSMDAMFI 176
Query: 249 EVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSHVGVG-IFQKSFIEVK 307
+V IP+FK++ + L LGL F G + M +S V V + K++I+V
Sbjct: 177 DV---HIPKFKVTGSYNLVDALVKLGLTEVFGST-GDYSNMSNSDVSVDAMIHKTYIDVN 232
Query: 308 EEGTEAAAASAAV 320
EE TEAAAA++A+
Sbjct: 233 EEYTEAAAATSAL 245
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 1e-05
Identities = 46/338 (13%), Positives = 90/338 (26%), Gaps = 106/338 (31%)
Query: 69 SELVAIVFADGSANGGPRLSVANGV-WIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAV 127
+ + V + + + W+ +L N+ + ++ + + +Q+D N
Sbjct: 164 TWVALDVCLSYK----VQCKMDFKIFWL--NLKNCNSPETVLEML-QKLLYQID-PNWTS 215
Query: 128 EVSREINF-----WAEKETNGFIKEVLPPGS---VDDSSKLVFANALYFKGVWN----EA 175
N + E +K + + V N A
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN--------------VQNAKAWNA 261
Query: 176 FD-SSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLP-------YKQDE-LP 226
F+ S K LL T++ KQ+ + DE
Sbjct: 262 FNLSCKI------LL----------TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 227 ALEKKTGSQSGFL----KDHIPY------EMIEVGDFRIPRFKISFGIEVSRVLKALGLV 276
L K + L P E I G +K +++ ++++ V
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365
Query: 277 LSFSRKGGRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVA 336
L + E + +F S I L
Sbjct: 366 LEPA-------EYRKMFDRLSVFPPS---AH-------------IPTILLSLI------- 395
Query: 337 DHPFIFMIREDATGVVLSLVMFSILSIINK---VVLHS 371
+ +I+ D VV L +S++ K + + S
Sbjct: 396 ---WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS 430
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 5e-04
Identities = 54/390 (13%), Positives = 120/390 (30%), Gaps = 143/390 (36%)
Query: 1 MDDVLESISEQTDITLSL-SKHIKAPTS-------SSSPLSIHVLLSMIAAGSKGPTLQQ 52
+D +++ D SL K++ +++P LS+IA
Sbjct: 291 LDHHSMTLTP--DEVKSLLLKYLDCRPQDLPREVLTTNPR----RLSIIAE--------- 335
Query: 53 LLSFLKSKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLS------FKNTFK 106
++ N+ V D +L+ I+ SL+ ++ F
Sbjct: 336 ---SIRDGLATWDNWKH-----VNCD-------KLTTI----IESSLNVLEPAEYRKMFD 376
Query: 107 QTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANAL 166
+ ++ S + + W + + +V +V N L
Sbjct: 377 RLS--VFPPS---AHIPTILLSL-----IWFDVIKS----DV-----------MVVVNKL 411
Query: 167 YFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDELP 226
+ + + S +L +K+ + ++ +V ++ K + D+L
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLEL--KVKLENEYALHRSIVDHYNIPKT----FDSDDLI 465
Query: 227 ALEKKTGSQSGFLKDHIPYEM--IEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGG 284
+ HI + + IE + R+ F++ F L F
Sbjct: 466 PPY-----LDQYFYSHIGHHLKNIEHPE-RMTLFRMVF--------------LDF----- 500
Query: 285 RLTEMVDSHVGVGIFQKSFIEVK--EEGTEAAAASAAVITLKSL-----------PRFDK 331
F+E K + T A+ + + TL+ L P++++
Sbjct: 501 -----------------RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER 543
Query: 332 -----IDFVADHPFIFMIREDATGVV-LSL 355
+DF+ +I T ++ ++L
Sbjct: 544 LVNAILDFLPKIEEN-LICSKYTDLLRIAL 572
|
| >3f02_C Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 1jjo_E Length = 48 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 3e-05
Identities = 10/21 (47%), Positives = 13/21 (61%)
Query: 333 DFVADHPFIFMIREDATGVVL 353
+ DHPF F+IR TG +L
Sbjct: 7 QVIVDHPFFFLIRNRRTGTIL 27
|
| >2h4p_B MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_B Length = 34 | Back alignment and structure |
|---|
Score = 38.1 bits (89), Expect = 1e-04
Identities = 9/23 (39%), Positives = 13/23 (56%)
Query: 331 KIDFVADHPFIFMIREDATGVVL 353
+ F DHPF F IR + + +L
Sbjct: 2 VLKFKVDHPFHFFIRHNKSKTIL 24
|
| >1hle_B Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 31 | Back alignment and structure |
|---|
Score = 37.6 bits (88), Expect = 2e-04
Identities = 11/21 (52%), Positives = 15/21 (71%)
Query: 333 DFVADHPFIFMIREDATGVVL 353
+F ADHPFIF IR + + +L
Sbjct: 3 NFNADHPFIFFIRHNPSANIL 23
|
| >1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 55 | Back alignment and structure |
|---|
Score = 37.7 bits (88), Expect = 3e-04
Identities = 11/55 (20%), Positives = 30/55 (54%), Gaps = 4/55 (7%)
Query: 16 LSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN 66
+ + + I + SP SI +L+++ G+ G T +QL +++ ++++ ++
Sbjct: 1 MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADKNKD 55
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 375 | |||
| 3le2_A | 393 | Serpin-ZX; apoplast, glycoprotein, protease inhibi | 100.0 | |
| 4ga7_A | 389 | Leukocyte elastase inhibitor; serpin, conformation | 100.0 | |
| 3f5n_A | 407 | Neuroserpin; cleaved form, fenib, human, tissue PL | 100.0 | |
| 3nda_A | 377 | Serpin-2; vaccination target, TICK, hydrolase inhi | 100.0 | |
| 2h4r_A | 415 | MENT, heterochromatin-associated protein MENT; ser | 100.0 | |
| 3kcg_I | 432 | Antithrombin-III, ATIII; michaelis complex, blood | 100.0 | |
| 3ne4_A | 424 | Alpha-1-antitrypsin; serpin, LUNG disease, liver d | 100.0 | |
| 1uhg_A | 385 | Ovalbumin, S-ovalbumin; allergen, egg white protei | 100.0 | |
| 2ceo_A | 379 | Thyroxine-binding globulin; transport, serpin, hor | 100.0 | |
| 3sto_A | 406 | Serine protease inhibitor; serpin fold, hydrolase | 100.0 | |
| 1wz9_A | 375 | Maspin precursor; serpin, tumor suppressor, serpin | 100.0 | |
| 4dy0_A | 379 | GLIA-derived nexin; serpin, protease inhibitor, th | 100.0 | |
| 2zv6_A | 401 | Serpin B3; serine proteinase inhibitor, reactive s | 100.0 | |
| 2arr_A | 382 | Plasminogen activator inhibitor-2; serpin, peptide | 100.0 | |
| 4ajt_A | 427 | Protein Z-dependent protease inhibitor; blood clot | 100.0 | |
| 2vdx_A | 373 | Corticosteroid-binding globulin; transport protein | 100.0 | |
| 4au2_A | 392 | HSP47, serpin peptidase inhibitor, clade H (heat s | 100.0 | |
| 1lj5_A | 379 | Plasminogen activator inhibitor-1; beta-barrell, b | 100.0 | |
| 3f1s_A | 385 | Protein Z-dependent protease inhibitor; PZ, ZPI, c | 100.0 | |
| 1sek_A | 378 | Serpin K; serine protease inhibitor, protease; 2.1 | 100.0 | |
| 1yxa_A | 398 | Serine (OR cysteine) proteinase inhibitor, clade 3 | 100.0 | |
| 3ozq_A | 376 | Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito | 100.0 | |
| 3pzf_A | 397 | Serpin 2; protease inhibitor, melanization, hydrol | 100.0 | |
| 1qmn_A | 401 | AACT, alpha-1-antichymotrypsin; serpin, serine pro | 100.0 | |
| 3b9f_I | 395 | Protein C inhibitor; michaelis complex, acute phas | 100.0 | |
| 2pef_A | 373 | Serine protease inhibitor; serpin; 1.60A {Thermoan | 100.0 | |
| 1jmo_A | 480 | HC-II, heparin cofactor II, HLS2, serin; serpin, t | 100.0 | |
| 2v95_A | 371 | Corticosteroid-binding globulin; transport protein | 100.0 | |
| 1imv_A | 398 | PEDF, pigment epithelium-derived factor; serpin, a | 100.0 | |
| 2wxy_C | 453 | Angiotensinogen, serpin A8; glycoprotein, hyperten | 100.0 | |
| 1sng_A | 370 | COG4826: serine protease inhibitor; serine proteas | 100.0 | |
| 2wxw_A | 453 | Angiotensinogen, serpin A8; glycoprotein, hyperten | 100.0 | |
| 2r9y_A | 430 | Alpha-2-antiplasmin; inhibitory serpin, plasmin in | 100.0 | |
| 2oay_A | 390 | C1-inhibitor, plasma protease C1 inhibitor, C1 INH | 100.0 | |
| 3f02_A | 359 | Neuroserpin; cleaved form, fenib, human, disease M | 100.0 | |
| 3ndd_A | 343 | Alpha-1-antitrypsin; serpin, hydrolase inhibitor; | 100.0 | |
| 1hle_A | 345 | Horse leukocyte elastase inhibitor; hydrolase inhi | 100.0 | |
| 3dy0_A | 336 | N-terminus plasma serine protease inhibitor; serpi | 100.0 | |
| 2xn6_A | 350 | Thyroxine-binding globulin; transport, cleaved pro | 100.0 | |
| 2h4p_A | 394 | MENT, heterochromatin-associated protein MENT; ser | 100.0 | |
| 4afx_A | 387 | Protein Z dependent protease inhibitor; hydrolase | 100.0 | |
| 1as4_A | 341 | Antichymotrypsin, ACT; serpin, serine protease inh | 100.0 | |
| 1mtp_A | 323 | Serine proteinase inhibitor (serpin), chain A; str | 100.0 | |
| 1f0c_A | 305 | ICE inhibitor; apoptosis, caspase inhibitor, prote | 100.0 | |
| 1m93_B | 245 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 100.0 | |
| 3ndd_B | 36 | Alpha-1-antitrypsin; serpin, hydrolase inhibitor; | 99.36 | |
| 1hle_B | 31 | Horse leukocyte elastase inhibitor; hydrolase inhi | 99.35 | |
| 4afx_B | 36 | Protein Z dependent protease inhibitor; hydrolase | 99.35 | |
| 2riv_B | 40 | Thyroxine-binding globulin; TBG, serpin, cleaved, | 99.35 | |
| 2xn6_B | 35 | Thyroxine-binding globulin; transport, cleaved pro | 99.34 | |
| 1as4_B | 37 | Antichymotrypsin, ACT; serpin, serine protease inh | 99.33 | |
| 2h4p_B | 34 | MENT, heterochromatin-associated protein MENT; ser | 99.33 | |
| 3f02_C | 48 | Neuroserpin; cleaved form, fenib, human, disease M | 99.21 | |
| 1m93_C | 41 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 99.21 | |
| 1m93_A | 55 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 99.17 | |
| 1mtp_B | 43 | Serine proteinase inhibitor (serpin), chain B; str | 99.13 | |
| 3dy0_B | 29 | C-terminus plasma serine protease inhibitor; serpi | 99.07 |
| >3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} SCOP: e.1.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-82 Score=614.79 Aligned_cols=359 Identities=58% Similarity=0.878 Sum_probs=322.9
Q ss_pred hhHHhhhhhhhHHHHHHHHh-cCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHH
Q 036497 3 DVLESISEQTDITLSLSKHI-KAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVF 76 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~-~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~ 76 (375)
|+++.+.++++||++||+++ ... .+ +|||+||+.+|+|+++||+|+|++||.++||++..++++ .++.+...+.
T Consensus 4 ~~~~~~~~~~~Fa~~L~~~l~~~~~~~~Ni~~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~l~~~l~ 83 (393)
T 3le2_A 4 DVRESISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLKFSSTDQLNSFSSEIVSAVL 83 (393)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHTSCTTCCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHHTCSSHHHHHHHHHHTHHHHH
T ss_pred cHHHHHHhhhHHHHHHHHHHhcccCCCCCEEECHHHHHHHHHHHHhcCCCcHHHHHHHHhCCCCHHHHHHHHHHHHHHhh
Confidence 78999999999999999999 432 23 999999999999999999999999999999999777777 8888887776
Q ss_pred hCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCc
Q 036497 77 ADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD 156 (375)
Q Consensus 77 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~ 156 (375)
.+..+..+..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|+++++++++++
T Consensus 84 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~ 163 (393)
T 3le2_A 84 ADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAASNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADS 163 (393)
T ss_dssp SCCGGGTSCEEEEEEEEEEETTSCBCHHHHHHHHHHSCCEEEEECHHHHHHHHHHHHHHHHHHHTTTSCCCSSCTTCSCT
T ss_pred ccccCCCCcEEEeeeehhhcCCCCcChHHHHHHHHhhcceEEEecccccHHHHHHHHHHHHHHhhcCchhhhCCccCCCC
Confidence 43333456789999999999999999999999999999999999998767889999999999999999999999889999
Q ss_pred cCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecCCeEEEEecccC--------------
Q 036497 157 SSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------- 222 (375)
Q Consensus 157 ~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLPy~~-------------- 222 (375)
+|+++|+||+||+|.|+.||++..|..++||..+|++++||||++.+.++|.+.+++++|+|||++
T Consensus 164 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~vleLPy~~~~~~~~~sm~iiLP 243 (393)
T 3le2_A 164 MTKLIFANALYFKGTWNEKFDESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYLP 243 (393)
T ss_dssp TCCEEEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEECCSCEEEEEETTEEEEEEEBCCTTCSCCEEEEEEEE
T ss_pred CcEEEEEEeeeEecccccCCChhhccccccEeCCCcEEEEccccccCeeeeeeccCcEEEEeecCCCCCCCcEEEEEEeC
Confidence 999999999999999999999999999999999999999999999987777777899999999983
Q ss_pred ---CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC-----C-
Q 036497 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS-----H- 293 (375)
Q Consensus 223 ---~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-----~- 293 (375)
.+|.+++++|+....++.+++...++..++|.||||++++++||+++|++||++++|++ .|||++|+++ +
T Consensus 244 ~~~~~l~~l~~~L~~~~~~l~~~~~~~~v~~~~l~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~~~~~~~~l 322 (393)
T 3le2_A 244 DANNGLSDLLDKIVSTPGFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSPFSG-EEGLTEMVESPEMGKNL 322 (393)
T ss_dssp SSTTCHHHHHHHHHHSTTTGGGCCCCSEEEEEEEEEECEEEEEEEETHHHHHHTTCCGGGST-TTCCTTTBSCHHHHTTC
T ss_pred CCCCCHHHHHHHHhcCHHHHHHhhhhceeeecceECcEEeccCCcchHHHHHhCCchhhcCC-cCCccccccccccCCCe
Confidence 46899999997433556666776666667899999999999999999999999999998 9999999985 5
Q ss_pred CccceeeeeEEEEcCCcccchhhhhhhhhhccCCC-CCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 294 VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPR-FDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 294 ~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~-~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
+|++++||++|+|||+||+|||+|++....++.+. +++++|+|||||+|+|+|+.||.|||+|||.+|+
T Consensus 323 ~vs~v~hka~ieV~E~GteAaAaT~~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 392 (393)
T 3le2_A 323 CVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDEIDFVADHPFLLVVTENITGVVLFIGQVVDPL 392 (393)
T ss_dssp CCCEEEEEEEEEECSCBCSCCCCCCCHHHHHTTTSCCCEEEEECCSCEEEEEEETTTCCEEEEEEESCTT
T ss_pred eEeEEEEEEEEEEcCCCchhhcccceeeeeccCCCCCCCceEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 99999999999999999999999987666666543 2236899999999999999999999999999996
|
| >4ga7_A Leukocyte elastase inhibitor; serpin, conformational change, serine protease inhibitor, Ca inhibitor, chymase inhibitor, chymotrypsin inhibitor; 2.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-81 Score=601.67 Aligned_cols=352 Identities=30% Similarity=0.405 Sum_probs=305.4
Q ss_pred hhHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHh
Q 036497 3 DVLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFA 77 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~ 77 (375)
++..+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++..++++ .++.++..+.
T Consensus 10 ~~~~l~~~~~~Fa~~L~~~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~- 88 (389)
T 4ga7_A 10 GMEQLSSANTRFALDLFLALSENNPAGNIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTVEEVHSRFQSLNADIN- 88 (389)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGCTTHHHHHHHHHHHHT-
T ss_pred cHHHHHHHHhHHHHHHHHHHhhcCCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCHHHHHHHHHHHHHHHh-
Confidence 45567789999999999999753 23 999999999999999999999999999999998666777 8898888774
Q ss_pred CCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCcc
Q 036497 78 DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDS 157 (375)
Q Consensus 78 ~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~ 157 (375)
.+..+..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++
T Consensus 89 --~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~l~~~ 166 (389)
T 4ga7_A 89 --KRGASYILKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTEGKIPELLASGMVDNM 166 (389)
T ss_dssp --CTTCSSEEEEEEEEEEETTSCBCHHHHHHHHHHTSCCEEEECHHHHHHHHHHHHHHHHHHHTTTSSTTSSCTTSSCTT
T ss_pred --CCCCCcEEEEeeeeeecCCCccCHHHHHHHHHHhCCeeEecccccCHHHHHHHHHHHHHHhhCCchhhccCCCCCCCC
Confidence 234567899999999999999999999999999999999999998778899999999999999999999998899999
Q ss_pred CeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC-------------
Q 036497 158 SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ------------- 222 (375)
Q Consensus 158 t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~------------- 222 (375)
|+++|+||+||+|.|+.||++..|.+++|++.+|++++||||++.+.+.|+. ..++++|+|||++
T Consensus 167 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~ 246 (389)
T 4ga7_A 167 TKLVLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKKFAYGYIEDLKCRVLELPYQGEELSMVILLPDDI 246 (389)
T ss_dssp CCEEEEEEEEEECCBSSCCCTTTCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEEEESSC
T ss_pred ceEEEEEEEEEEeeecCCCCccCccccceEeCCCcEEEEEEEEEeeeEEEEEECCCCEEEEEEECCCCCEEEEEEecCCC
Confidence 9999999999999999999999999999999999999999999998776654 4589999999987
Q ss_pred ----CChHHHHHHccCcHHHHhccC--CccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--C
Q 036497 223 ----DELPALEKKTGSQSGFLKDHI--PYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--V 294 (375)
Q Consensus 223 ----~~l~~l~~~L~~~~~~l~~~~--~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~ 294 (375)
.+|.+++++|+. ..+..|. ...+...++|.||||++++++||+++|++||++++|+++.|||++|++++ +
T Consensus 247 ~~~~~~L~~le~~L~~--~~l~~~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~ 324 (389)
T 4ga7_A 247 EDESTGLKKIEEQLTL--EKLHEWTKPENLDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGMSGARDIF 324 (389)
T ss_dssp CSSSSSCHHHHHHCCH--HHHHHHHSGGGCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTBCCSSCC
T ss_pred ccccccHHHHHHHhCH--HHHHHHhhhhcCcceEEEEEeccEEEEEeechHHHHHHcCcHhhcCCCcCCcccccCCCCcc
Confidence 258999999963 4455555 33455667999999999999999999999999999997689999999875 9
Q ss_pred ccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 295 GVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 295 vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
|++++||++|||||+||+|||+|++....++.+ ++..|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 325 vs~v~hka~ieVnE~GteAaAaT~~~~~~~s~~--~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 389 (389)
T 4ga7_A 325 ISKIVHKSFVEVNEEGTEAAAATAGIATFCMDD--PEENFTADHPFLFFIRHNSSGSILFLGRFSSP 389 (389)
T ss_dssp EEEEEEEEEEEECSCBC----------CCCSSS--CEEEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred eeeEEEEEEEEecCCCcccccccccccccccCC--CCCcEEccCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999999999999999998655555543 24689999999999999999999999999998
|
| >3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-81 Score=603.01 Aligned_cols=355 Identities=26% Similarity=0.462 Sum_probs=306.1
Q ss_pred chhHHhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh--hhHH-HHHHHHHH
Q 036497 2 DDVLESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN--EQQN-FASELVAI 74 (375)
Q Consensus 2 ~~~~~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--~~~~-~~~~l~~~ 74 (375)
+++..+.+++++||++||+++.... + +|||+||+.+|+|+++||+|+|++||.++||++.. .+++ .++.++..
T Consensus 14 ~~~~~l~~~~~~Fa~~L~~~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~l~~~ 93 (407)
T 3f5n_A 14 TGATFPEEAIADLSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGEEFSFLKEFSNM 93 (407)
T ss_dssp -----CTHHHHHHHHHHHHHHHHTTTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHCCC----CCCHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHHHHHhhCCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHH
Confidence 4567788899999999999997542 3 99999999999999999999999999999999864 3566 88888876
Q ss_pred HHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCC
Q 036497 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSV 154 (375)
Q Consensus 75 l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~ 154 (375)
+. .+..+..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++++++
T Consensus 94 l~---~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~~~~l 169 (407)
T 3f5n_A 94 VT---AKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQ-NVAVANYINKWVENNTNNLVKDLVSPRDF 169 (407)
T ss_dssp TT---C-CCSCEEEEEEEEEEETTCCBCTTHHHHHHHTSCCEEEEECTTS-HHHHHHHHHHHHHHTTTTCSCCCCCGGGC
T ss_pred Hh---ccCCCcEEEEEEEEEEeCCCccCHHHHHHHHHhhcCceEEcCCCC-hHHHHHHHHHHHHHhhCCchhhcCCcccC
Confidence 64 234567899999999999999999999999999999999999994 78999999999999999999999988899
Q ss_pred CccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--C------eEEEEecccC----
Q 036497 155 DDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--G------FKVLVLPYKQ---- 222 (375)
Q Consensus 155 ~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~------~~vveLPy~~---- 222 (375)
+++|+++|+||+||+|.|+.||++..|+.++|++.+|++++||||++.+.++|++.+ + +++|+|||++
T Consensus 170 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~y~~~~~l~~~~~~~~~vleLPY~~~~~s 249 (407)
T 3f5n_A 170 DAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEIS 249 (407)
T ss_dssp CTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECC-----CEEEEEEEEBTTSSEE
T ss_pred CCCceEEEEEeeeeecccccCCCccCceeeeEEcCCCeEEEEeEEEEeeeeeeEEccccccccCcceEEEEEECCCCcEE
Confidence 999999999999999999999999999999999999999999999999988887754 4 9999999997
Q ss_pred ---------CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC
Q 036497 223 ---------DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH 293 (375)
Q Consensus 223 ---------~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~ 293 (375)
.+|.+++++|+. ..+..|....+...++|.||||++++++||+++|++||++++|+. .|||++|++++
T Consensus 250 m~iiLP~~~~~L~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~ 326 (407)
T 3f5n_A 250 MMLVLSRQEVPLATLEPLVKA--QLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIK-DANLTGLSDNK 326 (407)
T ss_dssp EEEEECCTTCCGGGTGGGCCH--HHHHHHHHHCEEEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGST-TCCCTTTBSCT
T ss_pred EEEEECCCCCCHHHHHHHhCH--HHHHHHHHhCcceEEEEECCCEEEeeecChHHHHHhCCchhhcCC-CCCcccccCCC
Confidence 479999999863 445555555556667999999999999999999999999999996 89999998755
Q ss_pred --CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcchhh
Q 036497 294 --VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSIIN 365 (375)
Q Consensus 294 --~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~~~ 365 (375)
+|++++||++|||||+||+|||+|++....++++. +..|+|||||+|+|+|+.||.|||+|+|.+|+..|
T Consensus 327 ~l~vs~v~hka~ieVnE~GteAAAaT~~~~~~~~~~~--~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~~~~ 398 (407)
T 3f5n_A 327 EIFLSKAIHKSFLEVNEEGSEAAAVSGMIAISRMAVL--YPQVIVDHPFFFLIRNRRTGTILFMGRVMHPETMN 398 (407)
T ss_dssp TCCCCEEEEEEEEEECSCBCCCCC-----CCSSSEEE--ECEEECCSCEEEEEEETTTCCEEEEEEESCCCCC-
T ss_pred CceeeeEEEEEEEEecCCccccccccceeeccccCCC--CCcEEecCCEEEEEEECCCCcEEEEEEeCCcCCCC
Confidence 99999999999999999999999986554444422 23899999999999999999999999999998655
|
| >3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-80 Score=593.97 Aligned_cols=352 Identities=24% Similarity=0.355 Sum_probs=314.6
Q ss_pred CchhHHhhhhhhhHHHHHHHHhcCC--CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC----hhhHH-HHHHHH
Q 036497 1 MDDVLESISEQTDITLSLSKHIKAP--TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS----NEQQN-FASELV 72 (375)
Q Consensus 1 ~~~~~~~~~~~~~f~~~l~~~~~~~--~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~----~~~~~-~~~~l~ 72 (375)
|.++.++..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++. .++++ .++.++
T Consensus 1 ~~~~~~l~~~~~~Fa~~l~~~l~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~i~~~~~~l~ 80 (377)
T 3nda_A 1 MQEEAKLTKANNRFGLRLLRALPSGPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGFSDVDLTDAGVLDAYTHHT 80 (377)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHSCCBTTBCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTTGGGTCCHHHHHHHHHHHH
T ss_pred CchHHHHHHHHHHHHHHHHHHHhhcCCCCEEEecHHHHHHHHHHHhhccchhHHHHHHHhCCCCcCCCHHHHHHHHHHHH
Confidence 6678889999999999999999753 23 9999999999999999999999999999999974 24577 888888
Q ss_pred HHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCC
Q 036497 73 AIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPG 152 (375)
Q Consensus 73 ~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~ 152 (375)
..+.. +.++..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++ ++
T Consensus 81 ~~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~ll-~~ 156 (377)
T 3nda_A 81 ERLKS---TPSNSTLDVANAAAIQRTLALLNSYESALQSSFGAELHKVDFAGEPQAAVDFVNNWVKRKTHDKIEKLF-NE 156 (377)
T ss_dssp HHHHH---CCCSSEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHHHTTTSCCCSC-SS
T ss_pred HHhcC---CCCCcEEEEEeEEEEeCCCCchHHHHHHHHHhccCceEEecCCCCHHHHHHHHHHHHHHHhcCchhhhc-CC
Confidence 77753 345678999999999999999999999999999999999999766889999999999999999999999 78
Q ss_pred CCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC--------
Q 036497 153 SVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ-------- 222 (375)
Q Consensus 153 ~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~-------- 222 (375)
+++++|+++|+||+||+|.|+.||++..|..++||..+|++++||||++.+.+.|++. .++++++|||++
T Consensus 157 ~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~~~~sm~ii 236 (377)
T 3nda_A 157 PLDPDTLLVLLNAIYFKGEWNTAFVKEHTEKRQFFNGGVTPVEVDTMRLEARIKYRFFDDLQVEVVELPYRGLDYTMAIL 236 (377)
T ss_dssp CCCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEETTTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEE
T ss_pred CCCCCceEEEEehheeccccccCCCCccccccceecCCCeEEEEeeEeeECeEEEEEEcCCCeEEEEEecCCCcEEEEEE
Confidence 9999999999999999999999999999999999999999999999999988877765 489999999997
Q ss_pred -----CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-Ccc
Q 036497 223 -----DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGV 296 (375)
Q Consensus 223 -----~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs 296 (375)
.+|.+++++|+. ..+.+++...+...++|.||||++++++||+++|++||++++|++ .|||++|++.+ +|+
T Consensus 237 LP~~~~~l~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~~~l~vs 313 (377)
T 3nda_A 237 LPKENTGVEGLKQNLTI--DRFQNYLSDLRERKITVLLPKFKLETKYSLKAPLQSLGIKQIFES-GADLSGINDGSLRVS 313 (377)
T ss_dssp EESSTTCHHHHHHHCCH--HHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHSSCEEEE
T ss_pred EcCCCCCHHHHHHHhCH--HHHHHHHHhCCeEEEEEEecceEeEeecCHHHHHHhCCchhhcCC-CCCCcccCCCCceEe
Confidence 579999999963 455555555556667999999999999999999999999999998 89999999966 999
Q ss_pred ceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCC
Q 036497 297 GIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSI 360 (375)
Q Consensus 297 ~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~ 360 (375)
+++||++|+|||+||+|||+|++....++.+ +++..|++||||+|+|+|+.||.|||+|+|.+
T Consensus 314 ~v~hka~ieV~E~GteAaAaT~~~~~~~s~~-~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~ 376 (377)
T 3nda_A 314 AVEHKAVVEVNEEGTVAAATTGVVIVPYSLG-PEPVVFRVDHPFLFFIRNTRTDDIFFVGQVNK 376 (377)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEEEEEEC----CCCCEEECCSCEEEEEEETTTCCEEEEEEECC
T ss_pred EEEEEEEEEECCCCccccccceeeeecccCC-CCCCeEEeeCCEEEEEEECCCCcEEEEEEEec
Confidence 9999999999999999999998655555543 23568999999999999999999999999986
|
| >2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-79 Score=595.57 Aligned_cols=354 Identities=26% Similarity=0.414 Sum_probs=305.3
Q ss_pred hhHHhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----------------
Q 036497 3 DVLESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN---------------- 62 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~---------------- 62 (375)
++..+..++++||++||+++...+ + +|||+||+.+|+|+++||+|+|++||.++||++..
T Consensus 5 ~~~~l~~~~~~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~ 84 (415)
T 2h4r_A 5 SMEQVSASIGNFTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRP 84 (415)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSCCC----------------
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCcccccccccccccccccc
Confidence 455778899999999999998643 3 99999999999999999999999999999999752
Q ss_pred ------------hhHH-HHHHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHH
Q 036497 63 ------------EQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEV 129 (375)
Q Consensus 63 ------------~~~~-~~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~ 129 (375)
++++ .++.++..+. ....+..+.++|+||+++++.++++|++.++++|+++++.+||.++++.+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~l~---~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a 161 (415)
T 2h4r_A 85 KRRRMDPEHEQAENIHSGFKELLTAFN---KPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQS 161 (415)
T ss_dssp -----------CHHHHHHHHHHHHHHT---CSSCSSEEEEEEEEEEETTSCBCHHHHHHHHHHHSCCCEEECTTTCHHHH
T ss_pred cccccccccccHHHHHHHHHHHHHHHh---CCCCCcEEEEEEeehhhCCCCcCHHHHHHHHHHhCCeEEEecCCCCHHHH
Confidence 4566 7888887774 23456789999999999999999999999999999999999997668999
Q ss_pred HHHHHHHHHHHhcccccccCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee
Q 036497 130 SREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA 209 (375)
Q Consensus 130 ~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~ 209 (375)
++.||+||+++|+|+|++++++++++++|+++|+||+||+|.|+.||++..|..++||..+|+.++||||++.+.+.|+.
T Consensus 162 ~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~ 241 (415)
T 2h4r_A 162 RKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLI 241 (415)
T ss_dssp HHHHHHHHHHHTTTSCCCCSCGGGCCSSCCEEEEEEEEEECBBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEE
T ss_pred HHHHHHHHHHHhcCchhhhcCccccCCcceEEEEEhheEeceecCCCCcccCeeeEEEecCCcEEEeeEEeecCcEeEEE
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999998766655
Q ss_pred --cCCeEEEEecccC------------C-----ChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHH
Q 036497 210 --FDGFKVLVLPYKQ------------D-----ELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSR 268 (375)
Q Consensus 210 --~~~~~vveLPy~~------------~-----~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~ 268 (375)
..++++|+|||++ . +|.+++++|+. ..+..+.. ..+...++|.||||++++++||++
T Consensus 242 ~~~l~~~vleLPY~~~~~sm~iiLP~~~~~~~~~L~~le~~L~~--~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~ 319 (415)
T 2h4r_A 242 MEKMNFKMIELPYVKRELSMFILLPDDIKDGTTGLEQLERELTY--ERLSEWADSKMMTETLVDLHLPKFSLEDRIDLRD 319 (415)
T ss_dssp ETTTTEEEEEEEBGGGSEEEEEEEESSCCSSSSSCHHHHTTCCH--HHHHHHHTCTTCEEEEEEEEEECEEECCEEECHH
T ss_pred eCCCCEEEEEeeCCCCcEEEEEEecCCCcccccCHHHHHHHhCH--hHHHHHhhhhcccceeEEEECCeEEEeeeecHHH
Confidence 4599999999987 2 68999999963 45555554 344566799999999999999999
Q ss_pred HHHhCCcccCCCCCCCCCcCCcCCC--CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEE
Q 036497 269 VLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIRE 346 (375)
Q Consensus 269 ~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~ 346 (375)
+|++|||+++|+. .|||++|++++ +|++++||++|+|||+||+|||+|++....++.+.+++.+|+|||||+|+|+|
T Consensus 320 ~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~~~f~~drPFlf~I~~ 398 (415)
T 2h4r_A 320 TLRNMGMTTAFTT-NADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAVIISFTTSVINHVLKFKVDHPFHFFIRH 398 (415)
T ss_dssp HHHHTTCCGGGST-TCCCTTTBSSSCCCCCEEEEEEEEEECSSBSSCCC---------------CEEEECCSCEEEEEEE
T ss_pred HHHHcChhhhhcC-ccccccccCCCCeEEEEEEEEEEEEecCCCcccccccchhhccccCCCCCCcEEEecCCEEEEEEE
Confidence 9999999999995 89999999854 99999999999999999999999986655555533223789999999999999
Q ss_pred CCCCcEEEEEEeCCcc
Q 036497 347 DATGVVLSLVMFSILS 362 (375)
Q Consensus 347 ~~t~~ilf~G~v~~p~ 362 (375)
+.||.|||+|+|.+|.
T Consensus 399 ~~t~~iLF~G~v~~P~ 414 (415)
T 2h4r_A 399 NKSKTILFFGRFCCPV 414 (415)
T ss_dssp TTTTEEEEEEEECSCC
T ss_pred CCCCcEEEEEEeCCCC
Confidence 9999999999999996
|
| >3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} SCOP: e.1.1.1 PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-80 Score=602.15 Aligned_cols=355 Identities=29% Similarity=0.473 Sum_probs=314.0
Q ss_pred hHHhhhhhhhHHHHHHHHhcC-C---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-----hhHH-HHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKA-P---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-----EQQN-FASELV 72 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~-~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-----~~~~-~~~~l~ 72 (375)
+..+..++++||++||+++.. . .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.+.
T Consensus 48 ~~~l~~~~~~Fa~~L~k~l~~~~~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~i~~~f~~l~ 127 (432)
T 3kcg_I 48 VWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLN 127 (432)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSCTTSCCCBCHHHHHHHHHHHHTTCCHHHHHHHHHHTTCTTSCHHHHHTHHHHHHHHH
T ss_pred HHHHHHHHhHHHHHHHHHHhhccCCCCCEEEcHHHHHHHHHHHHhhcccHHHHHHHHHhCCCccccccHHHHHHHHHHHH
Confidence 567788999999999999975 2 23 99999999999999999999999999999999731 4566 888888
Q ss_pred HHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCC
Q 036497 73 AIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPG 152 (375)
Q Consensus 73 ~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~ 152 (375)
..+.+. ...+..+.++|+||+++++.++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|+++++++
T Consensus 128 ~~l~~~--~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~ 205 (432)
T 3kcg_I 128 CRLYRK--ANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSE 205 (432)
T ss_dssp HHHHHH--HTTTEEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECHHHHHHHHHHHHHHHHHHHTTTSSCCSSCTT
T ss_pred HHHhcc--cCCCcEEEEEEEEEEcCCCccCHHHHHHHHHHhCCeEEeccCCCCHHHHHHHHHHHHHhhccCchhccCCcc
Confidence 776531 124568999999999999999999999999999999999999976677788899999999999999999988
Q ss_pred CCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC-CeEEEEecccC---------
Q 036497 153 SVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD-GFKVLVLPYKQ--------- 222 (375)
Q Consensus 153 ~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~-~~~vveLPy~~--------- 222 (375)
+++++|+++|+||+||+|.|+.||++..|..++||+.+|++++||||++.+.+.|++.+ ++++++|||++
T Consensus 206 ~l~~~T~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~~~~vleLPy~~~~~sm~iiL 285 (432)
T 3kcg_I 206 AINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLIL 285 (432)
T ss_dssp SSCTTCCEEEEEEEEEEECBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEECGGGCEEEEEEBTTSSEEEEEEE
T ss_pred cCCCCceEEEEeHHhhhhhhhcCCCcccceeeeEEECCCeEEEEEEEEecceeeEEEecCCcEEEEEEcCCCceEEEEEe
Confidence 89999999999999999999999999999999999999999999999999988887765 89999999997
Q ss_pred ----CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcC---CC-C
Q 036497 223 ----DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD---SH-V 294 (375)
Q Consensus 223 ----~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~---~~-~ 294 (375)
.+|.+++++|+ ...+.+|+...+...++|.||||++++++||+++|++||++++|+++.|||++|++ .+ +
T Consensus 286 P~~~~~L~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~~~l~ 363 (432)
T 3kcg_I 286 PKPEKSLAKVEKELT--PEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLY 363 (432)
T ss_dssp CCTTSCHHHHHHSCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTSCSSSSCCC
T ss_pred cCCCCCHHHHHHHcC--HHHHHHHHHhCceeeEEEEecCEEEecccchhhhHhhCCchhhccCccCCcccccccCCCCce
Confidence 46999999996 34555565555666779999999999999999999999999999966899999987 34 9
Q ss_pred ccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 295 GVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 295 vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
|++++||++|+|||+||+|||+|++....++.+ +.++.|+|||||+|+|+|+.||.|||+|||.+|.+
T Consensus 364 vs~v~hka~ieVnE~GteAaAaT~~~~~~~s~~-~~~~~F~adrPFlf~I~d~~t~~iLF~G~V~~P~~ 431 (432)
T 3kcg_I 364 VSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLN-PNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV 431 (432)
T ss_dssp CCEEEEEEEEEECSCBCCCCCCCCCCCEESSCC-TTCEEEECCSCCEEEEEETTTTEEEEEC-CCCCCC
T ss_pred eeeEEEEEEEEecCCCccccccchhhcccccCC-CCCcEEecCCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 999999999999999999999998655555543 33578999999999999999999999999999974
|
| >3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-79 Score=595.63 Aligned_cols=346 Identities=23% Similarity=0.370 Sum_probs=308.7
Q ss_pred HHhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHH
Q 036497 5 LESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIV 75 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l 75 (375)
.++..++++||++||+++.... + +|||+||+.+|+||++||+|+|++||.++||++.. ++++ .++.++..+
T Consensus 54 ~~l~~~~~~Fa~~L~~~l~~~~~~~Ni~~SP~SI~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~i~~~f~~ll~~l 133 (424)
T 3ne4_A 54 NKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTL 133 (424)
T ss_dssp CTTHHHHHHHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHh
Confidence 3567889999999999997532 3 99999999999999999999999999999999742 4677 889998877
Q ss_pred HhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCC
Q 036497 76 FADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVD 155 (375)
Q Consensus 76 ~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~ 155 (375)
. .+.++..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +++
T Consensus 134 ~---~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~gkI~~ll~--~l~ 207 (424)
T 3ne4_A 134 N---QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD-TEEAKKQINDYVEKGTQGKIVDLVK--ELD 207 (424)
T ss_dssp T---CSSCSSCCEEEEEEEEETTSCBCHHHHHHHHTTTCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCSCCC--CCC
T ss_pred c---CCCCCcEEEEEEEEEEcCCCCcCHHHHHHHHHhhcceEEEecCCC-hHHHHHHHHHHHHHhhCCCcccccc--CCC
Confidence 4 234567899999999999999999999999999999999999995 7899999999999999999999997 799
Q ss_pred ccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC-----------
Q 036497 156 DSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ----------- 222 (375)
Q Consensus 156 ~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~----------- 222 (375)
++|+++|+||+||+|.|+.||++..|.+++|++.+|++++||||++.+.+.|++. .+++||+|||++
T Consensus 208 ~~t~lvLvNaiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~~sm~iiLP~~ 287 (424)
T 3ne4_A 208 RDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDE 287 (424)
T ss_dssp TTCCEEEEEEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEEEEEEEECT
T ss_pred CcchhhhhhHHhhehhhhcCCCcccceeEeeeccCCcEEEEEEEEeecceeEEEecCCCeEEEEEecCCCeEEEEEEcCc
Confidence 9999999999999999999999999999999999999999999999987777665 489999999997
Q ss_pred CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccceee
Q 036497 223 DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQ 300 (375)
Q Consensus 223 ~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~q 300 (375)
++|.+++++|+ ...+.+|....+...++|.||||++++++||+++|++|||+++|++ .|||++|++++ +|++++|
T Consensus 288 ~~l~~le~~L~--~~~l~~~~~~l~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~Vs~v~h 364 (424)
T 3ne4_A 288 GKLQHLENELT--HDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTEEAPLKLSKAVH 364 (424)
T ss_dssp TCHHHHHHHCC--HHHHHHHHHCCCCEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGST-TCCCTTTBSSSCCCCCEEEE
T ss_pred CCHHHHHHHhC--HHHHHHHHHhCccceEEEEcCCEEEEeecchhhhhhhCChhhhcCC-CCCcccccCCCCcceeeEEE
Confidence 57999999996 3445555555555667999999999999999999999999999998 89999999854 9999999
Q ss_pred eeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 301 KSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 301 k~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
|++|+|||+||||||+|++....++. +..|++||||+|+|+|+.||.|||+|+|.+|.+
T Consensus 365 ka~ieVnE~GteAAAaT~~~~~~~s~----~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~~ 423 (424)
T 3ne4_A 365 KAVLTIDEKGTEAAGAMFLEAIPMSI----PPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ 423 (424)
T ss_dssp EEEEEECSSSSSSCCCCCCCCCCSSC----CCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred EEEEEEcCCCcccccccceeeeecCC----CCceeccCCEEEEEEECCCCeEEEEEEecCCCC
Confidence 99999999999999999864443332 347999999999999999999999999999975
|
| >1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-79 Score=591.40 Aligned_cols=346 Identities=24% Similarity=0.366 Sum_probs=308.9
Q ss_pred HhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-----------h---hHH-
Q 036497 6 ESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-----------E---QQN- 66 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-----------~---~~~- 66 (375)
.+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. + +++
T Consensus 2 ~l~~~~~~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 81 (385)
T 1uhg_A 2 SIGAASMEFCFDVFKELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHS 81 (385)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHTTTTSCTTTTH
T ss_pred chhhHHHHHHHHHHHHHHhcCCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCcccccccccccccchHHHHHH
Confidence 35678999999999999753 23 99999999999999999999999999999999753 3 666
Q ss_pred HHHHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhccccc
Q 036497 67 FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIK 146 (375)
Q Consensus 67 ~~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~ 146 (375)
.++.++..+. ....+..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|+
T Consensus 82 ~~~~l~~~l~---~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~gkI~ 158 (385)
T 1uhg_A 82 SLRDILNQIT---KPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGIIR 158 (385)
T ss_dssp HHHHHHHHHT---SCCSSEEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHHHTTTCSC
T ss_pred HHHHHHHHHh---CCCCCcEEEEEEEeeccCCCCccHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHHHHHhcCchh
Confidence 8888887774 2334678999999999999999999999999999999999999766889999999999999999999
Q ss_pred ccCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC--
Q 036497 147 EVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ-- 222 (375)
Q Consensus 147 ~~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~-- 222 (375)
+++++++++++|+++|+||+||+|.|+.||++..|..++|+..+|++++||||++.+.+.|++ ..++++|+|||++
T Consensus 159 ~l~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~ 238 (385)
T 1uhg_A 159 NVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGT 238 (385)
T ss_dssp CCSCTTSSCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSS
T ss_pred hhCCcccCCCccceEeeeeeEEeeeecCCCCcCCCcCcEEEECCCeEEEEEEEEeeceEEEEEeCCCCeEEEEeccCCCc
Confidence 999988999999999999999999999999999999999999999999999999998776655 4599999999997
Q ss_pred -----------CChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCC
Q 036497 223 -----------DELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEM 289 (375)
Q Consensus 223 -----------~~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~i 289 (375)
.+|.+++++|+ ...+..+.. ..+...++|.||||++++++||+++|++||++++|+. .|||++|
T Consensus 239 ~sm~iiLP~~~~~l~~l~~~L~--~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~i 315 (385)
T 1uhg_A 239 MSMLVLLPDEVSGLEQLESIIN--FEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSS-SANLSGI 315 (385)
T ss_dssp EEEEEEEESSTTCHHHHHHHCC--HHHHHHHTSTTTCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhC--hhHHHHHhhhhcccceEEEEEccceeecceecHHHHHHHcChhhhhcC-ccccccc
Confidence 47999999996 355666665 4555667999999999999999999999999999995 8999999
Q ss_pred cCCC--CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 290 VDSH--VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 290 s~~~--~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++++ +|++++||++|+|||+||+|||+|++....++. +.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 316 s~~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 385 (385)
T 1uhg_A 316 SSAESLKISQAVHAAHAEINEAGREVVGSAEAGVDAASV----SEEFRADHPFLFCIKHIATNAVLFFGRCVSP 385 (385)
T ss_dssp BCSTTCCEEEEEEEEEEEECSCEEECCCHHHHHHHHTTC----CCEEECCSCEEEEEEETTTCCEEEEEEESCC
T ss_pred cCCCCeEEEEEEEEEEEEecCCCcccccccchheeccCC----CCEEEeeCCEEEEEEECCCCcEEEEEEcCCC
Confidence 9865 999999999999999999999999866655553 3589999999999999999999999999998
|
| >2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-79 Score=588.57 Aligned_cols=350 Identities=21% Similarity=0.294 Sum_probs=305.8
Q ss_pred HHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHH
Q 036497 5 LESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIV 75 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l 75 (375)
.++..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..+
T Consensus 4 ~~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l 83 (379)
T 2ceo_A 4 YKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICSL 83 (379)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCCcCCCHHHHHHHHHHHHHHh
Confidence 456789999999999999642 23 99999999999999999999999999999999753 4667 888888777
Q ss_pred HhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCC
Q 036497 76 FADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVD 155 (375)
Q Consensus 76 ~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~ 155 (375)
. ....+..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +++
T Consensus 84 ~---~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~~--~l~ 157 (379)
T 2ceo_A 84 N---FPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSN-ISAAKQEINSHVEMQTKGKVVGLIQ--DLK 157 (379)
T ss_dssp S---SCCTTEEEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECTTC-HHHHHHHHHHHHHHHTTTSSCCCCC--CCC
T ss_pred h---CCCCCcEEEEeEhhhhhCCCChhHHHHHHHHHHhCCeeeecCCCC-HHHHHHHHHHHHHHHhCCcchhhcc--CCC
Confidence 4 234567899999999999999999999999999999999999985 7889999999999999999999996 499
Q ss_pred ccCeeEEEEeEEeeccccccccCCCCeeee-eecCCCcEEeecceeccccceeeecC--CeEEEEecccC----------
Q 036497 156 DSSKLVFANALYFKGVWNEAFDSSKTKEYD-FHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ---------- 222 (375)
Q Consensus 156 ~~t~lvlvna~~f~~~W~~~F~~~~T~~~~-F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~---------- 222 (375)
++|+++|+||+||+|.|+.||++..|.+++ ||+.+|+.++||||++.+.+.|++.+ ++++|+|||++
T Consensus 158 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~sm~iiLP~ 237 (379)
T 2ceo_A 158 PNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVLPK 237 (379)
T ss_dssp SSCCEEEEEEEEEEEBBSSCCCGGGCEEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSEEEEEEEEC
T ss_pred CCCEEEEEEHhhhhchhcCCCChhhCccCCceEeCCCcEEEEEEEEeeeeEeEEEeCCCCeEEEEeecCCCeeEEEEeeC
Confidence 999999999999999999999999999999 99999999999999999887777654 79999999987
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Ccccee
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIF 299 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~ 299 (375)
++|.+++++|+. ..+..+....+...++|.||||++++++||+++|++||++++|+. .|||++|++++ +|++++
T Consensus 238 ~~~l~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~ 314 (379)
T 2ceo_A 238 EGQMESVEAAMSS--KTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSE-NADFSGLTEDNGLKLSNAA 314 (379)
T ss_dssp TTCHHHHHHHCSH--HHHHHHHHHCEEEEEEEEEECEEEEEEEETHHHHHHHTCCTTTST-TCCCTTTBSSSCCCCCEEE
T ss_pred CCcHHHHHHHhCH--HHHHHHHHhcccCcceEECCcEEEeeeecHHHHHHhcCccccccC-CCCcccCCCCCCeEEeccc
Confidence 579999999973 445555544555667999999999999999999999999999985 89999999864 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 300 QKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
||++|||||+||+|||+|++....++.+.+++.+|+|||||+|+|+|+.||.|||+|||.+|..
T Consensus 315 hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 378 (379)
T 2ceo_A 315 HKAVLHIGEKGTEAAAVPEVELSDQPENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPTE 378 (379)
T ss_dssp EEEEEEECSSBSSCCCCCC--------CCSCSCEEECCSCEEEEEEETTTTEEEEEEEESCSBC
T ss_pred eeEEEEecCCCcccccccchhhccccCCCCCCCeEEecCCEEEEEEECCCCcEEEEEecCCCCC
Confidence 9999999999999999998655555554333478999999999999999999999999999964
|
| >3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-79 Score=595.57 Aligned_cols=354 Identities=19% Similarity=0.376 Sum_probs=297.2
Q ss_pred HHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHh--cCChhHHHHHHHhcCCCCh----------hhHH-H
Q 036497 5 LESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAA--GSKGPTLQQLLSFLKSKSN----------EQQN-F 67 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~--ga~g~T~~el~~~L~~~~~----------~~~~-~ 67 (375)
.....++++||++||+++... .+ +|||+||+.+|+||++ ||+|+|++||.++||++.. ++++ .
T Consensus 13 ~~~~~~~~~Fa~~l~~~l~~~~~~~Ni~~SP~Si~~aLaml~~~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~~~~ 92 (406)
T 3sto_A 13 YANISSHKAFTHAYLSTVTADFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTMRLKSTSSSWNSSEAQQEMKSL 92 (406)
T ss_dssp ---CCHHHHHHHHHHHHHTGGGTTSCEEECHHHHHHHHHHHHHTSCSCHHHHHHHHHHTTCSTTSSSCCHHHHHHHHHHH
T ss_pred hhccchhhHHHHHHHHHHhhcCCCCCEEEccHHHHHHHHHHHhccccCchHHHHHHHHhCCCcccccccccCCHHHHHHH
Confidence 345678999999999999752 23 9999999999999999 9999999999999999842 4566 8
Q ss_pred HHHHHHHHHhCCC---CCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhccc
Q 036497 68 ASELVAIVFADGS---ANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGF 144 (375)
Q Consensus 68 ~~~l~~~l~~~~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~ 144 (375)
++.++..+..... +..+..+.++|+||++++++++++|++.++++|+++++.+||. +++.+++.||+||+++|+|+
T Consensus 93 ~~~l~~~l~~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~WV~~~T~gk 171 (406)
T 3sto_A 93 YQELNNSLTSEKTFLNEKEENVVRISTGIFVEKTYEVERRFNESIANDSEGELKQVDFS-NRTSATVDINDWVDQQSNGL 171 (406)
T ss_dssp HHHHHHHHHTCEECC---CEESEEEEEEEEEETTSCCCHHHHHHHHTCSSEEEEEECTT-SHHHHHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHhccCcccccCCCcEEEEEeeeeecCCCccCHHHHHHHHHHhCCeEEEeCCC-ChHHHHHHHHHHHHHHhcCc
Confidence 8888877753110 0114679999999999999999999999999999999999995 47889999999999999999
Q ss_pred ccccCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC
Q 036497 145 IKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ 222 (375)
Q Consensus 145 i~~~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~ 222 (375)
|+++++++ ++++|+++|+||+||+|.|++||++..|..++||..+|++++||||++.+.+.|++. .++++++|||++
T Consensus 172 I~~ll~~~-l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~ 250 (406)
T 3sto_A 172 LEKFFTDD-IPDDTAMILVNVFYFRDFWQSPFEPHYTRKEDFYISPDRQITVDMMTQEGVMKYGKFEDEGFEIVSKPLNN 250 (406)
T ss_dssp C---------CCSCCEEEEEEEEECEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSS
T ss_pred chhhccCC-CCCCceEEEEEeeEEEeecccCCCccCCcCceEECCCCeEEEEeEEEeeCceEEEEEcCCCeEEEEEecCC
Confidence 99999876 999999999999999999999999999999999999999999999999988877764 589999999997
Q ss_pred -------------CChHHHHHHcc-CcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcC
Q 036497 223 -------------DELPALEKKTG-SQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTE 288 (375)
Q Consensus 223 -------------~~l~~l~~~L~-~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~ 288 (375)
.+|.+++++|+ . ..+.+|+...+...++|.||||++++++||+++|++||++++|++..|||++
T Consensus 251 ~~~sm~iiLP~~~~~l~~l~~~L~~~--~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsg 328 (406)
T 3sto_A 251 TRFTFVIVLPLEKWSLNGATELLNGN--KVLSEYVKNLKETTVSLRLPKFTLKNTLDLVPTLKSIGVVDLFDPVKSDLSG 328 (406)
T ss_dssp TTEEEEEEEESSSSCCTTHHHHHSSS--SCHHHHHTTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTT
T ss_pred CcEEEEEEecCCCCCHHHHHHHcCch--HHHHHHHHhCcEeEEEEEecCEEEeeecChhhhhhhCCchhhcCCCCCCccc
Confidence 57899999997 4 3445555555666679999999999999999999999999999976899999
Q ss_pred CcCCC--CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 289 MVDSH--VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 289 is~~~--~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
|++++ +|++++||++|||||+||+|||+|++....++.+ +++..|+|||||+|+|+|+.||.|||+|||.+|.+
T Consensus 329 is~~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~s~~-~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 404 (406)
T 3sto_A 329 ITPNPNLYVNEFIQTNVLKLNESGIEATTVTSPIFVPFSAI-IPEVDFHVTHPFICFIYDQQLTMPIMAAKVMNPVL 404 (406)
T ss_dssp TCSSTTCCCSEEEEEEEEEECSSEESCCC-------CCCSC-CCSEEEECCSCEEEEEEETTTTEEEEEEEESSCC-
T ss_pred ccCCCCceEEEEEEEEEEEecCCcccccccceeeeecccCC-CCCceEEeeCCEEEEEEECCCCcEEEEEEeCCccC
Confidence 99874 9999999999999999999999998665555542 23578999999999999999999999999999975
|
| >1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-79 Score=586.98 Aligned_cols=345 Identities=24% Similarity=0.349 Sum_probs=299.4
Q ss_pred HhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCC
Q 036497 6 ESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGS 80 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~ 80 (375)
.+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++..++++ .++.++..+..
T Consensus 3 ~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~--- 79 (375)
T 1wz9_A 3 ALQLANSAFAVDLFKQLCEKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVNK--- 79 (375)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTSCCEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCHHHHHHHHHHHHHH---
T ss_pred hHhHHHHHHHHHHHHHHhccCCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCCHHHHHHHHHHHHHHhhc---
Confidence 56789999999999999752 23 999999999999999999999999999999998666777 88888877753
Q ss_pred CCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCee
Q 036497 81 ANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKL 160 (375)
Q Consensus 81 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~l 160 (375)
...+..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++|++
T Consensus 80 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~l~~~~~l~~~t~l 159 (375)
T 1wz9_A 80 LSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKI 159 (375)
T ss_dssp HTTTSEEEEEEEEEEEGGGCCCHHHHHHHTTTTTTTEEEECTTTCHHHHHHHHHHHHHHHTTTSCSCTTTTSCCCTTCCE
T ss_pred CCCCcEEEEeeeeeeeCCcchhHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHHHHHhcCchhhccCcccCCccchh
Confidence 23467899999999999999999999999999999999999976688999999999999999999999998899999999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC---------C------
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ---------D------ 223 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~---------~------ 223 (375)
+|+||+||+|.|+.||++..|..++|+..+|+.++||||++.+.+.|++ ..++++++|||++ .
T Consensus 160 vLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~~~~ 239 (375)
T 1wz9_A 160 LVVNAAYFVGKWMKKFPESETKECPFRLNKTDTKPVQMMNMEATFCMGNIDSINCKIIELPFQNKHLSMFILLPKDVEDE 239 (375)
T ss_dssp EEEEEEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEESSCCCH
T ss_pred hheeheeeecccCCCCCccCceeeeEEeCCCeEEEEEEEEeeeeEeeEEeCCcceEEEEeecCCCeEEEEEEecCccccc
Confidence 9999999999999999999999999999999999999999998776655 4589999999987 1
Q ss_pred --ChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccc
Q 036497 224 --ELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVG 297 (375)
Q Consensus 224 --~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~ 297 (375)
+|.+++++|+ ...+..+.. ..+...++|.||||++++++||+++|++||++++|++..|||++|++++ +|++
T Consensus 240 ~~~l~~l~~~L~--~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~vs~ 317 (375)
T 1wz9_A 240 STGLEKIEKQLN--SESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKACLENLGLKHIFSEDTSDFSGMSETKGVALSN 317 (375)
T ss_dssp HHHHHHHHHHCC--HHHHHHHTCGGGCEEEEEEEEEECEEEEEEECHHHHHHHHTCCSTTCTTTCCCTTTCCCTTCCEEE
T ss_pred CccHHHHHHHhC--HHHHHHHhhhhcceeeeEEEEcceEEecceechHHHHhhCChhhhcCCCCCcccccCCCCCeEEEE
Confidence 4778888886 345666666 4555667999999999999999999999999999996589999999754 9999
Q ss_pred eeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 298 IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 298 ~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++||++|+|||+||+|||+|++....++ .+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 318 v~hka~ieV~E~GteAaAaT~~~~~~~~------~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 375 (375)
T 1wz9_A 318 VIHKVCLEITEDGGDSIEVPGARILQHK------DELNADHPFIYIIRHNKTRNIIFFGKFCSP 375 (375)
T ss_dssp EEEEEEEEECSCC------------CEE------EEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred EEEeeeEEecCCCcccccccchhhcccC------CEEEecCCEEEEEEECCCCcEEEEEEeCCC
Confidence 9999999999999999999986444333 479999999999999999999999999998
|
| >4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-79 Score=586.90 Aligned_cols=347 Identities=24% Similarity=0.408 Sum_probs=297.5
Q ss_pred hHHhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhC
Q 036497 4 VLESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFAD 78 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~ 78 (375)
-..+.+++++||++||+++...+ + +|||+||+.+|+|+++||+|+|++||.++||++.. +++ .++.+...+..
T Consensus 5 ~~~l~~~~~~f~~~L~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~-~~~~~~~~l~~~l~~- 82 (379)
T 4dy0_A 5 PLSLEELGSNTGIQVFNQIVKSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVN-GVGKILKKINKAIVS- 82 (379)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTSCST-TTHHHHHHHHHHHHC-
T ss_pred ccCHHHHhhHHHHHHHHHHHhhCcCCcEEECHHHHHHHHHHHHHHcChHHHHHHHHHhCCChh-HHHHHHHHHHHHHhc-
Confidence 35677889999999999997643 3 99999999999999999999999999999999754 445 77777766652
Q ss_pred CCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCcc-
Q 036497 79 GSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDS- 157 (375)
Q Consensus 79 ~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~- 157 (375)
..++..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++++++++.
T Consensus 83 --~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~g~I~~ll~~~~~~~~~ 159 (379)
T 4dy0_A 83 --KKNKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFED-PASACDSINAWVKNETRDMIDNLLSPDLIDGVL 159 (379)
T ss_dssp --GGGSSCCEEEEEEEESCTTSSCHHHHHHHHHHHCEEEEECCTTS-HHHHHHHHHHHHHHHTTTCCCCCCCGGGCCTTT
T ss_pred --cCCCceeeeeeeeeeEccccccchhhhhhhhcCCcEEEEeccCC-hHHHHHHHHHHHHHhcCCcccccCCcccCCccc
Confidence 34456799999999999999999999999999999999999986 78999999999999999999999998888764
Q ss_pred CeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee-----cCCeEEEEecccC----------
Q 036497 158 SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA-----FDGFKVLVLPYKQ---------- 222 (375)
Q Consensus 158 t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~-----~~~~~vveLPy~~---------- 222 (375)
|+++|+||+||+|.|+.||++..|..++||..+|+++.||||++.+.++|++ ..++++|+|||++
T Consensus 160 T~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~~~~~~~~~~~~l~~~vl~LPy~~~~~sm~iiLP 239 (379)
T 4dy0_A 160 TRLVLVNAVYFKGLWKSRFQPENTKKRTFVAADGKSYQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGESISMLIALP 239 (379)
T ss_dssp CCEEEEEEEEECCCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEEE
T ss_pred ceEEEEEEEEEEeeecCCCchhhCeeeeEEeCCCceEEeeeeEeeeeecccccccccccceEEEEeccCCCceEEEEEec
Confidence 9999999999999999999999999999999999999999999998776653 3479999999997
Q ss_pred ----CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC--C-Cc
Q 036497 223 ----DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS--H-VG 295 (375)
Q Consensus 223 ----~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~--~-~v 295 (375)
.+|..+++.|+ ...+.+++...+...++|.||||++++++||+++|++||++++|+++.|||++|++. + +|
T Consensus 240 ~~~~~~l~~~~~~l~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~~L~~~L~~lGi~~~F~~~~Adfs~is~~~~~l~v 317 (379)
T 4dy0_A 240 TESSTPLSAIIPHIS--TKTIDSWMSIMVPKRVQVILPKFTAVAQTDLKEPLKVLGITDMFDSSKANFAKITTGSENLHV 317 (379)
T ss_dssp SSTTSCGGGTSTTCC--HHHHHHHHTTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTTCCCTTTCC---CCCC
T ss_pred CccccchhHhhhhcC--HHHHHHHHHhccceEEEEeccceEEEEEeechHhHHhCCchhhcCCCCCCcccccCCCCCeEe
Confidence 35777777775 356667777777777899999999999999999999999999998778999999864 4 99
Q ss_pred cceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 296 VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 296 s~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++++||++|+|||+||+|||+|++....++. +..|+|||||+|+|+|+.||.|||+|||.+|
T Consensus 318 s~v~hka~ieVnE~GteAaAaT~~~~~~~s~----~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P 379 (379)
T 4dy0_A 318 SHILQKAKIEVSEDGTKASAATTAILIARSS----PPWFIVDRPFLFFIRHNPTGAVLFMGQINKP 379 (379)
T ss_dssp CEEEEEEEEEECSCBC------------CCC----CCEEECCSCEEEEEEETTTTEEEEEEEESCC
T ss_pred eeeEEEEEEEECCCceeecccceeeeccCCC----CCEEEecCCEEEEEEECCCCCEEEEEEecCC
Confidence 9999999999999999999999866555443 3589999999999999999999999999998
|
| >2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-79 Score=592.48 Aligned_cols=349 Identities=30% Similarity=0.442 Sum_probs=296.6
Q ss_pred HhhhhhhhHHHHHHHHhcCC--CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----------------hhHH
Q 036497 6 ESISEQTDITLSLSKHIKAP--TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----------------EQQN 66 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~--~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----------------~~~~ 66 (375)
.+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++
T Consensus 14 ~~~~~~~~Fa~~l~~~l~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (401)
T 2zv6_A 14 SLSEANTKFMFDLFQQFRKSKENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTGKAATYHVDRSGNVH 93 (401)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCSCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHTTC--------------------CTH
T ss_pred HHHHHHHHHHHHHHHHHhhCCCCCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCcccccccccccccccccHHHHH
Confidence 45678999999999999753 34 99999999999999999999999999999999762 3566
Q ss_pred -HHHHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccc
Q 036497 67 -FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFI 145 (375)
Q Consensus 67 -~~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i 145 (375)
.++.++..+.. ...+..+.++|+||+++++.++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|
T Consensus 94 ~~~~~l~~~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI 170 (401)
T 2zv6_A 94 HQFQKLLTEFNK---STDAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFANAPEESRKKINSWVESQTNEKI 170 (401)
T ss_dssp HHHHHHHHHHHS---CCSSCCEEEECCEEEETTSCCCHHHHHHHHHHHSCCEEEECTTTCHHHHHHHHHHHHHHHTTTCS
T ss_pred HHHHHHHHHhhC---CCCCcEEEEEEEEEecCCCChhHHHHHHHHHHhCCEEEEccCCCCHHHHHHHHHHHHHHhhCCcc
Confidence 88888887753 34467899999999999999999999999999999999999976689999999999999999999
Q ss_pred cccCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC-
Q 036497 146 KEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ- 222 (375)
Q Consensus 146 ~~~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~- 222 (375)
++++++++++++|+++|+||+||+|.|+.||++..|..++|++.+|+.++||||++.+.+.|+. ..++++|+|||++
T Consensus 171 ~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~f~~~~~~~l~~~vleLPY~~~ 250 (401)
T 2zv6_A 171 KNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEKFWPNKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYKGK 250 (401)
T ss_dssp CCSSCTTTSCTTCCEEEEEEEEECCCBSSCCCTTSEEEEEECSSSSCCEEEEEEEEEEEEEECEETTTTEEEEEEEBTTS
T ss_pred ccccCcccCCCcceEEEEEhheeccccCCCCCCCCceeeEEEecCCceEEeEEEeccCceeEEEeCCCCEEEEEeecCCC
Confidence 9999988999999999999999999999999999999999999999999999999998766654 4599999999997
Q ss_pred ------------CChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcC
Q 036497 223 ------------DELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTE 288 (375)
Q Consensus 223 ------------~~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~ 288 (375)
.+|.+++++|+ ...+..+.. ..+...++|.||||++++++||+++|++||++++|+. .|||++
T Consensus 251 ~~sm~iiLP~~~~~L~~le~~L~--~~~l~~~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~F~~-~Adfsg 327 (401)
T 2zv6_A 251 DLSMIVLLPNEIDGLQKLEEKLT--AEKLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDTLRTMGMVDIFNG-DADLSG 327 (401)
T ss_dssp SSEEEEEEESSTTCHHHHHHHCC--HHHHHHHTCGGGCEEEEEEEEEECCEEEEEEECHHHHHHTTCCGGGST-TCCCHH
T ss_pred cEEEEEEecCCCCCHHHHHHHhC--HhHHHHHhhhcccceeEEEEEeeeEEEEEEecHHHHHHhcCccccCCC-cccccc
Confidence 57999999996 345666665 3455667999999999999999999999999999995 899999
Q ss_pred CcCCC--CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 289 MVDSH--VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 289 is~~~--~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
|++++ +|++++||++|||||+||+|||+|++....++.+. ++.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 328 is~~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~-~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P 401 (401)
T 2zv6_A 328 MTGSRGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTS-TNEEFHCNHPFLFFIRQNKTNSILFYGRFSSP 401 (401)
T ss_dssp HHSSSCCCEEEEEEEEEEECCSCC--------------------CEEEECSSCEEEEECCTTTTCCCCEEEECCC
T ss_pred cCCCCCeEEEEEEEEEEEEecCCCcccccccchhhccccCCC-CCCEEEecCCEEEEEEECCCCeEEEEEEeCCC
Confidence 99754 99999999999999999999999986655555532 23689999999999999999999999999998
|
| >2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-79 Score=588.72 Aligned_cols=349 Identities=28% Similarity=0.436 Sum_probs=297.6
Q ss_pred HhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC----hhhHH-HHHHHHHHHH
Q 036497 6 ESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS----NEQQN-FASELVAIVF 76 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~----~~~~~-~~~~l~~~l~ 76 (375)
.+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++. .++++ .++.++..+.
T Consensus 3 ~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~ 82 (382)
T 2arr_A 3 DLCVANTLFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQFNEVGAAADKIHSSFRSLSSAIN 82 (382)
T ss_dssp CTTHHHHHHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTTTTC-----CHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHhhcCCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCccccHHHHHHHHHHHHHHHh
Confidence 45678999999999999753 23 9999999999999999999999999999999986 34677 8888888775
Q ss_pred hCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCc
Q 036497 77 ADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD 156 (375)
Q Consensus 77 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~ 156 (375)
. ...+..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|+++++++++++
T Consensus 83 ~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~l~~~~~l~~ 159 (382)
T 2arr_A 83 A---STGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDG 159 (382)
T ss_dssp C---CCSSEEEEEEEEEEEETTCCCCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHHHHHHTTTSSCCCSCTTSSCT
T ss_pred C---CCCCcEEEeeeehHHhCCCCccHHHHHHHHHHhCCEEEEecCcCcHHHHHHHHHHHHHHHhcCchhhhCCCcCCCC
Confidence 2 3346789999999999999999999999999999999999996557899999999999999999999999889999
Q ss_pred cCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC-----------C
Q 036497 157 SSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ-----------D 223 (375)
Q Consensus 157 ~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~-----------~ 223 (375)
+|+++|+||+||+|.|++||++..|..++||..+|+.++||||++.+.+.|+. ..++++++|||++ .
T Consensus 160 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~sm~iiLP~~~ 239 (382)
T 2arr_A 160 DTRMVLVNAVYFKGKWKTPFEKKLNGLFPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAGDVSMFLLLPDEI 239 (382)
T ss_dssp TEEEEEEEEEEEEECBSSCCEECC---EEEEEETTEEEEECEEEEEEEEEEEEEGGGTEEEEEEEBSSSEEEEEEEEC--
T ss_pred cceEEEEEeeEecccccCCCChhhcccceEecCCCceeeeeEEeccCcEeEEEECCCCeEEEEecCCCcEEEEEEecCCC
Confidence 99999999999999999999999999999999999999999999998776655 4599999999986 2
Q ss_pred -----ChHHHHHHccCcHHHHhccCCc--cceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--C
Q 036497 224 -----ELPALEKKTGSQSGFLKDHIPY--EMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--V 294 (375)
Q Consensus 224 -----~l~~l~~~L~~~~~~l~~~~~~--~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~ 294 (375)
+|.+++++|+. ..+..+... .+...++|.||||++++++||+++|++||++++|++..|||++|++++ +
T Consensus 240 ~~~~~~l~~l~~~L~~--~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~ 317 (382)
T 2arr_A 240 ADVSTGLELLESEITY--DKLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMSERNDLF 317 (382)
T ss_dssp CCSSSSCHHHHHHCCH--HHHHHHHCC--CEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGCTTTCCCTTTCTTCCEE
T ss_pred ccccccHHHHHHHhCH--HHHHHHhhhccccceEEEEECcCEEeeccccHHHHHHhcCccccCCCCCCChhhcCCCCCeE
Confidence 68999999963 445555542 445567999999999999999999999999999996689999999865 9
Q ss_pred ccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 295 GVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 295 vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
|++++||++|||||+||+|||+|++....++.+ .+.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 318 vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~--~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 382 (382)
T 2arr_A 318 LSEVFHQAMVDVNEEGTEAAAGTGGVMTGRTGH--GGPQFVADHPFLFLIMHKITNCILFFGRFSSP 382 (382)
T ss_dssp EEEEEEEEEEEECCCBC----------CCCCCC--CSCEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred EEEEEEeeeeeecCCCcccccccchhhccccCC--CCCeEEecCCEEEEEEECCCCcEEEEEEeCCC
Confidence 999999999999999999999998655555543 24689999999999999999999999999998
|
| >4ajt_A Protein Z-dependent protease inhibitor; blood clotting, ZPI; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-78 Score=588.81 Aligned_cols=345 Identities=24% Similarity=0.334 Sum_probs=300.9
Q ss_pred HHhhhhhhhHHHHHHHHhcCCC--C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCC-----ChhhHH-HHHHHHHHH
Q 036497 5 LESISEQTDITLSLSKHIKAPT--S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSK-----SNEQQN-FASELVAIV 75 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~~--~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~-----~~~~~~-~~~~l~~~l 75 (375)
..++.++++||++||+++.... + +|||+||+.+|+|+++||+|+|++||.++||++ ..++++ .++.++..+
T Consensus 56 ~~l~~~~~~Fa~~L~~~l~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~i~~~f~~l~~~l 135 (427)
T 4ajt_A 56 QQLSNETSSFGFNLLRKISMRHDGNVIFSPFGLSVAMVNLMLGTKGETKVQIENGLNLQALSQAGPLILPALFKKVKETF 135 (427)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCCSCEEECHHHHHHHHHHHHHHCCTHHHHHHHHHHTCHHHHTSCTTHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCccccCCHHHHHHHHHHHHHHh
Confidence 4567889999999999996432 4 999999999999999999999999999999998 335677 888888777
Q ss_pred HhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCC
Q 036497 76 FADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVD 155 (375)
Q Consensus 76 ~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~ 155 (375)
. +..+..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++ ++++
T Consensus 136 ~----~~~~~~L~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll--~~l~ 208 (427)
T 4ajt_A 136 S----SNRDLGLSQGSFAFIHKDFDIKETYFNLSKKYFDIEYVSINFQN-SSQARGLINHCIVKETEGKIPKLF--DEIN 208 (427)
T ss_dssp H----TCTTSCEEEEEEEEEETTSCCCHHHHHHHHHHSCCCEEEECTTS-HHHHHHHHHHHHHHHTTTSSCSCC--SCCC
T ss_pred C----CCCCceehhhhHHHHccCCchhHHHHHHHHHhhcceeEEcCCCC-hHHHHHHHHHHHHHhhCCcccccc--cCCC
Confidence 5 23456799999999999999999999999999999999999965 788999999999999999999999 5799
Q ss_pred ccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC-----------
Q 036497 156 DSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ----------- 222 (375)
Q Consensus 156 ~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~----------- 222 (375)
++|+++|+||+||+|.|++||++..|..++||+.+|+.++||||++.+.+.|+. ..+++||+|||++
T Consensus 209 ~~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~~~~~~~l~~~vleLPY~~~~sm~iiLP~~ 288 (427)
T 4ajt_A 209 PETKLILVDYVLFKGKWLTPFDPSFTEADTFHLDKYRAIKVPMMYREGNFTSTFDKKFRCHILKLPYQGNATMLVVLMEK 288 (427)
T ss_dssp TTCCEEEEEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEEGGGEEEEEEEECT
T ss_pred CcceeEEeeeeeeeeeecCCCChhhccccceeccCCCEEEEEEEEecCceeEEEecCCceEEEEEEcCCCeEEEEEecCC
Confidence 999999999999999999999999999999999999999999999998776554 4489999999997
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcC-C-C-Cccce
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD-S-H-VGVGI 298 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~-~-~-~vs~~ 298 (375)
++|.+++++|+. ..+..+....+...++|.||||++++++||+++|++|||+++|++ .|||++|++ + + +|+++
T Consensus 289 ~~~L~~le~~L~~--~~l~~~~~~l~~~~v~v~LPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~~l~Vs~v 365 (427)
T 4ajt_A 289 TGDYLALEDYLTV--DLVETWLQNMKTRKMEVFFPKFKLNQRYEMHELLKQMGIRRLFST-SADLSELSAMARNLQVSRV 365 (427)
T ss_dssp TSCHHHHTTTCCH--HHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCSSCSSCCCCEE
T ss_pred CCCHHHHHHhcCH--HHHHHHHHhCcceEEEEeccCEEEEeccChHHHHHHcCCchhhcC-CCCcccccCCCCCceEEEE
Confidence 579999999863 445555555556667999999999999999999999999999998 899999998 4 4 99999
Q ss_pred eeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 299 FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 299 ~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
+||++|+|||+||+|||+|++....++. +..|+|||||+|+|+|+.||.|||+|+|.+|++
T Consensus 366 ~hka~ieVnEeGteAAAaT~~~~~~~s~----p~~f~adrPFlF~I~d~~t~~iLF~G~v~~P~~ 426 (427)
T 4ajt_A 366 LQQSVLEVDERGTEAVSGTLSEIIAYSM----PPAIKVNRPFHFIIYEEMSRMLLFLGRVVNPTV 426 (427)
T ss_dssp EEEEEEEECSCBCC-------CCBCCSS----CCEEECCSCEEEEEEETTTTEEEEEEEESSCC-
T ss_pred EEEEEEEECCCcccccccceeeecccCC----CCEEEEeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 9999999999999999999865444443 358999999999999999999999999999975
|
| >2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-78 Score=582.53 Aligned_cols=346 Identities=24% Similarity=0.332 Sum_probs=305.4
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAI 74 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~ 74 (375)
..++..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..
T Consensus 4 ~~~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~ 83 (373)
T 2vdx_A 4 HRGLASANVDFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQL 83 (373)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 4567789999999999999642 23 99999999999999999999999999999999742 4677 88888887
Q ss_pred HHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCC
Q 036497 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSV 154 (375)
Q Consensus 75 l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~ 154 (375)
+.. +..+..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ ++
T Consensus 84 l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~~--~l 157 (373)
T 2vdx_A 84 FAK---SDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQD-WATASRQINSYVKNKTQGKIVDLFS--GL 157 (373)
T ss_dssp HHS---CCSSCEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHHTTTCSCCSSC--C-
T ss_pred hhc---cCCcccceeEEEEEEECCCChHHHHHHHHHHHhCCeeEeecCcc-hHHHHHHHHHHHHHHhcCchhhhcc--CC
Confidence 753 34567899999999999999999999999999999999999985 7889999999999999999999996 59
Q ss_pred CccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC----------
Q 036497 155 DDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ---------- 222 (375)
Q Consensus 155 ~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~---------- 222 (375)
+++|+++|+||+||+|.|+.||++..|.+++||+.+|++++||||++.+.+.|++.+ ++++++|||++
T Consensus 158 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~sm~iiLP~ 237 (373)
T 2vdx_A 158 DSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVGNGTVFFILPD 237 (373)
T ss_dssp CCCCSEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEECSSSSEEEEEEEBSSSEEEEEEEEC
T ss_pred CCCCeEEEEEHHhhhhhhhCcCCccccccceEEeCCCcEEEEEEEEeeeeEeeEEeCCCCeEEEEEecCCCeEEEEEecC
Confidence 999999999999999999999999999999999999999999999999888777654 79999999997
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Ccccee
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIF 299 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~ 299 (375)
.+|.+++++|+. ..+..+....+...++|.||||++++++||+++|++||++++|+. .|||++|++++ +|++++
T Consensus 238 ~~~l~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~~l~vs~v~ 314 (373)
T 2vdx_A 238 KGKMNTVIAALSR--DTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTT-QANFSRITQDAQLKSSKVV 314 (373)
T ss_dssp TTCHHHHHHTCSH--HHHHHHHHHCEEEEEEEEEECCEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCSSCCEEEEEEE
T ss_pred CCCHHHHHHHhCH--HHHHHHHHhhhceeeEEeeeEEEeecccchHHHHHhcCchhhccC-CCCcccccCCCCeEEeeee
Confidence 369999999963 445555544555667999999999999999999999999999995 89999999865 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 300 QKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
||++|+|||+||+|||+|++....++. +..|+|||||+|+|+|+.||.|||+|+|.+|.
T Consensus 315 hka~ieVnE~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 373 (373)
T 2vdx_A 315 HKAVLQLNEEGTEAAGAMFLEAIPRSK----PIILRFNQPFIIMIFDHFTWSSLFLARVMNPV 373 (373)
T ss_dssp EEEEEEECSSEEEEEEEEEEEEEEC-C----CEEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred eeeeEEecCCcccccccccccccccCC----CceEEecCCEEEEEEECCCCcEEEEEEeCCCC
Confidence 999999999999999999854443332 46899999999999999999999999999994
|
| >4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-78 Score=586.03 Aligned_cols=347 Identities=20% Similarity=0.300 Sum_probs=301.8
Q ss_pred hHHhhhhhhhHHHHHHHHhcCCCC----eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh--hhHH-HHHHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAPTS----SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN--EQQN-FASELVAIVF 76 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~~~----v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--~~~~-~~~~l~~~l~ 76 (375)
..++++++++||++||++++..++ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..+.
T Consensus 6 ~~~l~~~~~~Fa~~L~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l~ 85 (392)
T 4au2_A 6 AATLAERSAGLAFSLYQAMAKDQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLRDEEVHAGLGELLRSLS 85 (392)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCTTCCSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTSCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHhhcCCCCeEEECHHHHHHHHHHHHhhcCcHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHh
Confidence 356788999999999999976543 99999999999999999999999999999999864 4566 7888877663
Q ss_pred hCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCc
Q 036497 77 ADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD 156 (375)
Q Consensus 77 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~ 156 (375)
. ....+..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ ++++
T Consensus 86 ~--~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~~--~~~~ 160 (392)
T 4au2_A 86 N--STARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRD-KRSALQSINEWAAQTTDGKLPEVTK--DVER 160 (392)
T ss_dssp C-------CCCEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCCSCS--CCCC
T ss_pred c--CCCCCceEEEEEEEEeecCCchhHHHHHHHHHhhCCeeEEecCCC-hHHHHHHHHHHHHHhcCCCccchhc--ccCC
Confidence 2 223456799999999999999999999999999999999999986 7899999999999999999999986 5999
Q ss_pred cCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC------------
Q 036497 157 SSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ------------ 222 (375)
Q Consensus 157 ~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~------------ 222 (375)
+|+++|+||+||+|.|+.||++..|.+++|++.+|+++.||||++.+.+.|+. ..++++|+|||++
T Consensus 161 ~t~lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~illP~~ 240 (392)
T 4au2_A 161 TDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKLQIVEMPLAHKLSSLIILMPHH 240 (392)
T ss_dssp SSSEEEEEEEEECCCBSSCCCTTSEEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEESS
T ss_pred cchhhheehhheeccccCCCCccccccCceecCCCceeEEeeeeecceeeEEeeccCceeEEEeecCCCcEEEEEEeCCC
Confidence 99999999999999999999999999999999999999999999998766654 4589999999998
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Ccccee
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIF 299 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~ 299 (375)
+++..+++.|+ ...+..+....+...++|.||||++++++||+++|++||++++|+++.|||++|++++ +|++++
T Consensus 241 ~~~l~~le~~l~--~~~l~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~v~ 318 (392)
T 4au2_A 241 VEPLERLEKLLT--KEQLKIWMGKMQKKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVF 318 (392)
T ss_dssp SCCTHHHHHHCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHHTCCTTTCTTTCCCHHHHSSSCCCEEEEE
T ss_pred CCcHHHHHHHhh--HHHHHHHHhcccceEEEEEecceEEEEEechHHHHHhcCCcccCCCCCCccccCCCCCCeEEEeeE
Confidence 67999999986 3456666666666678999999999999999999999999999998789999999775 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 300 QKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
||++|+|||+||+|+|+|.+... ...+..|+|||||+|+|+|+.||.|||+|||.+|.
T Consensus 319 hka~ieVnE~GteAaaat~~~~~-----~~~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~ 376 (392)
T 4au2_A 319 HATAFEWDTEGNPFDQDIYGREE-----LRSPKLFYADHPFIFLVRDTQSGSLLFIGRLVRPK 376 (392)
T ss_dssp EEEEEEECSCBCSCC-------------CCSCEEEECCSCEEEEEEETTTCCEEEEEEESCCS
T ss_pred EEEEEEECCCcccchhhheeccc-----CCCCCEEEeeCCEEEEEEECCCCcEEEEEEEeCCC
Confidence 99999999999999998874322 12246899999999999999999999999999996
|
| >1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-78 Score=583.74 Aligned_cols=349 Identities=24% Similarity=0.386 Sum_probs=309.0
Q ss_pred hhHHhhhhhhhHHHHHHHHhc-CC--CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-hhHH-HHHHHHHHHH
Q 036497 3 DVLESISEQTDITLSLSKHIK-AP--TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-EQQN-FASELVAIVF 76 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~-~~--~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~-~~~~l~~~l~ 76 (375)
+...+..++++||++||+++. .. .+ +|||+||+.+|+|+++||+|+|++||.++||++.. .+++ .++.++..+.
T Consensus 4 ~~~~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~l~~~l~ 83 (379)
T 1lj5_A 4 PPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELM 83 (379)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHSTTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTTSTTHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHhhcCCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCCHHHHHHHHHHHHHHHh
Confidence 456788899999999999997 22 23 99999999999999999999999999999999865 4676 8888887775
Q ss_pred hCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCc
Q 036497 77 ADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD 156 (375)
Q Consensus 77 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~ 156 (375)
. +..+..+.++|+||+++++.++++|++.++++|+++++.+||.+ +..+++.||+||+++|+|+|+++++++++++
T Consensus 84 ~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~Wv~~~T~g~I~~l~~~~~l~~ 159 (379)
T 1lj5_A 84 G---PWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSE-VERARFIINDWVKTHTKGMISNLLGKGAVDQ 159 (379)
T ss_dssp C---GGGSSEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECTTS-HHHHHHHHHHHHHHTTTTSCCCSSCTTSSCT
T ss_pred C---CCCCcEEEEEEeeeeeCCcchhHHHHHHHHHHhCCEEEEECCCC-hHHHHHHHHHHHHhhcCCccccccCcccCCC
Confidence 2 33457899999999999999999999999999999999999987 5788999999999999999999999888999
Q ss_pred cCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceee--e--c-CCeEEEEecccC---------
Q 036497 157 SSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVT--A--F-DGFKVLVLPYKQ--------- 222 (375)
Q Consensus 157 ~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~--~--~-~~~~vveLPy~~--------- 222 (375)
+|+++|+||+||+|.|+.||++..|..++||..+|++++||||++.+.++|+ + . .++++++|||++
T Consensus 160 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~gl~~~vleLPy~~~~~sm~iiL 239 (379)
T 1lj5_A 160 LTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239 (379)
T ss_dssp TCCEEEEEEEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEE
T ss_pred ccceeeeeeeeecccccCCCCcccccceeEEeCCCeEEEEeEEeeEeeeceeeeEcCCCCceEEEEEecCCCcEEEEEEE
Confidence 9999999999999999999999999999999999999999999999877773 3 3 479999999987
Q ss_pred -----CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cc
Q 036497 223 -----DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VG 295 (375)
Q Consensus 223 -----~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~v 295 (375)
.+|.+++++|+. ..+..+....+...++|.||||++++++||+++|++||++++|++..|||++|++++ +|
T Consensus 240 P~~~~~~l~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~l~v 317 (379)
T 1lj5_A 240 PYEKEVPLSALTNILSA--QLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHV 317 (379)
T ss_dssp ESSTTSCTHHHHTTCCH--HHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCSSSCCCE
T ss_pred ecCCCCCHHHHHHHhCH--HHHHHHHHhCcceEEEEEeeEEEEeeeechHHHHHhcCCccCCCCCCCCccccCCCCCeEE
Confidence 368889999863 445555555555667999999999999999999999999999998569999999874 99
Q ss_pred cceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 296 VGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 296 s~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++++||++|+|||+||+|||+|++....++. +.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 318 s~v~hka~ieV~E~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 379 (379)
T 1lj5_A 318 AQALQKVKIEVNESGTVASSSTAVIVSARMA----PEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379 (379)
T ss_dssp EEEEEEEEEEECSSEEEEEEEEEEEESSCCC----CCCCCBCCEEEEEEEETTTTEEEEEEEEECC
T ss_pred eeeeEEeEEEecCCCcCcccccceeecccCC----CCEEEecCCEEEEEEECCCCeEEEEEEecCC
Confidence 9999999999999999999999854333321 3579999999999999999999999999998
|
| >3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-78 Score=582.10 Aligned_cols=347 Identities=25% Similarity=0.338 Sum_probs=309.4
Q ss_pred hHHhhhhhhhHHHHHHHHhcCCC--C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC----hhhHH-HHHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAPT--S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS----NEQQN-FASELVAIV 75 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~~--~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~----~~~~~-~~~~l~~~l 75 (375)
..++..++++||++||+++.... + +|||+||+.+|+|+++||+|+|++||.++||++. .++++ .++.++..+
T Consensus 13 ~~~l~~~~~~Fa~~l~~~l~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l 92 (385)
T 3f1s_A 13 RQQLAKETSNFGFSLLRKISMRHDGNMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFKGLRET 92 (385)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCCSCEEECHHHHHHHHHHHTTTCCTHHHHHHHHHTTCTTCCCSSTTHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhCCCCcEEEchHHHHHHHHHHHHhcchHHHHHHHHhcCCCCCcCCHHHHHHHHHHHHHHh
Confidence 45677899999999999997533 5 9999999999999999999999999999999986 25677 888888777
Q ss_pred HhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCC
Q 036497 76 FADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVD 155 (375)
Q Consensus 76 ~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~ 155 (375)
.. ...+..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++ ++++
T Consensus 93 ~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~--~~l~ 166 (385)
T 3f1s_A 93 LS---RNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRN-ASQAKRLMNHYINKETRGKIPKLF--DEIN 166 (385)
T ss_dssp HH---HCSSSCEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECCSS-HHHHHHHHHHHHHHHTTTSSSCCC--SCCC
T ss_pred hc---CCCCcEEEEEEEEEEECCCchhHHHHHHHHHHhCCeeEEeCCCC-hHHHHHHHHHHHHHHhcCchhhHh--hccC
Confidence 53 23457899999999999999999999999999999999999985 789999999999999999999999 5799
Q ss_pred ccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC-----------
Q 036497 156 DSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ----------- 222 (375)
Q Consensus 156 ~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~----------- 222 (375)
++|+++|+||+||+|.|+.||++..|.+++||..+|++++||||++.+.+.|++.+ ++++++|||.+
T Consensus 167 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~sm~iiLP~~ 246 (385)
T 3f1s_A 167 PETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQGNATMLVVLMEK 246 (385)
T ss_dssp TTCCEEEEEEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEEEEEEEECT
T ss_pred CCCeEEEEEhhhccchhcCCCCccCccceEEEECCCEEEEEEEEeccCcccEEEeCCCCeEEEEecCCCcEEEEEEeCCC
Confidence 99999999999999999999999999999999999999999999999888777655 78999999943
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcC--CC-Cccce
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD--SH-VGVGI 298 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~--~~-~vs~~ 298 (375)
.+|.+++++|+. ..+.++....+...++|.||||++++++||+++|++||++++|+. .|||++|++ .+ +|+++
T Consensus 247 ~~~L~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~~~l~vs~v 323 (385)
T 3f1s_A 247 MGDHLALEDYLTT--DLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSP-FADLSELSATGRNLQVSRV 323 (385)
T ss_dssp TSCHHHHGGGCCH--HHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBCCCSCCCCCEE
T ss_pred CCCHHHHHHHhhH--HHHHHHHHhccceeeEEeeeEEEEEeeecHHHHHHhcCccccccC-CCCcccccCCCCCeEEEEE
Confidence 579999999963 456666655666678999999999999999999999999999995 899999997 44 99999
Q ss_pred eeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 299 FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 299 ~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
+||++|+|||+||+|||+|++....+ +.+..|+|||||+|+|+|+.||.|||+|+|.+|..
T Consensus 324 ~hka~ieV~E~GteAaAaT~~~~~~~----~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 384 (385)
T 3f1s_A 324 LQRTVIEVDERGTEAVAGILSEITAY----SMPPVIKVDRPFHFMIYEETSGMLLFLGRVVNPTL 384 (385)
T ss_dssp EEEEEEEECSCBCCCCCCCCCCCCSS----CCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred EEeeEEEecCCcceeccccccccccC----CCCCEEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 99999999999999999998544332 23468999999999999999999999999999964
|
| >1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-78 Score=580.49 Aligned_cols=347 Identities=26% Similarity=0.387 Sum_probs=303.2
Q ss_pred HHhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhH-HHHHHHHHHHHhCC
Q 036497 5 LESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQ-NFASELVAIVFADG 79 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~-~~~~~l~~~l~~~~ 79 (375)
..+..++++||++||+++...+ + +|||+||+.+|+|+++||+|+|++||.++||++..+.. ..++.+...+.
T Consensus 9 ~~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~--- 85 (378)
T 1sek_A 9 KILRESNDQFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNVTKDVFADLNRGVR--- 85 (378)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTSTTSCEEECSTTTHHHHHHHHHHCCHHHHHHHHHHHTCCCHHHHHHHHHHHHHTCS---
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCCEEEcHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCCCchHHHHHHHHHHHHh---
Confidence 3577899999999999997533 3 99999999999999999999999999999999875332 24555554432
Q ss_pred CCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCe
Q 036497 80 SANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSK 159 (375)
Q Consensus 80 ~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~ 159 (375)
..++..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++++++++++|+
T Consensus 86 -~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~ 163 (378)
T 1sek_A 86 -AVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVK-SVEAAGAINKWVEDQTNNRIKNLVDPDALDETTR 163 (378)
T ss_dssp -CCTTEEEEEEEEEEEETTSCBCHHHHHHHHHTTCCEEEEECGGG-HHHHHHHHHHHHHHHTTTSSCCCSCGGGCCTTCC
T ss_pred -ccCCCeEEeeeehhhhCCCCHhHHHHHHHHHHhCCeeEeeCCcC-HHHHHHHHHHHHHHHhCCcccccCCcccCCCCCe
Confidence 22356799999999999999999999999999999999999975 7889999999999999999999998889999999
Q ss_pred eEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC-------------CC
Q 036497 160 LVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ-------------DE 224 (375)
Q Consensus 160 lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~-------------~~ 224 (375)
++|+||+||+|.|++||++..|..++||..+|++++||||++.+.++|++.+ ++++|+|||++ .+
T Consensus 164 lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~~sm~iiLP~~~~~ 243 (378)
T 1sek_A 164 SVLVNAIYFKGSWKDKFNKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPNQVDG 243 (378)
T ss_dssp EEEEEEEEEEECBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBGGGSEEEEEEEESSTTT
T ss_pred EEEEEeeEEeccccCCCCCCCcccceEEeCCCEEEEeeEEEeeceEeEEEeCCCCeEEEEEECCCCcEEEEEEEeCCCCC
Confidence 9999999999999999999999999999999999999999999888777655 78999999986 57
Q ss_pred hHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC--C-Cccceeee
Q 036497 225 LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS--H-VGVGIFQK 301 (375)
Q Consensus 225 l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~--~-~vs~~~qk 301 (375)
|.+++++|+. ...+..+....+...++|.||||++++++||+++|++||++++|+...|||++|+++ + +|++++||
T Consensus 244 l~~l~~~L~~-~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~~l~vs~v~hk 322 (378)
T 1sek_A 244 ITALEQKLKD-PKALSRAEERLYNTEVEIYLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKTKESLYVDAAIQK 322 (378)
T ss_dssp HHHHHHHTTS-TTHHHHHHTTCEEEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGSTTTCCCTTTBTTCCCCCCCEEEEE
T ss_pred HHHHHHHhcc-hhHHHHHHHhccceEEEEEeeeEEeecccccHHHHHhcCCcccccCCcCCchhhcCCCCCeEEeeeeeE
Confidence 9999999972 234555555555666799999999999999999999999999995448999999864 3 99999999
Q ss_pred eEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 302 SFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 302 ~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++|+|||+||+|||+|++....++.+. +..|++||||+|+|+| ++.|||+|+|.+|
T Consensus 323 a~ieV~E~GteAaAaT~~~~~~~~~~~--~~~f~~drPFlf~I~~--~~~iLF~G~v~~P 378 (378)
T 1sek_A 323 AFIEVNEEGAEAAAANAFKITTYSFHF--VPKVEINKPFFFSLKY--NRNSMFSGVCVQP 378 (378)
T ss_dssp EEEEECSCBSSCTTSSTTCCCCSCCCC--CCEEECCSCEEEEEEE--TTEEEEEEEESCC
T ss_pred EEEEeCCCCcccccccchhhccccCCC--CCeEEecCCEEEEEEe--CCEEEEEEEecCC
Confidence 999999999999999986554455432 3469999999999999 6899999999998
|
| >1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-78 Score=584.30 Aligned_cols=349 Identities=24% Similarity=0.363 Sum_probs=307.0
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAI 74 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~ 74 (375)
...+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..
T Consensus 24 ~~~l~~~~~~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~ 103 (398)
T 1yxa_A 24 SLTLASINTDFAFSLYKELVLKNPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLKFNLTETSEADIHQGFGHLLQR 103 (398)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCCCCEEEchHHHHHHHHHHHhhcccHHHHHHHHHhCCCcccCCHHHHHHHHHHHHHH
Confidence 3456788999999999999642 23 99999999999999999999999999999999742 4666 88888877
Q ss_pred HHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCC
Q 036497 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSV 154 (375)
Q Consensus 75 l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~ 154 (375)
+. .+..+..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ ++
T Consensus 104 l~---~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~l 177 (398)
T 1yxa_A 104 LN---QPKDQVQISTGSALFIEKRQQILTEFQEKAKTLYQAEAFTADFQQ-PRQAKKLINDYVRKQTQGMIKELVS--DL 177 (398)
T ss_dssp HS---SCBTTBEEEEEEEEEEETTSCCCHHHHHHHHHHHSCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSSCCCC--CC
T ss_pred Hh---CCCCCceeeeeeEEEEeCCCchhHHHHHHHHHHhCCceeecCCCC-HHHHHHHHHHHHHHHhcCchhhhhh--cc
Confidence 74 234567899999999999999999999999999999999999985 7889999999999999999999996 49
Q ss_pred CccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccc-cceeeecC--CeEEEEecccC---------
Q 036497 155 DDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN-KQLVTAFD--GFKVLVLPYKQ--------- 222 (375)
Q Consensus 155 ~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~-~~~~~~~~--~~~vveLPy~~--------- 222 (375)
+++|+++|+||+||+|.|+.||++..|..++||+.+|++++||||++.+ .+.|++.+ ++++++|||++
T Consensus 178 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~~sm~iiLP 257 (398)
T 1yxa_A 178 DKRTLMVLVNYIYFKAKWKVPFDPLDTFKSEFYCGKRRPVIVPMMSMEDLTTPYFRDEELSCTVVELKYTGNASALFILP 257 (398)
T ss_dssp CTTCCEEEEEEEEEECBBSSCCCGGGCEEEEECCCCSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSEEEEEEEE
T ss_pred CCCcEEEEEEHHhhhhhhhCCCCcccCeeeEEEeCCCeEEEEEEEEEcCceEEEEEeCCCCeEEEEEecCCCeeEEEEec
Confidence 9999999999999999999999999999999999999999999999998 88777654 79999999997
Q ss_pred --CChHHHHHHccCcHHHHhccCCccceeee-eeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccc
Q 036497 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVG-DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVG 297 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~~~~~~~~~-~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~ 297 (375)
.+|.+++++|+. ..+..+....+...+ +|.||||++++++||+++|++||++++|+. .|||++|++++ +|++
T Consensus 258 ~~~~L~~le~~L~~--~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~ 334 (398)
T 1yxa_A 258 DQGRMQQVEASLQP--ETLRKWKNSLKPRMIDELHLPKFSISTDYSLEDVLSKLGIREVFST-QADLSAITGTKDLRVSQ 334 (398)
T ss_dssp CTTCHHHHHHTCSH--HHHHHHHHHCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHSSSCCCCCE
T ss_pred CcCcHHHHHHHhCH--HHHHHHHHhccceeeeEEecceEEeecccchHHHHHHcCcccccCC-cCCcccCCCCCCeEEEE
Confidence 349999999963 445555555555667 999999999999999999999999999995 89999999865 9999
Q ss_pred eeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 298 IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 298 ~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
++||++|+|||+||+|||+|++....++.+ +++.+|+|||||+|+|+|+.||.|||+|+|.+|.
T Consensus 335 v~hka~ieVnE~GteAaAaT~~~~~~~s~~-~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~ 398 (398)
T 1yxa_A 335 VVHKAVLDVAETGTEAAAATGVKFVPMSAK-LYPLTVYFNRPFLIMIFDTETEIAPFIAKIANPK 398 (398)
T ss_dssp EEEEEEEEECSSBSSCCCCCSCCCCCCCCC-SSCCEEECCSCEEEEEEETTTCCCSEEEEESCCC
T ss_pred EEEEEEEEEcCCccccccccchhhcccccC-CCCCeEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 999999999999999999998655444443 2356899999999999999999999999999994
|
| >3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-78 Score=579.09 Aligned_cols=346 Identities=28% Similarity=0.435 Sum_probs=298.9
Q ss_pred hhHHhhhhhhhHHHHHHHHhcC--CCC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-hhHH-HHHHHHHHHHh
Q 036497 3 DVLESISEQTDITLSLSKHIKA--PTS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-EQQN-FASELVAIVFA 77 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~~--~~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~-~~~~l~~~l~~ 77 (375)
+..++..++++||++||+++.. ..+ +|||+||+.+|+|+++||+|+|++||.++||++.. .+++ .++.++..+.
T Consensus 7 ~~~~l~~~~~~Fa~~l~~~l~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~l~- 85 (376)
T 3ozq_A 7 TLQEFPNAVNSFTPSVYKEVLKTEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLHFVGDREKAEGAVKEVLSKLT- 85 (376)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHCCSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCHHHHHHHHHHHHHHTB-
T ss_pred hHHHHHHHHhHHHHHHHHHHhhCCCCCEEEcHHHHHHHHHHHHhHCchHHHHHHHHHHCCCCcHHHHHHHHHHHHHHhc-
Confidence 4567889999999999999962 233 99999999999999999999999999999999654 3344 6666665442
Q ss_pred CCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCcc
Q 036497 78 DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDS 157 (375)
Q Consensus 78 ~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~ 157 (375)
.....+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++++++++++
T Consensus 86 ----~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~gkI~~ll~~~~l~~~ 160 (376)
T 3ozq_A 86 ----NEEYTLHTANKIYVKTNFSVREEFQKIAVEVYGAQSENVDFSE-KNDAAKLMNAWVEEQTQHKIQNLVDPEILNNL 160 (376)
T ss_dssp ----CSSCEEEEEEEEEEETTSCCCHHHHHHHHHTTSCEEEEECCSS-HHHHHHHHHHHHHHHTTTCSCCCSCGGGCCTT
T ss_pred ----CCCcEEeeehhHHHhCCCcchHHHHHHHHHhhCCeeEEecCCC-hHHHHHHHHHHHHhhhcCchhhccCcccCCCc
Confidence 2345899999999999999999999999999999999999998 47899999999999999999999988899999
Q ss_pred CeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeeccee-ccccceeeecC--CeEEEEecccC------------
Q 036497 158 SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMT-SKNKQLVTAFD--GFKVLVLPYKQ------------ 222 (375)
Q Consensus 158 t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~-~~~~~~~~~~~--~~~vveLPy~~------------ 222 (375)
|+++|+||+||+|.|+.||++..|+.++||..+|++++||||+ +.+.+.|++.+ ++++++|||++
T Consensus 161 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~vleLPy~~~~sm~iiLP~~~ 240 (376)
T 3ozq_A 161 TRVVLINALYFNAKWLVPFPPFHTRKSDFHKSAKEVVQVDTMYLDEQYFNYYECHHLDAKLLELPFKGGASLTIVLSNQI 240 (376)
T ss_dssp CCEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSCEEEEEEESST
T ss_pred ceEEEEehhhhhhhhccCCCcccceeeeeEecCCcEEEEeehhhccCceeEEEecCCCeEEEEEeCCCCEEEEEEeCCCC
Confidence 9999999999999999999999999999999999999999999 88887777654 79999999997
Q ss_pred CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC--C-Ccccee
Q 036497 223 DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS--H-VGVGIF 299 (375)
Q Consensus 223 ~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~--~-~vs~~~ 299 (375)
.+|.+++++|+. ..+.+ ..+...++|.||||++++++||+++|++||++++|+. .|||++|+++ + +|++++
T Consensus 241 ~~l~~l~~~L~~--~~l~~---~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfs~is~~~~~l~vs~v~ 314 (376)
T 3ozq_A 241 EGLVSLESKIKR--SFLPH---NLTKQLVNVALPKFKIESTVDFKKVLKKLGVKKAFGD-EADLSGIAGEKGDLVISNIV 314 (376)
T ss_dssp TCHHHHHHTHHH--HHSCC---CCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTSSSTTSCCEEEEE
T ss_pred CCHHHHHHHhCH--HHHHh---hCCeeEEEEEcccEEeecccchHHHHHhcCchhhcCC-CCCCccccCCCCCeEEeeeE
Confidence 579999998863 33333 3445567899999999999999999999999999995 8999999985 5 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhh-hccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 300 QKSFIEVKEEGTEAAAASAAVIT-LKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~-~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
||++|||||+||+|||+|++... .++++..++.+|+|||||+|+|+|+ |.|||+|||.+|.
T Consensus 315 hka~ieV~E~GteAaAaT~~~~~~~~s~~~~~p~~f~~drPFlf~I~~~--~~iLF~G~v~~p~ 376 (376)
T 3ozq_A 315 QKSFIDVSEEGVEAAAATYIPVILPEMALPDSPKQFIVDHPFIFYIKVK--GMILFAGRVTTLN 376 (376)
T ss_dssp EEEEEEECSSEESCCCCCCCCC---------CCEEEECCSCEEEEEEET--TEEEEEEEECCCC
T ss_pred eeEEEEECCCCccccccceeeecccccccCCCCceEEeECCEEEEEEEC--CEEEEEEEecCCC
Confidence 99999999999999999986554 5555333346899999999999998 8999999999984
|
| >3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-78 Score=579.22 Aligned_cols=345 Identities=24% Similarity=0.387 Sum_probs=299.3
Q ss_pred hhhhhHHHHHHHHhcCCC--C-eeehHHHHHHHHHHHhcCChhH------HHHHHHhcCCCCh-hhHH-HHHHHHHHHHh
Q 036497 9 SEQTDITLSLSKHIKAPT--S-SSSPLSIHVLLSMIAAGSKGPT------LQQLLSFLKSKSN-EQQN-FASELVAIVFA 77 (375)
Q Consensus 9 ~~~~~f~~~l~~~~~~~~--~-v~SP~si~~~L~~l~~ga~g~T------~~el~~~L~~~~~-~~~~-~~~~l~~~l~~ 77 (375)
+++++||++||+++.... + +|||+||+.+|+|+++||+|+| .+|+.+.|++... ++.+ .++.++..+..
T Consensus 20 ~~~~~Fa~~L~k~l~~~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~~~~~~~~~l~~l~~~~~~~~~~~~~~~ll~~l~~ 99 (397)
T 3pzf_A 20 QRQNEFDLMFVKEIFKNHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQNDNIDHTRSYYKQLLESAQQ 99 (397)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCEEECHHHHHHHHHHHHHHSGGGCC-CCCHHHHHGGGGSSTTCHHHHHHHHHHHHHHHHC
T ss_pred chhhHHHHHHHHHHHhCCCCCEEEchHHHHHHHHHHHhhcCCCCccChHHHHHHHHHcCCCCchHHHHHHHHHHHHHHhc
Confidence 478899999999997422 3 9999999999999999999998 7777777766443 4555 78888877753
Q ss_pred CCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCcc
Q 036497 78 DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDS 157 (375)
Q Consensus 78 ~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~ 157 (375)
..++..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++++.++ +
T Consensus 100 ---~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~~~~~~-~ 174 (397)
T 3pzf_A 100 ---DNKDYDLNIATNFFVDDFIEVINKYQQIANTHYHAMLEKVSYSN-PTQTAATINNWVSEHTNGRLREIVTPDSLE-G 174 (397)
T ss_dssp ---CCSSCEEEEEEEEEEETTCCBCHHHHHHHHHHHCEEEEEECTTS-HHHHHHHHHHHHHHHTTTSCCCCCCGGGGT-T
T ss_pred ---CCCCcEEEEeeeeeEeCCCccchHHHHHHHHHhCCeEEEeCCCC-hHHHHHHHHHHHHHHhCCcccccCCCCCcc-c
Confidence 34567899999999999999999999999999999999999987 688999999999999999999999877787 8
Q ss_pred CeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC-------------
Q 036497 158 SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ------------- 222 (375)
Q Consensus 158 t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~------------- 222 (375)
|+++|+||+||+|.|+.||++..|..++|++.+|++++||||++.+.+.|++.+ ++++++|||++
T Consensus 175 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~~sm~iiLP~~~ 254 (397)
T 3pzf_A 175 AVITLVNVIYFKGLWTYPFPEVANNVKPFYGTRGKPTNAQYMEQNGQFYYDNSADLGAQILRLPYRGNKLAMYFILPNPD 254 (397)
T ss_dssp CSEEEEEEEEEEEEBSSCCCCCSCCEEEECCSSSSCEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEEEECTT
T ss_pred ceeEEeeheecccccCccCCcccccccccccCCCcEEEEEEEEecCCcCeEEccCCCEEEEEEEcCCCceEEEEEECCCC
Confidence 999999999999999999999999999999999999999999999888777644 89999999997
Q ss_pred CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC-----C-Ccc
Q 036497 223 DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS-----H-VGV 296 (375)
Q Consensus 223 ~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-----~-~vs 296 (375)
.+|.+++++|+ ...+.+|....+...++|.||||++++++||+++|++|||+++|++ .|||++|+++ + +|+
T Consensus 255 ~~l~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~~~~~l~vs 331 (397)
T 3pzf_A 255 NTVNQVLDRIN--SASLHQALWYMEENEVNVTLPKFKFDFSEQLNEPLQQVGIREIFSQ-NASLPLLARGRGARDEVRVS 331 (397)
T ss_dssp SCHHHHHHHCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEESHHHHHHTTCCGGGST-TCCCTTTBCC-----CCCCC
T ss_pred CCHHHHHHhhC--HHHHHHHHhhCceEEEEEEcCcEEEEeccChHHHHHhCCchhhcCC-CCCcccccCCCCCCCceEEE
Confidence 57999999996 3556666666666678999999999999999999999999999998 6999999953 3 999
Q ss_pred ceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 297 GIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 297 ~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
+++||++|||||+||||||+|++....++.+.+.+ .|+|||||+|+|+|+.||.|||+|+|.+|+
T Consensus 332 ~v~hka~ieVnE~GteAAAaT~~~~~~~~~~~~~~-~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 396 (397)
T 3pzf_A 332 RIFQKAGITINELGSEAYAATEIQLVNKFGGDGVQ-IFNANRPFIFFIEDETLGTMLFAGKIENPV 396 (397)
T ss_dssp EEEEEEEEEECSSEESCCCCSCC--------CCCE-EEECCSCEEEEEEETTTCCEEEEEEESSCC
T ss_pred eEEEEEEEEECCCccccccccceeeeccccCCCCC-eEEecCCEEEEEEECCCCcEEEEEEecCCc
Confidence 99999999999999999999986554443332223 499999999999999999999999999996
|
| >1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-78 Score=587.64 Aligned_cols=349 Identities=23% Similarity=0.337 Sum_probs=304.1
Q ss_pred HhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHHH
Q 036497 6 ESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIVF 76 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l~ 76 (375)
.+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..+.
T Consensus 26 ~l~~~~~~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~ 105 (401)
T 1qmn_A 26 GLASANVDFAFSLYKQLVLKAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLN 105 (401)
T ss_dssp -CHHHHHHHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTCCTTTCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCEEEecHHHHHHHHHHHhhccCHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHHh
Confidence 56789999999999999643 23 99999999999999999999999999999999743 4667 8888887774
Q ss_pred hCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCc
Q 036497 77 ADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD 156 (375)
Q Consensus 77 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~ 156 (375)
....+..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ ++++
T Consensus 106 ---~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~ 179 (401)
T 1qmn_A 106 ---QSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQD-SAAAKKLINDYVKNGTRGKITDLIK--DLDS 179 (401)
T ss_dssp ---CCSSSCEEEEEEEEEEESSCCCCHHHHHHHHHHHCCEEEEECGGG-HHHHHHHHHHHCSSEEEEEEEECC------C
T ss_pred ---cCCCCceEEEEEEEEeeCCCchHHHHHHHHHHhcCCeEEecCccC-HHHHHHHHHHHHHHHhcCchhhhcc--CCCC
Confidence 234567899999999999999999999999999999999999985 7889999999999999999999996 4999
Q ss_pred cCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceecccc-ceeeecC--CeEEEEecccC-----------
Q 036497 157 SSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNK-QLVTAFD--GFKVLVLPYKQ----------- 222 (375)
Q Consensus 157 ~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~-~~~~~~~--~~~vveLPy~~----------- 222 (375)
+|+++|+||+||+|.|+.||++..|..++||+.+|+.++||||++.+. +.|++.+ ++++|+|||++
T Consensus 180 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~~sm~iiLP~~ 259 (401)
T 1qmn_A 180 QTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQ 259 (401)
T ss_dssp CCCEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSEEEEEEEECT
T ss_pred CceEEEEEeeeeeehhcCCCChhcCccceEEcCCCcEEEeeEEEEcCceEEEEEeCCCceEEEEEecCCCeEEEEEEECC
Confidence 999999999999999999999999999999999999999999999987 8877654 79999999987
Q ss_pred CChHHHHHHccCcHHHHhccCCccceeee-eeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Ccccee
Q 036497 223 DELPALEKKTGSQSGFLKDHIPYEMIEVG-DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIF 299 (375)
Q Consensus 223 ~~l~~l~~~L~~~~~~l~~~~~~~~~~~~-~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~ 299 (375)
.+|.+++++|+ ...+.++....+...+ +|.||||++++++||+++|++|||+++|+. .|||++|++++ +|++++
T Consensus 260 ~~L~~le~~L~--~~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~ 336 (401)
T 1qmn_A 260 DKMEEVEAMLL--PETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTS-KADLSGITGARNLAVSQVV 336 (401)
T ss_dssp TCHHHHHTTCS--HHHHHHHHHSCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHSSSCEEEEEEE
T ss_pred CCHHHHHHHhC--HHHHHHHHHhCcceEcceEeeeeEEEeccccHHHHHHhcCccccccC-cCCcccccCCCCeEEEeee
Confidence 57999999996 3455556555556667 999999999999999999999999999985 89999999864 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 300 QKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
||++|+|||+||+|||+|++....++.+.+++..|+|||||+|+|+|+.||.|||+|+|.+|..
T Consensus 337 hka~ieVnE~GteAaAaT~~~~~~~s~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 400 (401)
T 1qmn_A 337 HKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQ 400 (401)
T ss_dssp EEEEEEECSSEEESSCCCC-----CCCCCCCSCEEECCSCEEEEEEETTSSCCSEEEEESCTTC
T ss_pred eEEEEEeCCCccccccccchhhccccCCCCCCceEEecCCEEEEEEECCCCcEEEEEEcCCCCC
Confidence 9999999999999999998655555554333478999999999999999999999999999963
|
| >3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-77 Score=577.83 Aligned_cols=345 Identities=22% Similarity=0.388 Sum_probs=297.0
Q ss_pred hHHhhhhh-hhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHH
Q 036497 4 VLESISEQ-TDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVA 73 (375)
Q Consensus 4 ~~~~~~~~-~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~ 73 (375)
...+..++ ++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++.
T Consensus 26 ~~~l~~~~~~~Fa~~L~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~i~~~~~~l~~ 105 (395)
T 3b9f_I 26 GATVAPSSRRDFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQ 105 (395)
T ss_dssp ----------CHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTC----CCHHHHHHHHHHHHH
T ss_pred HHHHHHhhHHHHHHHHHHHHhccCCCCCEEEcHHHHHHHHHHHHHHcccHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 34566788 99999999999642 23 99999999999999999999999999999999742 4566 8888887
Q ss_pred HHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCC
Q 036497 74 IVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGS 153 (375)
Q Consensus 74 ~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~ 153 (375)
.+. .+..+..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +
T Consensus 106 ~l~---~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~ 179 (395)
T 3b9f_I 106 ELN---QPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRD-SAGAMKQINDYVAKQTKGKIVDLLK--N 179 (395)
T ss_dssp HTT---SCCTTCCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCCCCS--C
T ss_pred HHh---CCCCCceeEEEEEEEEECCCccchHHHHHHHHHhCCEeEEcCCCC-HHHHHHHHHHHHHHHhCCchhhhcc--C
Confidence 664 234567899999999999999999999999999999999999975 7889999999999999999999996 4
Q ss_pred CCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC---------
Q 036497 154 VDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ--------- 222 (375)
Q Consensus 154 ~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~--------- 222 (375)
++++|+++|+||+||+|.|+.||++..|..++|++.+|++++||||++.+.+.|++.+ ++++|+|||++
T Consensus 180 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~~sm~iiLP 259 (395)
T 3b9f_I 180 LDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNATALFILP 259 (395)
T ss_dssp CCTTCSEEEEEEEEECCCEEECCCTTTCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSCEEEEEEE
T ss_pred CCCCceEEEEEhheeeccccCCCChhhCeeeEEEeCCCeEEEEEEEEeeeeEeEEEECCCCeEEEEEecCCCeeEEEEEe
Confidence 9999999999999999999999999999999999999999999999999877776644 89999999987
Q ss_pred --CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccce
Q 036497 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGI 298 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~ 298 (375)
.+|.+++++|+ ...+.++....+...++|.||||++++++||+++|++||++++|+. .|||++|++++ +|+++
T Consensus 260 ~~~~L~~le~~L~--~~~l~~~~~~l~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v 336 (395)
T 3b9f_I 260 SEGKMQQVENGLS--EKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTS-HADLSGISNHSNIQVSEM 336 (395)
T ss_dssp CTTCHHHHHHHCS--HHHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTGGGGTCCGGGST-TCCCTTTBSCSSCCCSEE
T ss_pred CCCCHHHHHHHhC--HHHHHHHHHhcceeEEEEEeeEEEEEEeecHHHHHHHcCCccccCC-CCCcccCcCCCCeeeecc
Confidence 57999999996 3455556555555667999999999999999999999999999986 89999999854 99999
Q ss_pred eeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 299 FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 299 ~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
+||++|+|||+||+|||+|++....++++ +.+..|+|||||+|+|+| |.|||+|+|.+|
T Consensus 337 ~hka~ieVnE~GteAaAaT~~~~~~~~~~-~~~~~f~~drPFlf~I~~---~~iLF~G~v~~P 395 (395)
T 3b9f_I 337 VHKAVVEVDESGTRAAAATGTIFTFRSAR-LNSQRLVFNRPFLMFIVD---NNILFLGKVNRP 395 (395)
T ss_dssp EEEEEEEECSCEEECCCSCSCSSBCCSCC-CCCEEEECCSCEEEEEES---SSEEEEEEESCC
T ss_pred ceEEEEEEcCCCcccccccchhhhhccCC-CCCCEEEEeCCEEEEEEc---CCEEEEEEeCCC
Confidence 99999999999999999998655444442 235789999999999998 899999999998
|
| >2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-77 Score=576.71 Aligned_cols=344 Identities=24% Similarity=0.386 Sum_probs=302.7
Q ss_pred HhhhhhhhHHHHHHHHhcCCC-C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-hhHH-HHHHHHHHHHhCCCC
Q 036497 6 ESISEQTDITLSLSKHIKAPT-S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-EQQN-FASELVAIVFADGSA 81 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~~-~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~-~~~~l~~~l~~~~~~ 81 (375)
++..++++||++||+++.... + ++||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..+..
T Consensus 8 ~~~~~~~~Fa~~L~~~l~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~l~~~l~~---- 83 (373)
T 2pef_A 8 KFIYNTADFSIELFKNSIDDKENSLISPLSAMLALAMTANGADNETLAQMEKALGKDISIEDLNKYLYTYMKKLPN---- 83 (373)
T ss_dssp HHHHHHHHHHHHHHHTSCCSSSCCEECHHHHHHHHHHHHTTCCHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHSCC----
T ss_pred HHHHHHHHHHHHHHHHhhCCCCCEEEccHHHHHHHHHHHhhccChHHHHHHHHhCCCCCHHHHHHHHHHHHHHhhc----
Confidence 466789999999999996543 3 99999999999999999999999999999998643 5677 88888876631
Q ss_pred CCCCeEEEEEeeeec-CCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCee
Q 036497 82 NGGPRLSVANGVWID-QSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKL 160 (375)
Q Consensus 82 ~~~~~l~~an~l~~~-~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~l 160 (375)
..+..+.++|+||++ +++.++++|++.++++|+++++.+||. +.+++.||+||+++|+|+|+++++ +++++|++
T Consensus 84 ~~~~~l~~an~l~~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~---~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~l 158 (373)
T 2pef_A 84 EEKSKLTIANSIWFKENDFMPSKDFLQIIADYYKADIFKAAFD---SSTVSDINNWVKSKTNGMIDKILN--KIDPEDVM 158 (373)
T ss_dssp BTTEEEEEEEEEEEETTTEEECHHHHHHHHHHHCCEEEEECCS---HHHHHHHHHHHHHHTTTSCCCSCS--CCCTTCCE
T ss_pred CCCcEEEEEEEEEEecCCCchhHHHHHHHHHHhCCeeEecCch---HHHHHHHHHHHHHhccCchhhhhc--cCCCCceE
Confidence 345789999999999 799999999999999999999999997 478999999999999999999995 69999999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecCCeEEEEecccC-------------CChHH
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-------------DELPA 227 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLPy~~-------------~~l~~ 227 (375)
+|+||+||+|.|+.||++..|..++||..+|++++||||++.+.+ |.+..++++++|||++ .+|.+
T Consensus 159 vLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-y~~~~~~~vleLPy~~~~~sm~iiLP~~~~~L~~ 237 (373)
T 2pef_A 159 YLINAVAFDAEWETVYEKASVHEDIFTDVYGNRQKVEFMNSEENL-YIEEENAVGFVKPYAKNHYSFVAILPDENISVNE 237 (373)
T ss_dssp EEEEEEEEEEEBSSCCCGGGEEEEEEECTTSCEEEEEEEEEEEEE-EEEETTEEEEEEEBGGGSEEEEEEEECTTSCHHH
T ss_pred EEEEeeeeeccccccCChhhccccceecCCCeEEEechhhccCeE-EeecCCeEEEEEecCCCcEEEEEEECCCCCCHHH
Confidence 999999999999999999999999999999999999999999877 7778899999999997 57999
Q ss_pred HHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC---C-CccceeeeeE
Q 036497 228 LEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS---H-VGVGIFQKSF 303 (375)
Q Consensus 228 l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~---~-~vs~~~qk~~ 303 (375)
++++|+. ..+..++...+...++|.||||++++++||+++|++||++++|++..|||++|+++ + +|++++||+.
T Consensus 238 l~~~L~~--~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~~~l~vs~v~hka~ 315 (373)
T 2pef_A 238 YIKTLTG--QKFIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDAFLPDKADFSKLGKSDIGNLYISEVLHKTF 315 (373)
T ss_dssp HHHHCCH--HHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTEEETTSCCCCCCEEEEEE
T ss_pred HHhhhhh--hHHHHHHhhceeeEEEEECceEEeecccchHHHHHhcCCccccCCCcCchhhcccCCCCCeEEcchhheeE
Confidence 9999963 44555555555666799999999999999999999999999999658999999874 5 9999999999
Q ss_pred EEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 304 IEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 304 iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
|+|||+||+|||+|++....++.+ +.+.+|+|||||+|+|+|+.||.|||+|+|.+|.
T Consensus 316 ieVnE~GteAaAaT~~~~~~~~~~-~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~p~ 373 (373)
T 2pef_A 316 ISVDELGTKAGAVTSVDITAAGIP-VNFKTVKLNRPFIFAIIDNSTNLPIFIGTVLSLK 373 (373)
T ss_dssp EEECSSEEEEEEEEEESCC--------CCSEEEEEEEEEEEEETTTTEEEEEEEEEEEC
T ss_pred EEECCCccccccccchhhccccCC-CCCCeEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 999999999999998655444442 2346899999999999999999999999999984
|
| >1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-77 Score=581.74 Aligned_cols=345 Identities=24% Similarity=0.361 Sum_probs=307.4
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC-C---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC---------hhhHH-HH
Q 036497 4 VLESISEQTDITLSLSKHIKAP-T---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS---------NEQQN-FA 68 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~-~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~---------~~~~~-~~ 68 (375)
...+..++++||++||+++... . + +|||+||+.+|+|+++||+|+|++||.++||++. .++++ .+
T Consensus 104 ~~~l~~~~~~Fa~~L~k~l~~~~~~~~NivfSP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~~~~~~~~~~~i~~~f 183 (480)
T 1jmo_A 104 IQRLNILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYEITTIHNLF 183 (480)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhccCCCCCEEEcHHHHHHHHHHHHHhcCcHHHHHHHHHhCCCccccccccCCHHHHHHHH
Confidence 4567788999999999999763 2 3 9999999999999999999999999999999874 24667 88
Q ss_pred HHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhccccccc
Q 036497 69 SELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEV 148 (375)
Q Consensus 69 ~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~ 148 (375)
+.++..+.. ...+..+.++|+||+++++.++++|++.++++|+++++.+||.+. .. ++.||+||+++|+|+|+++
T Consensus 184 ~~ll~~l~~---~~~~~~L~~AN~lfv~~~~~l~~~F~~~~~~~y~a~~~~vDF~~~-~~-~~~IN~WV~~~T~gkI~~l 258 (480)
T 1jmo_A 184 RKLTHRLFR---RNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDP-AF-ISKTNNHIMKLTKGLIKDA 258 (480)
T ss_dssp HHHHHHHHS---SCSSSEEEEEEEEEEETTSCCCHHHHHHHHHHHSCCEEEECTTCH-HH-HHHHHHHHHHHTTTSSCCT
T ss_pred HHHHHHhhc---CCCCceEEEEEEEeecCCCcccHHHHHHHHHhhccceeeecccCH-HH-HHHHHHHHHHhhCCChhhh
Confidence 888887753 345678999999999999999999999999999999999999874 45 8999999999999999999
Q ss_pred CCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC----
Q 036497 149 LPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ---- 222 (375)
Q Consensus 149 l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~---- 222 (375)
+ ++++++|+++|+||+||+|.|+.||++..|..++||+.+|++++||||++.+.+.|++.+ ++++|+|||++
T Consensus 259 l--~~l~~~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~~SM 336 (480)
T 1jmo_A 259 L--ENIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGGISM 336 (480)
T ss_dssp T--CSCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEEE
T ss_pred h--cccCCCCeEEEEehHeeeccccCCCCCCCceeEEEEeCCCcEEEEEEEEEecceeeEEeCCCceEEEEEecCCcEEE
Confidence 9 589999999999999999999999999999999999999999999999999888777655 69999999976
Q ss_pred --------CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-
Q 036497 223 --------DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH- 293 (375)
Q Consensus 223 --------~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~- 293 (375)
.+|.+++++|+ ...+.++....+...++|.||||++++++||+++|++|||+++|+. .|||++|++.+
T Consensus 337 ~IiLP~~~~~L~~le~~L~--~~~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~LGi~~~F~~-~ADfsgis~~~L 413 (480)
T 1jmo_A 337 LIVVPHKMSGMKTLEAQLT--PRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDK-NGNMAGISDQRI 413 (480)
T ss_dssp EEEEESSGGGHHHHHHHCC--HHHHHHHHHHCEEEEEEEEEECEEEECCEECHHHHHHHTCCGGGST-TSCCTTTCSSCC
T ss_pred EEEecCCCCCHHHHHHhhC--HHHHHHHHhcccceEEEEEeccEEEEEeecHHHHHHhCCccccccC-CCCcCcccCCCc
Confidence 57999999997 3455566555555667999999999999999999999999999975 89999999855
Q ss_pred CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 294 VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 294 ~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
+|++++||++|+|||+||+|||+|++....++.+ ..|+|||||+|+|+|+.||.|||+|+|.+|+
T Consensus 414 ~VS~v~HKa~IeVnEeGtEAAAaT~v~~~~~s~~----~~F~aDrPFlF~I~d~~t~~iLF~G~v~~P~ 478 (480)
T 1jmo_A 414 AIDLFKHQGTITVNEEGTQATTVTTVGFMPLSTQ----VRFTVDRPFLFLIYEHRTSCLLFMGRVANPS 478 (480)
T ss_dssp CEEEEEEEEEEEECSCBSCCCCCCCCSEEECSCC----CEEECCSCEEEEEEETTTTEEEEEEEESCTT
T ss_pred eecchheeEEEEccCCccccccccccccccccCC----CcEEecCCEEEEEEECCCCcEEEEEEeCCCC
Confidence 9999999999999999999999998655444432 2899999999999999999999999999996
|
| >2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-77 Score=572.58 Aligned_cols=343 Identities=19% Similarity=0.305 Sum_probs=282.4
Q ss_pred hhHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHH
Q 036497 3 DVLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVA 73 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~ 73 (375)
+..++..++++||++||+++... .+ +|||+||+.+|+|+++|| |++||.++||++.. ++++ .++.++.
T Consensus 5 ~~~~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA---T~~el~~~L~~~~~~~~~~~~~~~~~~l~~ 81 (371)
T 2v95_A 5 SHRGLAPTNVDFAFNLYQRLVALNPDKNTLISPVSISMALAMVSLGS---AQTQSLQSLGFNLTETSEAEIHQSFQYLNY 81 (371)
T ss_dssp GGGTTHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHTTTC-----CHHHHHHTCCTTTSCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHhccCCCCcEEEchHHHHHHHHHHHHHH---HHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 34567789999999999999642 23 999999999999999999 99999999999742 4677 8888887
Q ss_pred HHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCC
Q 036497 74 IVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGS 153 (375)
Q Consensus 74 ~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~ 153 (375)
.+.. +.++..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +
T Consensus 82 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~~--~ 155 (371)
T 2v95_A 82 LLKQ---SDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDFED-WTKASQQINQHVKDKTQGKIEHVFS--D 155 (371)
T ss_dssp HHTT---GGGSEEEEEEEEEEECTTCCBCHHHHHHHHHHSCCEEEECCCSS-HHHHHHHHHHHHHHHTTTCCCCSCC--C
T ss_pred HHhC---CCCCcEEEEEEEEeEeCCCchhHHHHHHHHHHhCCceEEecCcc-HHHHHHHHHHHHHHHhcCchhhhcc--C
Confidence 7742 23457899999999999999999999999999999999999985 7889999999999999999999995 5
Q ss_pred CCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC---------
Q 036497 154 VDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ--------- 222 (375)
Q Consensus 154 ~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~--------- 222 (375)
++++|+++|+||+||+|.|++||++..|.+++||+.+|+.++||||++.+.+.|++.+ ++++++|||++
T Consensus 156 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~sm~iiLP 235 (371)
T 2v95_A 156 LDSPASFILVNYIFLRGIWELPFSPENTREEDFYVNETSTVKVPMMVQSGSIGYFRDSVFPCQLIQMDYVGNGTAFFILP 235 (371)
T ss_dssp --CCCSEEEEEEEEEEECBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSEEEEEEEE
T ss_pred CCCCceEEEEEHHhhhhhhhCcCCCcccceeEEEECCCeEEEEEEEEeeeeEeeEEeCCCCEEEEEEecCCCeEEEEEec
Confidence 9999999999999999999999999999999999999999999999999887777654 79999999997
Q ss_pred --CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccce
Q 036497 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGI 298 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~ 298 (375)
.+|.+++++|+. ..+..+....+...++|.||||++++++||+++|++||++++|+. .|||++|++++ +|+ +
T Consensus 236 ~~~~l~~le~~L~~--~~l~~~~~~l~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs-v 311 (371)
T 2v95_A 236 DQGQMDTVIAALSR--DTIDRWGKLMTPRQVNLYIPKFSMSDTYDLKDVLEDLNIKDLLTN-QSDFSGNTKDVPLTLT-M 311 (371)
T ss_dssp CTTCHHHHHHHCSH--HHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTSCSCCHHHHBCC-------------CCEE-E
T ss_pred CCCCHHHHHHHhCH--HHHHHHHHhhhcccceEeeeEEEeecccchHHHHHhcCCccccCC-CCCcCCCCCCCCeeEE-E
Confidence 469999999973 445555554555667999999999999999999999999999995 89999999865 999 9
Q ss_pred eeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 299 FQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 299 ~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
+||++|||||+||+|||+|++....++. +..|+|||||+|+|+|+.||.|||+|||.+|.
T Consensus 312 ~hka~ieVnE~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 371 (371)
T 2v95_A 312 VHKAMLQLDEGNVLPNSTNGAPLHLRSE----PLDIKFNKPFILLLFDKFTWSSLMMSQVVNPA 371 (371)
T ss_dssp EEEEEEEESCCCCC----------CCCC----CEEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred EEEEEEEecCCcccccccccccccccCC----CcEEEeeCCEEEEEEECCCCcEEEEEEecCCC
Confidence 9999999999999999999865444332 46899999999999999999999999999994
|
| >1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-76 Score=570.17 Aligned_cols=342 Identities=21% Similarity=0.272 Sum_probs=297.0
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh--hhHH-HHHHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN--EQQN-FASELVAIVF 76 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--~~~~-~~~~l~~~l~ 76 (375)
...+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. .+++ .++.++..+.
T Consensus 31 ~~~l~~~~~~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l~ 110 (398)
T 1imv_A 31 VNKLAAAVSNFGYDLYRVRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISSPDIHGTYKELLDTVT 110 (398)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGCCCSCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHccCCCCCEEEChHHHHHHHHHHHHhcccHHHHHHHHHhCCCCCCcHHHHHHHHHHHHHhh
Confidence 4567789999999999999642 23 99999999999999999999999999999999743 3677 8888887774
Q ss_pred hCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCc
Q 036497 77 ADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD 156 (375)
Q Consensus 77 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~ 156 (375)
. .+..+.++|+||+++++.++++|++.++++|+++++.+| .+ ++.+++.||+||+++|+|+|+++++ ++++
T Consensus 111 ~-----~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vd-~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~ 181 (398)
T 1imv_A 111 A-----PQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLT-GN-PRLDLQEINNWVQAQMKGKLARSTK--EIPD 181 (398)
T ss_dssp S-----TTSCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECC-SC-HHHHHHHHHHHHHHHTTTCSCCCCS--CCCS
T ss_pred C-----CCCCeEEEEEEeecCCCcHHHHHHHHHHHHhCCcceecC-CC-HHHHHHHHHHHHHHhhcCchhhhhh--ccCC
Confidence 2 234577999999999999999999999999999999999 65 7899999999999999999999995 6999
Q ss_pred cCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceecc-ccceeeec--CCeEEEEecccC-----------
Q 036497 157 SSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSK-NKQLVTAF--DGFKVLVLPYKQ----------- 222 (375)
Q Consensus 157 ~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~-~~~~~~~~--~~~~vveLPy~~----------- 222 (375)
+|+++|+||+||+|.|+.||++..|..++|++.+|++++||||++. +.+.|++. .++++|+|||++
T Consensus 182 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~f~~~~~~~l~~~vleLPY~~~~sm~iiLP~~ 261 (398)
T 1imv_A 182 EISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGSMSIIFFLPLK 261 (398)
T ss_dssp SCSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEEEEEEEESS
T ss_pred CceEEEEEhhhhhhhhcCcCChhhCeeeEEEeCCCEEEEEEEEEEecceeEEEEecCCCeEEEEEccCCCeEEEEEEeCC
Confidence 9999999999999999999999999999999999999999999999 87777654 489999999986
Q ss_pred --CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-Ccccee
Q 036497 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIF 299 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~ 299 (375)
.+|.+++++|+ ...+.++....+...++|.||||++++++||+++|++|||+++| . .|||++|++.+ +|++++
T Consensus 262 ~~~~L~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F-~-~Adfsgis~~~l~vs~v~ 337 (398)
T 1imv_A 262 VTQNLTLIEESLT--SEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLF-D-SPDFSKITGKPIKLTQVE 337 (398)
T ss_dssp CCSCCHHHHTTCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHTTTTTHHH-H-SCCCTTTCSSCCCEEEEE
T ss_pred CCCCHHHHHHHhC--HHHHHHHHHhcceeEEEEEeeeEEEEeEEchhHhhhhcChhhcc-c-ccCCCCCcCCCEEEEEEE
Confidence 46889999986 34555665555566779999999999999999999999999999 5 79999999866 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 300 QKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
||++|+|||+||+|||+|++....+ ..+..|+|||||+|+|+|+.||.|||+|+|.+|.
T Consensus 338 hka~ieVnE~GteAaAaT~~~~~~~----~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 396 (398)
T 1imv_A 338 HRAGFEWNEDGAGTTPSPGLQPAHL----TFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPR 396 (398)
T ss_dssp EEEEEEECSCEEECC--------CC----CCCCEEECCSCEEEEEEETTTCCEEEEEEESCTT
T ss_pred EEEEEEecCCccccccccccccccC----CCCceEEccCCEEEEEEECCCCeEEEEEEeCCCC
Confidence 9999999999999999998544321 1246899999999999999999999999999996
|
| >2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-75 Score=572.55 Aligned_cols=348 Identities=18% Similarity=0.202 Sum_probs=295.6
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC----CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----------hhHH-H
Q 036497 4 VLESISEQTDITLSLSKHIKAP----TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----------EQQN-F 67 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~----~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----------~~~~-~ 67 (375)
...+..++++||++||+++... +- +|||+||+.+|+|+++||+|+|++||.++||++.. .+++ .
T Consensus 70 ~~~l~~~~~~Fa~~L~~~l~~~~~~~Ni~v~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~ 149 (453)
T 2wxy_C 70 AAQVAMITNFVGFRMYKMLNEAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVKEGDCTSRLDGHKVLAA 149 (453)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCCCSSEEEECHHHHHHHHHHHHHTCCTTHHHHHHHHTTCCCCTTCGGGSBCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhcCCCCcEEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCcccccccccccHHHHHHH
Confidence 3456789999999999999752 22 69999999999999999999999999999999753 2355 7
Q ss_pred HHHHHHHHHhCC--CCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCe-eeEeeCCCChHHHHHHHHHHHHHHhccc
Q 036497 68 ASELVAIVFADG--SANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS-SHQVDFQNKAVEVSREINFWAEKETNGF 144 (375)
Q Consensus 68 ~~~l~~~l~~~~--~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~-~~~~dF~~~~~~~~~~IN~wv~~~T~g~ 144 (375)
++.+...+.... .+.....+.++|+||+++++.++++|++.++++|++. ++.+||..+++.+++.||+||+++|+|+
T Consensus 150 ~~~l~~~l~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~~~~~a~~~IN~WV~~~T~gk 229 (453)
T 2wxy_C 150 LRAVQGLLVTQGGSSSQTPLLQSIVVGLFTAPGFRLKHSFVQSLALFTPALFPRSLDLSTDPVLATEKINRFIKAVTGWK 229 (453)
T ss_dssp HHHHHHHHHC--------CEEEEEEEEEEECTTCCEEHHHHHHHHTTCSCEEEEECCCSSCHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHhhccccCCCCccEEEEEEeEeEeCCCCccHHHHHHHHHHcCCCceeeecccCCHHHHHHHHHHHHHHhcCCc
Confidence 777777665311 1223457999999999999999999999999999996 9999995457899999999999999999
Q ss_pred ccccCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC
Q 036497 145 IKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ 222 (375)
Q Consensus 145 i~~~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~ 222 (375)
|+++++ +++++|+++|+||+||+|.|+.+|++.. .++||+.+|++++||||++.+.+.|++.+ ++++++|||++
T Consensus 230 I~~ll~--~l~~~t~lvLvNaiyFKg~W~~~F~~~~--~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~ 305 (453)
T 2wxy_C 230 MNLPLE--GVSTDSTLLFNTYVHFQGTMRGFSQLPG--VHEFWVDNSISVSVPMISGTGNFQHWSDAQNNFSVTCVPLGE 305 (453)
T ss_dssp CCCCCC--CCCTTCCEEEEEEEEEEEEEEEEEECSS--CEEEEEETTEEEEECEEEEEEEEEEEEETTTTEEEEEEESSS
T ss_pred hhhhhc--ccCCCCeEEEEehheeeccCCCCCCCcc--CCCcEeCCCeEEEEEEEEEeCCCCEEEecCCCcEEEEEECCC
Confidence 999995 5999999999999999999999999987 79999999999999999999888777654 89999999987
Q ss_pred ------------CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCc
Q 036497 223 ------------DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMV 290 (375)
Q Consensus 223 ------------~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is 290 (375)
.+|.+++++|+. ..+..++...+...++|.||||++++++||+++|++|||+++|+. .|||++|+
T Consensus 306 ~~sm~iiLP~~~~~L~~le~~L~~--~~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~lGi~~~F~~-~Adfsgis 382 (453)
T 2wxy_C 306 RATLLLIQPHCISDLDRVEALIFQ--NDLLTWIENPPPRAIRLTLPQLEIRGSYNLQDLLAEDKLPTLLGA-EANLNNIG 382 (453)
T ss_dssp SEEEEEEEESSGGGHHHHHHHHTC---CCCTTCCCCCCEEEEEEEECEEEEEEEEHHHHHHHTTCTTTTST-TCCCTTTB
T ss_pred CEEEEEEecCCCCCHHHHHHHhCH--HHHHHHHHhccccccEEecceEEEeccccHHHHHHhcChhhhhcc-cCCccccc
Confidence 479999999974 234556655556667999999999999999999999999999985 89999999
Q ss_pred CCC-CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 291 DSH-VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 291 ~~~-~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
+++ +|++++||++|+|||+||+|||+|+.. . +. +.+..|+|||||+|+|+|+.||.|||+|+|.+|..
T Consensus 383 ~~~l~Vs~v~hka~ieVnEeGteAaAaT~~~-~--~~--~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~P~~ 451 (453)
T 2wxy_C 383 DTNPRVGEVLNSILLELKAGEEEQPTTSVQQ-P--GS--PEALDVTLSSPFLFAIYEQDSGTLHFLGRVNNPQS 451 (453)
T ss_dssp SSCCCBCCCEEEEEEEEEEEECCCC---------------CCEEEECCSCEEEEEEETTTCCEEEEEEESCCC-
T ss_pred CCCceeeEEEEEEEEEecCCCcccccccccc-c--cC--CCCceEEeeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 988 999999999999999999999999742 2 11 23568999999999999999999999999999964
|
| >1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-75 Score=557.32 Aligned_cols=341 Identities=21% Similarity=0.341 Sum_probs=284.6
Q ss_pred HhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCC
Q 036497 6 ESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGS 80 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~ 80 (375)
.+..++++||++||+++...+ + +|||+||+.+|+|+++||+|+|++||.++|| ++++ .++.+ ..+.
T Consensus 9 ~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~----~~~~~~~~~l-~~l~---- 79 (370)
T 1sng_A 9 FLRDDHLEFALHLHRRLAEAVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLG----TDPAPLLAAL-DRAV---- 79 (370)
T ss_dssp CCCHHHHHHHHHHHHHHHHTSTTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHT----SCHHHHHHHH-HHTT----
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHHH----HHHHHHHHHH-HHHh----
Confidence 456789999999999997532 3 9999999999999999999999999999999 4566 77877 5552
Q ss_pred CCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCee
Q 036497 81 ANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKL 160 (375)
Q Consensus 81 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~l 160 (375)
..+..+.++|+||+++++.++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++|++
T Consensus 80 -~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~l~~~~~l~~~t~l 158 (370)
T 1sng_A 80 -TDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVTPDLRA 158 (370)
T ss_dssp -TTCTTEEEEEEEEEETTSCCCHHHHHHHHTSTTEEEEEECTTTCHHHHHHHHHHHHHHHTTTSSCCSSCTTSCCTTCCE
T ss_pred -CCCceEEEeeeeeeeCCCcccHHHHHHHHhhhCCeEEEecCcCCHHHHHHHHHHHHHHHhcCchhhccCccccCCcccE
Confidence 3456799999999999999999999999999999999999986688999999999999999999999998899999999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC---------CChHHHH
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ---------DELPALE 229 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~---------~~l~~l~ 229 (375)
+|+||+||+|.|+.||++..|..++|| .+|+.++||||++.+.+.|++.+ ++++|+| -.+ .+|.+++
T Consensus 159 vLvNaiyFkg~W~~~F~~~~T~~~~F~-~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleL-~~~~sm~iiLP~~~L~~l~ 236 (370)
T 1sng_A 159 ILTNALWAKARWTTPFEAHLTRAGTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHA-HDELAVDVLLPPGTNAAAV 236 (370)
T ss_dssp EEEEEEEEECCBSSCCCGGGCEEEEEE-ETTEEEEEEEEEEEEEEEEEEETTEEEEEEEB-STTCEEEEEECCGGGTTCC
T ss_pred EEEEEEEEccccccCCCcccCeeeeEe-cCCeEEEeEEEEEeeeeeeEEeCCCCEEEEEE-CCCEEEEEEecCCCHHHHh
Confidence 999999999999999999999999999 99999999999999888887766 5677888 221 2455554
Q ss_pred HHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-CccceeeeeEEEEcC
Q 036497 230 KKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQKSFIEVKE 308 (375)
Q Consensus 230 ~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~qk~~iev~E 308 (375)
+ ....+.++....+...++|.||||++++++||+++|++||++++|+. .|||++|++++ +|++++||++|+|||
T Consensus 237 ~----~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~l~vs~v~hka~ieV~E 311 (370)
T 1sng_A 237 P----TAPLLTALHRRSASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTA-SADLSGISTVPLYVDTVIHQARLRVDE 311 (370)
T ss_dssp C----CHHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TCCCTTTCSSCCCCCEEEEEEEEEECS
T ss_pred h----CHHHHHHHHHhCcceeEEEEcceEEEecccchHHHHHhcCcchhcCC-ccCcccCCCCCeEEEEEEEEEEEEEcC
Confidence 4 34556666555566677999999999999999999999999999995 89999999888 999999999999999
Q ss_pred CcccchhhhhhhhhhccCC-CCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcchhh
Q 036497 309 EGTEAAAASAAVITLKSLP-RFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSIIN 365 (375)
Q Consensus 309 ~G~~aaa~t~~~~~~~~~~-~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~~~ 365 (375)
+||+|||+|++....++.+ .+.+.+|+|||||+|+|+|+ |.|||+|+|.+|...+
T Consensus 312 ~GteAaAaT~~~~~~~~~~~~~~~~~f~~drPFlf~I~~~--~~iLF~G~v~~P~~~~ 367 (370)
T 1sng_A 312 RGAEGAAATAAMMLLAGAMPPRRTIRFSVDRPFHIVVRRR--GAILFLGSIADPHDPG 367 (370)
T ss_dssp CC--------------------CCEEEECCSCEEEEEEET--TEEEEEEEESSCCCCC
T ss_pred CCcccccccchhhccccccCCCCCCEEEeeCCEEEEEEEC--CEEEEEEEcCCCCCCC
Confidence 9999999998655555543 12357899999999999998 8999999999997643
|
| >2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-75 Score=569.66 Aligned_cols=346 Identities=14% Similarity=0.145 Sum_probs=294.2
Q ss_pred hHHhhhhhhhHHHHHHHHhcCCC----C--eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----------hhHH-
Q 036497 4 VLESISEQTDITLSLSKHIKAPT----S--SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----------EQQN- 66 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~~----~--v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----------~~~~- 66 (375)
...+..++++||++||+++.... - +|||+||+.+|+|+++||+|+|++||.++||++.. .+++
T Consensus 71 ~~~l~~~~~~Fa~~L~k~l~~~~~~~Nin~v~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~ 150 (453)
T 2wxw_A 71 AAMVGMLANFLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNCTSRLDAHKVLS 150 (453)
T ss_dssp HHHHHHHHHHHHHHHGGGCSCTTTSCSBSSEECHHHHHHHHHHHHHSCCTTHHHHHHHHHTCCCCTTCTTTSBCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhcCCCCCcCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCccccccccccHHHHHH
Confidence 34567899999999999997632 2 69999999999999999999999999999999753 2355
Q ss_pred HHHHHHHHHHhCC--CCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCe-eeEeeCCCChHHHHHHHHHHHHHHhcc
Q 036497 67 FASELVAIVFADG--SANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKAS-SHQVDFQNKAVEVSREINFWAEKETNG 143 (375)
Q Consensus 67 ~~~~l~~~l~~~~--~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~-~~~~dF~~~~~~~~~~IN~wv~~~T~g 143 (375)
.++.+...+.... .+.....+.++|+||+++++.++++|++.++++|++. ++.+||.+ ++.+++.||+||+++|+|
T Consensus 151 ~~~~l~~~l~~~~~~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~-~~~a~~~IN~WV~~~T~g 229 (453)
T 2wxw_A 151 ALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDFTE-LDVAAEKIDRFMQAVTGW 229 (453)
T ss_dssp HHHHHHHHHSCCTTTCSCCCEEEEEEEEEECCTTCCEEHHHHHHHHHHCSCEEECBCCTTS-HHHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhhcccccCCCccEEEEEEeEeEECCCccCHHHHHHHHHHhCccceeeeCCCC-HHHHHHHHHHHHHHHhcC
Confidence 7777777664311 1223457999999999999999999999999999995 99999965 789999999999999999
Q ss_pred cccccCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEeccc
Q 036497 144 FIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYK 221 (375)
Q Consensus 144 ~i~~~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~ 221 (375)
+|+++++ +++++|+++|+||+||+|.|+.+|++.. .++||+.+|++++||||++.+.+.|++.+ ++++++|||+
T Consensus 230 kI~~ll~--~l~~~t~lvLvNaiyFKg~W~~~F~~~~--~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~ 305 (453)
T 2wxw_A 230 KTGCSLM--GASVDSTLAFNTYVHFQGKMKGFSLLAE--PQEFWVDNSTSVSVPMLSGMGTFQHWSDIQDNFSVTQVPFT 305 (453)
T ss_dssp CCSCSST--TCCSSCCCEEEEEEEEEEEETTEEECSS--CCCBCSSSSCCBCCCCEEEEEEEEEECCTTTTEEEEECCBT
T ss_pred chhhhhc--CcCCCCeEEEEehhEEeccCCCCCCccc--CCCcEeCCCEEEEEEEEEEecccceEEecCCCeEEEEEecC
Confidence 9999996 5999999999999999999999999987 79999999999999999999888877654 8999999998
Q ss_pred C------------CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCC
Q 036497 222 Q------------DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEM 289 (375)
Q Consensus 222 ~------------~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~i 289 (375)
+ .+|.+++++|+.. .+..|+...+...++|.||||++++++||+++|++|||+++|+. .|||++|
T Consensus 306 ~~~sm~iiLP~~~~~L~~le~~L~~~--~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~lGi~~~F~~-~Adfsgi 382 (453)
T 2wxw_A 306 ESACLLLIQPHYASDLDKVEGLTFQQ--NSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLLAQAELPAILHT-ELNLQKL 382 (453)
T ss_dssp TTEEEEEEEESSCSCHHHHHHTTSCT--THHHHCCCCCEEEEEEEECCCEEEEEEEHHHHSCTTSCHHHHHS-SSCCCSS
T ss_pred CcEEEEEEeCCCCCCHHHHHHHhCHH--HHHHHHHhcccccceEecceEEecccccHHHHHHhcCchhhcCC-CCCCCcc
Confidence 7 4899999999753 45566666666677999999999999999999999999999985 8999999
Q ss_pred cCCC-CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 290 VDSH-VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 290 s~~~-~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
++++ +|++++||++|+|||+||+|||+|... +. +.+..|++||||+|+|+|+.||.|||+|||.+|..
T Consensus 383 s~~~l~Vs~v~hka~ieVnEeGteAaAat~~~----~~--~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~~ 451 (453)
T 2wxw_A 383 SNDRIRVGEVLNSIFFELEADEREPTESTQQL----NK--PEVLEVTLNRPFLFAVYDQSATALHFLGRVANPLS 451 (453)
T ss_dssp CSSCCCCSCCEEEEEEEEEECC------------------CCCEEEECCSCEEEEEEETTTTEECCEEEESCCC-
T ss_pred cCCCceEeEEEEEEEEEecCCCcccccccccc----cC--CCCCeEEEeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 9988 999999999999999999999988631 11 23568999999999999999999999999999964
|
| >2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-74 Score=555.71 Aligned_cols=340 Identities=22% Similarity=0.319 Sum_probs=289.3
Q ss_pred hhHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHh
Q 036497 3 DVLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFA 77 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~ 77 (375)
+...+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++...+++ .++.+...
T Consensus 17 ~~~~l~~~~~~Fa~~L~k~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~~~~~~~~~l~~~--- 93 (430)
T 2r9y_A 17 ETRRLAQAMMAFTTDLFSLVAQTSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNTGSCLPHLLSHFYQN--- 93 (430)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCCSSSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCCTTSCHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCCCCEEECHHHHHHHHHHHHhhcCcHHHHHHHHHhCCCcHHHHHHHHHHHHhh---
Confidence 35567889999999999999642 23 999999999999999999999999999999998655565 66665432
Q ss_pred CCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCcc
Q 036497 78 DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDS 157 (375)
Q Consensus 78 ~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~ 157 (375)
..+..+.++|+||+++++.++++|++.++++|++++..+||. ++.+++.||+||+++|+|+|+++++ +++++
T Consensus 94 ----~~~~~L~~An~l~~~~~~~l~~~F~~~~~~~y~a~~~~~d~~--~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~ 165 (430)
T 2r9y_A 94 ----LGPGTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTGK--QEEDLANINQWVKEATEGKIEDFLS--ELPDS 165 (430)
T ss_dssp ----SCSSSEEEEEEEEECTTCCCCHHHHHHHHHHHSSCCEECCSC--HHHHHHHHHHHHHHHTTTSCCCCCC--CCCSS
T ss_pred ----ccCceEEeeehhhhhCCCcccHHHHHHHHHHhCCceeecCCC--cHHHHHHHHHHHHHhcCCCccchhh--ccCcc
Confidence 134679999999999999999999999999999999988864 5788999999999999999999995 69999
Q ss_pred CeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccc-cceee--ecCCeEEEEecccC------------
Q 036497 158 SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN-KQLVT--AFDGFKVLVLPYKQ------------ 222 (375)
Q Consensus 158 t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~-~~~~~--~~~~~~vveLPy~~------------ 222 (375)
|+++|+||+||+|.|+.+|++..|..++|++.+|+.++||||++.+ .+.|+ +..++++|+|||++
T Consensus 166 T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~l~~~vleLPY~~~~SM~iiLP~~~ 245 (430)
T 2r9y_A 166 TVLLLLNAIHFHGFWRTKFDPSLTQKDFFHLDERFTVSVDMMHAVSYPLRWFLLEQPEIQVAHFPFKNNMSFVVVMPTYF 245 (430)
T ss_dssp CSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSEEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSEEEEEEEESSS
T ss_pred cceeEeeeeEEecccCCCCCCCCcccceEEecCCeEEEEEeeeecccceeEEEecCCcEEEEEeecCCCEEEEEEecCCC
Confidence 9999999999999999999999999999999999999999999875 34444 45699999999987
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-Cccceee
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQ 300 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~q 300 (375)
.+|.+++++|+. ..+..+ ..+...++|.||||++++++||+++|++|||+++|+. |||++|++++ +|++++|
T Consensus 246 ~~~L~~le~~L~~--~~l~~~--~~~~~~v~v~LPKFkie~~~dL~~~L~~lGi~~~F~~--Adfsgis~~~l~Vs~v~H 319 (430)
T 2r9y_A 246 EWNVSEVLANLTW--DTLYHP--SLQERPTKVWLPKLHLQQQLDLVATLSQLGLQELFQG--PDLRGISEQNLVVSSVQH 319 (430)
T ss_dssp CCCHHHHHTTCCH--HHHSCC--CSCCEEEEEEEECEEEEEEEECHHHHHHHTTGGGGTC--CCCTTTCSSCCCEEEEEE
T ss_pred CCCHHHHHHhcCH--HHHHHh--cccCceEEEEeccEEEEeeecHHHHHHhcCccccccc--ccccccCCCCeEeeccce
Confidence 269999999863 344433 2233456899999999999999999999999999974 9999999888 9999999
Q ss_pred eeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcchh
Q 036497 301 KSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSII 364 (375)
Q Consensus 301 k~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~~ 364 (375)
|++|+|||+||+|||+|++... ++. ...|+|||||+|+|+|+.||.|||+|+|.+|..-
T Consensus 320 ka~ieVnEeGteAAAaT~~~~~-~~s----~~~f~adrPFlF~I~d~~t~~iLF~G~v~~P~~~ 378 (430)
T 2r9y_A 320 QSTMELSEAGVEAAAATSVAMN-RMS----LSSFTVNRPFLFFIMEDTIGVPLFVGSVRNPNPS 378 (430)
T ss_dssp EEEEEECSCEEECC----------CC----CEEEECCSCEEEEEEETTTCCEEEEEEESCSCTT
T ss_pred EEEEEecCCCcccccccccccc-ccC----CceEEecCCEEEEEEECCCCcEEEEEEecCCCcc
Confidence 9999999999999999985433 222 2379999999999999999999999999999763
|
| >2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-72 Score=539.26 Aligned_cols=332 Identities=23% Similarity=0.320 Sum_probs=281.4
Q ss_pred HHhhhhhhhHHHHHHHHhcCC----CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-hhHH-HHHHHHHHHHh
Q 036497 5 LESISEQTDITLSLSKHIKAP----TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-EQQN-FASELVAIVFA 77 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~----~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~-~~~~l~~~l~~ 77 (375)
..+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. .+++ .++.+.
T Consensus 30 ~~l~~~~~~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~~~~i~~~~~~l~----- 104 (390)
T 2oay_A 30 AVLGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCVHQALKGFT----- 104 (390)
T ss_dssp HHHHHHHHHHHHHHHHHHCC----CCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTCCTTCTTHHHHHHTTC-----
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCcHHHHHHHHHHHh-----
Confidence 356789999999999999741 23 99999999999999999999999999999999764 3455 444321
Q ss_pred CCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCcc
Q 036497 78 DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDS 157 (375)
Q Consensus 78 ~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~ 157 (375)
...+.++|+||++++++++++|++.++++|+++++.+|+ +++.+++.||+||+++|+|+|+++++ +++++
T Consensus 105 ------~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~~~--~~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~ 174 (390)
T 2oay_A 105 ------TKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSN--NSDANLELINTWVAKNTNNKISRLLD--SLPSD 174 (390)
T ss_dssp ------CSSEEEEEEEEECTTSCCCHHHHHHHHHHHSCCCEECCS--CHHHHHHHHHHHHHHTTTTSCSCSCS--CCCTT
T ss_pred ------hCchhhhhhHhHhcCCcccHHHHHHHHHHhCceeeeccC--ChHHHHHHHHHHHHHhhCCccccccc--ccCcc
Confidence 124899999999999999999999999999999999985 36789999999999999999999995 69999
Q ss_pred CeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccc-cceeeec--CCeEEEEecccC------------
Q 036497 158 SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN-KQLVTAF--DGFKVLVLPYKQ------------ 222 (375)
Q Consensus 158 t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~-~~~~~~~--~~~~vveLPy~~------------ 222 (375)
|+++|+||+||+|.|+.||++..|.+++|+.. ++.++||||++.. .+.|.++ .+++|++|||++
T Consensus 175 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~-~~~v~V~mM~~~~~~~~~~~~~~l~~~vleLpy~~~~sm~iiLP~~~ 253 (390)
T 2oay_A 175 TRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFK-NSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSHNLSLVILVPQNL 253 (390)
T ss_dssp CCEEEEEEEEEEEEBSSCCCTTSCEEEEECC---CCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSTTEEEEEEEESST
T ss_pred cceEEEeeEEEecccCCCCCccccEEeeeEEC-CceEEEEEEEeCceeEEEEecccCceEEEEEecCCcEEEEEEeCCcc
Confidence 99999999999999999999999999999995 5678999999764 2334443 389999999986
Q ss_pred -CChHHHHHHccCcHHHHhccCC---ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Ccc
Q 036497 223 -DELPALEKKTGSQSGFLKDHIP---YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGV 296 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~---~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs 296 (375)
.+|.+++++|+. ..+..++. ..+...++|.||||++++++||+++|++||+.+ |+. .|||++|++++ +|+
T Consensus 254 ~~~L~~le~~L~~--~~l~~~~~~l~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~-f~~-~Adfsgis~~~~l~vs 329 (390)
T 2oay_A 254 KHRLEDMEQALSP--SVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFD-FSY-DLNLCGLTEDPDLQVS 329 (390)
T ss_dssp TSCHHHHHHHCCH--HHHHHHHHHHHTCCEEEEEEEEECCEEEEEEEHHHHHGGGSSSC-GGG-GCCCTTTCSCCCCCCC
T ss_pred CCCHHHHHHHhCH--HHHHHHHHhCcccccceeEEecceEEEeccccHHHHHhhcCccc-ccc-cCCccccCCCCCeEEc
Confidence 269999999973 33433332 222345689999999999999999999999999 875 79999999865 999
Q ss_pred ceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 297 GIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 297 ~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
+++||++|||||+||+|||+|++.. .++ ...|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus 330 ~v~hka~ieVnE~GteAaAaT~~~~-~~~-----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 389 (390)
T 2oay_A 330 AMQHQTVLELTETGVEAAAASAISV-ART-----LLVFEVQQPFLFMLWDQQHKFPVFMGRVYDPR 389 (390)
T ss_dssp CEEEEEEEEECSSEEEEEEEEEESC-CCC-----EEECCCCSCEEEEEEETTTTEEEEEEEECCC-
T ss_pred chhhcceEEECCCCccccccccccc-cCC-----CCeEEecCCEEEEEEECCCCCEEEEEEecCCC
Confidence 9999999999999999999998432 221 35799999999999999999999999999995
|
| >3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-69 Score=514.97 Aligned_cols=312 Identities=27% Similarity=0.468 Sum_probs=267.0
Q ss_pred chhHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh--hhHH-HHHHHHHH
Q 036497 2 DDVLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN--EQQN-FASELVAI 74 (375)
Q Consensus 2 ~~~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--~~~~-~~~~l~~~ 74 (375)
++...+.+++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. .+++ .++.++..
T Consensus 14 ~~~~~l~~~~~~Fa~~L~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~ 93 (359)
T 3f02_A 14 TGATFPEEAIADLSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGEEFSFLKEFSNM 93 (359)
T ss_dssp -------CHHHHHHHHHHHHHHHHSTTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTCCC----CHHHHHHCC---
T ss_pred CccHHHHHHHHHHHHHHHHHHhhcCCCCCEEEcHHHHHHHHHHHHhhcCChHHHHHHHHhCCCCCCHHHHHHHHHHHHHH
Confidence 456678889999999999999753 23 99999999999999999999999999999999865 3566 77777766
Q ss_pred HHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCC
Q 036497 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSV 154 (375)
Q Consensus 75 l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~ 154 (375)
+.+ +..+..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++++++
T Consensus 94 l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~~~~l 169 (359)
T 3f02_A 94 VTA---KESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQ-NVAVANYINKWVENNTNNLVKDLVSPRDF 169 (359)
T ss_dssp ----------CEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHTTTTCSCCSSCGGGC
T ss_pred Hhc---CCCCcEEEEEEEEEEeCCCccchHHHHHHHHHhcCceEEcCCCC-HHHHHHHHHHHHHhhhCCcccccCCcccC
Confidence 642 34567899999999999999999999999999999999999994 78999999999999999999999988899
Q ss_pred CccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--Ce------EEEEecccC----
Q 036497 155 DDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GF------KVLVLPYKQ---- 222 (375)
Q Consensus 155 ~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~------~vveLPy~~---- 222 (375)
+++|+++|+||+||+|.|+.||++..|..++|+..+|++++||||++.+.+.|++.+ ++ ++|+|||++
T Consensus 170 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~~~y~~~~~l~a~~~~~~~vleLPY~~~~~s 249 (359)
T 3f02_A 170 DAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEIS 249 (359)
T ss_dssp STTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECCC---CCEEEEEEEEBTTSSEE
T ss_pred CCCceEEEEeHHHHhHHhhccCCcccceeeeeEecCCcEEEccceEeeceEeEEEccCcCcccccccEEEEeEcCCCcEE
Confidence 999999999999999999999999999999999999999999999999988777644 44 999999987
Q ss_pred ---------CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC
Q 036497 223 ---------DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH 293 (375)
Q Consensus 223 ---------~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~ 293 (375)
.+|.+++++|+. ..+..+....+...++|.||||++++++||+++|++||++++|+. .|||++|++++
T Consensus 250 m~iiLP~~~~~L~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~ 326 (359)
T 3f02_A 250 MMLVLSRQEVPLATLEPLVKA--QLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIK-DANLTGLSDNK 326 (359)
T ss_dssp EEEEECCTTSCHHHHGGGCCH--HHHHHHHHHCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTCSCT
T ss_pred EEEEEcCCCCCHHHHHHHhCH--HHHHHHHHhCcceEEEEEeeeeEeEeeechHHHHHHcCchhhcCC-CCCccccCCCC
Confidence 479999999963 445555555556667999999999999999999999999999996 89999998755
Q ss_pred --CccceeeeeEEEEcCCcccchhhhhhh
Q 036497 294 --VGVGIFQKSFIEVKEEGTEAAAASAAV 320 (375)
Q Consensus 294 --~vs~~~qk~~iev~E~G~~aaa~t~~~ 320 (375)
+|++++||++|||||+||+|||+|++.
T Consensus 327 ~l~vs~v~hka~ieVnE~GteAaAaT~~~ 355 (359)
T 3f02_A 327 EIFLSKAIHKSFLEVNEEGSEAAAVSGMI 355 (359)
T ss_dssp TEEEEEEEEEEEEEECSSEEEEEEEEEEE
T ss_pred CeeEEEEEEEEEEEECCCCchhhhhheee
Confidence 999999999999999999999999853
|
| >3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-68 Score=506.63 Aligned_cols=308 Identities=24% Similarity=0.394 Sum_probs=275.9
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAI 74 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~ 74 (375)
..++..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..
T Consensus 8 ~~~l~~~~~~Fa~~l~~~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~l~~~ 87 (343)
T 3ndd_A 8 FNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRT 87 (343)
T ss_dssp -CTTHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhHHHHHHHHHHhhcCCCCCEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 3567789999999999999753 23 99999999999999999999999999999999842 4577 88888877
Q ss_pred HHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCC
Q 036497 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSV 154 (375)
Q Consensus 75 l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~ 154 (375)
+. .+.++..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ ++
T Consensus 88 l~---~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~g~I~~ll~--~l 161 (343)
T 3ndd_A 88 LN---QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD-TEEAKKQINDYVEKGTQGKIVDLVK--EL 161 (343)
T ss_dssp HT---SCCTTCEEEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCSCCS--CC
T ss_pred Hh---CCCCCceEEeehhhHhhCCCChhHHHHHHHHHHhccccEeecCCC-HHHHHHHHHHHHHHhhcCchhhhhh--cC
Confidence 74 244567899999999999999999999999999999999999995 7899999999999999999999997 79
Q ss_pred CccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC----------
Q 036497 155 DDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ---------- 222 (375)
Q Consensus 155 ~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~---------- 222 (375)
+++|+++|+||+||+|.|+.||++..|..++|++.+|+.++||||++.+.+.|++. .++++|+|||++
T Consensus 162 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~l~~~vleLPY~~~~sm~iiLP~ 241 (343)
T 3ndd_A 162 DRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHAKKLSSWVLLMKYLGNATAIFFLPD 241 (343)
T ss_dssp CTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBSSSEEEEEEEEC
T ss_pred CCCceEEEEeHHHHhHHHhcccCCccccCcceecCCCcEEEEEEEEEEeeEEEEEeccCCeEEEEEecCCCeEEEEEEeC
Confidence 99999999999999999999999999999999999999999999999987777654 489999999997
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Ccccee
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIF 299 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~ 299 (375)
++|.+++++|+ ...+.+|....+...++|.||||++++++||+++|++||++++|++ .|||++|++++ +|++++
T Consensus 242 ~~~l~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~ 318 (343)
T 3ndd_A 242 EGKLQHLENELT--HDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTEEAPLKLSKAV 318 (343)
T ss_dssp TTCHHHHHHHCC--HHHHHHHHHCCCCEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCSSSCEEEEEEE
T ss_pred ccCHHHHHHHhC--HHHHHHHHHhCCcceEEEecccEEEeeccchHHHHHhCCcHhhcCC-CCCCcccCCCCCeeEEEEE
Confidence 57999999996 3445555544555667999999999999999999999999999998 89999999854 999999
Q ss_pred eeeEEEEcCCcccchhhhhhh
Q 036497 300 QKSFIEVKEEGTEAAAASAAV 320 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~ 320 (375)
||++|||||+||+|||+|++.
T Consensus 319 hka~ieV~E~GteAaAaT~~~ 339 (343)
T 3ndd_A 319 HKAVLTIDEKGTEAAPDDDDE 339 (343)
T ss_dssp EEEEEEECSSEEEEEEEEEEE
T ss_pred EEEEEEECCCCcceeccccee
Confidence 999999999999999999753
|
| >1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-68 Score=505.63 Aligned_cols=309 Identities=30% Similarity=0.415 Sum_probs=277.6
Q ss_pred HhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCC
Q 036497 6 ESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGS 80 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~ 80 (375)
.+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++..++++ .++.++..+. .
T Consensus 4 ~l~~~~~~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~---~ 80 (345)
T 1hle_A 4 QLSTANTHFAVDLFRALNESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDTVEDIHSRFQSLNADIN---K 80 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTGGGSTTHHHHHHHHHHHHT---C
T ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCCHHHHHHHHHHHHHHHh---C
Confidence 56789999999999999753 23 999999999999999999999999999999998666777 8888888774 2
Q ss_pred CCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCee
Q 036497 81 ANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKL 160 (375)
Q Consensus 81 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~l 160 (375)
+..+..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++|++
T Consensus 81 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~l 160 (345)
T 1hle_A 81 PGAPYILKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEINEWVKGQTEGKIPELLVKGMVDNMTKL 160 (345)
T ss_dssp SSCSSEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHHHTTTSSSCSSCTTSSCTTEEE
T ss_pred CCCCcEEEEEEEeeecCCCchhHHHHHHHHHHhCCeEEEecCCCCHHHHHHHHHHHHHHHhcCchhhhcCCcCCCCcceE
Confidence 34567899999999999999999999999999999999999976689999999999999999999999998899999999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC------------C---
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ------------D--- 223 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~------------~--- 223 (375)
+|+||+||+|.|+.||++..|..++||..+|+.++||||++.+.+.|+. ..++++++|||++ .
T Consensus 161 vLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~~~~ 240 (345)
T 1hle_A 161 VLVNAIYFKGNWQQKFMKEATRDAPFRLNKKDTKTVKMMYQKKKFPYNYIEDLKCRVLELPYQGKELSMIILLPDDIEDE 240 (345)
T ss_dssp EEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSSEEEEEEEESSCCSS
T ss_pred EEEEeeEecccccCCCCcccCcceeEEeCCCeEEEEEEEEeeceEeeEEeCCCCeEEEEecCCCCeEEEEEEecCCCccc
Confidence 9999999999999999999999999999999999999999998776655 4599999999987 2
Q ss_pred --ChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccc
Q 036497 224 --ELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVG 297 (375)
Q Consensus 224 --~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~ 297 (375)
+|.+++++|+. ..+..+.. ..+...++|.||||++++++||+++|++||++++|++..|||++|++++ +|++
T Consensus 241 ~~~l~~l~~~L~~--~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~ 318 (345)
T 1hle_A 241 STGLEKIEKQLTL--DKLREWTKPENLYLAEVNVHLPRFKLEESYDLTSHLARLGVQDLFNRGKADLSGMSGARDLFVSK 318 (345)
T ss_dssp SSSCHHHHHTCCH--HHHHHHHCGGGCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGCTTTCCCHHHHSSSCEEEEE
T ss_pred CcCHHHHHHHhCH--HHHHHHhhhhccccceEEEEcceEeeecccchHHHHHhcChhhcCCCCCCCcccCCCCCCeEEee
Confidence 68999999963 45555554 3445567999999999999999999999999999996589999999754 9999
Q ss_pred eeeeeEEEEcCCcccchhhhhh
Q 036497 298 IFQKSFIEVKEEGTEAAAASAA 319 (375)
Q Consensus 298 ~~qk~~iev~E~G~~aaa~t~~ 319 (375)
++||++|+|||+||+|||+|++
T Consensus 319 v~hka~ieV~E~GteAaAaT~~ 340 (345)
T 1hle_A 319 IIHKSFVDLNEEGTEAAAATAG 340 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE
T ss_pred EEEEEEEEECCCCeeeccccce
Confidence 9999999999999999999974
|
| >3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-68 Score=502.86 Aligned_cols=303 Identities=23% Similarity=0.398 Sum_probs=269.7
Q ss_pred hhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHHHhC
Q 036497 8 ISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIVFAD 78 (375)
Q Consensus 8 ~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l~~~ 78 (375)
..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..+.
T Consensus 6 ~~~~~~Fa~~l~~~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~l~~~l~-- 83 (336)
T 3dy0_A 6 PSSRRDFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQELN-- 83 (336)
T ss_dssp ----CCHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCHHHHHHHHHHHHHHHHHTT--
T ss_pred cchhhHHHHHHHHHHhhhCCCCCEEEchHHHHHHHHHHHhHCcHHHHHHHHHHhCCCCCcCCHHHHHHHHHHHHHHHh--
Confidence 467889999999999753 23 99999999999999999999999999999999863 3566 8888887664
Q ss_pred CCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccC
Q 036497 79 GSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSS 158 (375)
Q Consensus 79 ~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t 158 (375)
.+.++..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +++++|
T Consensus 84 -~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~g~I~~l~~--~l~~~t 159 (336)
T 3dy0_A 84 -QPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRD-SAGAMKQINDYVAKQTKGKIVDLLK--NLDSNA 159 (336)
T ss_dssp -SCCSSSEEEEEEEEEECTTCCBCHHHHHHHHHHHCCEEEECCTTS-HHHHHHHHHHHHHHHTTTSSCCCCC--SCCSCE
T ss_pred -CCCCCcEEEEeehhhhCCCCCccHHHHHHHHHHhCCeeEEECCCC-hHHHHHHHHHHHHHhhcCcHhHhhc--CCCCCC
Confidence 234567899999999999999999999999999999999999995 7899999999999999999999997 799999
Q ss_pred eeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC-----------CCh
Q 036497 159 KLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ-----------DEL 225 (375)
Q Consensus 159 ~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~-----------~~l 225 (375)
+++|+||+||+|.|++||++..|..++||+.+|++++||||++.+.+.|.+. .++++|+|||++ ++|
T Consensus 160 ~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~~~~~~~l~~~vleLPy~~~~sm~iiLP~~~~l 239 (336)
T 3dy0_A 160 VVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNATALFILPSEGKM 239 (336)
T ss_dssp EEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSCEEEEEEECTTCH
T ss_pred eEEeEehheeeeeccCCCCcccccccceeccCCcEEEEeeEEEEeEEEEEEecCCCeEEEEeecCCCeEEEEEecCCCCH
Confidence 9999999999999999999999999999999999999999999987777654 489999999997 679
Q ss_pred HHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--CccceeeeeE
Q 036497 226 PALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQKSF 303 (375)
Q Consensus 226 ~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk~~ 303 (375)
.+++++|+. ..+.+|....+...++|.||||++++++||+++|++||++++|++ .|||++|+++. +|++++||++
T Consensus 240 ~~le~~L~~--~~l~~~~~~l~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka~ 316 (336)
T 3dy0_A 240 QQVENGLSE--KTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTS-HADLSGISNHSNIQVSEMVHKAV 316 (336)
T ss_dssp HHHHHHCCH--HHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTGGGGTCCGGGST-TCCCTTTBCSTTCEEEEEEEEEE
T ss_pred HHHHHHhCH--HHHHHHHHhCCcceEEEEcCcEEEEeccchHHHHHhCChhhhhCC-CCCcccccCCCCceeeeeEEEEE
Confidence 999999963 445555555555667999999999999999999999999999998 89999999854 9999999999
Q ss_pred EEEcCCcccchhhhhh
Q 036497 304 IEVKEEGTEAAAASAA 319 (375)
Q Consensus 304 iev~E~G~~aaa~t~~ 319 (375)
|||||+||+|||+|++
T Consensus 317 ieV~E~GteAaAaT~~ 332 (336)
T 3dy0_A 317 VEVDESGTRAAAATGT 332 (336)
T ss_dssp EEECSSEEEEEEEEEE
T ss_pred EEECCCcchhhhheee
Confidence 9999999999999974
|
| >2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-68 Score=503.56 Aligned_cols=313 Identities=21% Similarity=0.309 Sum_probs=276.9
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAI 74 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~ 74 (375)
..++..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..
T Consensus 8 ~~~l~~~~~~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~ 87 (350)
T 2xn6_A 8 LYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICS 87 (350)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCccCCCHHHHHHHHHHHHHH
Confidence 3467789999999999999642 23 99999999999999999999999999999999743 4677 88888887
Q ss_pred HHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCC
Q 036497 75 VFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSV 154 (375)
Q Consensus 75 l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~ 154 (375)
+.. ...+..+.++|+||+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ ++
T Consensus 88 l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~l 161 (350)
T 2xn6_A 88 LNF---PKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSN-ISAAKQEINSHVEMQTKGKVVGLIQ--DL 161 (350)
T ss_dssp HHS---CBTTEEEEEEEEEEEETTCCBCHHHHHHHHHHSCEEEEEECTTS-HHHHHHHHHHHHHHHTTTCSCCCCS--CC
T ss_pred hhC---CCCCcEEEEEEeehhhCCCcHHHHHHHHHHHHhCCEEEeeCCCC-HHHHHHHHHHHHHHhhCCchhhhhc--cc
Confidence 753 34567899999999999999999999999999999999999985 7889999999999999999999996 49
Q ss_pred CccCeeEEEEeEEeeccccccccCCCCeeee-eecCCCcEEeecceeccccceeeecC--CeEEEEecccC---------
Q 036497 155 DDSSKLVFANALYFKGVWNEAFDSSKTKEYD-FHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ--------- 222 (375)
Q Consensus 155 ~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~-F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~--------- 222 (375)
+++|+++|+||+||+|.|+.||++..|..++ ||+.+|+.++||||++.+.+.|++.+ ++++|+|||++
T Consensus 162 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vleLPy~~~~sm~iiLP 241 (350)
T 2xn6_A 162 KPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMDQYYHLVDMELNCTVLQMDYSKNALALFVLP 241 (350)
T ss_dssp CTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSEEEEEEEE
T ss_pred CCCceeeeeeHHHHhhHhhccCChhhCccCCceEeCCCcEEEEEEEEEeeeEeEEEeCCCCeEEEEeecCCCeEEEEEec
Confidence 9999999999999999999999999999999 99999999999999999877777654 79999999987
Q ss_pred --CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccce
Q 036497 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGI 298 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~ 298 (375)
++|.+++++|+. ..+..+....+...++|.||||++++++||+++|++|||+++|+. .|||++|++++ +|+++
T Consensus 242 ~~~~l~~le~~L~~--~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~~l~vs~v 318 (350)
T 2xn6_A 242 KEGQMESVEAAMSS--KTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSE-NADFSGLTEDNGLKLSNA 318 (350)
T ss_dssp CTTCHHHHHHHCSH--HHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TCCCTTTBTTCCEEEEEE
T ss_pred CCCCHHHHHHHhCH--HHHHHHHHhhhcccceeeeeEEEEEeeecHHHHHHhcCchhhccC-cCCcccccCCCCceeeee
Confidence 579999999973 445555544555667999999999999999999999999999985 89999999854 99999
Q ss_pred eeeeEEEEcCCcccchhhhhhhhhhcc
Q 036497 299 FQKSFIEVKEEGTEAAAASAAVITLKS 325 (375)
Q Consensus 299 ~qk~~iev~E~G~~aaa~t~~~~~~~~ 325 (375)
+||++|||||+||+|||+|++....++
T Consensus 319 ~hka~ieVnE~GteAaAaT~~~~~~~s 345 (350)
T 2xn6_A 319 AHKAVLHIGEKGTEAAGAMFLEAIPRS 345 (350)
T ss_dssp EEEEEEEECSSEEEEEEEEEEEEEEC-
T ss_pred eEEEEEEECCCceeeccccceeecccC
Confidence 999999999999999999986544443
|
| >2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-67 Score=509.00 Aligned_cols=310 Identities=26% Similarity=0.410 Sum_probs=276.0
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-----------------
Q 036497 4 VLESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----------------- 62 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----------------- 62 (375)
...+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++..
T Consensus 26 ~~~l~~~~~~Fa~~L~k~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~ 105 (394)
T 2h4p_A 26 MEQVSASIGNFTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRPK 105 (394)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSSCC-----------------
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCCCCEEEChHHHHHHHHHHHHhccChHHHHHHHHhCCCccccccccccccccccccc
Confidence 4567789999999999999753 23 99999999999999999999999999999999752
Q ss_pred -----------hhHH-HHHHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHH
Q 036497 63 -----------EQQN-FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVS 130 (375)
Q Consensus 63 -----------~~~~-~~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~ 130 (375)
++++ .++.++..+. ....+..+.++|+||++++++++++|++.++++|+++++.+||.++++.++
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~l~~~l~---~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a~ 182 (394)
T 2h4p_A 106 RRRMDPEHEQAENIHSGFKELLTAFN---KPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSR 182 (394)
T ss_dssp -------CCCCHHHHHHHHHHHHHHT---CCCSSSEEEEEEEEEEETTSCCCHHHHHHHHHHHCCEEEEECTTTCHHHHH
T ss_pred ccccccccccHHHHHHHHHHHHHHhh---cCCCCcEEEEEEEEEEeCCCCccHHHHHHHHHHhCCeeEEecCcCCHHHHH
Confidence 4566 8888887774 234567899999999999999999999999999999999999976789999
Q ss_pred HHHHHHHHHHhcccccccCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee-
Q 036497 131 REINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA- 209 (375)
Q Consensus 131 ~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~- 209 (375)
+.||+||+++|+|+|++++++++++++|+++|+||+||+|.|+.||++..|..++|++.+|+.++||||++.+.+.|+.
T Consensus 183 ~~IN~WV~~~T~gkI~~ll~~~~l~~~T~lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~f~~~~~ 262 (394)
T 2h4p_A 183 KEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIM 262 (394)
T ss_dssp HHHHHHHHHHTTTCC-CCSCTTTSCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEE
T ss_pred HHHHHHHHHhhCCchhhccCccccCCccceeeeeeeeEEceeCCCCCcccccceEEEecCCeEEECceEeccCceeeEEe
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999998776655
Q ss_pred -cCCeEEEEecccC------------C-----ChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHH
Q 036497 210 -FDGFKVLVLPYKQ------------D-----ELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRV 269 (375)
Q Consensus 210 -~~~~~vveLPy~~------------~-----~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~ 269 (375)
..++++|+|||++ . +|.+++++|+. ..+..+.. ..+...++|.||||++++++||+++
T Consensus 263 ~~l~~~vleLPY~~~~~sM~iiLP~~~~~~~~~L~~le~~L~~--~~l~~~~~~~~~~~~~v~v~lPKFkie~~~dL~~~ 340 (394)
T 2h4p_A 263 EKMNFKMIELPYVKRELSMFILLPDDIKDGTTGLEQLERELTY--ERLSEWADSKMMTETLVDLHLPKFSLEDRIDLRDT 340 (394)
T ss_dssp TTTTEEEEEEEBGGGSEEEEEEEESSCCSSSSSCHHHHHSCCH--HHHHHHHTCTTCEEEEEEEEEECEEEEEEEECHHH
T ss_pred CCCCEEEEEeecCCCcEEEEEEecCCCcccCccHHHHHHHhCH--HHHHHHhhhhccccceEEEecceEEEeeeechHHH
Confidence 4599999999987 2 68999999963 45555554 3445667999999999999999999
Q ss_pred HHhCCcccCCCCCCCCCcCCcCCC--CccceeeeeEEEEcCCcccchhhhhh
Q 036497 270 LKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQKSFIEVKEEGTEAAAASAA 319 (375)
Q Consensus 270 L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk~~iev~E~G~~aaa~t~~ 319 (375)
|++|||+++|+. .|||++|++++ +|++++||++|+|||+||+|||+|++
T Consensus 341 L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka~ieVnE~GteAaAaT~~ 391 (394)
T 2h4p_A 341 LRNMGMTTAFTT-NADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAV 391 (394)
T ss_dssp HHHHTCCGGGST-TCCCTTSCSSSCCCEEEEEEEEEEEECSSEEEEEEEEEE
T ss_pred HHhcCCccccCC-ccCcccccCCCCeEEeeeEEEEEEEECCCCchhhcceee
Confidence 999999999995 89999999754 99999999999999999999999974
|
| >4afx_A Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_A 3h5c_A* 3f1s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-67 Score=505.82 Aligned_cols=309 Identities=25% Similarity=0.345 Sum_probs=276.3
Q ss_pred hhHHhhhhhhhHHHHHHHHhcCCC--C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC-----hhhHH-HHHHHHH
Q 036497 3 DVLESISEQTDITLSLSKHIKAPT--S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS-----NEQQN-FASELVA 73 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~~~~--~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~-----~~~~~-~~~~l~~ 73 (375)
+...+..++++||++||+++.... + +|||+||+.+|+||++||+|+|++||.++||++. .++++ .++.++.
T Consensus 50 ~~~~l~~~~~~Fa~~L~~~l~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~~~~~~l~~ 129 (387)
T 4afx_A 50 SRQQLAKETSNFGFSLLRKISMRHDGNMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFKGLRE 129 (387)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCCSCEEECHHHHHHHHHHHHTTCCTHHHHHHHHHTTCTTCSCCCTTHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHhhcCCCCEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCccccCCHHHHHHHHHHHHH
Confidence 456788899999999999997532 4 9999999999999999999999999999999986 25677 8888887
Q ss_pred HHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCC
Q 036497 74 IVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGS 153 (375)
Q Consensus 74 ~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~ 153 (375)
.+.. ..+..+.++|+||+++++.++++|++.++++|+++++.+||.+ +..+++.||+||+++|+|+|++++ ++
T Consensus 130 ~l~~----~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll--~~ 202 (387)
T 4afx_A 130 TLSR----NLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRN-ASQAKRLMNHYINKETRGKIPKLF--DE 202 (387)
T ss_dssp HHHH----CGGGCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSSCSC--CC
T ss_pred Hhcc----CCCceEEEEEEEeecCCCchhHHHHHHHHHHhccceEecCCCC-hHHHHHHHHHHHHHhcCCCccccc--cC
Confidence 7752 3456799999999999999999999999999999999999986 677999999999999999999999 68
Q ss_pred CCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC---------
Q 036497 154 VDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ--------- 222 (375)
Q Consensus 154 ~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~--------- 222 (375)
++++|+++|+||+||+|.|+.||++..|..++||+.+|+.++||||++.+.+.|++. .+++||+|||++
T Consensus 203 l~~~t~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~~sM~iiLP 282 (387)
T 4afx_A 203 INPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQGNATMLVVLM 282 (387)
T ss_dssp CCTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSEEEEEEEE
T ss_pred CCCCceEEEEeeeEEEeecccCCCcccceeeeeecCCCcEEEEEEEEeeeeEeEEEecCCceEEEEEEcCCcEEEEEEec
Confidence 999999999999999999999999999999999999999999999999988777654 489999999997
Q ss_pred ---CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcC-C-C-Ccc
Q 036497 223 ---DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD-S-H-VGV 296 (375)
Q Consensus 223 ---~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~-~-~-~vs 296 (375)
.+|.+++++|+. ..+..|....+...++|.||||++++++||+++|++|||+++|++ .|||++|++ + + +|+
T Consensus 283 ~~~~~L~~le~~L~~--~~l~~~~~~l~~~~v~v~LPKFki~~~~dL~~~L~~lGi~~~F~~-~ADfsgis~~~~~l~Vs 359 (387)
T 4afx_A 283 EKMGDHLALEDYLTT--DLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSP-FADLSELSATGRNLQVS 359 (387)
T ss_dssp SCCSSCCCGGGTCCH--HHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBSSCCCCEEE
T ss_pred CCCCCHHHHHHHhCH--HHHHHHHHhCceeEEEEecCcEEEEeeccHHHHHHhcChhhhhCC-CCCcccccCCCCCceee
Confidence 568888888863 445555555556667999999999999999999999999999998 999999997 4 4 999
Q ss_pred ceeeeeEEEEcCCcccchhhhhhhh
Q 036497 297 GIFQKSFIEVKEEGTEAAAASAAVI 321 (375)
Q Consensus 297 ~~~qk~~iev~E~G~~aaa~t~~~~ 321 (375)
+++||++|+|||+||+|||+|++.+
T Consensus 360 ~v~Hka~ieVnEeGteAAAaT~~~~ 384 (387)
T 4afx_A 360 RVLQRTVIEVDERGTEAVAGILSEI 384 (387)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEEEE
T ss_pred eEEEEEEEEECCCcccccccceeee
Confidence 9999999999999999999998543
|
| >1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-67 Score=497.25 Aligned_cols=306 Identities=24% Similarity=0.374 Sum_probs=273.1
Q ss_pred HHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHH
Q 036497 5 LESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIV 75 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l 75 (375)
.++..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++||++.. ++++ .++.++..+
T Consensus 5 ~~l~~~~~~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l 84 (341)
T 1as4_A 5 LGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTL 84 (341)
T ss_dssp -CHHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhccCCCCcEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCcCCCHHHHHHHHHHHHHHH
Confidence 356778999999999999642 23 99999999999999999999999999999999743 4667 888888777
Q ss_pred HhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCC
Q 036497 76 FADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVD 155 (375)
Q Consensus 76 ~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~ 155 (375)
.. +..+..+.++|+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +++
T Consensus 85 ~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~l~ 158 (341)
T 1as4_A 85 NQ---SSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQD-SAAAKKLINDYVKNGTRGKITDLIK--DLD 158 (341)
T ss_dssp CE---ECSSCEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSCCCSCC--CCC
T ss_pred hc---cCCCcEEEeeehhHHhCCCchhHHHHHHHHHHhCCceEecCCCC-HHHHHHHHHHHHHHhhcCchhhHhh--ccC
Confidence 42 34567899999999999999999999999999999999999985 7889999999999999999999996 499
Q ss_pred ccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceecccc-ceeeecC--CeEEEEecccC----------
Q 036497 156 DSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNK-QLVTAFD--GFKVLVLPYKQ---------- 222 (375)
Q Consensus 156 ~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~-~~~~~~~--~~~vveLPy~~---------- 222 (375)
++|+++|+||+||+|.|+.||++..|..++||+.+|++++||||++.+. +.|++.+ ++++++|||++
T Consensus 159 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~~sm~iiLP~ 238 (341)
T 1as4_A 159 SQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPD 238 (341)
T ss_dssp TTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSEEEEEEEEC
T ss_pred CCceEEEEEhHhhcchhcCCCCccccccceeEeCCCeEEEEEEEEecCceEEEEEecCCCeEEEEecCCCCcEEEEEeeC
Confidence 9999999999999999999999999999999999999999999999987 8777654 89999999987
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeee-eeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC-C-Cccce
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVG-DFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS-H-VGVGI 298 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~-~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-~-~vs~~ 298 (375)
++|.+++++|+. ..+..+....+...+ +|.||||++++++||+++|++||++++|+. .|||++|+++ + +|+++
T Consensus 239 ~~~l~~le~~L~~--~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~~l~vs~v 315 (341)
T 1as4_A 239 QDKMEEVEAMLLP--ETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTS-KADLSGITGARNLAVSQV 315 (341)
T ss_dssp TTCHHHHHHTCCH--HHHHHHHHHCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHSSSCEEEEEE
T ss_pred CCCHHHHHHHhCH--HHHHHHHHhccccccceEeeeEEEEeeecchHHHHHHcCchhhccC-CCCcccccCCCCEEEeeE
Confidence 579999999963 445555555555667 899999999999999999999999999985 8999999985 4 99999
Q ss_pred eeeeEEEEcCCcccchhhhhh
Q 036497 299 FQKSFIEVKEEGTEAAAASAA 319 (375)
Q Consensus 299 ~qk~~iev~E~G~~aaa~t~~ 319 (375)
+||++|||||+||+|||+|++
T Consensus 316 ~hka~ieVnE~GteAaAaT~~ 336 (341)
T 1as4_A 316 VHKAVLDVFEEGTEASRATAV 336 (341)
T ss_dssp EEEEEEEECSSEEEEEEEEEE
T ss_pred EEEEEEEECCCccccccccce
Confidence 999999999999999999974
|
| >1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-65 Score=478.59 Aligned_cols=298 Identities=21% Similarity=0.346 Sum_probs=262.8
Q ss_pred HHhhhhhhhHHHHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCC
Q 036497 5 LESISEQTDITLSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADG 79 (375)
Q Consensus 5 ~~~~~~~~~f~~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~ 79 (375)
..+..++++||++||+++... .+ +|||+||+.+|+|+++||+|+|++||.++|| ++++ .++.+ ..+.
T Consensus 4 ~~l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~----~~~~~~~~~l-~~l~--- 75 (323)
T 1mtp_A 4 GFLRDDHLEFALHLHRRLAEAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLG----TDPAPLLAAL-DRAV--- 75 (323)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHSTTCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHT----SCHHHHHHHH-HHHT---
T ss_pred HHHHHHHHHHHHHHHHHHhccCCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHHH----HHHHHHHHHH-HHHh---
Confidence 356678999999999999752 23 9999999999999999999999999999999 4566 78888 6553
Q ss_pred CCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCe
Q 036497 80 SANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSK 159 (375)
Q Consensus 80 ~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~ 159 (375)
..+..+.++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++|+
T Consensus 76 --~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~l~~~~~l~~~t~ 153 (323)
T 1mtp_A 76 --TDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVTPDLR 153 (323)
T ss_dssp --CSCTTEEEEEEEEECTTSCBCHHHHHHHHHSTTCEEEECCTTTCHHHHHHHHHHHHHHHTTTSCSCSSCTTCSCTTEE
T ss_pred --CCCcEEeeeeeeeeECCcEecHHHHHHHHHHhCCEEEEEcCCCCHHHHHHHHHHHHHHHhcCcccccCCcCCCCcccc
Confidence 345679999999999999999999999999999999999998668899999999999999999999999889999999
Q ss_pred eEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC---------CChHHH
Q 036497 160 LVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ---------DELPAL 228 (375)
Q Consensus 160 lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~---------~~l~~l 228 (375)
++|+||+||+|.|+.||++..|.+++|| .+|++++||||++.+.++|++.+ ++++|+| -.+ .+|.++
T Consensus 154 lvLvNaiyFkg~W~~~F~~~~T~~~~F~-~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleL-~~~~sm~iiLP~~~l~~l 231 (323)
T 1mtp_A 154 AILTNALWAKARWTTPFEAHLTREGTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHA-HDELAVDVLLPPGTNAAA 231 (323)
T ss_dssp EEEEEEEEEEEEBSSCCCGGGCEEEEEE-ETTEEEEEEEEEEEEEEEEEEETTEEEEEEEB-STTEEEEEEECCGGGTTC
T ss_pred eeeeeeeeeeccccCCCCcccCeeeeee-cCCeEEEeeEEEeeeeEeeEEeCCCCEEEEEE-CCcEEEEEEecCCCHHHH
Confidence 9999999999999999999999999999 99999999999999888887766 5677888 221 245555
Q ss_pred HHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-CccceeeeeEEEEc
Q 036497 229 EKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQKSFIEVK 307 (375)
Q Consensus 229 ~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~qk~~iev~ 307 (375)
++ ....+.+++...+...++|.||||++++++||+++|++||++++|+. .|||++|++++ +|++++||++||||
T Consensus 232 ~~----~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~l~vs~v~hka~ieV~ 306 (323)
T 1mtp_A 232 VP----TAPLLTALHRRSASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTA-SADLSGISTVPLYVDTVIHQARLRVD 306 (323)
T ss_dssp CC----CHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBSSCCEEEEEEEEEEEEEE
T ss_pred Hh----CHHHHHHHHHhCcceeEEEEeeEEEEecccchHHHHHhCChhhhcCC-CCCcccCCCCCceeeeeEEEEEEEEC
Confidence 44 34455556555556667999999999999999999999999999995 89999999888 99999999999999
Q ss_pred CCcccchhhhhh
Q 036497 308 EEGTEAAAASAA 319 (375)
Q Consensus 308 E~G~~aaa~t~~ 319 (375)
|+||+|||+|++
T Consensus 307 E~GteAaAaT~~ 318 (323)
T 1mtp_A 307 ERGAEGAAATAA 318 (323)
T ss_dssp TTEEEEEEEEEE
T ss_pred CCccccccccce
Confidence 999999999974
|
| >1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-62 Score=457.66 Aligned_cols=278 Identities=26% Similarity=0.397 Sum_probs=240.7
Q ss_pred HHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHHHHHHHHHHHHhCCCCCCCCeEEEEE
Q 036497 16 LSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNFASELVAIVFADGSANGGPRLSVAN 91 (375)
Q Consensus 16 ~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~l~~~l~~~~~~~~~~~l~~an 91 (375)
++||+++.... + +|||+||+.+|+|+++||+|+|++||.++||++..+++ +...+.++|
T Consensus 1 ~~l~~~l~~~~~~~N~~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~-----------------~~l~l~~an 63 (305)
T 1f0c_A 1 MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADKNK-----------------DDISFKSMN 63 (305)
T ss_dssp CHHHHHHHHTTTTSCEEECHHHHHHHHHHHHHHCCTHHHHHHHTTC--------------------------CCSEEEEE
T ss_pred ChHHHHHhccCCCCCEEEchHHHHHHHHHHHHhcCChHHHHHHHHhCCCCcccc-----------------chhhhhhee
Confidence 37899986533 3 99999999999999999999999999999998753211 123469999
Q ss_pred eeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEEEeEEeecc
Q 036497 92 GVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGV 171 (375)
Q Consensus 92 ~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlvna~~f~~~ 171 (375)
+||++++++++++|++.++++| +.+||.+ + .+++.||+||+++|+|+|+++++ ..++.+|+++|+||+||+|.
T Consensus 64 ~l~~~~~~~l~~~f~~~~~~~y----~~vdF~~-~-~a~~~IN~WV~~~T~g~I~~l~~-~~~~~~t~lvLvNaiyFkg~ 136 (305)
T 1f0c_A 64 KVYGRYSAVFKDSFLRKIGDNF----QTVDFTD-C-RTVDAINKCVDIFTEGKINPLLD-EPLSPDTCLLAISAVYFKAK 136 (305)
T ss_dssp EEEEETTSCBCHHHHHHHGGGE----EEECSSS-T-HHHHHHHHHHHHHTTTSSCCSCC-SCCCTTEEEEEEEEEEEEEE
T ss_pred eEEEeCCCcHHHHHHHHHHHHh----hccCCCC-H-HHHHHHHHHHHHHhCCCcccccc-CCCCCCceeeeeehHhhhhh
Confidence 9999999999999999999998 8999986 5 89999999999999999999993 23556699999999999999
Q ss_pred ccccccCCCCeeeeeecCCCcEEeecceeccc-cceeeec--C--CeEEEEecccC------------CChHHHHHHccC
Q 036497 172 WNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN-KQLVTAF--D--GFKVLVLPYKQ------------DELPALEKKTGS 234 (375)
Q Consensus 172 W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~-~~~~~~~--~--~~~vveLPy~~------------~~l~~l~~~L~~ 234 (375)
|+.||++..|..++||..+|++++||||++.+ .+.|++. . ++++++|||++ .+|.+++++|+.
T Consensus 137 W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~~~vleLPy~~~~sm~iiLP~~~~~l~~l~~~L~~ 216 (305)
T 1f0c_A 137 WLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYVGDTSMVVILPDNIDGLESIEQNLTD 216 (305)
T ss_dssp BSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEECCTTCCEEEEEEEBSSSEEEEEEEESSTTCHHHHHTTCCH
T ss_pred hhccCCcccCeecEEEECCCEEEEEEEEEecCcceeeEEcccccCCCEEEEEeCCCCEEEEEEeCCCCCCHHHHHHHhCH
Confidence 99999999999999999999999999999998 7877654 4 78999999987 579999999963
Q ss_pred cHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-CccceeeeeEEEEcCCcccc
Q 036497 235 QSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQKSFIEVKEEGTEA 313 (375)
Q Consensus 235 ~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~qk~~iev~E~G~~a 313 (375)
..+..++...+...++|.||||++++++||+++|++||++++|++ .|||++|++.+ +|++++||++|+|||+||+|
T Consensus 217 --~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~l~vs~v~hka~ieV~E~GteA 293 (305)
T 1f0c_A 217 --TNFKKWCDSMDAMFIDVHIPKFKVTGSYNLVDALVKLGLTEVFGS-TGDYSNMCNSDVSVDAMIHKTYIDVNEEYTEA 293 (305)
T ss_dssp --HHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCSSSST-TCCCTTTBSSCCEEEEEEEEEEEEECSSEEEE
T ss_pred --HHHHHHHhhCceeEEEEecceEEEEeeechHHHHHhcCCCcCCCC-ccccccCCCCCcEeeeEEEEEEEEECCCceec
Confidence 445556555566678999999999999999999999999999997 89999999666 99999999999999999999
Q ss_pred hhhhhhh
Q 036497 314 AAASAAV 320 (375)
Q Consensus 314 aa~t~~~ 320 (375)
||+|++.
T Consensus 294 aAaT~~~ 300 (305)
T 1f0c_A 294 AAATCAL 300 (305)
T ss_dssp EEEEEEE
T ss_pred cccceee
Confidence 9999743
|
| >1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=379.86 Aligned_cols=223 Identities=26% Similarity=0.388 Sum_probs=202.4
Q ss_pred eEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCeeEEEEe
Q 036497 86 RLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANA 165 (375)
Q Consensus 86 ~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~lvlvna 165 (375)
.+.+||+||++++++++++|++.+++.| ..+||.+ +.+++.||+||+++|+|+|+++++++ ++++|+++|+||
T Consensus 3 ~l~~an~l~~~~~~~l~~~f~~~~~~~~----~~vdF~~--~~a~~~IN~WV~~~T~gkI~~ll~~~-l~~~t~lvLvNa 75 (245)
T 1m93_B 3 SFKSMNKVYGRYSAVFKDSFLRKIGDNF----QTVDFTD--SRTVDAINKSVDIFTEGKINPLLDEP-LSPDTSLLAISA 75 (245)
T ss_dssp SEEEEEEEEEETTSCBCHHHHHHHCSCE----EEECTTS--THHHHHHHHHHHHHTTTSSCCSCCSC-CCTTCCEEEEEE
T ss_pred EEEeEeeeeeeCCCCcCHHHHHHHHHHH----HhcCCCC--HHHHHHHHHHHHHHhcCchhhhcCCC-CCCCceEEEEEe
Confidence 5899999999999999999999999887 3799986 68999999999999999999999866 999999999999
Q ss_pred EEeeccccccccCCCCeeeeeecCCCcEEeeccee-ccccceeeec--C--CeEEEEecccC------------CChHHH
Q 036497 166 LYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMT-SKNKQLVTAF--D--GFKVLVLPYKQ------------DELPAL 228 (375)
Q Consensus 166 ~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~-~~~~~~~~~~--~--~~~vveLPy~~------------~~l~~l 228 (375)
+||+|.|+.||++..|..++||..+|+.++||||+ +.+.+.|++. . ++++++|||++ .+|.++
T Consensus 76 iyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~l~~~~~vleLPy~~~~sm~iiLP~~~~~l~~l 155 (245)
T 1m93_B 76 VYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYVGDTSMVVILPDNIDGLESI 155 (245)
T ss_dssp EEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEECSCEEEEEEECCTTCCEEEEEEEBSSSEEEEEEEESSTTCHHHH
T ss_pred eeeechhcCCCCcccCceeeEEecCCcEEEEeeeeeccCceeEEEecccccCCEEEEEecCCCeEEEEEecCCCCCHHHH
Confidence 99999999999999999999999999999999999 8887766654 4 88999999987 579999
Q ss_pred HHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-CccceeeeeEEEEc
Q 036497 229 EKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIFQKSFIEVK 307 (375)
Q Consensus 229 ~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~qk~~iev~ 307 (375)
+++|+. ..+..+....+...++|.||||++++++||+++|++||++++|++ .|||++|++++ +|++++||+.|+||
T Consensus 156 ~~~L~~--~~l~~~~~~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfs~is~~~l~vs~v~hka~ieV~ 232 (245)
T 1m93_B 156 EQNLTD--TNFKKWSDSMDAMFIDVHIPKFKVTGSYNLVDALVKLGLTEVFGS-TGDYSNMSNSDVSVDAMIHKTYIDVN 232 (245)
T ss_dssp HTTCCH--HHHHHHHHTCEEEECEEEEECEEEEEEEEHHHHHHHTTCTTSSST-TCCCTTTBSSCCCCCCEEEEEEEEEC
T ss_pred HHHhCH--HHHHHHHHhCccceEEEECCeEEEeeeeccHHHHHhcCccccCCC-ccCcccccCCCceEeeEEEEeEEEEC
Confidence 999963 345555555555667999999999999999999999999999998 89999999878 99999999999999
Q ss_pred CCcccchhhhh
Q 036497 308 EEGTEAAAASA 318 (375)
Q Consensus 308 E~G~~aaa~t~ 318 (375)
|+||+|||+|+
T Consensus 233 E~GteAaAaT~ 243 (245)
T 1m93_B 233 EEYTEAAAATS 243 (245)
T ss_dssp SSEEEEEEEEE
T ss_pred CCccccccccc
Confidence 99999999986
|
| >3ndd_B Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 1ezx_B 3ndf_B 7api_B* 8api_B* 9api_B* 2d26_B | Back alignment and structure |
|---|
Probab=99.36 E-value=8.8e-13 Score=80.74 Aligned_cols=33 Identities=18% Similarity=0.221 Sum_probs=30.7
Q ss_pred CcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 331 KIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 331 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
+..|.+||||+|+|+|+.|+.+||+|+|.+|++
T Consensus 3 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 35 (36)
T 3ndd_B 3 PPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ 35 (36)
T ss_dssp CCEEECCSCEEEEEEETTTCCEEEEEEESSCCC
T ss_pred CCEEEeeCCEEEEEEECCCCcEEEEEEecCCCC
Confidence 357999999999999999999999999999975
|
| >1hle_B Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-12 Score=77.71 Aligned_cols=30 Identities=47% Similarity=0.716 Sum_probs=28.4
Q ss_pred cEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 332 IDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 332 ~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
..|.+||||+|+|+|+.|+.+||+|+|.+|
T Consensus 2 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 31 (31)
T 1hle_B 2 ENFNADHPFIFFIRHNPSANILFLGRFSSP 31 (31)
T ss_dssp EEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred CEEEEeCCEEEEEEECCCCcEEEEEEecCC
Confidence 479999999999999999999999999987
|
| >4afx_B Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_B | Back alignment and structure |
|---|
Probab=99.35 E-value=1e-12 Score=80.40 Aligned_cols=32 Identities=31% Similarity=0.429 Sum_probs=30.3
Q ss_pred cEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 332 IDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 332 ~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
..|.+||||+|+|+|+.|+.+||+|+|.+|++
T Consensus 4 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 35 (36)
T 4afx_B 4 PVIKIDRPFHFMIYEETSGMLLFLGRVVNPTL 35 (36)
T ss_dssp CEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CEEEeeCCEEEEEEECCCCcEEEEEEecCCCC
Confidence 47999999999999999999999999999985
|
| >2riv_B Thyroxine-binding globulin; TBG, serpin, cleaved, mutation, glycoprotein, secreted, signaling protein; 1.50A {Homo sapiens} PDB: 2riw_B* 2xn3_B* | Back alignment and structure |
|---|
Probab=99.35 E-value=9.8e-13 Score=82.54 Aligned_cols=33 Identities=21% Similarity=0.164 Sum_probs=30.7
Q ss_pred CcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 331 KIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 331 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
+..|.+||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 7 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 39 (40)
T 2riv_B 7 HPIIQIDRSFMLLILERSTRSILFLGKVVNPTE 39 (40)
T ss_dssp CCEEECCBCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CCEEEecCCEEEEEEeCCCCcEEEEEEecCCCC
Confidence 468999999999999999999999999999964
|
| >2xn6_B Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn5_B* 2xn7_B* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=79.84 Aligned_cols=32 Identities=22% Similarity=0.162 Sum_probs=30.0
Q ss_pred cEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 332 IDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 332 ~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
..|.+||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 3 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 34 (35)
T 2xn6_B 3 PIIQIDRSFMLLILERSTRSILFLGKVVNPTE 34 (35)
T ss_dssp CEEECCBCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CEEEecCCEEEEEEECCCCcEEEEEEeCCcCC
Confidence 47999999999999999999999999999974
|
| >1as4_B Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_B* 3caa_B 4caa_B | Back alignment and structure |
|---|
Probab=99.33 E-value=8.1e-13 Score=81.42 Aligned_cols=33 Identities=12% Similarity=0.128 Sum_probs=30.7
Q ss_pred CcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 331 KIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 331 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
+..|.+||||+|+|+|+.|+.+||+|+|.+|..
T Consensus 4 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 36 (37)
T 1as4_B 4 GTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQ 36 (37)
T ss_dssp CEEEECCSCEEEEEEETTSSCCSEEEEESCTTC
T ss_pred CCEEEecCCEEEEEEeCCCCcEEEEEEeCCCCC
Confidence 468999999999999999999999999999974
|
| >2h4p_B MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_B | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-12 Score=78.78 Aligned_cols=31 Identities=32% Similarity=0.599 Sum_probs=29.6
Q ss_pred cEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 332 IDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 332 ~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
..|.+||||+|+|+|+.|+.+||+|+|.+|.
T Consensus 3 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 33 (34)
T 2h4p_B 3 LKFKVDHPFHFFIRHNKSKTILFFGRFCCPV 33 (34)
T ss_dssp EEEECCSCEEEEEEETTTTEEEEEEEECSCC
T ss_pred CEEEecCCEEEEEEECCCCeEEEEEEeCCCC
Confidence 5799999999999999999999999999996
|
| >3f02_C Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 1jjo_E | Back alignment and structure |
|---|
Probab=99.21 E-value=1.8e-11 Score=79.79 Aligned_cols=35 Identities=31% Similarity=0.530 Sum_probs=30.8
Q ss_pred CcEEEecCCeEEEEEECCCCcEEEEEEeCCcchhh
Q 036497 331 KIDFVADHPFIFMIREDATGVVLSLVMFSILSIIN 365 (375)
Q Consensus 331 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~~~ 365 (375)
+..|.+||||+|+|+|+.|+.+||+|+|.+|+.-+
T Consensus 5 ~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~~~ 39 (48)
T 3f02_C 5 YPQVIVDHPFFFLIRNRRTGTILFMGRVMHPETMN 39 (48)
T ss_dssp CCEEECCSCEEEEEEETTTCCEEEEEEESCCCC--
T ss_pred CCEEEeeCCEEEEEEECCCCcEEEEEEeCCCCccc
Confidence 35899999999999999999999999999997533
|
| >1m93_C Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_B 1f0c_B | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=77.24 Aligned_cols=32 Identities=38% Similarity=0.630 Sum_probs=29.0
Q ss_pred CcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 331 KIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 331 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
+..|.+||||+|+|+|+. +.+||+|+|.+|++
T Consensus 9 p~~f~~drPFlf~I~~~~-~~iLF~G~v~~P~~ 40 (41)
T 1m93_C 9 TNEFSADHPFIYVIRHVD-GKILFVGRYSSPTT 40 (41)
T ss_dssp CCEEECCSCEEEEEEETT-SCEEEEEEECSCC-
T ss_pred CCEEEeeCCEEEEEEECC-CCEEEEEEeCCcCC
Confidence 468999999999999998 99999999999974
|
| >1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.17 E-value=9.7e-12 Score=84.10 Aligned_cols=47 Identities=23% Similarity=0.457 Sum_probs=37.2
Q ss_pred HHHHHHhcCC---CC-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh
Q 036497 16 LSLSKHIKAP---TS-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN 62 (375)
Q Consensus 16 ~~l~~~~~~~---~~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~ 62 (375)
++||+++... .+ +|||+||..+|+|++.||+|+|++||.++|+++..
T Consensus 1 ~~L~~~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~ 51 (55)
T 1m93_A 1 MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEAD 51 (55)
T ss_dssp CHHHHHHHHHTTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHTTC-----
T ss_pred ChHHHHHHhcCCCCCEEECHHHHHHHHHHHHhhccchHHHHHHHHhCCCcc
Confidence 3688888642 23 99999999999999999999999999999999764
|
| >1mtp_B Serine proteinase inhibitor (serpin), chain B; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.13 E-value=5.2e-11 Score=75.63 Aligned_cols=32 Identities=28% Similarity=0.395 Sum_probs=29.0
Q ss_pred CcEEEecCCeEEEEEECCCCcEEEEEEeCCcchh
Q 036497 331 KIDFVADHPFIFMIREDATGVVLSLVMFSILSII 364 (375)
Q Consensus 331 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~~ 364 (375)
+..|++||||+|+|+|+ +.+||+|+|.+|...
T Consensus 8 p~~f~~drPFlf~I~~~--~~iLF~G~v~~P~~~ 39 (43)
T 1mtp_B 8 TIRFSVDRPFHIVVRRR--GAILFLGSIADPHDP 39 (43)
T ss_dssp CEEEECCSCEEEEEEET--TEEEEEEEESSCCCC
T ss_pred CCEEEeeCCEEEEEEEC--CEEEEEEEeCCcccc
Confidence 46899999999999998 899999999999753
|
| >3dy0_B C-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_B* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.4e-10 Score=67.15 Aligned_cols=27 Identities=22% Similarity=0.358 Sum_probs=25.1
Q ss_pred cEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 332 IDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 332 ~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
..|++||||+|+|+|+ .+||+|+|.+|
T Consensus 3 ~~f~~drPFlf~I~~~---~iLF~G~v~~P 29 (29)
T 3dy0_B 3 QRLVFNRPFLMFIVDN---NILFLGKVNRP 29 (29)
T ss_dssp EEEECCSCEEEEEESS---SEEEEEEESCC
T ss_pred CEEEecCCEEEEEEcC---ceEEEEEecCC
Confidence 4799999999999987 89999999987
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 375 | ||||
| d2b5ti1 | 426 | e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapien | 2e-65 | |
| d1uhga_ | 385 | e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId | 9e-64 | |
| d1by7a_ | 381 | e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Hu | 6e-62 | |
| d1lj5a_ | 379 | e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Hu | 8e-62 | |
| d1k9oi_ | 376 | e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornwor | 3e-60 | |
| g1hle.1 | 375 | e.1.1.1 (A:,B:) Elastase inhibitor {Horse (Equus c | 1e-58 | |
| g1jjo.1 | 334 | e.1.1.1 (A:,C:,E:) Neuroserpin {Mouse (Mus musculu | 4e-58 | |
| d1jmja_ | 420 | e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin | 7e-57 | |
| g1mtp.1 | 355 | e.1.1.1 (A:,B:) Thermopin {Thermobifida fusca [Tax | 4e-56 | |
| d1qlpa_ | 372 | e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sap | 1e-55 | |
| g1as4.1 | 369 | e.1.1.1 (A:,B:) Antichymotrypsin, alpha-1 {Human ( | 3e-55 | |
| d1xqga_ | 378 | e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: | 3e-55 | |
| g1lq8.1 | 358 | e.1.1.1 (A:,B:) Protein C inhibitor {Human (Homo s | 2e-54 | |
| d1imva_ | 383 | e.1.1.1 (A:) Pigment epithelium-derived factor, PE | 8e-51 | |
| g1m93.1 | 322 | e.1.1.1 (A:,B:,C:) Viral serpin crmA (cytokine res | 1e-47 |
| >d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} Length = 426 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antithrombin species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 2e-65
Identities = 103/372 (27%), Positives = 180/372 (48%), Gaps = 36/372 (9%)
Query: 12 TDITLSLSKHIKAPTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSFL------KSK 60
+ + +H+ + + SPLSI +M G+ TLQQL+ +
Sbjct: 51 SRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKT 110
Query: 61 SNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQV 120
S++ F ++L ++ AN +L AN ++ D+SL+F T++ + +Y A +
Sbjct: 111 SDQIHFFFAKLNCRLYRK--ANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPL 168
Query: 121 DFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSK 180
DF+ A + IN W +T G I +V+P ++++ + LV N +YFKG+W F
Sbjct: 169 DFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPEN 228
Query: 181 TKEYDFHLLNGGSIKVPFMTSKNK-QLVTAFDGFKVLVLPYKQDE-------------LP 226
T++ F+ +G S M + K + +G +VL LP+K D+ L
Sbjct: 229 TRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLA 288
Query: 227 ALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRL 286
+EK+ + L++ + + +PRF+I G + L+ +GLV FS + +L
Sbjct: 289 KVEKELTPE--VLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKL 346
Query: 287 TEMVDS-----HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFI 341
+V +V F K+F+EV EEG+EAAA++A VI +SL +++ F A+ PF+
Sbjct: 347 PGIVAEGRDDLYVS-DAFHKAFLEVNEEGSEAAASTAVVIAGRSLNP-NRVCFKANRPFL 404
Query: 342 FMIREDATGVVL 353
IRE ++
Sbjct: 405 VFIREVPLNTII 416
|
| >d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} Length = 385 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Ovalbumin species: Hen (Gallus gallus) [TaxId: 9031]
Score = 206 bits (524), Expect = 9e-64
Identities = 88/381 (23%), Positives = 149/381 (39%), Gaps = 39/381 (10%)
Query: 7 SISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK--- 58
SI + + K +K ++ P++I L+M+ G+K T Q+ ++
Sbjct: 2 SIGAASMEFCFDVFKELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDK 61
Query: 59 ---------SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTV 109
++ N S L I+ N S+A+ ++ ++ + Q V
Sbjct: 62 LPGFGDSIEAQCGTSVNVHSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCV 121
Query: 110 DNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFK 169
+Y+ ++FQ A + IN W E +TNG I+ VL P SVD + +V NA+ FK
Sbjct: 122 KELYRGGLEPINFQTAADQARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFK 181
Query: 170 GVWNEAFDSSKTKEYDFHLLNGGSIKVP--FMTSKNKQLVTAFDGFKVLVLPYKQDE--- 224
G+W +AF T+ F + S V + + A + K+L LP+
Sbjct: 182 GLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMSM 241
Query: 225 ---LP-------ALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALG 274
LP LE + +PR K+ ++ VL A+G
Sbjct: 242 LVLLPDEVSGLEQLESIINFEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMG 301
Query: 275 LVLSFSRKG--GRLTEMVDSHVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKI 332
+ FS ++ + + E+ E G E ++ A + S+
Sbjct: 302 ITDVFSSSANLSGISSAESLKIS-QAVHAAHAEINEAGREVVGSAEAGVDAASVS----E 356
Query: 333 DFVADHPFIFMIREDATGVVL 353
+F ADHPF+F I+ AT VL
Sbjct: 357 EFRADHPFLFCIKHIATNAVL 377
|
| >d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 381 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 6e-62
Identities = 96/376 (25%), Positives = 166/376 (44%), Gaps = 31/376 (8%)
Query: 6 ESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK-- 58
E + T L+L KH+ + + SP SI ++M+ GS+G T Q+ L+
Sbjct: 1 EDLCVANTLFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFN 60
Query: 59 SKSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSH 118
S ++ A ++ G L N ++ ++S SF+ + + Y +
Sbjct: 61 EVGAAADKIHSSFRSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQ 120
Query: 119 QVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDS 178
VDF A E ++IN W + +T G I +LP GSVD +++V NA+YFKG W F+
Sbjct: 121 AVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEK 180
Query: 179 SKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQDE-------LPALEKK 231
Y F + + V M + K + + K +L LP
Sbjct: 181 KLNGLYPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAGDVSMFLLLPDEIAD 240
Query: 232 TGSQSGFLKDHIPYEMIEVG-----------DFRIPRFKISFGIEVSRVLKALGLVLSFS 280
+ L+ I Y+ + + IP+FK+ E+ +L+++G+ +F+
Sbjct: 241 VSTGLELLESEITYDKLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFN 300
Query: 281 RKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
+ + M + + +F ++ ++V EEGTEAAA + V+T ++ FVAD
Sbjct: 301 KGRANFSGMSERNDLFLS-EVFHQAMVDVNEEGTEAAAGTGGVMTGRTGH--GGPQFVAD 357
Query: 338 HPFIFMIREDATGVVL 353
HPF+F+I T +L
Sbjct: 358 HPFLFLIMHKITNCIL 373
|
| >d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 379 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 8e-62
Identities = 93/367 (25%), Positives = 158/367 (43%), Gaps = 31/367 (8%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN 66
+D + + + + + SP + +L+M+ + G T QQ+ + + K +++
Sbjct: 12 ASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKG- 70
Query: 67 FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKA 126
A L + +S + +++ + L F +++++ QVDF
Sbjct: 71 MAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSE-V 129
Query: 127 VEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDF 186
IN W + T G I +L G+VD ++LV NALYF G W F S T F
Sbjct: 130 ERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLF 189
Query: 187 HLLNGGSIKVPFMTSKNKQLVTAF-----DGFKVLVLPYKQDEL-----------PALEK 230
H +G ++ VP M NK T F + +L LPY D L L
Sbjct: 190 HKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSA 249
Query: 231 KTGSQSGFLKDHIPYEMIEV-GDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEM 289
T S L H M + +P+F + +++ + L+ LG+ F + T +
Sbjct: 250 LTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSL 309
Query: 290 VDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIRE 346
D HV QK IEV E GT A++++A +++ + P + + D PF+F++R
Sbjct: 310 SDQEPLHVA-QALQKVKIEVNESGTVASSSTAVIVSARMAP----EEIIMDRPFLFVVRH 364
Query: 347 DATGVVL 353
+ TG VL
Sbjct: 365 NPTGTVL 371
|
| >d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} Length = 376 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Alaserpin (serpin 1) species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]
Score = 196 bits (500), Expect = 3e-60
Identities = 93/361 (25%), Positives = 156/361 (43%), Gaps = 29/361 (8%)
Query: 11 QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN 66
T + + S S+ L +A S G + +LL L ++ N
Sbjct: 13 NDQFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPND---N 69
Query: 67 FASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKA 126
++ A + A G L +A+ +++ + L + F +++ + VDF
Sbjct: 70 VTKDVFADLNRGVRAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVKSV 129
Query: 127 VEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDF 186
E + IN W E +TN IK ++ P ++D++++ V NA+YFKG W + F +T + DF
Sbjct: 130 -EAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFVKERTMDRDF 188
Query: 187 HLLNGGSIKVPFMTSKNKQLVTAFDGFK---------------VLVLPYKQDELPALEKK 231
H+ +IKVP M K +++LP + D + ALE+K
Sbjct: 189 HVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPNQVDGITALEQK 248
Query: 232 TGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVD 291
+ EV + +P+FKI ++ VL + + F+ RL ++
Sbjct: 249 LKDPKALSRAEERLYNTEV-EITLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLK 307
Query: 292 SHVGV---GIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDA 348
+ + QK+FIEV EEG EAAAA+A I KSL + + D PF F ++ D
Sbjct: 308 TKESLTVDAAIQKAFIEVNEEGAEAAAANAFGIVPKSLILY--PEVHIDRPFYFELKIDG 365
Query: 349 T 349
Sbjct: 366 I 366
|
| >d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} Length = 420 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Heparin cofactor II (Hc-II, leuserpin 2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-57
Identities = 82/369 (22%), Positives = 141/369 (38%), Gaps = 38/369 (10%)
Query: 12 TDITLSLSKHIKAPTSSS-----SPLSIHVLLSMIAAGSKGPTLQQLLSFLK-------S 59
+L + +K ++ +P+ I + MI+ G KG T +Q+ S L S
Sbjct: 52 AKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNAS 111
Query: 60 KSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQ 119
E + + N G L N ++I + FK V Y A +
Sbjct: 112 SKYEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQI 171
Query: 120 VDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSS 179
DF + A + N K T G IK+ L +D +++++ N +YFKG W F
Sbjct: 172 ADFSDPAFI--SKTNNHIMKLTKGLIKDALEN--IDPATQMMILNCIYFKGSWVNKFPVE 227
Query: 180 KTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFDGFK--------------VLVLPYKQDEL 225
T ++F L +KV M +K L ++V+P+K +
Sbjct: 228 MTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGGISMLIVVPHKMSGM 287
Query: 226 PALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGR 285
LE + ++ + +P+FK+ + LK +G+ + F + G
Sbjct: 288 KTLEAQL--TPRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDKNGN- 344
Query: 286 LTEMVDSHVGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMI 344
+ + D + + + I V EEGT+A + S + F D PF+F+I
Sbjct: 345 MAGISDQRIAIDLFKHQGTITVNEEGTQATTVTTVGFMPLSTQ----VRFTVDRPFLFLI 400
Query: 345 REDATGVVL 353
E T +L
Sbjct: 401 YEHRTSCLL 409
|
| >d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 372 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antitrypsin, alpha-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 1e-55
Identities = 79/361 (21%), Positives = 146/361 (40%), Gaps = 27/361 (7%)
Query: 12 TDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNE--QQ 65
+ SL + + ++S+ SP+SI +M++ G+K T ++L L E +
Sbjct: 9 AEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEA 68
Query: 66 NFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNK 125
++ + +L+ NG+++ + L + F + V +Y + + V+F +
Sbjct: 69 QIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDT 128
Query: 126 AVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYD 185
E ++IN + EK T G I +++ +D + N ++FKG W F+ T+E D
Sbjct: 129 -EEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEED 185
Query: 186 FHLLNGGSIKVPFMTSKNKQLVTAFDGFKVLVLPYKQ-----------DELPALEKKTGS 234
FH+ ++KVP M + VL K DE +
Sbjct: 186 FHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENEL 245
Query: 235 QSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKG--GRLTEMVDS 292
+ + E +P+ I+ ++ VL LG+ FS +TE
Sbjct: 246 THDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPL 305
Query: 293 HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVV 352
+ K+ + + E+GTEAA A S+P + + PF+F++ E T
Sbjct: 306 KLS-KAVHKAVLTIDEKGTEAAGAMFLEAIPMSIP----PEVKFNKPFVFLMIEQNTKSP 360
Query: 353 L 353
L
Sbjct: 361 L 361
|
| >d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} Length = 378 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Maspin species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-55
Identities = 80/376 (21%), Positives = 154/376 (40%), Gaps = 36/376 (9%)
Query: 5 LESISE-QTDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKS 59
++++ + + L K + SP+++ LS+ G+KG T ++ L
Sbjct: 4 MDALQLANSAFAVDLFKQLSEKEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHF 63
Query: 60 KSNEQQNFASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQ 119
++ + F + + + L + +++D+SL+ F + Y
Sbjct: 64 ENVKDVPFGFQ--TVTSDVNKLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELET 121
Query: 120 VDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSS 179
VDF++K E +IN + T+G + +L SV+D +K++ NA YF G W + F S
Sbjct: 122 VDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFSES 181
Query: 180 KTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQDE------LPALEKK 231
+TKE F + + V M + + D K++ LP++ LP +
Sbjct: 182 ETKESPFRVNKTDTKPVQMMNMEATFSMGNIDSINSKIIELPFQNKHLSMFILLPKDVED 241
Query: 232 TGSQSGFLKDHIPYEMIE-----------VGDFRIPRFKISFGIEVSRVLKALGLVLSFS 280
+ ++ + E + IP+FK+ I+ L+ LGL FS
Sbjct: 242 ESTGLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKASLENLGLKHIFS 301
Query: 281 RKGGRLTEMVDS---HVGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVAD 337
+ M ++ + + K +E+ E+G ++ A I + AD
Sbjct: 302 EDTSDFSGMSETKGVALS-NVIHKVSLEITEDGGDSIEVPGARILQHK------DELNAD 354
Query: 338 HPFIFMIREDATGVVL 353
HPFI++IR + T ++
Sbjct: 355 HPFIYIIRHNKTRNII 370
|
| >d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} Length = 383 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Pigment epithelium-derived factor, PEDF species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-51
Identities = 66/361 (18%), Positives = 134/361 (37%), Gaps = 31/361 (8%)
Query: 12 TDITLSLSKHIKAPTSSS----SPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQNF 67
++ L + + + ++ SPLS+ LS ++ G+ T + L +
Sbjct: 24 SNFGYDLYRVRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISSPDI 83
Query: 68 ASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAV 127
++ + L A+ + ++ L K++F ++ Y + +
Sbjct: 84 HGTYKELLDTVTAPQKN--LKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGNPR-- 139
Query: 128 EVSREINFWAEKETNGFIKEVLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFH 187
+EIN W + + G + + D ++ +FKG W FDS KT DF+
Sbjct: 140 LDLQEINNWVQAQMKGKLAR--STKEIPDEISILLLGVAHFKGQWVTKFDSRKTSLEDFY 197
Query: 188 LLNGGSIKVPFMTSKNKQLVTAFD---GFKVLVLPYKQDELPAL-----------EKKTG 233
L +++VP M+ L D K+ LP +
Sbjct: 198 LDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGSMSIIFFLPLKVTQNLTLIEES 257
Query: 234 SQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH 293
S F+ D +P+ K+S+ EV++ L+ + L F +++
Sbjct: 258 LTSEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFD--SPDFSKITGKP 315
Query: 294 VGVG-IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVV 352
+ + + ++ E E+G + + P +D+ + PFIF++R+ TG +
Sbjct: 316 IKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLTFP----LDYHLNQPFIFVLRDTDTGAL 371
Query: 353 L 353
L
Sbjct: 372 L 372
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 375 | |||
| d2b5ti1 | 426 | Antithrombin {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jmja_ | 420 | Heparin cofactor II (Hc-II, leuserpin 2) {Human (H | 100.0 | |
| d1by7a_ | 381 | Plasminogen activator inhibitor-2 {Human (Homo sap | 100.0 | |
| d1uhga_ | 385 | Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} | 100.0 | |
| g1hle.1 | 375 | Elastase inhibitor {Horse (Equus caballus) [TaxId: | 100.0 | |
| d1lj5a_ | 379 | Plasminogen activator inhibitor-1 {Human (Homo sap | 100.0 | |
| d1xqga_ | 378 | Maspin {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k9oi_ | 376 | Alaserpin (serpin 1) {Tobacco hornworm (Manduca se | 100.0 | |
| d1qlpa_ | 372 | Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1imva_ | 383 | Pigment epithelium-derived factor, PEDF {Human (Ho | 100.0 | |
| g1as4.1 | 369 | Antichymotrypsin, alpha-1 {Human (Homo sapiens) [T | 100.0 | |
| g1lq8.1 | 358 | Protein C inhibitor {Human (Homo sapiens) [TaxId: | 100.0 | |
| g1mtp.1 | 355 | Thermopin {Thermobifida fusca [TaxId: 2021]} | 100.0 | |
| g1jjo.1 | 334 | Neuroserpin {Mouse (Mus musculus) [TaxId: 10090]} | 100.0 | |
| g1m93.1 | 322 | Viral serpin crmA (cytokine response modifier prot | 100.0 |
| >d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antithrombin species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-77 Score=579.02 Aligned_cols=355 Identities=29% Similarity=0.472 Sum_probs=315.9
Q ss_pred hHHhhhhhhhHHHHHHHHhcCC-C---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-----hhHH-HHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAP-T---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-----EQQN-FASELV 72 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~-~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-----~~~~-~~~~l~ 72 (375)
+.++..++++||++||++++.. + + +|||+||+.+|+||++||+|+|++||.++||++.. ++++ .++.+.
T Consensus 43 ~~~l~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aLa~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~ 122 (426)
T d2b5ti1 43 VWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLN 122 (426)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTSCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGSCHHHHHTHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCCCCEEEECHHHHHHHHHHHHHhCchHHHHHHHHhcCCCCCCcchHHHHHHHHHHHH
Confidence 3458899999999999998632 2 2 99999999999999999999999999999998753 3466 788887
Q ss_pred HHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCC
Q 036497 73 AIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPG 152 (375)
Q Consensus 73 ~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~ 152 (375)
..+.. ....+..+.++|++|+++++.++++|++.++++|+++++.+||.++++.+++.||+|++++|+|+|+++++++
T Consensus 123 ~~l~~--~~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~ 200 (426)
T d2b5ti1 123 CRLYR--KANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSE 200 (426)
T ss_dssp HHHTS--CCCSSEEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECTTTCHHHHHHHHHHHHHHHTTTSCSCSSCTT
T ss_pred HHHhc--cCCCCcEEeeeehhhhcccccchHHHHHHHHHhcCCeEEEecccccHHHHHHHHHHHHHHhcCCCccCCCCcc
Confidence 76653 2344668999999999999999999999999999999999999988888999999999999999999999988
Q ss_pred CCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC-CeEEEEecccC---------
Q 036497 153 SVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD-GFKVLVLPYKQ--------- 222 (375)
Q Consensus 153 ~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~-~~~vveLPy~~--------- 222 (375)
+++++|.++|+||+||+|.|+++|++..|..++|+..+|+.+.|+||++.+.+.|++.+ ++++|+|||++
T Consensus 201 ~l~~~t~l~Lvna~yFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~~~~~~~~~~~~vveLPy~~~~~sm~iiL 280 (426)
T d2b5ti1 201 AINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLIL 280 (426)
T ss_dssp CSCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEECCSSSCCEEEEEEEEEEEEEEEECGGGCEEEEEEBTTSSEEEEEEE
T ss_pred CCCchhHHHHHhhhhhccccccCccccccccceeecCCCeEEEeecceeecceeeEEccCCeEEEEeecCCCceEEEEEe
Confidence 99999999999999999999999999999999999999999999999999988777644 79999999997
Q ss_pred ----CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC---C-C
Q 036497 223 ----DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS---H-V 294 (375)
Q Consensus 223 ----~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~---~-~ 294 (375)
++|.++++.|+ ...+..+....+...++|.||||++++++||+++|++||++++|++..|||++|+.+ + +
T Consensus 281 P~~~~~l~~le~~L~--~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~~~l~ 358 (426)
T d2b5ti1 281 PKPEKSLAKVEKELT--PEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLY 358 (426)
T ss_dssp CCSSSCHHHHHHHCC--HHHHHHHHHHCEEEEEEEEEECEEEECCSCHHHHHHTTTCCGGGCTTTCCCTTTSCSSSSCCC
T ss_pred cCCCCCHHHHHHhhh--HHHHHHHHHhhhhccceEeeeeEEEEEeecHHHHHHHcCChhhcCCccccCccccccCCCCcE
Confidence 67999999996 455666666666667899999999999999999999999999999768999999854 3 9
Q ss_pred ccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 295 GVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 295 vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
|++++||+.|+|||+||+|+|+|.+....++. .++++.|+|||||+|+|+|+.||.|||+|||.+|++
T Consensus 359 vs~v~hka~ieVdE~GteAaa~T~~~~~~~s~-~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~Pt~ 426 (426)
T d2b5ti1 359 VSDAFHKAFLEVNEEGSEAAASTAVVIAGRSL-NPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPCV 426 (426)
T ss_dssp CCEEEEEEEEEECSSEESCCCCCCCCCSCCCC-CTTCCCEECCSCEEEEEEETTTCCEEEEEEESCCCC
T ss_pred EEeEEEEEEEEECCCceeccccceeeeccccC-CCCCcEEEecCCEEEEEEECCCCCEEEEEEecCCCC
Confidence 99999999999999999999999865554444 344678999999999999999999999999999974
|
| >d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Heparin cofactor II (Hc-II, leuserpin 2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-74 Score=558.26 Aligned_cols=347 Identities=24% Similarity=0.359 Sum_probs=308.0
Q ss_pred hhHHhhhhhhhHHHHHHHHhcCC-C---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh---------hhHH-H
Q 036497 3 DVLESISEQTDITLSLSKHIKAP-T---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN---------EQQN-F 67 (375)
Q Consensus 3 ~~~~~~~~~~~f~~~l~~~~~~~-~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~---------~~~~-~ 67 (375)
.+.++..++++||++||++++.. + + ++||+||+.+|+||++||+|+|++||.++||+++. .+++ .
T Consensus 43 ~~~~l~~~n~~F~~~ly~~l~~~~~~~~Niv~SP~si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~i~~~ 122 (420)
T d1jmja_ 43 RIQRLNILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYEITTIHNL 122 (420)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCCCCcEEECHHHHHHHHHHHHhhcchhHHHHHHHHcCCCCcCCcccchhHHHHHHH
Confidence 45667778899999999999753 2 3 99999999999999999999999999999998631 3455 7
Q ss_pred HHHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccc
Q 036497 68 ASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKE 147 (375)
Q Consensus 68 ~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~ 147 (375)
++.+.+.+.. ...+..+.++|++|++++++++++|++.++++|+++++.+||.+ + .+++.||+||+++|+|+|++
T Consensus 123 ~~~l~~~l~~---~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~~df~~-~-~~~~~IN~wv~~~T~g~I~~ 197 (420)
T d1jmja_ 123 FRKLTHRLFR---RNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSD-P-AFISKTNNHIMKLTKGLIKD 197 (420)
T ss_dssp HHHHHHHHHS---CCSSEEEEEEEEEEEETTSCCCHHHHHHHHHHSSCCEEEECTTC-H-HHHHHHHHHHHHHTTTSCCC
T ss_pred HHHHHHHHhc---CCCCcEehhhHHHHhhCCccccHHHHHHHHHhhCceeeccccch-H-HHHHHHhHhHHhccCCcccc
Confidence 8888877763 34567899999999999999999999999999999999999987 3 46678999999999999999
Q ss_pred cCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC---
Q 036497 148 VLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ--- 222 (375)
Q Consensus 148 ~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~--- 222 (375)
+++ +++++|+++|+||+||+|.|++||++..|..++|+..+|+++.|+||++.+.+.|++.+ ++++++|||++
T Consensus 198 ~l~--~i~~~t~lvLvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vl~Lpy~~~~s 275 (420)
T d1jmja_ 198 ALE--NIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGGIS 275 (420)
T ss_dssp TTS--SCCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEE
T ss_pred hhc--ccCCccHHHHHHHHHHHhhhhccCCcccccccceecCCCceeeeeeeeeeccEEEeeccCCCEEEEEEeecCCee
Confidence 995 58999999999999999999999999999999999999999999999999987776654 89999999998
Q ss_pred ---------CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC
Q 036497 223 ---------DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH 293 (375)
Q Consensus 223 ---------~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~ 293 (375)
.+|.++++.|+ ...+..+....+...++|.||||++++++||+++|++||++++|++ .|||++|++++
T Consensus 276 m~iiLP~~~~~l~~l~~~l~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dL~~~L~~lGi~~~F~~-~ad~s~is~~~ 352 (420)
T d1jmja_ 276 MLIVVPHKMSGMKTLEAQLT--PRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDK-NGNMAGISDQR 352 (420)
T ss_dssp EEEEEESSTTHHHHHHHHCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TSCCTTTCSSC
T ss_pred EEEEecCCCCchhHHHHhhC--HHHHHHHHhhCccceEEEEEEEEEEEeEechHHHHHHcCchhhcCC-CCcccccCCCC
Confidence 56999999996 3556666666677778999999999999999999999999999997 79999999888
Q ss_pred -CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 294 -VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 294 -~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
+|++++|++.|+|||+||+|+|+|.+.... .+.++.|++||||+|+|+|+.||.|||+|||.+|++
T Consensus 353 l~vs~v~hka~ieVdE~GteAaa~T~~~~~~----~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~Ptk 419 (420)
T d1jmja_ 353 IAIDLFKHQGTITVNEEGTQATTVTTVGFMP----LSTQVRFTVDRPFLFLIYEHRTSCLLFMGRVANPSR 419 (420)
T ss_dssp CCCSEEEEEEEEEECSSEESCCCCCCSCCCC----SCCSEEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred ceeeeEEEEEEEEEcCCceeecccceeeecc----CCCCcEEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 999999999999999999999999754332 223578999999999999999999999999999985
|
| >d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-73 Score=545.89 Aligned_cols=349 Identities=28% Similarity=0.444 Sum_probs=289.4
Q ss_pred HhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHHH
Q 036497 6 ESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIVF 76 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l~ 76 (375)
.+..++++||++||++++..+ + |+||+||+.+|+||++||+|+|++||.++||++.. ++++ .++.+...+.
T Consensus 2 ~l~~~~~~Fa~~L~~~l~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~ 81 (381)
T d1by7a_ 2 DLCVANTLFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGAAADKIHSSFRSLSSAIN 81 (381)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTTTTTCCG-GGHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHHHHHhcCCCCcEEECHHHHHHHHHHHHHhcchHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHHh
Confidence 356789999999999986533 3 99999999999999999999999999999999753 4566 7888887764
Q ss_pred hCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCc
Q 036497 77 ADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD 156 (375)
Q Consensus 77 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~ 156 (375)
....+..+.++|++|+++++.++++|++.+++.|+++++.+||.++++.+++.||+|++++|+|+|+++++++++++
T Consensus 82 ---~~~~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~ 158 (381)
T d1by7a_ 82 ---ASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDG 158 (381)
T ss_dssp ---------CEEEEEEEEEETTSCBCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHHHHHHTTTSCTTSSCTTSCCT
T ss_pred ---cCCCCcEEeeccchhcccCCccCHHHHHHHHHhhCCceeccccccchHHHHHHHHHHHHHhhcCCccccCCcccCCC
Confidence 23455679999999999999999999999999999999999998866788999999999999999999999889999
Q ss_pred cCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec--CCeEEEEecccC------------
Q 036497 157 SSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF--DGFKVLVLPYKQ------------ 222 (375)
Q Consensus 157 ~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLPy~~------------ 222 (375)
+|+++|+||+||+|.|++||++..|...+|+..+|+++.|+||++.+.+.|++. .++++|+|||++
T Consensus 159 ~t~~~lvna~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~~~~~~~~~~~~~~v~lp~~~~~~m~iilp~~~ 238 (381)
T d1by7a_ 159 DTRMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAGDVSMFLLLPDEI 238 (381)
T ss_dssp TCCEEEEEEEEECCCBSSCCEECC---EEEEEETTEEEEECEEEEEEEEEEEEETTTTEEEEEEEETTTEEEEEEEESSC
T ss_pred ccHhhhhheeEEeecccCCCccccccccccccCCCeeEEEeeeeeccccccccccCcCeEEEEeccCCCeEEEEEecCCc
Confidence 999999999999999999999999999999999999999999999987776654 489999999987
Q ss_pred ----CChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--C
Q 036497 223 ----DELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--V 294 (375)
Q Consensus 223 ----~~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~ 294 (375)
.+|..+++.++ ...+..+.. ..+...++|.||||++++++||+++|++||++++|++..|||++|++++ +
T Consensus 239 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~v~v~lPkF~i~~~~dl~~~L~~lGi~~~F~~~~Adfs~is~~~~l~ 316 (381)
T d1by7a_ 239 ADVSTGLELLESEIT--YDKLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMSERNDLF 316 (381)
T ss_dssp CSSSSSCHHHHHHCC--HHHHHHHTSTTTEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTBSCSCCC
T ss_pred cchhhhhHHhhhhcc--HHHHHHHhhhhcccceeEEEecccEEEEeeechHHHHHhcCchhhhccccccccccCCCCCce
Confidence 24666777764 334444443 2345567999999999999999999999999999998789999999765 9
Q ss_pred ccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 295 GVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 295 vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
|+++.|++.|+|||+|++|+|+|......++.+ ++++|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 317 vs~i~q~~~ieVdE~Gt~aaa~t~~~~~~~~~~--~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P 381 (381)
T d1by7a_ 317 LSEVFHQAMVDVNEEGTEAAAGTGGVMTGRTGH--GGPQFVADHPFLFLIMHKITNCILFFGRFSSP 381 (381)
T ss_dssp CCEEEEEEEEEECSCBC-------------------CCEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred EeeEEEEEEEEECCCccccccccceeeecccCC--CCCEEEecCCEEEEEEECCCCCEEEEEEecCC
Confidence 999999999999999999999998655554442 35689999999999999999999999999998
|
| >d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Ovalbumin species: Hen (Gallus gallus) [TaxId: 9031]
Probab=100.00 E-value=4.6e-72 Score=539.21 Aligned_cols=345 Identities=24% Similarity=0.366 Sum_probs=303.8
Q ss_pred hhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh--------------hhHH-H
Q 036497 7 SISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN--------------EQQN-F 67 (375)
Q Consensus 7 ~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--------------~~~~-~ 67 (375)
+..++++||++||+++...+ + |+||+||+.+|+||++||+|+|++||.++||++.. .+++ .
T Consensus 3 l~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~si~~~Laml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (385)
T d1uhga_ 3 IGAASMEFCFDVFKELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHSS 82 (385)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHTTTTSCTTTTHH
T ss_pred HHHHHHHHHHHHHHHHhccCcCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCCCccccchhhhhcccHHHHHHH
Confidence 56789999999999986533 3 99999999999999999999999999999998641 2344 7
Q ss_pred HHHHHHHHHhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccc
Q 036497 68 ASELVAIVFADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKE 147 (375)
Q Consensus 68 ~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~ 147 (375)
++.+.+.+. .+.++..+.++|++|++++++++++|++.++++|+++++.+||...++.+++.||+|++++|+|+|++
T Consensus 83 ~~~~~~~~~---~~~~~~~l~~~~~l~v~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~a~~~IN~wv~~~T~g~i~~ 159 (385)
T d1uhga_ 83 LRDILNQIT---KPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGIIRN 159 (385)
T ss_dssp HHHHHHHHT---SCCSSEEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHHHTTTCSCC
T ss_pred HHHHHHHhh---CCCCCceEEEEEEEEEecCccccHHHHHHHHHHhCCcccccccccHHHHHHHHHHHHHHHHccCCccc
Confidence 788887774 34456689999999999999999999999999999999999999878889999999999999999999
Q ss_pred cCCCCCCCccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeee--cCCeEEEEecccC---
Q 036497 148 VLPPGSVDDSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTA--FDGFKVLVLPYKQ--- 222 (375)
Q Consensus 148 ~l~~~~~~~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLPy~~--- 222 (375)
++++++++++++++++||+||+|.|+.||++..|...+|+..+|+++.|+||++.+.+.|++ ..++++|+|||++
T Consensus 160 ~v~~~~l~~~t~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~~~~~~~~~~~~~~v~Lpy~~~~~ 239 (385)
T d1uhga_ 160 VLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTM 239 (385)
T ss_dssp CSCTTSSCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSSE
T ss_pred cCCccCCCcccceeeeeeEEEecccccccccccccccccccCCCceeeehhheeccccccccccccCcEEEEccccCCCe
Confidence 99988999999999999999999999999999999999999999999999999988766654 4599999999997
Q ss_pred ----------CChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCc
Q 036497 223 ----------DELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMV 290 (375)
Q Consensus 223 ----------~~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is 290 (375)
.++.++++.|. ...+..+.. ..+...++|.||||++++++||+++|++||++++|++ .|||++|+
T Consensus 240 sm~iilP~~~~~l~~~~~~l~--~~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~lGl~~~F~~-~adfs~is 316 (385)
T d1uhga_ 240 SMLVLLPDEVSGLEQLESIIN--FEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSS-SANLSGIS 316 (385)
T ss_dssp EEEEEEESSTTCHHHHHHHCC--HHHHHHHTSTTTCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTB
T ss_pred EEEEEECCccCchhhhhhhcc--hhhHHHHhhhhcccceEEEEEeeeEEeecceeHHHHHHhcCCchhhcC-CCCcccCC
Confidence 67999999986 344444443 3455667999999999999999999999999999998 79999999
Q ss_pred CCC--CccceeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 291 DSH--VGVGIFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 291 ~~~--~vs~~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
+++ +|++++|++.|+|||+|++|+++|......++. +.+|++||||+|+|+|+.||.|||+|||.+|
T Consensus 317 ~~~~l~vs~i~q~~~i~v~E~Gt~a~a~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~~lf~G~v~~P 385 (385)
T d1uhga_ 317 SAESLKISQAVHAAHAEINEAGREVVGSAEAGVDAASV----SEEFRADHPFLFCIKHIATNAVLFFGRCVSP 385 (385)
T ss_dssp CSTTCCEEEEEEEEEEEECSCEEECCCHHHHHHHHTTC----CCEEECCSCEEEEEEETTTCCEEEEEEESCC
T ss_pred CCCCceeeeEEEEEEEEECCCCcccccccccccccCCC----CCEEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence 765 999999999999999999999999865443332 4589999999999999999999999999998
|
| >d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-72 Score=539.19 Aligned_cols=345 Identities=24% Similarity=0.407 Sum_probs=304.2
Q ss_pred hhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh-hhHH-HHHHHHHHHHhCCC
Q 036497 7 SISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN-EQQN-FASELVAIVFADGS 80 (375)
Q Consensus 7 ~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~-~~~~l~~~l~~~~~ 80 (375)
++++.++||++||+++.... + |+||+||+.+|+||++||+|+|++||.++||++.. .+++ .++.+...+..
T Consensus 8 ~~~~~~~F~~~l~~~l~~~~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~~--- 84 (379)
T d1lj5a_ 8 VAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMG--- 84 (379)
T ss_dssp HHHHHHHHHHHHHHHHHHHSTTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTTSTTHHHHHHHHHHHHHC---
T ss_pred HHHHHhHHHHHHHHHHHhhCcCCcEEECHHHHHHHHHHHHHhCCcHHHHHHHHHhCCCCChHHHHHHHHHHHHHhhC---
Confidence 45789999999999986533 3 99999999999999999999999999999999865 3455 77888777753
Q ss_pred CCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCee
Q 036497 81 ANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKL 160 (375)
Q Consensus 81 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~l 160 (375)
..++..++++|+||++++++++++|++.+++.|+++++.+||.+ +..+++.||+|++++|+|+|+++++++++++++++
T Consensus 85 ~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~-~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~t~~ 163 (379)
T d1lj5a_ 85 PWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSE-VERARFIINDWVKTHTKGMISNLLGKGAVDQLTRL 163 (379)
T ss_dssp GGGSSEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECTTS-HHHHHHHHHHHHHHTTTTSCCCSSCTTSSCTTCCE
T ss_pred cccccchhhhhHHHHhccCcccHHHHHHHHHhhcceeccccccc-hHHHHHHHHHHHHhhcCCccccccCccCCCcccee
Confidence 34567899999999999999999999999999999999999986 78999999999999999999999998899999999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeec-----CCeEEEEecccC-------------
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAF-----DGFKVLVLPYKQ------------- 222 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~-----~~~~vveLPy~~------------- 222 (375)
+++||+||+|.|+.||++..|..++|+..+|+++.|+||++.+.++|++. .++++|+|||++
T Consensus 164 ~lvna~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~~M~~~~~~~~~~~~~~~~~~~~vv~Lp~~~~~~sm~iilP~~~ 243 (379)
T d1lj5a_ 164 VLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEK 243 (379)
T ss_dssp EEEEEEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEEESST
T ss_pred eeEeeEEEeeeecCcCCccccccccccccCCceEeecceeeccceeeEEeeccccceeEEEEeecCCCcEEEEEecCCcc
Confidence 99999999999999999999999999999999999999999987777653 358999999998
Q ss_pred -CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Ccccee
Q 036497 223 -DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIF 299 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~ 299 (375)
.+|..+++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|++..|||++|+++. +|++++
T Consensus 244 ~~~l~~l~~~l~~--~~~~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~ 321 (379)
T d1lj5a_ 244 EVPLSALTNILSA--QLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQAL 321 (379)
T ss_dssp TSCTHHHHTTCCH--HHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCSSSCCCEEEEE
T ss_pred ccchHHHhhhccH--HHHHHHHhhccccccEEEEEEEEEeeeecHHHHHHhCCChhhcCcccccccccCCCCCcEEeeeE
Confidence 358888888862 334444444445556899999999999999999999999999998789999999765 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 300 QKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
|++.|+|||+|++|+|+|.+....++. +.+|++||||+|+|+|+.||.|||+|||.+|
T Consensus 322 hk~~iev~E~G~~a~a~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~~lf~G~v~~P 379 (379)
T d1lj5a_ 322 QKVKIEVNESGTVASSSTAVIVSARMA----PEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379 (379)
T ss_dssp EEEEEEECSSEEEEEEEEEEEESSCCC----CCCCCBCCEEEEEEEETTTTEEEEEEEEECC
T ss_pred EEEEEEECCCceeecccceeeeccCCC----CCEEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999999999999854433332 3579999999999999999999999999998
|
| >d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Maspin species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-72 Score=537.25 Aligned_cols=345 Identities=25% Similarity=0.362 Sum_probs=305.4
Q ss_pred HhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHHHhCCC
Q 036497 6 ESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIVFADGS 80 (375)
Q Consensus 6 ~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l~~~~~ 80 (375)
.+..++++||++||+++...+ + |+||+||+.+|+||++||+|+|+.||.++||+++..+++ .++.+.+.+.+
T Consensus 6 ~l~~a~~~Fa~~L~~~l~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~--- 82 (378)
T d1xqga_ 6 ALQLANSAFAVDLFKQLSEKEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVNK--- 82 (378)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTGGGCSSHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHHHHHhhCCCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCChHHHHHHHHHHHHHHhc---
Confidence 456789999999999986533 3 999999999999999999999999999999997666676 77777776653
Q ss_pred CCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCccCee
Q 036497 81 ANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDSSKL 160 (375)
Q Consensus 81 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~t~l 160 (375)
......+.++|++|+++++.++++|++.++++|+++++.+||.++++.++..||+|++++|+|+|++++++.+++++|++
T Consensus 83 ~~~~~~l~~~~~l~~~~~~~~~~~f~~~~~~~y~~~v~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~~~~~~~~~~t~~ 162 (378)
T d1xqga_ 83 LSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKI 162 (378)
T ss_dssp HTTTSSEEEEEEEEEETTSCCCHHHHHHTTTTTTTCEEEECHHHHHHHHHHHHHHHHHHHTTTSCSCCSCTTSCCTTCCE
T ss_pred ccCCceEEEeechhhcccccccHHHHHHhhhhccceeEeccccchhhHHHHHHHHHHHHhccCCcccccCCCCCCCCceE
Confidence 23456799999999999999999999999999999999999988777889999999999999999999998899999999
Q ss_pred EEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC----------------
Q 036497 161 VFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ---------------- 222 (375)
Q Consensus 161 vlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~---------------- 222 (375)
+++||+||+|.|+.+|++..|+..+|+..+++++.|+||++.+.+.|++.+ ++++|+|||++
T Consensus 163 ~l~na~~f~~~W~~~F~~~~T~~~~F~~~~~~~~~v~mm~~~~~~~~~~~~~l~~~vv~Lp~~~~~~sm~iilP~~~~~~ 242 (378)
T d1xqga_ 163 LVVNAAYFVGKWMKKFSESETKESPFRVNKTDTKPVQMMNMEATFSMGNIDSINSKIIELPFQNKHLSMFILLPKDVEDE 242 (378)
T ss_dssp EEEEEEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBGGGSSEEEEEEESSCCSS
T ss_pred EEEEEeEEeeeecCCCccccceecceecCCCceEecccccccceeeeeeccCCCeEEEEeecCCCcEEEEEEecCccccc
Confidence 999999999999999999999999999999999999999999877666544 89999999997
Q ss_pred -CChHHHHHHccCcHHHHhccCC--ccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccc
Q 036497 223 -DELPALEKKTGSQSGFLKDHIP--YEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVG 297 (375)
Q Consensus 223 -~~l~~l~~~L~~~~~~l~~~~~--~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~ 297 (375)
.+|.++++.|+. ..+..++. ..+...++|.||||++++++||+++|++||++++|+++.|||++|++++ +|++
T Consensus 243 ~~~L~~l~~~l~~--~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~ 320 (378)
T d1xqga_ 243 STGLEKIEKQLNS--ESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKASLENLGLKHIFSEDTSDFSGMSETKGVALSN 320 (378)
T ss_dssp SSSCHHHHHSCSH--HHHHHHTCGGGCEEEEEEEEEECEEEEEEECTHHHHHHHTCCGGGCTTTCCCTTTCSCSSCCEEE
T ss_pred cchHHHHHHhcCH--HHHHHHhhhhhceeEEEEEEeeeEEEEEeechHHHHHhcCchhccCCCCCccccCCCCCCceEEE
Confidence 258999999863 44555553 3344557899999999999999999999999999998789999999865 9999
Q ss_pred eeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 298 IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 298 ~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++|++.|+|||+|++|+++|.... .+.+.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 321 i~qk~~i~vdE~G~~a~~~t~~~~------~~~~~~f~~drPFlf~I~d~~t~~~Lf~G~v~~P 378 (378)
T d1xqga_ 321 VIHKVSLEITEDGGDSIEVPGARI------LQHKDELNADHPFIYIIRHNKTRNIIFFGKFSSP 378 (378)
T ss_dssp EEEEEEEEECSCBCCCCCCTTTTT------SSCCCCCBCCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred eEEEEEEEEccCcccccccccccc------CCCCCEEEccCCEEEEEEECCCCCEEEEEEecCC
Confidence 999999999999999998887422 1224579999999999999999999999999998
|
| >d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Alaserpin (serpin 1) species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]
Probab=100.00 E-value=4.5e-72 Score=537.57 Aligned_cols=350 Identities=27% Similarity=0.407 Sum_probs=306.1
Q ss_pred chhHH-hhhhhhhHHHHHHHHhcCCCC----eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCChhhHH-HHHHHHHHH
Q 036497 2 DDVLE-SISEQTDITLSLSKHIKAPTS----SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSNEQQN-FASELVAIV 75 (375)
Q Consensus 2 ~~~~~-~~~~~~~f~~~l~~~~~~~~~----v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~-~~~~l~~~l 75 (375)
+|+.+ +.+++++||++||+++...++ |+||+||+.+|+||+.||+|+|++||.++||++..+..+ .++.+...+
T Consensus 3 ~~~~~~l~~~~~~F~~~l~~~~~~~~~~~N~v~SP~si~~~La~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~~ 82 (376)
T d1k9oi_ 3 TDLQKILRESNDQFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNVTKDVFADLNRGV 82 (376)
T ss_dssp HHHHTTHHHHHHHHHHHHHHHHHTTSTTSCEEECSGGGHHHHHHHTTTBCTHHHHHHHHHTTCSCTTHHHHHHHHHTSSC
T ss_pred chHHHHHHHHHHHHHHHHHHHHHhhCCCCeEEECHHHHHHHHHHHHHhcChHHHHHHHHHcCCCCcchHHHHHHHHHHHH
Confidence 35555 557889999999999987543 999999999999999999999999999999998765555 565554322
Q ss_pred HhCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCC
Q 036497 76 FADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVD 155 (375)
Q Consensus 76 ~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~ 155 (375)
....+..+.++|++|++++++++++|.+.++++|+++++.+||.+ +..+++.||+|++++|+|+|++++++++++
T Consensus 83 ----~~~~~~~~~~~~~i~~~~~~~~~~~f~~~~~~~y~~~~~~vdf~~-~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~ 157 (376)
T d1k9oi_ 83 ----RAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVK-SVEAAGAINKWVEDQTNNRIKNLVDPDALD 157 (376)
T ss_dssp ----SCCSSBCCEEEEEEEEESSCCBCSGGGSTTTSSSCCCEEEECTTS-HHHHHHHHHHHHHHHTTTSSCCCSCGGGCC
T ss_pred ----hhcCCCcEEEeeehhhhcCCCcchHHHHHHHhhcCceeecccccc-cHHHHHHHHHHHHHhhCCceeeccCCCCCC
Confidence 223455789999999999999999999999999999999999997 567999999999999999999999988999
Q ss_pred ccCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC-----------
Q 036497 156 DSSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ----------- 222 (375)
Q Consensus 156 ~~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~----------- 222 (375)
++++++|+||+||+|.|+.||++..|..++|+..+|+.+.|+||++.+.++|++.+ ++++|||||++
T Consensus 158 ~~~~~~lvna~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~~~~~~~~~l~~~vveLP~~~~~~sm~iilP~ 237 (376)
T d1k9oi_ 158 ETTRSVLVNAIYFKGSWKDKFVKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPN 237 (376)
T ss_dssp TTCCEEEEEEEEEEBCBSSCCCGGGCEEEEECSSSSCCEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEES
T ss_pred cchhhhhhhhhhhhhhhcCCCCccccccceeecCCCceEEEEeeeecccEEEEeeCCCCEEEEEeecCCCceEEEEEecC
Confidence 99999999999999999999999999999999999999999999999987777654 89999999997
Q ss_pred --CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCC--C-Cccc
Q 036497 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDS--H-VGVG 297 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~--~-~vs~ 297 (375)
+++..++++|.. ...+..+....+...++|.||||++++++||+++|++||++++|++..|||++|++. + +|++
T Consensus 238 ~~~~l~~~~~~l~~-~~~~~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~lGl~~~F~~~~ad~s~~~~~~~~l~vs~ 316 (376)
T d1k9oi_ 238 QVDGITALEQKLKD-PKALSRAEERLYNTEVEITLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKTKESLTVDA 316 (376)
T ss_dssp STTTHHHHHHHTTS-TTTTTTTTTSCEEEEEEEEEECEEEEEEEEHHHHHHTTTCCSTTSTTTSCBTTTBSSCCCCCCSE
T ss_pred CCcchhHHHhhhcc-hhhHHHHHhhccceEEEEEeeeEEEeeeecHHHHhhhcCCccccCccccccccccCCCCCEEEEe
Confidence 678889988863 234555566666677899999999999999999999999999999878999999764 3 9999
Q ss_pred eeeeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCc
Q 036497 298 IFQKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSIL 361 (375)
Q Consensus 298 ~~qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p 361 (375)
++|++.|+|||+|++|+|+|......++.+. ..+|++||||+|+|++. |.|||+|||.+|
T Consensus 317 v~q~~~ievdE~G~~a~a~t~~~~~~~~~~~--~~~f~~drPF~f~I~~~--~~~lf~G~v~~P 376 (376)
T d1k9oi_ 317 AIQKAFIEVNEEGAEAAAANAFGIVPKSLIL--YPEVHIDRPFYFELKID--GIPMFNGKVIEP 376 (376)
T ss_dssp EEEEEEEEECSCBSSCSSSCCSSSEESCCCC--CCEEECCSCEEEEEEES--SSEEEEEEESCC
T ss_pred eEEEEEEEECCCceeeecccceeeeccCCCC--CCeEEeeCCEEEEEEEC--CeEEEEEEecCC
Confidence 9999999999999999999986544444432 45899999999999974 799999999998
|
| >d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antitrypsin, alpha-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-70 Score=527.72 Aligned_cols=344 Identities=23% Similarity=0.378 Sum_probs=305.4
Q ss_pred hhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCCh----hhHH-HHHHHHHHHHh
Q 036497 7 SISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKSN----EQQN-FASELVAIVFA 77 (375)
Q Consensus 7 ~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~-~~~~l~~~l~~ 77 (375)
+..++++||++||+.++... + |+||+||+.+|+||++||+|+|++||.++|+++.. .+++ .++.+.+.+.
T Consensus 4 ~~~~~~~Fa~~l~~~l~~~~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~- 82 (372)
T d1qlpa_ 4 ITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLN- 82 (372)
T ss_dssp THHHHHHHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHHHS-
T ss_pred hhHhHHHHHHHHHHHHhhhCCCCcEEECHHHHHHHHHHHHHhccHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHHhh-
Confidence 56788999999999985433 3 99999999999999999999999999999999753 3445 7777777664
Q ss_pred CCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCcc
Q 036497 78 DGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDDS 157 (375)
Q Consensus 78 ~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~~ 157 (375)
.+..+..+.++|++|+++++++.++|++.++++|+++++.+||.+ +..+++.||+|++++|+|+|++++. +++++
T Consensus 83 --~~~~~~~l~~~n~i~~~~~~~l~~~f~~~~~~~f~~~~~~~df~~-~~~~~~~iN~wv~~~T~g~i~~~~~--~~~~~ 157 (372)
T d1qlpa_ 83 --QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD-TEEAKKQINDYVEKGTQGKIVDLVK--ELDRD 157 (372)
T ss_dssp --CSSCCCCEEEEEEEEEETTCCBCHHHHHHHHHTSCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCSCCC--CCCTT
T ss_pred --ccCcchhhhhheeeeeccCCccCHHHHHHHHHHhCceeecccccc-hHHHHHHHHHHHHHHhCCCCccccc--CCCCc
Confidence 344567899999999999999999999999999999999999986 6889999999999999999999996 58999
Q ss_pred CeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccccceeeecC--CeEEEEecccC-----------CC
Q 036497 158 SKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKNKQLVTAFD--GFKVLVLPYKQ-----------DE 224 (375)
Q Consensus 158 t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLPy~~-----------~~ 224 (375)
+.++++||+||+|.|..||++..|...+|+..+|..+.|+||++.+.+.|++.+ ++++++|||++ .+
T Consensus 158 t~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~f~~~~~~~l~~~~~~lp~~~~~~~~il~~~~~~ 237 (372)
T d1qlpa_ 158 TVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGK 237 (372)
T ss_dssp CCEEEEEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEEEEEEEECTTC
T ss_pred chhhhhhhheeecccccccchhccccccccccCCceEEEeeeecccceeeeccccCCeEEEecccCCCceEEEEECCcCC
Confidence 999999999999999999999999999999999999999999999877776654 89999999998 68
Q ss_pred hHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC--Cccceeeee
Q 036497 225 LPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH--VGVGIFQKS 302 (375)
Q Consensus 225 l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~--~vs~~~qk~ 302 (375)
|.++++.|+ ...+..+....+...++|.||||++++++||+++|++||++++|++ .+||++|+++. +|++++|++
T Consensus 238 l~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dl~~~L~~lGl~~~F~~-~ad~~~i~~~~~l~vs~v~q~~ 314 (372)
T d1qlpa_ 238 LQHLENELT--HDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTEEAPLKLSKAVHKA 314 (372)
T ss_dssp HHHHHHHCC--HHHHHHHHHCCCCEEEEEEEECEEEEEEEEHHHHTGGGTCCGGGST-TCCCTTTBSSSCCCCCEEEEEE
T ss_pred HHHHHHhhh--HHHHHHHHHhccceEEEEEEEEEEEeeeccHHHHHHhcCchhhhcc-hhhhcCcCCCCCceeeeEEEEE
Confidence 999999996 3455556566666778999999999999999999999999999998 78999999765 999999999
Q ss_pred EEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcch
Q 036497 303 FIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILSI 363 (375)
Q Consensus 303 ~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~~ 363 (375)
.|+|||+|++|+++|......++. +.+|+|||||+|+|+|+.||.|||+|||.+|++
T Consensus 315 ~i~v~E~Gteaaa~t~~~~~~~s~----~~~f~~drPFlf~I~~~~t~~iLf~G~v~~Pt~ 371 (372)
T d1qlpa_ 315 VLTIDEKGTEAAGAMFLEAIPMSI----PPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ 371 (372)
T ss_dssp EEEECSCSSSSCCCCCCCCCCSSC----CCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred EEEECCCccchhhhheeecccCCC----CCeEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 999999999999988754433332 458999999999999999999999999999985
|
| >d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Pigment epithelium-derived factor, PEDF species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-71 Score=529.11 Aligned_cols=342 Identities=20% Similarity=0.266 Sum_probs=294.7
Q ss_pred hHHhhhhhhhHHHHHHHHhcCCC---C-eeehHHHHHHHHHHHhcCChhHHHHHHHhcCCCC--hhhHH-HHHHHHHHHH
Q 036497 4 VLESISEQTDITLSLSKHIKAPT---S-SSSPLSIHVLLSMIAAGSKGPTLQQLLSFLKSKS--NEQQN-FASELVAIVF 76 (375)
Q Consensus 4 ~~~~~~~~~~f~~~l~~~~~~~~---~-v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~--~~~~~-~~~~l~~~l~ 76 (375)
+.++..++++||++||++++..+ + |+||+||+.+|+||++||+|+|++||.++|+++. ..+++ .+++++..+.
T Consensus 16 ~~~~~~~~~~F~~~L~~~l~~~~~~~Niv~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~~~ 95 (383)
T d1imva_ 16 VNKLAAAVSNFGYDLYRVRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISSPDIHGTYKELLDTVT 95 (383)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGCCCSCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhccCcCCcEEECHHHHHHHHHHHHHhcChHHHHHHHHHhCCCCCChHHHHHHHHHHHHhhh
Confidence 45677899999999999986543 3 9999999999999999999999999999999863 35677 8888887764
Q ss_pred hCCCCCCCCeEEEEEeeeecCCCCcchHHHHHHHhhhCCeeeEeeCCCChHHHHHHHHHHHHHHhcccccccCCCCCCCc
Q 036497 77 ADGSANGGPRLSVANGVWIDQSLSFKNTFKQTVDNIYKASSHQVDFQNKAVEVSREINFWAEKETNGFIKEVLPPGSVDD 156 (375)
Q Consensus 77 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~l~~~~~~~ 156 (375)
..+..+.++|+||+++++.++++|++.++++|++.++.+||. +..+++.||+|++++|+|+|++++. ++++
T Consensus 96 -----~~~~~l~~~n~i~v~~~~~~~~~f~~~~~~~y~~~~~~~~~~--~~~~~~~IN~wv~~~T~g~I~~~~~--~~~~ 166 (383)
T d1imva_ 96 -----APQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGN--PRLDLQEINNWVQAQMKGKLARSTK--EIPD 166 (383)
T ss_dssp -----STTSCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECCSC--HHHHHHHHHHHHHHHTTTCSCCCCS--CCCS
T ss_pred -----cCCcchHHHHHHHhccCCccchHHHHHHHhhcCceeeecccc--HHHHHHHHHHHHHhhCccccccccc--ccCc
Confidence 234569999999999999999999999999999999999984 5788999999999999999999875 6899
Q ss_pred cCeeEEEEeEEeeccccccccCCCCeeeeeecCCCcEEeecceeccc-cceeee--cCCeEEEEecccC-----------
Q 036497 157 SSKLVFANALYFKGVWNEAFDSSKTKEYDFHLLNGGSIKVPFMTSKN-KQLVTA--FDGFKVLVLPYKQ----------- 222 (375)
Q Consensus 157 ~t~lvlvna~~f~~~W~~~F~~~~T~~~~F~~~~g~~~~v~mM~~~~-~~~~~~--~~~~~vveLPy~~----------- 222 (375)
++.++|+||+||+|.|++||++..|..++|+..+|+++.|+||++.+ .++|+. ..++++++|||++
T Consensus 167 ~t~~~lvna~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~vv~lp~~~~~sm~iiLP~~ 246 (383)
T d1imva_ 167 EISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGSMSIIFFLPLK 246 (383)
T ss_dssp SCSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEEEEEEEESS
T ss_pred cceeeeecceeeecccccccccccccccccccCCCeEEEeecccccccceeeeeccccceEEEEeecCCCeEEEEEEecc
Confidence 99999999999999999999999999999999999999999999864 455554 4599999999997
Q ss_pred --CChHHHHHHccCcHHHHhccCCccceeeeeeeeceeeEecccChHHHHHhCCcccCCCCCCCCCcCCcCCC-Ccccee
Q 036497 223 --DELPALEKKTGSQSGFLKDHIPYEMIEVGDFRIPRFKISFGIEVSRVLKALGLVLSFSRKGGRLTEMVDSH-VGVGIF 299 (375)
Q Consensus 223 --~~l~~l~~~L~~~~~~l~~~~~~~~~~~~~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~vs~~~ 299 (375)
++|..+++.++ ...+..+....+...++|.||||++++++||+++|++||++++|+. |||++|++++ +|++++
T Consensus 247 ~~~~l~~l~~~l~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dL~~~L~~lGl~~~F~~--adfs~is~~~l~vs~v~ 322 (383)
T d1imva_ 247 VTQNLTLIEESLT--SEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFDS--PDFSKITGKPIKLTQVE 322 (383)
T ss_dssp CCSCCHHHHTTCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHTTTTTHHHHS--CCCTTTCSSCCCEEEEE
T ss_pred cCCChHHHhhhcc--HHHHHHHHhhccceEEEEeeceEEEeeecchhHhhhhcchhhhccc--cCccccCCCCcEeeeEE
Confidence 46888888875 3455555555556667999999999999999999999999999974 9999999888 999999
Q ss_pred eeeEEEEcCCcccchhhhhhhhhhccCCCCCCcEEEecCCeEEEEEECCCCcEEEEEEeCCcc
Q 036497 300 QKSFIEVKEEGTEAAAASAAVITLKSLPRFDKIDFVADHPFIFMIREDATGVVLSLVMFSILS 362 (375)
Q Consensus 300 qk~~iev~E~G~~aaa~t~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~p~ 362 (375)
|++.|+|||+|++|+++|......+ ..+++|++||||+|+|+|+.||.|||+|||.+|.
T Consensus 323 hka~ieVdE~G~~a~a~t~~~~~~~----~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P~ 381 (383)
T d1imva_ 323 HRAGFEWNEDGAGTTPSPGLQPAHL----TFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPR 381 (383)
T ss_dssp EEEEEEECSCEEECC--------CC----CCCCEEECCSCEEEEEEETTTCCEEEEEEESCTT
T ss_pred EEEEEEECCCccccccccceecccC----CCCcEEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 9999999999999999987433222 2256999999999999999999999999999996
|